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CHAPTER ONE
INTRODUCTION
Before describing the experimental work in this study, an
introduction to the kinetic terms and concepts and the
classification of cell populations is appropriate.
1.1.1 The cell cycle:
The cell cycle is usually considered to begin with the
completion of one cell division and to end with the completion of 
the next division. An important marker of kinetic events and
cellular proliferation before the studies of Howard and Pelc (1953) 
was mitosis. Progress through the cell cycle may be assessed by
observing two stages, that of mitosis, and of DNA synthesis as
shown by Howard and Pelc (1953). Howard and Pelc (1953) suggested 
that the cell cycle could be represented in terms of progression 
around a clock face, divided into four successive intervals. Gap 1 
(Gl ), S (DNA synthesis), Gap 2 (G2) and mitosis (M). Gi and G2are 
gaps during which no DNA synthesis occurred.
The Gi phase;
The Gi phfse of the cell cycle is important with regard to the
control of cellular proliferation. This is because the cell upon
- 1
reaching Gihas the option to continue in the proliferative cycle, 
or leave the proliferative cycle (decycle). A probable control 
point in this phase is the initiation of DNA synthesis. RNA and 
protein synthesis are required in Gi for the initiation of DNA 
synthesis, (Baserga 1976, Prescott 1976). The progress of cells in 
Giis divided into 2 distinct compartments GiA and GiB, cells in GiA 
can not progress directly to S phase before passing into GiB. The 
transition into Gi B is accompanied by an increase in RNA above a 
certain level, and above this level of required RNA content the 
cells move to S phase, (Darzynkiewicz et al., 1980). Liskay et al.,
(1980) have used the V 79-8 Chinese hamster cells which lacked a Gi
phase under normal conditions. When the amount of protein 
synthesis was decreased with cycloheximide, the flow of cells into 
S phase was delayed. The generation time increased by 5 hours, S, 
G2and M phases remained relatively stable, and Gi phase was 
acquired. The amount of DNA in Gicells is half that of cells in S 
phase, where the DNA is duplicated. The cytoplasm is important in
the initiation of DNA synthesis, in particular the ratio of
cytoplasm to nucleus, a higher cytoplasm to nucleus ratio, 
initiates Gi cells for DNA synthesis, (Prescott 1976). Specific 
molecules are also associated with growth and initiation of DNA 
synthesis, acting as positive or negative control mechanisms for 
entry into S phase
Yanishevsky and Stein (1981) have shown that fusion of Hela 
cell nuclei in certain binucleate combinations from early, middle 
and late Gi cells; resulted in acceleration towards S phase; the 
highest contribution in acceleration was by late Gi nuclei and the 
smallest was by early Gi nuclei.
Baserga (1978) used temperature sensitive mutants to assess
the potential of Gi blocked cells in initiating DNA synthesis. 
Temperature sensitive mutant cells (ts) arrested in Gi at the
non-permissive temperature were fused to chicken erythrocytes; the 
(ts) mutants could not initiate DNA synthesis in the erythrocytes, 
while (ts) mutants used at the permissive temperature did initiate 
DNA synthesis in the erythrocytes. Similarly, Baserga (1978) has 
used cytoplasmic extracts from cells blocked in Gi at the
non-permissive temperature and cycling cells. Extracts from Gi 
blocked cells could not initiate DNA synthesis in frog nuclei, 
while extracts from cycling cells initiated DNA synthesis.
Yanishevsky and Stein (1981), have demonstrated in three 
cycling cell types, one normal and two transformed, which could not 
induce DNA synthesis in senescent HDC cells, when fused to them; 
rather, the senescent HDC cells impaired the ability of the cycling 
cells to enter S phase. The fusion experiments may show that the 
entry into S phase in cycling cells is positively controlled 
together with a negative control mechanism available in resting 
cells.
The S Phasei
At the end of Gi phase, enzymes associated with DNA synthesis 
start to rise. At the Gi-S boundary, the DNA polymerases necessary 
for DNA synthesis are active, and in S phase DNA and chromsoraal
proteins are duplicated. Proteins and RNA syntheses are required 
for DNA synthesis, (Baserga 1976, Prescott 1976). In vitro, S 
phase serves as a marker for cells using radiolabelled nucleotides, 
in autoradiography and other techniques that make use of
- 1 -
radioactive substances. Proliferating cells are sensitive to 
various inhibitors which can affect DNA synthesis in in vitro 
cultures and this will be discussed later.
The G2phase:
The G2 phase is of short duration and is a period for 
preparation to mitosis. Cells may arrest at G2phase as shown by 
Gelfant (1977, 1901). Protein synthesis in G2 is required for 
mitosis, (Siaken and Iwasaki 1969). RNA is also required to 
complete G2and enter mitosis, (Kishimoto and Liebermann 1964).
Mitosis:
In this phase, the segregation of chromosomes occurs, after 
which, the cell divides into two new individual cells. The process 
of mitosis is divided into four phases: prophase, metaphase,
anaphase and telophase.
In mitosis most of RNA synthesis ceases before metaphase is 
reached, and the rate of protein synthesis also drops with 
exception of chromosomal proteins (Baserga 1976, Prescott 1976).
Regulation of cell production is attained by causing the cells 
to arrest in Gi and G2,(Epifanova and Treskikh 1969) and in S phase 
(Darzynkiewioz et al,, 1980). The Gi phase in a homogeneous 
population is more variable than S G2and M phases, (Sisken and 
Kinosita I96I). The variableness in the length of the Gi period in 
cells gives rise to most of the variability in generation times
within a cell population. It may be that the variability 
represents a variable rate with which the cells may move along the 
whole or part of the Gi phase; or the cells may be transiently 
arrested for various time periods. The arrest in the Gi and 
transition to Goand its reversibility may reflect a mechanism by 
which cell reproduction is regulated (Prescott 1976).
Environmental changes that may account for different 
generation times in CtlO cells grown in various sera, gave different 
generation times for each type of sera. The difference in 
generation times was accounted for by the changes in the average 
duration of Gi , with small changes in S, Ggand M phases, (Tobey et 
al., 1967). .The frequent trend among normal or tumour cells is a 
variable Gi period (Prescott 1967), although the example of Lala and 
Patt (1966) showed a constant Gi in the ascites tumour cells. The 
variability in Gimay also relate to cell size, (Killander and
Zetterberg 1965), (Yen et al., 1975), (Precott 1976), (Yanishevsky 
and Stein 1981). The variability in the length of Gimay be due to 
the variability in the cell's mass at the start of Gi phase. 
Daughter cells produced at mitosis may not be equal in size, small 
sized daughter cells take a longer time to reach a critical 
division size than larger cells, i.e. sizer model effect, (Pantes
and Nurse 1981). Fournier and Pardee (1975) have shown that cell
size and mass did not influence the passage of cells in Gi ,
although Yen and Pardee (1979), have shown that cells with small 
nuclei after mitosis take longer to reach S-phase than cells with 
larger nuclei.
In vitro the cell is responsive to changes in the 
extracellular environment such as nutrients, serum, pH and cell 
density, and the cell may arrest in Gi if the associated changes are
-  «5 -
unfavourable to its proliferation, (Pardee 1974), (Pardee and 
Dubrow 1977), (Pardee et al., 1978). Pardee (1974) has introduced 
the term restriction point to describe the reversible arrest of 
cell proliferation at the same point in Gi due to suboptimal 
conditions of nutrients. Thus the cells due to unfavourable 
environmental conditions may decycle at this point. Won specific 
regulation influencing the cell cycle may be due to the 
unfavourable conditions like deprivation of nutrients required by 
the cells. Won specific regulations can be seen in unicellular 
organisms or in vitro cultures; but in multicellular organisms 
where environmental and nutrient conditions are usually favourable, 
the regulation of cell production may be acieved by humoral 
mediators, such as hormones or chalones. Thus nutrient restriction 
and specific regulations of cell production may influence 
proliferative behaviour of cells,
1.1.2 The Phase of proliferative rest. Gvcling and noncvcling 
cells.:
In an ideal cell population where all the cells in a 
population are continually cycling, with no cell loss imposed upon 
them; the cells will double their number after completing their 
transit through all the phases of the cell cycle in one cell cycle 
time (Tc). This is an unusual situation in vivo where some cells 
are not engaged in the cell cycle; the cells may be in a state of 
proliferative rest or are dying. Some resting cells are able to 
enter the cell cycle when responding to environmental stimuli. The 
state of no cycle or dormancy (D-state) was described by Lajtha et 
al., (1962), and there after this no cycle state has been referred 
to as a Gostate by Lajtha (1963), Gilbert and Lajtha (1965), Lajtha
and Gilbert (1967) and Lajtha (1983). The putative Gostate is an 
out of cycle resting state under normal physiological conditions, 
and acts as a reservoir to keep the tissue in its optimal size, 
when the tissue is subject to cell depletion or injury. A Go
hepatocyte has a DNA content similar to a Gicell, and in partial
hepatectomy the Goare triggered back into cycle with a delay of 
around 15 hours to reach S phase in a wave like pattern, followed 
by a wave of mitosis. If these triggered hepatocytes were in a 
lengthy Gi , then the expected shortening of time (to 15 hours) 
would reflect an immediate increase in DNA synthesis and mitosis, 
(Lajtha 1963). Following Osgood's (1957) description that a cell 
upon division yields an immature cell and another cell for the
differentiation pathway, Cairnie et al., (1965) used the terms P 
and Q to describe proliferating cells and non proliferating 
quiescent cells. The populations of cells suggested by Lajtha et 
al., (1962) and as reviewed by Epifanova and Terskikh (1969) would 
be composed of a resting population and a 
proliferating-differentiating population which is supplied from the 
self maintaining resting population, which will be triggered into 
cycle to supply them. Apart from proliferative rest at Go ,
Epifanova and Terskikh (1969) have shown that cells may arrest also 
at Gland G2. Quiescent cells may be a distinct out of cycle state 
(Lajtha 1963), (Baserga 1976-1978), (Pardee 1974), (Pardee et al., 
1978), or quiescent cells may be in a very extended Gi (Prescott
1976), and no requirement for Gq compartment was described by 
Shields and Smith (1977),
Burns and Tannock (1970) proposed that the cell cycle has 2 
phases, Gq phase, and the C phase which consists of part of Gi,S, 
and G2&nd mitosis. The cells leave Go to the C phase with a 
constant probability per unit time. Smith and Martin (1973-1974)
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proposed a similar description to that of Burns and Tannock (1970), 
the cell cycle is divided into a probabilistic A-state and a 
deterministic B phase; the B-phase consists of part of Gi, S, Ggand 
mitosis. That is after mitosis all cells go into the A-state for 
any length of time, after which they progress towards B phase.
The transition probability (P) is fixed, although it may
change as the environmental conditions change, and it may vary 
according to cell type. The transition probability model is 
compatible with the view that quiescent cells are cycling slowly, 
because it suggests that quiescent cells are in fact cycling Gi 
cells with a low transition probability. The transition 
probability may explain that the variability in generation times is 
due to the probabilistic transition from the A state to the B 
phase, ( i.e. the cells are being held in a state of no progress 
towards mitosis), being part of the cell cycle in Giphase; the cell 
will remain in the A-state for any period of time, but will leave 
the A state exponentially with respect to the time they have spent 
in the A-state.
A further addition to the transition probability model was 
described by Brooks (1981), (see Figure A.) to take into account 
some of the experimental variables which are connected with the 
cell's lag duration when stimulated to proliferate and the 
commitment event into DNA synthesis; and also to take into account 
the similarity of time durations of the lag period and the minimum
cycle time (Ï ) of B phase.
The model also shows that the differences in cell cycle times 
between sister cells can be described in terms of an exponential as 
the Q —  ^L part of the sequence occurs in the mother cell and thus 
is common to the two sister cells, to account for the identical
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Fig. A: Alternative models of the cell cycle; (a ) Biii'ns 
& Tannock (1970); (B ) Smith & Martin (1973); and (C) the
modification introduced by Brooks (1981).
B-phase in sister cells. The cell cycle therefore, according to 
Brooks (1981) contains two random transitions and that the 
quiescent cells are located not in the A state but in another 
indeterminate state called Q. In order to pass from Q to A state, 
cells must complete a process L which occupies most of the lag- 
period. The cells in progress towards division leave the Q-state 
with a random transition and start the L-process, then after 
completing the L-process the cells go into A-state, Cells in the 
A-state, will leave this state with a certain transition 
probability to DNA synthesis passing through the Q-state and 
L-process.
Small quiescent cells take a longer time to reach S phase than 
large cells. It is possible that both deterministic and 
probabilistic models account for cell cycle controls (Nurse 1980). 
If in a cell the accumulation of subunits and assembly of structure 
required for mitosis is cell size dependent (deterministic size 
related mechanism), smaller cells require more time than larger 
cells. Upon completion of the structure, the iniation of mitosis 
involves an interaction between a certain cellular component and 
the structure, and this may be a random process, forming the 
probabilistic element in control. If the formation of materials 
required for the structure is slow, the assembly of the structure 
will be the rate limiting factor in the cycle, division control is 
consistent with size control. i.e. deterministic control of 
division. If the formation of substances and their assembly is 
rapid, then the event limiting the rate of cell cycle progress is 
consistent with transition probability model; (Nurse 198O, Fantes 
and Nurse 1981). Darzynkiewioz et al., (I98O) have shown that the 
rate of cell exit across two subcompartments in Gl(GiA— >GiB) 
correlates with their RNA content, thus Darzynkiewioz et al.,
(1980) have concluded that the relationship between RNA and the 
position of cells in the cycle may show that the indeterminate 
A-state is not the sole factor responsible for large intercellular 
variations in generation times.
The view that cycling cells and resting cells may be different 
in character was shown by Sander and Pardee (1972) on nutrient 
deprived cells in cultures. The time required by the isoleucine 
arrested cells to reach S phase after adding isoleucine was longer 
than the time required by cells reaching S phase directly from 
mitosis. i.e. Giis longer in resting cells that were stimulated 
into cycle, than normal cycling cells.
Further evidence for the Gostate of rest was suggested by the 
work of Augenlicht and Baserga (1974). They showed that when W1-38 
cells were cultured in vitro, up to the stage of confluence, the 
cells will arrest in Gi; thereafter the cells will shift into a 
different state of arrest as the period of rest increases after 
reaching confluence. This was proved by stimulating resting cells 
with serum at different periods of time after reaching quiescence; 
the longer the cells remain quiescent, the fewer cells and a longer 
pre-replicative period before reaching S phase after restimulation 
with serum ; i.e. a deeper Gostate is developing in the quiescent 
cells, (Baserga 1976-1978). Potter (1978) has extended the Go idea 
of Lajtha (1963) by stating that cells after mitosis can shift to Go 
and can exist in a variety of Gostates with a terminal state Gq of 
differentiation, followed by death. The different stages of the Go 
phase are associated with intermediate or new stages of 
differentiation, a Go cell at any point before reaching the Gjstate, 
can recycle again into Gi ; whereas upon reaching Gjthe cell can not 
recycle. Apart from arrest and cell cycle regulation in Gi, cells
10 -
may arrest in S phase (Martin and Oppenheim 1977), (Darzynkiewicz 
et al,/ 1980), and G2phase (Gelfant 1977, 1981).
Different states of rest were shown by Radley et al., (1976) 
who have demonstrated in the acinar cells of that rat salivary 
gland which were stimulated by isoproterenol twice and by a third 
stimulation after 28, 52, 76 hours, reflected a correlating
increase in the time period to reach DMA synthesis of 16,2, 20,9
and 25.6 hours respectively. Another mechanism linking the state 
of rest and proliferation was demonstrated by Alison and Wright 
(1979a) who have assessed the labelling and mitotic indices in the 
seminal vesicle of castrated mice at 3, 9, and 14 days after
castration. The mice received testosterone injections at these 
specified time periods. The prereplicative period between 
quiescence and DNA synthesis gets progressively shorter, as the 
interval between castration and testosterone administration gets 
longer (Alison and Wright 1981).
Alison and Wright (1979a, 1981) have proposed that there was a 
shallower level within Gqus the period of physiological quiescence 
gets longer with respect to androgen deprivation. Terskikh et al.
(1981) have described their in vitro results as similar to those of 
Augenlicht and Baserga (1974). Wallen et al., (198a,b) in their 
studies on Q~~> p recruitment, have shown that when mammary tumour 
cell lines were cultured to a plateau level, and when the cells 
were recultured again at various intervals after reaching the 
plateau level, the time to reach DNA synthesis increased as the 
period between the plateau level and the reculturing increased. 
This was also reflected in an exponential decline in the colony 
forming efficiency as a function of time spent in culture, Wallen 
et al., (1984b) remarked that these results may represent a
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situation similar to that of Augenlicht and Baserga (1974), or may 
have a more probable explanation, that these cells were not 
progressing into a deeper Go state but that the cells in the Q state 
observed in these tumour cell lines were progressing towards death. 
As the cells move away from the P state fewer cells can make the 
Q— >P transition; although not all the cells that make the 
transition are clonogenic. The clonogenicity of all the cell lines 
tested decreased, but at those time periods when the cells were 
subcultured for colony efficiency analysis, they were able to 
proliferate when subcultured for proliferation assays,
Epifanova (1977) has defined a resting cell as a cell 
withdrawn from the mitotic cycle for an indefinite time interval 
surviving in this state and retaining the potential for 
proliferation. This implies that in the resting state a cell loses 
some of its characteristics of a proliferating cell, being in a 
different physiological state with special metabolic patterns, 
Epifanova et al,, (1980) have stated that there were processes 
regulating the transition of cells from proliferation to rest and 
vice versa, that cell proliferation needed some metabolic processes 
to be suppressed and some processes to maintain the viability of 
resting cells. Polunovsky et al., (1984) have shown in their 
experiments that the fusion of resting cells (serum deprived NÏH 
3T3), with proliferating (serum stimulated) cells, inhibited the 
onset of DNA synthesis in the proliferating cell’s nucleus. This 
indicated a negative control on cell proliferation via an 
endogenous inhibitor that prevented the onset of DNA synthesis. 
Resting cells produced an endogenous inhibitor of cell 
proliferation whose formation depended upon synthesis of protein. 
Upon stimulating resting cells, proliferation can start only after 
decreasing the level of the inhibitor. Cells grown to high cell
- 12 -
density stationary phase contain an inhibitor of protein synthesis, 
that was not detected in proliferating low density cell cultures, 
(Englehardt 1971).
â variety of differences between resting and growing cells 
have been reported. Evans et al., (1974) have shown that there was 
more microvilli on the surface of actively growing 313 fibroblasts, 
compared to a smooth surface with fewer microvilli in resting 
cells. There is also a decreased permeability to low molecular
weight substances in resting cells such as amino acids, sugars and
/
phosphates, (Pardee et al., 1978), Putrescine transport is also 
reduced in resting human fibroblasts as compared to growing 
fibroblasts, (Pohjanpelto 1976). The concentration of adenine 
nucleotides in stationary phase cultures of the V/RL-10A cell line 
was about half the amount of that available in actively growing 
cultures; (Glinos and Warren 1980). Wallen et al., (1984a) have 
shown that the quiescent cells arrested in Gywere 50^ smaller in 
size than proliferating cells and the RWA content decreased by more 
than half the amount to that available in proliferating cells. 
Sander and Pardee (1972) have shown that differences existed 
between resting cells in Ggand cycling cells. In nutrient deprived 
arrested cells, the uptake of 2-araino-isobutyric acid did not 
increase for a 3 hour period after stimulating the arrested cells 
with isoleucine; while in cells cycling normally from mitosis to S 
phase the uptake of 2-amino-butyric acid doubled within half an 
hour after entering Gi from M phase. The time required to reach S 
phase was longer in stimulated cells than in cells cycling normally 
from mitosis to S phase; i.e., Ggare different to early Gicells as 
shown by the longer pre-replicative period and time for uptake of 
2-amino-butyric acid.
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Farber and Baserga (1969) have shown that after stimulating 
the salivary glands and kidney cells with appropriate stimuli, and 
hepatocytes after partial hepateotomy, the stimulated cells that 
were triggered to flow to DMA synthesis were not killed by 
hydroxyurea, although hydroxyurea was cytotoxic to normal cycling 
cells of the jejunum and tongue epithelium. A small fraction of 
the isoproterenol stimulated cells were necrotic because of the 
action of hydroxyurea. Ara/c and nitrogen mustard were also tested 
and were effective in killing cells that were in normal cycle, and 
not the isoproternol stimulated cells.
The same differential cytoxicity between stimulated resting 
cells of the seminal vesicle and cycling cells of the crypts in
mice in terras of the effects of Ara/c and hydroxyurea were
described by Alison and Wright (1979b, 1981).
Cress and Gerner (1980) and Magun and Gerner (1981) have found 
that the induction of ornithine decarboxylase ( a rate limiting 
enzyme in polyamine biosynthesis) in dividing cells may be under 
different regulations as compared to quiescent cells. Hydroxyurea 
inhibited the induction of ODC in dividing cells, but did not 
inhibit the induction of ODC in quiescent cells stimulated to
proliferate. Darzynkiewicz et al,/ (1979) have found differences 
between quiescent and stimulated lymphocytes, the chromatin in
quiescent cells was more sensitive to acid dénaturation than the 
DNA in cycling interphase lymphocytes. The former has a higher red 
shift in acridine orange-DNA complex, while in the latter there was 
a corresponding green shift, Darzynkiewicz et al., (1981) reported 
some differences between quiescent lymphocytes (Gq) and PH A 
stimulated lymphocytes in response to uptake of rhodamine 123. 
Nonstimulated (Gq ) lymphocytes show low and uniform value of
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rhodamine 123 flourescence, while in the PHA stimulated lymphocytes 
the uptake of rhodamine increases several folds. Riddle and Pardee 
(1980) have demonstrated that there was an enhanced actin synthesis 
in cells stimulated into cycle by the addition of serum, relative 
to the actin synthesis in normally cycling cells, while some three 
other proteins were higher in cycling cells than in quiescent 
cells. Higher actin synthesis may represent a process that these 
cells may perform before entering Q\ .
The criteria for the various resting and stimulated cell 
populations has been discussed by Gelfant,(1977). Resting cells 
are present in tumours and they are held back from proliferation by 
lack of essential nutrients and some homeostatic mechanisms, but 
they are able to recycle when conditions are favourable (Steel
1977). Kallman et al., (1980) have described the proliferative 
classes of cells in a tumour; proliferating (P) cells in active j
cycle and have clonogenic potential; P cells can produce 2 P cells, ^
one P and one Q cell or 2 Q cells. There is also a p— >Q 
transition without division. The Q cells are composed of Q 
undifferentiated and noncycling, and a Q maturing differentiating 
cell. The Q cells are available because of environmental factors 
restricting their proliferation and may recycle, or can feed the Q 
compartment. In the Q compartment, some non-cycling cells in well 
differented tumours may be withheld from proliferation because they 
have not escaped completely from the homoestatic mechanisms 
regulating the tissue of origin.
The Q cells can recycle and have been shown to produce 
colonies like P cells by Barendsen et al., (1973), Hermans and 
Barendsen (1978), Kallman (1980) and Wallen et al., (1984). The Q 
cells can also repopulate a tumour after cytotoxic treatment as
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shown by Stephen and Steel,(1980), The transitions between the -I
eyoling and noncyoling states in tumours and normal tissues can be 
viewed as a proliferative ecosystem which confers adaptive survival 
to the tissue and which allows for a variety of tissue ?
proliferative responses,(Gelfant 1981).
?
1.1.3 The growth fraction:
Mendelsohn,(i960,1962) observed that in tumours there was a higher 
frequency of thymidine labelling among mitotic figures than among 
cells in the tumour; and suggested that tumours may be 
heterogeneous in terms of proliferation due to a mixture of cycling 
and non-cycling cells, (Mendelsohn 1963, 1965). Mendelsohn
developed a relation for cycling and non-proliferating cells and 
termed it the growth fraction (G.F or Ip)
GFk labelled cells/100 (labelled + unlabelled) cells
labelled mitosis/100 (labelled + unlabelled) mitosis 
Ip = No/N
Ip is the proliferative index (Growth fraction), No is the 
number of cycling cells, and N is the total number of cells in the 
population, (Aiierne et al./ 1977). Therefore assuming a cell 
population that has no cell loss and has some cells which were not 
proliferating; the time taken to double the size of the population 
will be longer than the median intermitotic time of the fraction of 
the proliferating cells in the population. This extended period of 
time to double the population size is the potential population 
doubling time (Tpd); (Steel and Bensted 1965), (Steel 1968, 1977);
and is also called the apparent cell cycle time (Tea); (Wright 
1975), (Aherne et al./ 1977).
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The cell production rate is determined by the growth fraction |
and the cell cycle time of the proliferating cells. When a growth |
fraction is present, it indicates that some cells are decycling and 
some cells are entering the cell cycle, Bresciani,(1968) proposed 
a relation (the distribution ratio) between cycling and decycling
<—  —$ 4—cells. The distribution ratio = n/n, that is :n is the proportion
of cells in cycle or recycling cells and n is the proportion of
cells decycling to the quiescent non-proliferating compartment.
The ratio between the number of cycling and decycling is associated —&with Ip: when n/n >1, there is expansion in growth.
The d-ratio of Bresoiani (1968), was developed further by 
Appleton et al., (1973) into the decycling probability, described 
by its effect on the growth fraction, and as a computer simulated 
model for Gq hormone stimulated cells that have various 
probabilities of decycling.
1.1.4 The classification of cell populations:
In cell population studies it is necessary to classify the 
population in terms of morphology, anatomical site and 
proliferative ability. For example, in the crypt of Lieberkuhn of 
the small bowel mucosa, mitotic activity is available in the lower 
parts of the crypt. The lower part of the crypt is the 
proliferative zone or compartment which supplies cells to the 
villus which is the functional compartment. In the bone marrow 
spatial compartments are not as well defined as in the £aaall bowel 
mucosa, the bone marrow cells are defined in terms of their 
morphology, as they progress through their differentiation pathway 
from stem cells to mature cells.
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Leblond et al., (1959) have proposed a classification of mouse 
and rat tissues, based on the extent to which they take up 
3H-thymidine into their DNA. The percentage of labelled nuclei was 
estimated in the tissues of adult mice sacrificed 8 hours after 
3H-thymidine injections (cell formation test), and rats given 
3H-thymidine when 3 days old, and sacrificed 6 months later (cell 
retention test). The results led to a classification of the cell 
populations into 3 groups:
Group 1: stable cell populations, which showed no cell
formation in the adult animal, but in young rats the label was 
taken up when cells were proliferating, and was retained thereafter 
in the cells that remained in the population. This group includes 
smooth and voluntary muscles and neurones.
Group 2: growing or expanding cell populations, cells were
capable of both cell proliferation and cell retention of the label 
in adult life. This group included liver parenchymal cells, 
adrenal cortical and medullary cells.
Group 3: renewing cell populations, cells showed many
labelled nuclei in the cell formation test, but none in the cell 
retention test, the cell population was in a steady state, 
proliferating and losing cells continuously. The tissues in this 
group included the epidermis, bone marrow and small bowel mucosa.
Gilbert and Lajtha, (1965) proposed to characterise cell 
populations in terms of the relative importance of 3 parameters: 
the rates of cell input, output and cell division or production; 
and accordingly classified cell populations in terms of 
compartments that considered the above mentioned parameters.
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Aherne et al., (1977) have described the classification of 
cell populations, and their compartmental system as follows:
1. Closed static compartment: in which there was no renewal 
of cells and a negligible loss, e.g. the neurone population of the 
central nervous system.
2. Decaying compartment: there was no renewal of cells, and
output exceeded input, e.g: adult ovary.
3. Stem cell compartment: proliferating self renewing with
output but no input, and supplies cells to other compartments,
e.g.: basal layer of the epidermis.
4. Simple transit compartment: a functional compartment in 
which cells cease to proliferate. This compartment receives cells 
from the stem cell compartment, and outputs the cells eventually to 
their death pathway ; e.g. cells in the upper portion of the small 
bowel crypts.
5.Dividing transit compartment; such cells are found in the 
bone marrow and the proliferative portion of the small bowel crypt. 
There is input from the stem cell compartment, which has an output 
to feed the maturation comparment.
6. Closed dividing compartment: there is no output or input of
cells. There will be an increase in size in this compartment, as
cells which proliferate are retained. Examples for this group are
the liver cells regenerating after partial removal, proliferating 
tissue cultures and tumours in which its assumed that they have no 
cell loss .
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In tumours and growing normal tissues, cell production exceeds 
cell loss, and are therefore expanding populations. In the adult, 
renewing cell populations maintain a constant size; i.e.: cell
production equals cell loss, thus the tissues are in a steady 
state.
1,1.5 An:e distributions of cell populations:
Most cell populations in vivo are not synchronised, but have cells 
that are distributed in terms of cell age and phase. The age 
structure or distribution of cell ages, is necessary in calculating 
the growth of a population; it is a relationship between the number 
of cells in a phase of the cell cycle and the duration of that 
phase. There is an expanding distribution (exponential) and a 
steady state distribution, (Lala 1971), (BrynmorThomas 1974), 
(Steel 1977), (Aherne et al., 1977). When all the cells in a 
population are expanding in multiples of their numbers and their 
cell cycle time (To), with no cell loss, it is expected to conform 
to theoretical exponential growth. In real situations there is 
exponential growth, but coupled with cell loss. In the steady 
state, which has a constant population size with time, there is a 
rectangular distribution, where cell production is balanced by cell 
loss, and the number of cells in each phase is proportional to the 
time spent in that phase.
Therefore in steady state the mitotic index or the proportion 
of cells in mitosis = Im = tm/Tc
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The labelling index or the proportion of cell in DNA synthesis 
= LI or Is = ts/Tc
The mitotic rate = jQn/tm = kp cell production rate or KB 
(birth rate) (cell loss assumed to be insignificant at mitosis)
In terms of cell cycle time, Im/tm = 1/Tc = KB 
and in terms of the labelling index,
KB = Ll/ts
In the expanding exponential populations the cells are not 
distributed in proportion to their phase durations. The proportion 
of young cycling cells (a) produced, are highest at t = o, after 
mitosis, and their number falls gradually as cell age (t) 
approaches the next mitosis. Thus the rate of entry into S phase 
is greater than into mitosis.
The mitotic index, therefore, when all cells are in cycle;
Ira = In2 tm/Tc (Smith and Dendy 1962), (Cleaver 1967), (Lala 
1971), (Aherne et al./ 1977)
and
LI or Is = [exp(ts In2/Tc)-1][exp t2 ln2/To]
In a uniform population of cells, producing 2 proliferating 
cells per division (a=2), a growth fraction of unity, and no cell 
loss; the population will double its number per each cell cycle 
time Tc
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Nt = No exp ln2.t/ïc (Wt = the number of cells after an 
elapsed time and, No = initial number of cells before growth).
4~~If some proportion of the daughter cells do not recycle ( n ) 
into the proliferative (P-compartment) but decycle ( n ) into the 
quiescent [Q-compartment3, the proportion of cycling cells (a) lies 
between 1 and 2. The time to double in size will be longer, the 
growth fraction being less than one.
GF or Ip = a-1 (Lala 1971), (Steel 1977)
The cell population with a growth fraction and no cell loss, 
in which each cell entering mitosis, ta^ cells are born and ^a-1* 
cells are added to the population, two types of new cells are 
obtained,
Wo(a-I) new proliferating cells (cycling)
No(2-a) new non-proliferating cells (decycling) 
and the
GF = New proliferating cells/all new cells.
The age distribution will be influenced by the value of 
when the growth fraction is less than unity. If loss were random 
with respect to cell age or proliferative status, the age 
distribution will not be affected. If cell loss were selective, 
with respect to cycle phase or compartment, for example, at
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mitosis, "a" will decrease. The age distribution will be 
influenced by a small "a" and high rate of cell loss, to the extent 
that an exponential distribution is better described as a 
rectangular distribution.
1.1.6 Cgli. btctb and less rates;
The average birth rate is controlled jointly by the average 
cell cycle time and the growth fraction, thus:
1 .
In steady state, KB = Ip/Tc = rra Crm = rate of entry of cells 
into mitosis) and.
2 .
In exponentially growing populations:
KB = In C1+Ip)/Tc = rm
and assuming no cell loss, the growth rate of the population (KG) 
will reflect the birth rate KB. If the growth rate value was less 
than the expected birth rate, then the difference between the two 
rates is a measure of the rate of cell loss (KL)
KL = KB-KG
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The growth rate in solid tumours can be measured in terms of 
tumour weight or volume. Assuming exponential growth at early 
tumour age, a tangent can be drawn to the growth curve, the growth 
rate (KG) can be found at any point from the slope of the tangent. 
Because with increasing tumour age, associated with extensive cell 
loss and low growth fraction, the distribution is unlikely to be 
exponential.
For a population growing exponentially the growth can be 
determined as follows:
N =No exp (KGT)
2W = No exp (KGTd) i.e. the number of cells to double in an 
elapsed period of time (Td or cell doubling time)
ln2 = KGTd
KG = In2/Td
and the doubling time Td = In2/KG (Steel 1977, Aherne et al., 
1977).
The time taken for a tumour cell population to double in size, 
depends on the median intermitotic time (Tc), the growth fraction 
(Ip) and the rate of cell loss (KL). Thus the rate of cell loss 
(KL) may also be derived according to this expression:
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KL - ln(1+Ip)/To- In2/Td
modified after Lala and Patt (1966), Steel,(1968) and Lala/(1971).
Steel and Bensted,(1965) and Steel,(1968, 1977) have described 
the growth efficiency of a timiour which was not subject to cell 
loss, but influenced by the growth fraction. The parameter is the 
potential doubling time (Tpd).
In terms of the cell cycle time (Tc), the doubling time will 
depend on ^a^ as shown by Steel (1977):
Td = (ln2/lna)Tc.
The potential doubling time will be equal to the cell cycle time if 
the growth fraction is unity; and if there were no cell loss, Tpd 
is equal to tumour doubling time.
In terms of birth rate
Tpd = In2/KB =ln2 tm/Im = A  m tm/Im
and in terms of the labelling index 
= A ts/LI
where A is a correction factor, which depends on Ip and the 
position of S in the cell cycle, (Johnson 196I, Lamerton and Steel 
1968, Steel 1977). In an exponentially growing cell population in 
which tra is short compared with the cycle time
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Am =lo2 :: 0.693
and A  a will lie between ln2 and 21n2, depending on the position
of S phase within the cell cycle.
The cell loss rate may be expressed in terms of Tpd and Td 
that is,
N = No exp (ln2/Td)T
the growth of the population can also be formulated, using KB which 
is expressed in terms of Tpd;
KB = In2/Tpd,
and KL the cell loss rate that is influencing the tumour
i.e. N = No exp (In2/Tpd-KL)T 
therefore
KL = In2/Tpd (1-Tpd/Td ) = In2/Tpd-In2/Td 
therefore the ratio of cell loss to the rate of cell birth
- KL/KB = [ln2 (Td-Tpd)/ (Tpd)(Td)3 I Tpd/ln2] = 1-Tpd/Td = (j)
^ 55 the "cell loss factor" as defined by (Steel 1968, 1977) as loss 
expressed in terms of a fraction or percentage of total cell birth 
per unit of time. When Td is large, (|) approaches a high cell loss 
value. When Td equals Tpd, (|) equals zero. Tumour size increases 
when (j) is small, but grows relatively slower when d) is larger.
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In many tumours (j) is around 0.5 and in some it is around 0.9; 
Steel (1968, 1977), (Tubiana 1971), (Malaise et al., 1973),
(Rajewsky 1974), (Denekamp and Fowler 1977), (Denekarap 1982).
(|) expresses a size effect: a difference of volumes
contributed by cells produced and cells lost. (|) does not indicate 
the way in which cells were lost, nor whether they died before 
removal, or lost as viable cells via the blood stream, lymphatics 
or exfoliation at a surface.
If dying cells within a tumour progressively contribute to the 
increase in the mean tumour volume per cell, then the tumour 
doubling time is a biased estimate of the actual population 
doubling time within a tumour; i.e. the tumour volume will be 
increasing faster than the cell population. Therefore, cell loss 
will be underestimated.
Other factors also contribute to the enlargement of tumour 
size; when the mean tumour cell volume does not remain constant ( 
the size distribution or cells may change with time); accumulation 
of intercellular substances and fluids (Steel 1968); lymphocytes 
and macrophages migrating into the tumour (Elboira et al., 1977, 
Stern 1983).
Also an increase in uhe ratio of the tumour stroma relative to 
tumour cells (Denekamp 1972), contributes as with the above 
mentioned examples to tumour size, and thus underestimating cell 
loss. Areas of necrosis present in the tumour at various tumour 
sizes, when remaining in constant relation to tumour size; the cell 
loss factor will reflect invariably the actual loss. But if the 
areas of necrosis were to increase with time as tumour grows, and
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contributing to tumour size then, cell loss will be underestimated 
(Steel 1968) and a correction of (j) is required, Begg (1977).
KL is important in defining cell loss per unit time from a
growing cell population, but it does not reveal the magnitude of
this loss on the cell production rate as ^ does.
In some results, the derived values of KL were not that
appreciable, within the range of tumour doubling times, as has been i
shown by Lala and Patt (1966), and by Steel (1968) on the results 
of Lala and Patt (1966). This was also indicated in the results of 
cell loss described by Watson (1976) and Smadja-Joffe (1981),
When Steel (1968) applied the cell loss factor (j) to the 
results of Lala and Patt (1966), one can notice an appreciable 
increase in terms of cell loss in relation to cell birth rate, with 
increasing volume. This was not due to an increasing KL but due to 
the expression of cell loss in terms of a decreasing cell 
production rate.
There is another form of cell loss, which is a programmed form 
of cell death, or apoptosis (Kerr and Searle 198O).
Apoptosis may be described as a genetically programmed process 
of cell deletion. The cell shrinks through a mechanism from within 
the cell, finally breaking up to form "apoptotic bodies". These 
cell fragments are phagocytosed by adjacent cells and macrophages. 
Apoptosis, therefore, may have an important role in cell kinetics, 
as the regulation of population size may not only be viewed in 
terms of rates of cell production but also in terms of rates of 
cell deletion.
"i
i
t
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1.1,7 Tumour pzrowth :
Tumour growth is characterised by a mixture of growth rates. 
Tumours do not have a single growth rate, but rates which vary with 
tumour growth. There is a silent interval of growth at the 
earliest periods of tumour growth, where the new transformed cells 
that have developed are proliferating and selecting themselves 
against the host’s environment. When the host’s environment 
counteracts the new group of clones of proliferating cells, some 
tumour cells are killed and some may interact with the host’s 
response in a way which consequently make these new tumour cells 
dormant. When conditions are favourable, they will grow.
Tumour growth may be expressed or described in terms of 
various mathematical relations, taking into account tumour size and 
the period of tumour growth. Exponential growth may be used to 
describe the growth of tumour cell populations. Growth according 
to an exponential is characterized by a constant rate of growth 
(the specific growth rate) in terms of cell number or volime, with 
time, and is proportional to the number of cells or volume at an 
instant in time (Steel 1977),(Aherne et al., 1977) .
The cell number would therefore increase or double its size 
according to the following equation;
t/TcN = No 2 ' G
N = No o'"*
where N = number of cells at time t; No = initial number of cells; 
2 is the base for the growth equation where each cell produces 2 
cells; t s is the time of observation; Tc = median intermitotic
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time; m = slope of the curve.
The volume of a tumour may also be expressed as the equation 
above;
Vt = Vo exp ln2 t/Td
Vt = volume at time t, Vo - initial volume, t = time of 
observation, Td = tumour doubling time,
and on a logarithmic scale describing the growth curve, the 
equation is;
InVt = (0.693/Td)t +lnVo (Steel 1977)
The growth rate, is equal to In2/Td which is the slope; and Td 
is the tumour doubling time.
Cell proliferation is not uniform within a tumour, as the 
tumour contains a mixture of cells with respect to their 
intermitotic times. The cells contributing to tumour growth retain 
the growth characteristic from their anscestors, each cell will 
double its number according to its own cell cycle time.
Tumour growth analysis may assume serial estimation of cell 
number with time, as in ascites tumour growth in vivo or a cell 
suspension in vitro. In solid tumours, measurement of tumour 
volume or weight may be used for tumour growth analysis. Tumour 
volume may be an approximation when using the following formulae;
V ='^6 X (mean diameterf, or
30
V - [length X (wicithf ]/2 (Steel 1977)
or the product of 3 principal diameters as described by Dethlefsen 
et al,, (1968).
The tumour volume or weight can be transformed into 
logarithiraic scale, and growth can be assessed with respect to 
time. Such growth curves usually show progressive slowing of 
growth as the tumour enlarges, and the curves usually bend toward 
the time axis. The plot of the growth curve in general is not an 
exponential (although the earliest stages may be so ) , but often 
fits a Gompertz equation; i.e. an exponential growth with an 
exponential retarding process superimposed upon it. The mean
diameter of the tumour may also be used in a linear scale against 
time to assess tumour growth, (Steel 1977).
Mean diameter versus time usually gives a linear relationship 
when compared to the usual curvature produced on the logarithmic 
scale of tumour volume versus time, (Denekamp 1982).
Another type of growth curve assessment that gives a linear 
relationship with time, as compared to the logarithmic scale of 
volume, weight or cell number, is the cube root function.
The growth of ascites in vivo described by Klein and Revesz 
(1953) relating the increase of cell numbers on the logarithmic 
scale to time on the linear scale, followed a smooth convex curve 
along the time axis. When the increase in cell number was 
transformed into its cube root value, a linear relationship with |
time was obtained. The growth of ascites described by Lala and i
'IPatt (1966) using the logarithira of the increase in cell numbers j
versus the linear scale of time, was exponential, at least for the 
initial period up to 3 days, the curve was bent towards the time 1
■I
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axis at later periods of growth. The growth of the ascites 
described by Barford and Barford (1980b) was nearly exponential for 
the earliest period of growth, but eventually curved towards the 
time axis. Thus to express a relationship for the ascites growth 
Patt and Blackford (1954) suggested that the initial stages of 
growth may be approximated by an exponential fit, and later stages 
by the cube root transform; and that neither fit can describe the 
overall pattern of the growth curve. The cube root growth has been 
described by Mendelsohn (1963, 1965), Mendelsohn and Dethlefsen
(1968), and Steel (1977). Mendelsohn (1963-1965) summarized the 
patterns of growth by using the "rate of change of growth" equation
dy/dt = kyb
where y is the number of cells or the volume of the tumour, t is 
time, and k is a growth constant. The mode of growth is defined by 
the exponent b. When b = 1, the rate of growth is exponential and 
is proportional to y. When b is zero, rate of groivth is linear and 
is equal K. Values for b intermediate between zero and one, show 
that the growth rate increases in proportion to y raised to its 
corresponding power. Of the potential growth rates generated by
intermediate values of b is one in which the cube root of y
increases linearly with time; and this cube root transform is 
applicable when dy/dt = ky^^(Mendelsohn 1963) and this type of 
growth rate may be applicable if tumour growth rate were influenced 
by waste products, growth control substances, or diffusion of 
nutrients through the surface of the tumour. Steel (1977) has 
suggested that tumours need not be restricted only to this mode of 
growth when nutrient supply to the tumour is proportional to its 
surface area; but also by the internal vascular supply being
distributed in such a way that there is no uniform central
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necrosis, but a patchy distribution of avascular regions. In both 
cases it may be that tumour growth depends on the total nutrient 
supply and therefore to the tumour surface area, which results in 
cube-root growth. The cube-root growth may represent a balance 
between the tumour’s specific growth rate and its rate of growth 
decay, (Laird 1969). Steel (1977), described various equations for 
growth such as the logistic and the Gompertz. The Gompertz has 
been widely used and has been described by Laird (1964, 1966,
1969), MoCredie et al., (1965), Norton et al., ( 1976), Steel
(1977, 1980), Aherne et al., (1977), Gratton et al., (1978), and
Brunton and Wheldon (1978, 1980).
Tumour cells proliferate by a modified type of an exponential
process, in which successive doublings occur at increasingly longer
intervals; the specific growth rate for most tumours decreases
with time, the decrease in the growth rate is exponential with
time. Thus in the Gompertz equation
V/Vo = exp[A/B (1-exp (-Bt)]
V is tumour volume at any time t, Vo is the initial tumour volume,
A is the initial specific growth rate, B is the growth constant
that governs the decrease in growth (i.e. that determines the rate
of growth increase).
At the earliest period of growth when t is very small, or in
the special case when B is equal to zero, then:
V = Vo exp (At)
and growth is exponential, but apart from the two conditions 
mentioned above, tumour cells will proliferate by a modified
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exponential in which successive doubling will occur at increasingly 
longer intervals. The tumour reaches its plateau or asymptote 
according to ratio A/B; and can not pass this maximum value even 
when time is extended. The number (n) of successive tumour 
doublings is related to ratio A/B, i.e. n = A/B ln2. The larger 
the ratio of A/B the greater the number of doublings.
The retardation in the tumour exists at all times, and the 
size of volume at time (t) in
V = Vo exp [A/B(l-exp(-Bt)3,
is independent of the retardation process; the only factors that 
bear on whether growth of a tumour is near to or farther away from 
being simple exponential growth (and then throughout growth) is the 
ratio of the specific growth (A) to its rate of decay (B), (Laird 
1969).
Wheldon (1980) suggested a composite curve, a 
Gompertz-exponential known as "Gompex" to describe a tumour curve 
beginning with an exponential type, then shifts to Gompertz at
later stages of growth. The tumour has the usual three parameters,
i.e. (initial number of cells, the growth and retardation 
constants) and a fourth parameter, the nuraber of cells at which the
transition from the exponential to Gompertz occurs.
There are many factors which contribute to the slowing of
tumour growth, such as the progressive development of necrotic 
areas within the tumour, and these areas may increase as the tumour 
volume increases. Metabolic by-products and cytotoxic substances 
of necrosis are harmful to other proliferating cells within the 
tumour,(Holmberg I968).
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The availability of nutrients and blood supply to the tumour 
is also a factor that contributes to growth, (Burton 1966), 
(Summers 1966). Inadequate vasculature, and hence blood supply to 
the tumour, may also contribute to the retadation of tumour growth, 
(Tannock 1968, McCredie et al./ 1971, Hirst and Denekamp 1979, and 
Hirst et al., 1982). Apart from the above mentioned factors that 
influence tumour cell proliferation. Burns (1969) has suggested 
that homeostatic regulation mechanisms were involved in tumour 
growth control. Burns,(I968-I969) has suggested that the growth of 
ascites tumour cells in vivo had stopped because of the existence 
of a self-inhibition of growth mechanism that depended on the 
attainment of a critical number of viable tumour cells, mediated 
via the ascitic fluid. Homeostatic control mechanism may operate 
on tumours which retain some characteristics of the tissue of 
origin. Trotter (1961) has shown in the hepatoma of mice (where 
tumour growth was compared between partially hepatectomized and 
normal mice), that the time taken for the tumour to appear was 
shorter in partially hepatectomized mice than in normal mice. This 
was also shown to occur in some early transplant generations, and 
not later generation transplants or established hepatomas. Trotter 
(1961) has also shown that the time taken for tumours to appaer
after implantation in mice, was generally, inversely related to the
(
transplant generation number, i.e.: the higher the transplant
generation number, the shorter the period for the tumour to appear.
McCredie et al.; (1971) have compared the growth rates between 
a spontaneous C3H mammary tumour and its (900th) transplant 
generation, and have shown that the growth rate in the transplant 
generation increased, due to a higher (A/B - Gompertz constants) 
ratio than that in the spontaneous tumour. In the spontaneous 
tumour the initial growth rate was slow because the cells were well
differentiated, their generation time was long, while the Gompertz 
retardation constant (B) was small because of uniform blood supply* 
In the transplant generation there was a marked decrease in the 
fraction of tuiuour cells and an increase in necrosis. Poor 
differentiation of the tumour cells, have probably accounted for 
the initial rapid rate of growth, and the decrease in the relative 
vascular volume for the marked retardation (the B coefficient of 
the Gompertz equation). Steel et al., (1971) using the rat mammary 
fibroadenoma compared the changes in the growth rates between the 
spontaneous primary tumour and its corresponding transplant 
generations. The pattern of growth in the primary tumour, was 
irregular and slow, while that of the transplanted tumour was 
regular, and faster. The growth rate increased as the number of 
transplant generations increased. Serial transplantation of the 
tumour, influenced several parameters of the tumour growth. The 
volume doubling time Td, the median intermeitotic cell cycle time 
To, and the cell loss factor, decreased with serial 
transplantation, while the growth fraction Ip increased. Similar 
results were demonstrated by Steel (1972) and Kovacs and Evans 
(1977). Steel et al., (1971) have also shown that there was a 
kinetic relationship among the growth rates of the respective 
transplant generations. The initial growth rate of the fourth 
transplant generation was similar to the final growth rate of the 
third transplant generation. The same link existed between the 
third and the second transplant generations.
Steel (1977) has suggested, that the general rule upon serial 
transplantation, was an accelerated growth rate. Some exceptions 
to this rule, has been described by Begg (1971), where the growth 
rate slowed down upon successive transplantation, together with a 
change in the histological character of the tumour, and an increase
- 36 -
in Te (median intermitotic time). In general, therefore, with 
successive transplantation there is an associated increase in the 
growth potential of the tumour cells, through cellular selection 
and adaptation, (Nowell 1976, 1978), (Kovacs and Evans 1977),
(Steel and Stephens 1982).
The tumour growth rate also corresponds to the histological 
type of tumour, (Charbit et al., 1971), (Malaise et al., 1973), 
(Steel 1977), (Tubiana 1982). Also there are differences in the 
growth rates among the primary tumours between different anatomical 
sites; and also between the primary and metastatic growth, (Steel 
1977). The growth of the tumour may also be influenced by the
immunological environment of the host in which the tumour is 
growing, (Janik and Steel 1972, Rajewsky and Gruneisen 1972, Riches 
and Brynmor Thomas 1971).
Tumour cells are not to be assumed as undergoing an 
uncontrolled process of high frequency cell division contributing 
to tumour size. The general trend for the length of cell cycle 
time (median intermitotic time, Tc) in tumour cells is usually 
shorter than its counterpart in normal cells, (Denekamp and Fowler 
1977).
However, Tc, is not necessarily shorter in tumour cells than 
in some normal cells. Baserga and Wiebel (1969) have shown that in 
mice, the normal duodenal crypt cells have a Tc of 10.3 hours, 
whereas a transplanted fibrosarcoma has a To of 16.5-17.5 hours. 
Hasegawa et al., (1976) have shown that in the mouse cervix, the 
tumour cell cycle time was longer than its normal counterpart. 
When the tissue tends towards excessive growth, from a normal 
balanced proliferative state, to hyperplasia and neoplasia, so 
would Tc tend towards shorter durations, (Bresciani 1968).
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The growth of a cell population is regulated by the length of 
the cell cycle (median intermitotic time), the fractions of 
dividing and non-dividing cells, and the fraction of Ggor quiescent 
cells that may contribute to the population under an appropriate 
stimulus. An expansion in growth can be achieved by shortening the 
length of the cell cycle, increasing the growth fraction with 
recruitment from Goand a decrease of cell loss, or any combination 
of these, (Baserga 1976).
Considering some of the available data on the change of Tc 
which is associated with tumour growth, (Frindel et al . y  1967) have 
shown a very small increase in To with increasing tumour size, in 
the MCTC fibrosarcoma grown as a solid tumour in mice. 
Simpson-Herren and LLoyd (1970, as described by Lala 1977) have 
shown an increase in the adenocarcinoma cell cycle time with tumour 
growth. Lala (1972,1977) showed a very small increase in cell 
cycle time in the Ehrlioh ascites tumour growing in solid form, 
with progressive tumour growth. The plasmacytoma described by 
Simpson-Herren and Lloyd (1970 , as described by Lala 1977) had an 
increase in the cell cycle time between 6 and 7 days of tumour 
growth but no significant change in To was observed at later tumour 
growth between days 7 and 19. Several authors have also reported 
some increase in Tc with increasing tumour size, (Simpson-Herren et 
al. 1974, Simpson-Herren 1977, Zobl et al., 1975, and Féaux De 
Lacroix and Lennartz 1981).
Gunduz (1981), on the other hand, showed no correlation 
between tumour volume and an increase in cell cycle time; there was 
a slight increase in Tc for a short period, with no increase in To 
for the rest part of tumour growth. Proliferative activity within 
an individual tumour (solid tumours) also varies from the periphery
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to the centre of the tumour. Mermens and Barendsen (196?) observed 
minimal changes in Tc, although variations in labelling indices 
existed between periphery and centre. Tannock (1968) observed that
the labelling and mitotic indices were declining as the distance
between cells and their blood supply increased; the cell cycle time 
was nearly constant but the growth fraction dropped substantially 4
as the distance increased between the cells and their blood supply. !
Rockwell and Kallman (1972) observed no change in Tc and a minimal 
change in Ip between periphery and centre, although Kovacs and 
Evans (1977) reported some increase in To at the tumour centre 
relative to the periphery. Hirst and Denekamp (1979) studying the 
relation of vasculature to tumour cell proliferation observed a 
decreasing LI and Im as the cells were at a further position from 
blood supply. These decreased indices were associated with an 
increase in cell cycle time and small changes in Ip. i;
Hirst et al., (1982) have also observed higher LI and Im 
indices near blood areas relative to the poor supply areas, and 
have demonstrated that capillaries were not being formed fast 
enough to keep with the rate of tumour cell proliferation. The 
poor blood supply may be responsible for a low growth fraction.
Kovacs and Evans (1977) using the H411E tumour cultured in 
vitro, observed an increase in Tc with progressive tumour growth.
Woo et al., (1980) also reported an increase in the Tc of Burkitt’s 
lymphoma cell cultured in vitro. Similarly, the growth of the 
ascites in vivo was associated with a marked trend of increasing 
cell cycle time, with progressive tumour growth as described by 
Lala and Patt (1966), Frindel et al., (1969), Tannock (1969),
Schiffer et al., (1973), Dombernavsky et al., (1973), Schiffer and 
Markoe (1974), Lala (1977), and Muller et al., (1982).
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In ascitic tumours growing intraperitoneally,the deceleration 
of the growth rate is associated with a marked increase in Tc , a 
common feature associated with many ascites. The slowing of growth 
may also be linked to changes in the growth fraction and the amount 
of cell loss, or any combination of these. Tannock (1969) showed 
that the increase in Td was due to an increase in cell loss, but a 
nearly umiforra Ip.
Muller et al.^ (1982) using the JB-1 ascites also observed an 
increase in Td with increasing tumour age. An increase in Tc was 
the main cause for an extended Td , as the growth fraction of 
unity was nearly constant, and cell loss was almost zero up to 5
days of growth.
Several factors may contribute to the inhibition of ascitic 
tumour cell proliferation with increasing age, such as cell 
crowding, lack of nutrient and oxygen supply and accumulation of 
waste products (Tannock 1969). Specific inhibitors of tumour cell 
proliferation also contribute in controlling tumour growth, 
Barford (1981) and Barford and Scherbeck (1982) have demonstrated 
the effects of ohalones which were present in the ascitic fluid on 
the specific inhibition of cell influx from Gito S-phase.
In solid tumours the change in cell cycle time is not as
marked as that found in the ascites. The growth fraction in some
solid tumours decreases as the tumour grows in size, (Frindel et 
al. 1967), (Watson 1976), (Lala 1977), (Steel 1977), ( Feaux De
Lacroix and Lennartz 1981), (Gunduz 1981). Some exceptions to a
decreasing growth fraction, were reported by Simpson-Herren and
Lloyd (1970-as reported by Lala 1977) and Zobl et al.^ (1975).
Steel (1977) and Denekamp (1970, 1982) described the relation
between tumour growth, median intermitotic time, growth fraction
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and oeil loss factor,
Denekamp (1970, 1982) has suggested that there was a
correlation between an increasing median intermitotic time (Tc) and 
an increasing tumour volume doubling time (Td) among sarcomas 
rather than carcinomas. Steel (1977) showed that there was no 
correlation between an increase in Tc and an increase in Td among 
mice tumours, although there was some tendency for increase in the 
cell cycle time of the sarcomas and carcinomas of rats and hamsters 
with an increasing Td, including early transplant generations. 
There was a relatively better correlation between a decreasing Ip 
and an increasing tumour Td in the sarcomas, than in the carcinomas 
as described by Denekamp (1970-1982). This was also present in 
Steel's data (Steel 1977) among the tumours in mice, rats and 
hamsters, including early transplant generations.
Cell loss contributes an important part in determining the 
overall growth rate of tumour, and is often the main determinant of 
a slow growth rate, (Steel 1977). Cell loss is more important in 
spontaneous tumours than in tumours which have been serially 
transplanted for many generations, (Steel 1977) and (Denekamp 
1982).
Denekamp (1982) has shown that when tumours of similar size 
were considered, all of which growing as syngeneic transplants, 
there appeared a correlation between the cell loss factor and 
tumour volume doubling time (Td), especially with slow growing 
tumours such as the carcinomas, rather than relatively faster 
growing sarcomas, in which the main contributor was the median 
intermitotic cycle time (Tc). Denekamp (1982) has suggested that 
the cell loss associated with the carcinomas, may reflect the 
origin of carcinomas from epithelial surfaces where rapid cell
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production is balanced by rapid cell loss,
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1.2. Cell tggbBlaüÊg:
The kinetic parameters which have been discussed earlier can 
be estimated by some experimental procedures, and the purpose of 
this section is to describe the stathmokinetic method and briefly 
review other methods which are associated with the estimates of 
cell kinetic parameters.
1.2.1 âssêsts. a&âtbmskiDëtia methgd:
Substances that arrest dividing cells in metaphase 
(stathmokinetic agents), provide a useful method of studying cell 
production in tissues, (Wright and Appleton 1980). The first 
compound to be used in arresting metaphases was colchicine. 
Colchicine was obtained from the autumn crocus (Colchicura 
automnale), (Eigesti and Dustin 1955, Stevens Hooper 1961, Wilson 
et al., 1974, Ah erne et al., 1977). There i*s a variety of 
stathmokinetic compounds apart from colchicine, such as colceraid (a 
derivative of colchicine) (Puck and Steffen 1963, Clarke 1971, 
Smith et al., 1974, Thorud et al., 1980, and McDermott et al.,
1985), and the vinca alkaloids vinblastine and vincristine (Frei et 
al., 1964, Tannock 1967, Smith et al., 1974, Al-Dewachi et al., 
1975, Barford and Barford 1980a,b, Camplejohn et al., 1980, Ah erne 
et al., 1980, Jones and Camplejohn 1983, Samperiz et al., 1985, and 
Wynford-Thomas 1985).
Vincristine O^ qJ is obtained from the periwinkle plant,
Silî5â L. of the family Apocynaceae, (Johnstone et al.,
1963), used as vincristine sulphate (Oncovin: produced by Eli
Lilly Pic., U.K.) for the treatment of malignant disease.
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Vincristine has been shown by Smith et al., (1972-1974) to be a 
more effective stathmokinetic substance, when compared to 
vinblastine and coloemid. The stathmokinetic compounds when added 
in vitro to cultures of proliferating cells or given in vivo to 
laboratory animals or human patients, causes proliferating cells to 
accumulate in the metaphase stage of mitosis. The action of these |
mitotic inhibitory compounds is due to their interaction with 
tubulin in the cell, which results in the dissolution of 
raicrotubules (disruptive action on metaphase spindles), (Taylor 
1965 , Wilson et al., 1974 , Aherne et al., 1977 , Thorud et al.,
1980) , thus keeping the Chromosomes arrested in metaphase, with a 4;■;Â
characteristic clumped chromatin (short, thick and sometimes fused 
chromosomes, ball or plate like in appearance (Stevens Hooper 1961,
Taylor 1965, Clarke 1971).
Tannock (1967) proposed that an effective stathmokinetic agent I
should possess the following characteristics:
1. There must be an optimum dose, which is able to arrest all 
metaphases in the tissue of interest over a defined period of time.
2. The arrested metaphases should not degenerate into an 4 
unrecognisable state before the tissues can be examined for the 
number of metaphases.
3. The mitotic arrest properties should not be highly 
sensitive to dose.
4. The stathmokinetic substance should have no harmful 
effects on interphase cells.
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Tannock (1967) has stated that if these criteria were 
satisfied by aiy agent, it would show a broadly-peaked dose curve 
and a reasonably well-defined linear collection period in a 
linearity study. Tannock (1967) compared the relative 
effectiveness of several stathmokinetic substances on rat 
intestines and transplantable tumours, and concluded after 
comparing the kinetic results obtained with the stathmokinetic 
substance with the results obtained by direct tumour measurement, 
that vincristine appeared to have the advantage of becoming almost |
immediately available after injection and furnished the most 
accurate estimates of both tumour doubling time and the mean cell 
cycle time of the epithelial cells of the crypt.
When the entry of cells into metaphase is asynchronous, the 
rate at which metaphases collect after using a stathmokinetic 
agent, can give an estimate of the rate of cell production. The 
frequency of arrested metaphases in a cell population in an ideal
case, should be in direct proportion to the duration of metaphase si
arrest, that is, the rate of metaphase collection is independent of 
the duration of metaphase arrest. Therfore, a linear collection of 
metaphases is obtained, when the rate of entry into metaphase is 
constant, and the metaphases must be completely blocked by the 
stathmokinetic agent and must not degenerate.
The mitotic index can be a guide to the rate at which
tissues are proliferating, but it is inadequate because 3m depends 
on the rate at which cells enter mitosis (rra), and also on the time 
period the cells stay in that phase, i.e.: (mitotic duration tm) ,
(Wright 1975, Aherne et al., 1977, Steel 1977, Thorud et al.,
1980).
I
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Thus in steady state 
rm=Im/tm
m=Imet/ta (1) (Aherne et al., 1977).
ünet, is the metaphase index at the end of the arrest period (ta). 
Therefore, 3met = ta + tm/Tc (Wright and Appleton 1980) and thus 
the birth rate can also be calculated in terras of the turn-over 
time, i.e. ; the potential doubling time or apparent cell cycle 
time.
Therefore; Ira stm.rm
The flux of cells into mitosis depends on the proportion of cycling 
cells in the whole cell population and on the duration of the 
average intermitotic (cell cycle) time of the cycling cells i.e. 
Ip and Tc,
Therefore Im = Ip.tm/Tc for steady state
and Im = (Inl+Ip).tm/Tc for exponetial growth (Wright 1975). É
iIThus, under optimum conditions the rate of cells accumulating at 
metaphase, will be equal to rate of entry into mitosis i.e. at 
mitosis one cell generates two daughter cells, therefore rm is the 
slope of the curve of the metaphase collection function and is also .j
the birth rate (KB). I
I
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Thus, KB = rra = 1/Tca , for steady state conditions (Aherne et 
al., 1977).
In exponential growth, where the frequency of cells 
immediately after mitosis is higher relative to the number of cells 
entering mitosis.
Ira = exp t/Tc ln2 - 1 (Smith and Dendy 1962)
t is the time at which cell proliferation may be scored for the
number of cells in mitosis.
A similar equation to that described by Smith and Dendy (1962) is
that described by Puck and Steffen (1963):
Im (mitotic index) at time interval (t ) after the addition of 
colceraid,
tm = mitotic period
t = is the elapsed time after the addition of the
stathmokinetic substance
T = the total generation time. ^
Re-arranging in terms of the base (e)
3m = exp ln2(tm+t)/Tc -1
and re-arranging in terms of the common logarithm (Log^ )^,
log,p( 1+33n)=0.301/Tc(tra+t) ta>tm, assuming a growth fraction of
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unity. I
log^ Q (1+3ia) which is similar to log^ (1+3met) is called the 
"Collection Function" as described by Puck and Steffen(l963) as
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fe
log^Cl+NM); NM being the mitotic index, s
0,301/Tc is the slope and 0.301 tm/Tc is the intercept, and 
therefore:
rm = log (1+Imet)/ta : which is similar to equation 1.
and thus:
rra = 0.301/Tca when the growth fraction is unknown.
Thus: KB = 0.301/Tca
An optimal dose of the stathmokinetic agent must be determined 
for the tissue to be studied, (Wright and Appleton 1980). Tannock 
(1967) and None (1975) have shewn that the optimal dosage of 
different stathmokinetic substances were different in the same 
tissue, the same stathmokinetic substance has different optimal |
dosage values in different tissues, as will be described below.
Barford and Barford (1980a) have shown that the LIA2 ascites were 
sensitive to a dose of 0.05ug/ml vincristine, which was the dose 
that achieved the most effective metaphase accumulation, while for 
the JB-I-E and PNJ ascites 0.05ug/ml vincristine showed anaphase |
and telophase escape. Thus as the dose of the stathmokinetic
substance increases, so does the number of accumulating metaphases 
increase, up to a certain limit; as Tannock (1967), None (1975), 
and Duff ill et al., (1977), have demonstrated that the number of 
accumulating metaphases will drop as the concentration of the
'I
¥
stathmokinetic substance increases beyond the optimum dose. I
There are other effects to stathmokinetic substances.
Fitzgerald and Brehaut (1970) have diown that the rate of DNA 
synthesis was depressed in response to high doses of colchicine.
Similarly, Hell and Cox (1963) have reported that colchicine 
inhibited DNA synthesis in the guinea pig ear epidermis in vitro, 
but they have also reported that colcemid was less inhibitory at 
the same dose. In a different study Riches et al., (1981) have 
also reported differences of sensitivity by tissues towards 
vincristine; thus while a certain dose of vincristine did not 
suppress DNA synthesis in the maternal thymus, this same dose 
suppressed DNA synthesis in the foetal thymus. Clarke (1971) has 
concluded from his experimental study on the crypts of Lieberkuhn I
of the rat, that metaphase-blocking agents (vinblastine and 
colcemid) at suitable doses do not affect the rate of entry of 
cells into mitosis. The increase in metaphase numbers per increase 
in stathmokinetic dosage is due to the arrest of an increasing 
proportion of metaphases, (Tannock 1967), and as described by 
Taylor (1965), using colchicine in in vitro cultures of human 
cells, the effect of increasing the concentration of colchicine was 
to decrease the interval before metaphase accumulation began. Puck 
and Steffen (1963) have also observed a lag period in the action of 
colcemid in arresting metaphases; thus if the rate-limiting process 
involved colcemid diffusion, the lag should be decreased by 
increasing the colcemid concentration in the culture medium; 
however, as Puck and Steffen (1963) have observed, a 20-fold 
increase in colcemid concentration had no effect in lifting the 
curve to the Y-axis intercept. This implied that colceraid had been 
specifically prevented from acting on all cells which have already 
entered mitosis, even though they have not yet reached the point at
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3which the blocking action was exerted. Hence, only the cells that 
were exposed to colcemid before entering mitosis, were accumulated 
on reaching the metaphase-anaphase region, (Puck and Steffen 1963).
An optimum dose of a stathmokinetic agent to achieve a 
complete metaphase arrest in terms of a defined collection time
period is necessary, to insure against anaphase escape and against
metaphase degeneration, because if metaphase arrest was not 
complete, and blocked metaphases were degenerating due to an 
unsuitable dosage used, or extending the period of metaphase 
collection, then the mean birth rate (KB) will be underestimated I?
with the oonæquence of overestimating the mean apparant cell cycle |
time (Tea); (Stevens Hooper 1961, Puck et al., 1964, Tannock 1967,
Clarke 1971, Aherne and Camplejohn 1972, Wright 1975, Aherne et 
al., 1977, Wright and Appleton 1980, and Riches et al., 1981), The 
metaphase arrest technique is a relatively easier method to perform 
in cell kinetic studies, as compared to other methods which involve 
the use of tritiated thymidine.
«
1.2.2 Th§ üsê St üâdifiââtiYêly labelled pBfilêâtlâêa:
3H-Tdr and 125HJDR are specific lables for DNA, and when 
either of these labelled nucleotides are made available to cell 
populations, cells in S phase incorporate these labelled I
nucleotides into DNA. 3H-Tdr incorporation into DNA provides 
several methods for analyzing cell population kinetics, such as the 
pulse labelling index, the fraction of labelled mitosis technique 
(FLM), continuous labelling, double nucleotide labelling and grain 
counting. The uptake of 3H-Tdr and 125IÜDR by DNA can also be 
assessed by scintillation counting.
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1.2.2.1 Thê l a b â l l l m  iadgg:
Exposure of a cell population to labelled lUDR or Tdr for a 
short period will enable the proportion of cells in DNA synthesis 
to be determined. This fraction of labelled cells is therefore 
called the pulse labelling index (LI). Its use as a guide to the 
proliferative activity is similar to that of the mitotic index, 
however the labelling index is a larger fraction than the mitotic 
index, thus the LI has a relatively smaller error than the 3m, 
(Aherne et al., 1977).
1.2.2.2 DgMble lâbglilDg:
The double labelling technique enables the duration of S phase 
and the flux rates into and out of S phase to be determined, 
(Aherne et al., 1977). This technique makes use of the energy 
difference between the beta particles emitted by 14C and 3H. The 
underlying principle of this method is that between the first and 
second applications of labelled thymidine , a certain fraction of 
cells have left DNA synthesis phase, hence will not be labelled by 
the second isotope. The fraction of cells leaving the S phase in a 
given time duration is proportional to the ratio;
length of interval/total duration of S phase
Thus the duration of S phase can be calculated.
1 .2 .2 .3  The E iM tS fib M aü ê î
This technique is one of the earliest and informative of the 
isotope techniques used in the study of the mitotic cycle 
parameters.
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3H-Tdr is made available to the cell population for a period 
of time, and tissue or cell samples are later removed and fixed at 
preset time intervals. Histological sections are prepared from the 
samples and the cells that have taken up the labelled nucleotide
can be distinguished frcaa unlabelled cells by the use of
autoradiography, (Aherne et al., 1977).
Figure "B" shows an FLM curve of an idealized asynchronous 
cell population, without variations in the durations of the
respective phases. The cohort of 3H-labelled cells can be followed 
through the mitotic stage (window) in the serial samples by
observing the rise and fall of labelled mitotic cells with the 
passage of time.
The FLM remains zero, for a time interval of the minimum 
duration of G2, and the FLM value starts to increase until it fills 
(100%) the mitotic window, in a time interval equal to tm, and 
after a certain time interval the mitotic count drops to zero in a 
time interval equal to ts - tm. The curve, then continues to rise 
again, after a time interval of tg^+ tgg.
In real experiments such idealized curves are not found due to 
the variation in the rates at which individual cells traverse the 
phases, thus the second peak is somtimes reduced in height, or 
eventually due to the randomization within the "cell cycle" the FLM 
curve dampens and flattens.
The duration of the respective intermitotic phases and the 
intermitotic time (Tc) are usually read from the 0.5 level. This 
gives approximate median estimates for the cell population under 
study, (Aherne et al., 1977). The interval between the 3H-Tdr 
labelling to the 0.5 labelling point on the ascending limb of the
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THE FRACTION OF LABELLED MITOSIS CURVES
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F i  g  . B : On the left o f lliu diagram a cohort o f  labelled colli is dc;:ictcd, in o 'ir.e  through
the vcU cycle. As it moscs in to  M one sees an increasing proportion  o f labelled rnUuics, as 
sho'.vn on the tight o f  the diagram. The tim e m ierv.il from  the in jection o f  ’ H -ih y  iiiidm e  
to the m edian o f the a sa en ding lim b o f the idealized first uave measures + f f / 2 ) f  M- 
Wltcn the cohort of labelled cells has occupied M com plete ly , as at ( i ) ,  the proportion  o f  
labelled mitoses is uniiy  (o r. as it is sometimes stated, 100 per cent). Th is  is represented  
on the right by the peak o f the ideabzed first wave. In  ( ,f )  the cohort is musing assay from  
M in to  G j. When it reappears the duration o f the cyule ( rç )  .sill be rneaturs'd by the in te r,a l 
from  the median o f the first wave to the median o f the second.
R.' .l iMs.n f i ' on  .She rue o l  a l . ,  ( l 0 7 7 ) .
therefore Ip = LI/ts/Tc.
first wave is equal to tgg+ 1/2 tm. The median S phase period is 
the interval between the 0.5 labelling points on the ascending and
Îdescending limbs of the first wave of the labelled mitosis curve. 1|
■4The time interval of tgi+ tg2+ tm is equal to the interval between I
the 0.5 labelling point on the descending limb of the first wave 
and the ascending limb of the second. The intermitotic period (Tc)
'Àis equal to the interval between the 0,5 labelling points on the IIfirst and second ascending mitotic waves. Tg.^ may also be estimated 
by subtracting tm + ts + tg2frora the median Tc value. When there 
is no obvious second peak on an FLM curve, the curve describes a 
plateau level (L). The plateau FLM value depends on the ratio of 
ts to Tc
Therefore: L = ts/Tc
thus Tc z ts/L .
II 1
Ip can also be calculated after determining LI for the cell s
ipopulation after a pulse of 3H-Tdr; (
1.2.2.4 lâhêllilJg:
In this method, the cell population under study is 
continuously exposed to 3H-Tdr, so that all cells entering S phase %
will be labelled. In vivo, the label is made available by 
continuous infusion, or by repeated injections at periods shorter 
than the duration of S phase, (Steel, 1997). This technique is 
best suited to in vitro applications, where the label can be added 
without perturbing the culture. Samples of the cell population 
under study, are removed and fixed at intervals of time depending 
on the nature of the experimental study, and the proportion of
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labelled cells is recorded. The labelling index is thus determined 
at each time interval. If the time period for continuous labelling 
is extended, all proliferating cells become labelled, thus 
eventually the LI for the population will reach a plateau value 
after a time interval which is equal to tne mean durations of tgg+ 
tm + tg.^ . The interval tgg+ tm is the time required to label all 
mitosis.
The value of tg^is equal to:
(tg2+ tm+tg-|) - (tg2+ tm) .
The rate of entry into S (labelled cells per unit time) can be 
estimated, preferably before any labelled cells have had time to 
divide. The duration of S phase, can therefore be calculated after 
determining LI:
ts = Ll/rs
rs is the slope of the labelling index, (steady state), and in 
expanding populations
ts = LI (Tca/ln2), (Aherne et al., 197Y).
Tc can be estimated from the the combined sum of ts, tg^ , tm 
and tg^.
1.2.2.5 Grain counting:
In this technique, the cell population under study is pulsed 
with 3H-Tdr as in an FLM experiment, and later, the intensity of 
labelling on the interphase cell’s nucleus is assessed 
autoradiographically, with the passage of time, (Aherne et al.,
1977).
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The mean (or median) number of grains per nucleus is usually 
used to estimate Tc and ts. Thus after labelling with an isotope , 
cell samples are assessed in terms of a suitable number of nuclei, 
and a distribution of the grain count is recorded. For the 
estimate of Tc, it is assumed that the number of grains over an an
individual cell is halved at mitosis. Therefore, the halving time
for the average (mean or median) grain count is an indication of
the duration of the intermitotic cycle.
The first halving time, after the labelling with isotope is 
less than Tc, as the cells have a delay period of ts and tgg+ tm to
3
complete the cycle. After the first halving interval, the 
successive halving intervals should occur at intervals equal to Tc. 
Thus if the mean grain count is plotted against time, Tc can be 
estimated if the growth fraction is 1. If some cells decycle after 
being labelled, a skewed distribution of grain counts will be 
evident, and the average grain count will decrease more slowly, 
(i.e. for Ip<1).
This method is not as accurate as the FLM curve, but may be 
used when mitotic figures are rare and a construction of an FLM is 
difficult. In continuous labelling experiments , the maximum 
number of grains over a nucleus occurs when the whole genome has 
replicated, and this is achieved in a period equal to ts.
1.2 .2.6
In this technique, the uptake of isotope by tissues can be 
assessed in terms of the radiation particles emitted by the 
tissues. Tissue samples are made soluble in the hydroxide of 
hyamine lOx, followed by mixing with an organic liquid 
scintillator, which consists of a flourescent substance and an
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aromatic solvent, (tfek and Till 1963, Aherne et al., 1977).
The beta particles emitted by 3H or 14C labelled Tdr, or the 
gamma particles emitted by 125IÜDR strike the flourescent compound, 
to produce flashes of light which are detected by means of a 
photomultiplier device present in the scintillating machine. There 
are advantages in scintillation counting, such as the relative ease 
of obtaining results as compared to autoradiography. However, when 
a tissue is composed of different cell types, scintillation 
counting can not reveal which cells were labelled. Scintillation 
counting can not distinguish between the changes of isotope uptake, 
which may be either due to a change in cell number entering S phase 
(taking up the isotope), or to a change in the amount of isotope 
taken up by each cell.
In some experiments 125IUDR is the isotope used rather than 
3H-Tdr, because 125IÜDR is relatively less reutilizable than 3H-Tdr 
by cell populations and the gamma rays emitted by 125IUDR are 
relatively easier to detect than the low energy beta particles 
emitted by 3H-Tdr.
1.2.3 Î
In this technique the quantity of DNA in the nuclei of a cell 
population is estimated. Tissue fragments are flattened on 
microscope slides and are stained with a DNA specific stain such 
the Feulgen. The Feulgen stain varies with the quantity of DNA, 
and by using an instrument that measures the light absorbed by 
Feulgen stained nuclei at a specific wave length, one can assess 
whether cells have 2n DNA ( Gior Gq), or 4n DNA ( G2 cells ). S 
phase cells can be recognized and excluded by combining the 
technique with pulse labelling and autoradiography. In a cell
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population where all cells are proliferating, the distribution of 
cells in the respective cell cycle phases can be determined, Gi and 
Ggby densitometry, S by pulse labelling and mitotic cells visually. 
Thus the age distribution can be known, together with the relative 
durations of the phases of the cell cycle. There are some
difficulties in the assesanent of results using this technique, 
such as the inability to distinguish between Gi and Ggcells 
(tumours), and in cases where the cells contain variable amounts of 
DNA, (polyploid and anueploid cells).
Microflourometry is another method which estimates the amount 
of DNA per nucleus in the form of a histogram, and the proportion 
of cells in Gi, S , G2and M can be recorded. In this technique, 
propidium iodide is the substance used to stain the DNA. The 
advantages of this method, is the large number of cells (cell
1.3 rggülatlDa at figii PCSlifecâMfifi:
The regulation of cell reproduction is an intricate, yet a 
coordinated process. Cellular proliferation is controlled by mary 
factors, among which are the humoral mediators, such as hormones, 
chalones, cyclic AMP and poly amine s. The effect of these
substances on cell proliferation are usually interrelated, as the 
effect of one mediator may be complemented by the action of 
another. Lymphokines are also an essential group of substances 
which contribute to the regulation of proliferation of the immune
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;isuspension) that can be quantified in a short time. However, the S
method is not suited for the study of structured tissues, where 
proliferative rates vary with the position in the tissue 
microarchitecture.
I■I
system. Most of the early work on lyraphokines was associated with 
the macrophage, and in this regard, the macrophage is also another 
essential contributor to the regulation of cell proliferation. The 
contributions of some of the above mentioned mediators to cell 
proliferation will be discussed below.
1.3.1 Cyfiiifi Byplëa&idëp:
When cells reach a high density , intracellular cAMP level 
rises as compared to low cAMP levels in sparse density cultures 
(Seifert and Paul 1972). Bannai and Sheppard (1974) have shown 
that cell contact increases intracellular cAMP levels, reaching 
peak levels and remaining constant thereafter at the peak level of 
maximum cell density, when cells were not proliferating. That the 
initiation of DNA synthesis is associated with a drop in the levels 
of cAMP was observed when quiescent cells were stimulated to 
proliferate by adding insulin, (Pastan et al., 1975). Similarly,
Par sad (1981) has i^own that the replication of certain clones of 
hepatcana cells were inhibited by cAMP and its analogue 
dibutyryl-cAMP (Bt 2 cAMP). The association of high levels of cAMP 
with cellular quiesence, and low cAMP levels in the initiation of 
DNA synthesis, suggests that cAMP may act as a regulator which may 
contribute positively or negatively towards the control of cell 
proliferation (Boynton and Whitfield 1983), (Hunt and Martin 1980). 
Adenylate cyclase which is present in the cell membrane, catalyses 
the formation of cAMP. Qrclic AMP acts as a mediator between 
extra-cellular stimuli and intracellular constituents, and is 
involved with other factors that contribute to the control of 
cellular proliferation. The association between hormone effect on 
target tissue and increases in cAMP levels were demonstrated by 
Sutherland (l^lkinson 1978). Cyclic AMP acts as a second messenger
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for hormone action and contributes to various cellular metabolic 
and physiological functions, and is also involved in the 
replication process of DNA, (Malkinson 1978, Boynton and Whitfield 
1983, Hunt and tfertin 1980).
Stimuli by substances which are involved in the control of 
cell proliferation such as prostaglandins (Samuelsson et al., 
1975), chalones (Laurence 1979), lymphokines (Waksman 1979) may 
mediate their action by increasing intracellular cAMP levels.
The intracellular cAMP levels are also associated with other 
regulators of cell proliferation, such as the poly amines, as 
Boynton et al., (1980) have ^own that there was a link between 
increased ornithine decarboxylase activity and surges in cAMP 
accumulations. The intra-cellular concentration of cAMP induces 
the formation of a protein kinase which contributes to various 
physiological functions, through protein phosphorylation.
The cAMP-dependent protein kinase inhibits protein synthesis 
and polypeptide chain formation (Greengard 1978). The cell flux of 
mutant cell lines that lack protein kinase activity is not 
inhibited at the Gfphase of the cell cycle by Bt2cAMP, while normal
cells which have protein kinase activity respond to Bt2cAMP and are
arrested in the G-j phase of the cell cycle (Insel et al., 1975). 
The intra-cellular concentration of cAMP during the cell cycle may 
show increases at different phases in the cell cycle; Gi, S or G2, 
but a common observation was that the nucleotide level at mitosis 
was lower than other phases (Hunt and Martin 1980). The cyclic 
nucleotide influences the cell cycle in various ways; (1) 
increasing or decreasing recruitment of cells from the resting 
phase Gginto the cell cycle at Gi, (2) regulating the passage of
cells through certain control points within the cycle; (3)
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4stimulating or inhibiting the entry of cells into G , (Pardee 1974, r"
Pa Stan et al., 1975, Hunt and Martin 1980).
Boynton and Whitfield (1983), have diown that certain 
concentrations of cAMP and its derivatives and agents that elevated 
cAMP levels, arrested cells in G and G phases of the cycle.
MacManus and Whitfield (1969) have shown that low concentrations of 
cAMP stimulated DNA i^nthesis in rat thymic lymphocytes, although 
higher concentrations of the cyclic nucleotide inhibited their 
proliferation. tfelamud (1969) also related the effect of 
isoproterenol on stimulating cell proliferation on the increasing f
levels of adenylate cyclase activity. Hovi and Vaheri (1973) 
showed no significant drop in cAMP when quiescent chick fibroblasts 
were stimulated into cycle by fresh medium. In the salivary gland 
stimulated by isoproterenol to proliferate, two surges of cAMP were 
produced, (Tsang et al., 1980-1981), (Boynton and Whitfield 1983), 
the second anal 1er cAMP surge was needed for the initiation of DNA 
synthesis. Similar cAMP surges in kidney cells stimulated to |
proliferate by folic acid have been reported by Whitfield (1980).
Another cyclic nucleotide, cGMP, like cAMP, may also be »
involved in the regulation of cell proliferation. Goldberg et al.,
(1976) have suggested that cGMP and cAMP function together in a 
yin-yang fashion to control growth and cellular function where the 
ratio of cGMP to cAMP was important. Seifert and Rudland (1974) %
have demonstrated a an all stimulatory effect on the incorporation 
of thymidine in serum starved 3T3 cells by cGMP. Rudland et al.,
(1974) have shown that when cells reached confluent levels in 
culture, the levels of cGMP decreased while cAMP increased. When 
the cells were growing before reaching saturation density, cAMP 
level was low while cGMP level was high. When confluent resting ^
i
a
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cells were stimulated to proliferate by the addition of serum, cGMP 
level increased and cAMP decreased. In other cell culture ^sterns, 
Hovi et al., (1974) showed that upon the release of chick embroyo 
fibroblasts to proliferate from density dependent inhibition of 
growth, there was no significant alteration in the values of cAMP 
and cGMP. Boynton and Whitfield (1983) have suggested that cAMP 
was more of a positive regulator than a negative one, because some 
quiescent cells did not drop their cAMP upon proliferation, and the 
examples of quiescent cells in the salivary glands, kidney cells 
and hepatocytes which progress into DNA synthesis with high levels 
of oAMP,
Raising cAMP levels does not necessarily inhibit cell 
proliferation but keeping the nucleotide at high levels at certain 
points in the cycle may influence cell proliferation. Thus Rechler 
et al., (1977) have shown that when the cAMP level was prevented 
from falling in human fibroblasts during the first 4 hours after 
serum stimulation, did not stop the initiation of DNA synthesis, 
but if this high level was maintained later in G^  phase, it will 
prevent initiation into DNA synthesis. MLllis et al., (1974) have 
also shown, that preventing the cAMP level frcxm falling frcan its G2 
peak prevents the human lymphoid cells from entering mitosis.
Coffino et al., (1975), have demonstrated that exponentially 
growing lymphoma cells were blocked in Giphase, when treated with 
Bt2oAMP. The cell cycle of a mutant lymph cm a line which lacked the 
cAMP-dependent protein kinase was not affected by Bt2cAMP. The 
mutant lymphoma have been shown to maintain a normal cell cycle 
with a similar doubling time as their normal lymphoma counterparts. 
Thus, Coffino et al., (1975) have suggested that cAMP may not be an 
essential regulator of cell proliferation.
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Parsad (1981) described some of the data in the literature on 
the involvement of cyclic nucleotides in cell transformation, and 
showed that some carcinomas and fibrosarcomas have low levels of 
cAMP compared to their normal counterpart tissues. Parsad (1981) 
has shown that an increase in cAMP levels in certain clones of 
mouse neuroblastoma cells in culture, induced and increased the 
expression of biochemical and morphological functions which were 
characteristic of mature neurons, such as the formation of long 
neurites, blockade of the cells in G phase of the cell cycle, and 
an increase in the levels of cAMP phosphodiesterase. Çyclic GMP 
did not show a significant role in regulating the expression of 
differentiation in neuroblastoma cells. Thus cAMP can contribute 
in several ways to the control of cell proliferation.
1.3.2 The PgiyamiBgg:
The aliphatic polyamines, putrescine, spermidine, and 
spermine, are normal cell constituents that contribute an essential 
function in cell proliferation and differentiation; (Gaugas 1980), 
(Heby 1981), (Pegg and McCann 1982), (Goynes 1982). Seme of the 
contributions of poly amines to cell proliferation will be discussed 
below together with a description of poly amine biosynthesis; 
spermine and spermidine are formed frcm their precursor putrescine. 
Putrescine is formed by the direct decarboxylation of L-ornithine. 
L-ornithine is formed through the hydrolysis of L-arginine by the 
enzyme arginase.
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Polyamine biosynthesis starts with the hydrolysis of L-arginine by
L-arginine amidinohydrolase, to produce L-ornithine, COgand urea. #1
An increase in the activity of arginase and the formation of
■?spermidine from L-arginine has been described by Oka and Perry 3I
(1974). 1
:
L-ornithine decorboxylase (GDC, L-ornithine carboxy-lyase E.G.
4.1.1.17) catalyses the formation of putrescine frcm ornithine.
L-methionine and ATP acting as substrates for methionine 
adenosyltransferase E.G. 2.5.1.6.) to produce
S-adenosyl-L-methionine. S-adenosyl-L-methionine decarboxylase 
(SAMD) (E.G. 4.1.1.50) produces decarboxylated
S-adenosyl-L-methionine from S-adenosyl- L-methionine (SAM). SAMD 
is an important enzyme in the synthesis of spermine and spermidine.
Spermidine nthase catalyses the transfer of the propylamine group 
from SAM to putrescine to yield spermidine. Spermine gynthase 
transfers the propylamine group from SAM to spermidine to form 
spermine, (Sealabrino and Ferioli 1981), (Pegg and McGann 1982). f
Dykstra and Herbst (1965) were the first to suggest that polyamines 
might be involved in the proliferative response of cells in |
regenerating liver, where there was an increase in spermidine in 
the early period of the regenerative process.
Anders son and Heby ( 1980) have demonstrated in the Ehrlich |
ascites tumour cells growing in vivo, that the concentration of 
spermine and spermidine progressively increased from day 6 after 
transplantation until day 12 upon reaching stationary phase of %
growth, after which there was no increase in the levels of 
polyamines. The levels of RNA and to some extent DNA parallel the 
increase in polyamine frcxn day 6 to 12. By using inhibitors of 
polyamine biosynthesis, the requirement and involvement of these
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cationic molecules was demonstrated.
Fillingame et al., (1975) have used methylglyoxal 
hi8-gaunyIhydrazone or M3BG which inhibited the action of SAMD, to 
inhibit spermine and spermidine production in Con-A stimulated |
lymphocytes. In these polyamine deficient cells the rate of |
thymidine incorporation was inhibited. The MGBG block was reversed 4
by the addition of spermidine or spermine, thus, Fillingame et al.,
(1975), postulated that the increased levels of spermine and 
spermidine seen in rapidly proliferating tissues were necessary for 
enhanced rates of DNA replication. The rates of RNA and protein 
syntheses have decreased, together with a reduction in DNA content 
when E-coli mutant (SpeA) was partially blocked in arginine 
decarboxylase, and thus starved for polyamine. Thus polyamine have 
some effects on RNA, protein and DNA syntheses (Morris and Harada 
1980).
The levels of poly amines have a certain pattern around the 
cell cycle, and as described by Heby and Andersson (1980), the 
levels of spermine, spermidine, putrescine and GDC have 2 peaks in 
the cell cycle of CHG fibroblasts. The synthesis of polyamine was 
initiated in mid-Gi, and started to accumulate towards late Gi 
phase. The rates of syntheses of poly amines, and their content, 
were highest when the cells started to synthesize DNA. The 
activity decreased markedly during mid 8-phase, and towards the end 
of 8-phase, but started to increase again, that is through G2 and 
mitosis, and prior to cell division the polyamine levels were as 
high as those observed at Gi/S boundary. After cell division the 
polyamine content decreased.
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resting 3T3-L1 fibroblasts into adipocytes when stimulated with 
insulin, was associated with an increase in the intracellular 
levels of spermidine.
Thus poly amines are required for the normal progression of i
these cells during the cell cycle, as Andersson and Heby (1980) i
have shown that when M3BG was injected in Ehrlich ascites tumour t
bearing mice, the ascites started to accumulate at the S and G2 j
phases. |
,v
The process of cell division was also obstructed as Sunkara 3
and Rao (1981) have shown that the process of cytokinesis was 
affected by the depletion of poly amines. Cells treated with M3BG 
contained about 405» lower levels of spermidine and spermine, than 
those from untreated cell cultures. The decrease in polyamine 
levels was associated with a significant increase in binucleate 
cells, (Sunkara and Rao 1981). Addition of spermidine or spermine 
to mitotic cells collected from (M3BG) treated cell cultures 
reduced the incidence of binucleate cells.
Bethell and Pegg (1981) have found that the conversion of j
■€
I
Addition of a-dif1uoromethy1 ornithine (DFMO), depleted %cellular polyamine levels and prevented the conversion of 
fibroblasts into adipocytes. The inhibitory effect of DFMO was 
reversed by the addition of spermidine and putrescine along with 
the inhibitor. %is suggested that poly amines were needed in the 
process of differentiation.
Orinithine decarboxylase is an important enzyme in the 
biosynthesis of poly amines and its activity may be influenced by 
other humoral mediators of proliferation, such as, Bt2 cAMP which 
depresses the activity of GDC (Coffino 1981). The lymphokines also I
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influence ODC, and this will be discussed later in the lymphokine 
section.
Apart from the requirement for poly amines in cellular 
proliferation, their presence in tissue cultures environments that 
contain FCS or polyamine oxidase, will change their properties, so 
as to become inhibitory to cellular proliferation. Spermine and 
spermidine may be available in tissue extracts as free molecules or 
tightly bound to larger carrier molecules. The thymic chalone 
described by Allen et al., (1977) and the JB-1 ascites ch alone 
described by Barford (1980), both contained spermine, both were 
complexed with carrier molecules, and both were inhibitory to their 
target tissues.
1*3.3 Tfas ahaiama:
Weiss and Kavanau (1957) sugggested the tempiate-antitempiate 
theory in which tissues controlled their growth by a negative 
feedback mechanian. Each cell reproduced its protoplasm by a 
mechanism in which key compounds (templates) characteristics of the 
particular cell type acted as a stimulator for growth. Each cell 
also produced specific free diffusable compounds antagonistic to 
templates (antitemplates) which can block the reproductive activity 
of the corresponding templates. Thus when there was abundant 
antitemplates, blocking the effect of templates, the growth rate of é
the cell population will decline and eventually there will be a 
balance between templates and antitemplates and growth stops. If 
the level of anti-templates decreases due to tissue loss, growth 
will start again. Osgood (1957) has also suggested that cell 
proliferation was regulated by humoral inhibitors of cell division.
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A substance which can contribute to the control of cell 
proliferation by exerting a specific inhibitory action on the 
cellular proliferation of its tissue of origin, has been 
demonstrated by Bullough and Laurence (I960) in their experiment of 
wound healing on the mouse ear. Bullough (1962, as described by 
Bullough 1977 and Laurence 1979) termed such an inhibitory 
substance a chalone.
The chalone has been defined by Bullough (1962, as described 
by Laurence 1979) as "an internal secretion produced by a tissue 
for the purpose of controlling by inhibition the mitotic activity 
of the cells of that same tissue". The specific inhibition of 
mitotic activity in the limb blastema by the newt limb chalone was 
demonstrated by Coomber and Scadding (1983), and the control of 
population size in spermatagonia was described by de Rooij et al., 
(1985), where the length of the period of active proliferation of 
the undifferentiated spermatognia was regulated by a negative 
feedback from the differentiating spermatogonia.
The characteristics of chalones have been described by 
Thornley and Laurence (1975), Bullough (1977), Allen and Smith 
(1979), Laurence (1979), Patt and Houck (1980) and Iversen (1981), 
along similar lines, and Iversen (1981) has summed up these 
characteristics:
(1) Chalones are naturally occurring, physiological cell 
proliferation inhibitory substances, and are water soluble.
(2) Chalones are tissue or cell line specific or show tissue 
or cell line preference or selectivity.
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(3) Chalones must be produced in and be present in the tissues 
on which they selectively act. They are probably mainly produced 
by the more mature cells of the series.
(4) chalone action is non toxic and reversible, therefore 
chalones do not injure cells or cell membranes.
A variety of chalones of various tissues of origin have been 
reported in the literature as described by Laurence (1979) and 
Iversen (1981). Chalones are proteins or polypeptides with or 
without carbohydrate moieties, with a range of molecular weights 
from 500 to 50000, (Thornley and Laurence 1975), (Allen and Smith 
1979) and (Patt and Houck 1980). Iversen (1981) has suggested that 
there was a possibility that chalones in vivo were composite 
molecules consisting of a small peptide molecule which was the 
general growth inhibitor (which need not be tissue specific) 
coupled to a tissue specific glycoprotein which was specific for 
each type of differentiated cell. Chalones modulate the length of 
the cell cycle. Chalones block the entry of cells in to S phase 
and mitosis as has been shown in the epidermal Gi, and G2 chalones 
(Laurence et al., 1979), and as shown by Elgjo et al., (1981) the 
cell flux in the epidermis was inhibited at Gi -S, 8-G2 and G2 -M
transitions. Lord (1975- as described by Laurence 1979) has shown 
that the granulocytic chalone blocked the flux of cells form Gi to S 
phase, together with an increase in the cell Qrcle time. Chalones 
may also accelerate the maturation rate of granulocytes as has been 
described by Benestad and Rytcxnaa (1977).
The action of chalones is effected through the cell membrane. 
The association between the effects of chalone, adrenaline and 
cyclic AMP was first demonstrated by Bullough and Laurence (1964), 
which led Iversen (1969) to suggest a possible role for cAMP in
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chalone effects* Houck and Attalah (1975- as described by Laurence |
1979) have suggested that the chalone was part of the cell membrane 
which activated cAMP via adenyl cyclase, and that the chalone 
maintained a high level of adenyl cyclase activity (Attalah and 
Houck 1976). Laurence (1979) has suggested with regard to 
experimental evidence on chalone action on the epidermis, that cell 
proliferation may be raised either because chalone was depleted or 
cAMP was lowered or both. The activity of ornithine decarboxylase 
and the levels of spermine and spermidine have not been considered 
in relation to the effects of chalones as these substances are 
involved in cell proliferation, and hence, they may be involved 
somewhere in the sequence of cell proliferation control mechanisms 
by chalones. Nakai (1976) has shown that the Ehrlich ascites 
chalone may control the mitotic activity of the Ehrlich ascites by 
inhibiting alpha and beta polymerase activities in DNA. 
Furthermore, Nakai and Gregely (1980) have demonstrated that the 
Ehrlich ascites chalone could inhibit, DNA polymerase alpha, 
directly within the nucleus without an intermediate step such as a 
cell membrane receptor. Other factors which may be involved in the 
chalone mechanism are the anti chalones "stimulators" of cell 
proliferation, as described by %tomaa (1976) and Laurence (1979).
Tumour cells are responsive to chalone action, as demonstrated by 
Bullough and Laurence (1970), on the L5178Y- mouse lymphoma 
cultured in vitro, and in which the mitotic activity was inhibited 
by lymphoQyte and lymphoma extracts, which required the 
co-operation of adrenalin and hydrocortisone to produce this 
inhibition. The specific inhibitory effects of chalones were also 
demonstrated by Bichel and Barford (1977). The JB-1 ascites 
chalone decreased the proportion of JB-1 ascites tumour cells in S 
phase, while it had no inhibitory effect on the Lia ascites tumour.
I
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Similarly, Barford (1981) has demonstrated the specific and 
reversible inhibition of influx of the JB-1 ascites tumour cells 
from Gjto S phase, with JB-1 ascites chaloæ preparation. The 
inhibitory effects of chalones may also be due to poly amines, as 
Barford (1980) has demonstrated the presence of spermine in his 
ascites chalone preparation. Tumours may fail to respond to their 
chalone, probably because the tumour cells may synthesize a small 
amount of chalone but fail to retain it. Bullough (1977) and 
Laurence (1979) have suggested that the tumour cell membrane may be 
altered (i.e. the chalone was leaking into the blood circulation, 
or the receptors on the outer cell surface were abnormal, thus 
being unable to interact with the chalone, Bullough 1977). 
However, tumour cell proliferation can be controlled, if the tumour 
environment was made "hyperchalonic", (Laurence 1979). Cellular 
proliferation can be modulated by other substances apart fran 
chalones, such as the interferons which can inhibit or stimulate 
cell proliferation.
1.3.4 LymphakiBsa:
Lymphokines are lymphocyte glycoproteins (Pick et al., 1979), 
that possess hormone activity, secretion by one cell, specific 
interaction with another target cell, and physiologic regulation 
under feed back control of specific function, (Evans 1983). 
Lymphokines maintain homeostasis of the immune qystem and have the 
potential to influence the development of cancer, (Evans 
1982-1983). Some common Lymphokines are; thymosin, LAP
(lymphocyte activating factor), lyraphotoxin, MAP (macrophage 
activity factor), MMIF (macrophage migration inhibitory factor), 
TOGF (T cell growth factor) and leukocyte alFN (interferon) and
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immune IFN, (Brouty-Boye 1980), (Evans 1983).
From the above mentioned lymphokines, lymphotoxin and
interferon will be described in terms of their effects on cell 
growth. Interferon was first discovered by Isaacs and Lindenraann 
(1957) as an antiviral substance present in the supernatant from 
cultures of chick chorioallantoic membranes which were exposed to 
heat inactivated virus. The interferons are a heterogeneous family 4
of glycoproteins; type 1 (alpha and beta) interferons are produced
by leukocytes and fibroblasts induced by virus infection, while 4
-Itype 2 or immune interferon (gamma interferon) is produced by |
stimulated lymphocytes by specific antigens or mitogens. 3
Interferons have been shown to have a variety of effects, such as >
modifying the structure of cell membranes, contributing to cell 
differentiation, inducing the synthesis of new proteins, and 
inhibiting cellular proliferation, (Gresser 1977, Brouty-Boye 1980,
Evans 1983, Trinchieri and Perussia 1985). Cells of the immune 
system such as macrophages, T, B, and NK cells are influenced by 
interferon, and hence interferon among other lymphokines has an 
immunoregulatory role. Interferon induces the appearance of new 
surface markers (MHO class II) in a variety of cell types such as 
lymphoid cells, mast cells, melanocytes and melanoma cells, and 
other tumour-derived cell lines (Wong et al., 1983). Conditioned 1
medium from mitogen-induced lymphocytes contain factors, besides ^
interferon gamma that act [^nergistically with this type of 
interferon to induce differentiation in immature myeloid cells, and 
hence their ability to mediate an antibody-dependent cytotoxicity 
(AD-CMC) against their target cells which were sensitized with 
antibody, (Trinchieri and Perussia 1985).
I
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Interferon gamma has marked effects on macrophage dependent %
tumour cell killing (Meltzer et al., 1983), (Pace et al., 1983) and 
may act as a macrophage activating factor (MAF), as it induces or 
enhances the cytotoxicity of human monocytes against tumour targets 
(Prensky 1983). Interferon also contributes to the expression of 
surface markers associated with cell helper function and antigen 
presentation, (Steeg et al., 1982), (King and Jones 1983), (Zlotnik |
et al., 1983). Nakamura et al., (1984) have demonstrated that
gamma interferon enhanced the level of antibody response in vivo 
induced by several antigens, when interferon was administrated at 
the same time of immunization. Nakamura et al., (1984) have 
suggested that the effects of interferon may be mediated through 
the macrophages in terms of antigen processing or presentation. B 
cells are also affected by interferons, as Sonnenfeld et al.,
(1978) have demonstrated the potentiating effect of interferons on 
immunoglobulin secretion when added late during an immune response.
I
NK cells produce and respond to interferons by becoming more 
cytotoxic (Senik et al., 1980),and by recruiting pre-NK cells to 
differentiate them into cytotoxic forms, (Friedman and Vogel 1983). 
Similarly the interferons produced by T cells may contribute to the 
generation of cytotoxic T cells (Farrar et al., 1981), (Friedman
and Vogel 1983). Interferons inhibit the multiplication of both 
normal and tumour cells of different species, (Friedman and Vogel 
1983). Interferon inhibited the regeneration of liver in partially 
hepatectomized mice (Frayssinet et al., 1973), and when adminstered 
daily to suckling mice, interferon retarded their growth and 
development (Gresser et al., 1975). Interferon gamma has been
demonstrated by Broxmeyer et al., (1983) to inhibit the 
proliferation and differentiation of haemopoietic precursor cells. 
The proliferation of tumour cells and their growth rates in in
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vitro cultures were retarded by interferon and in some comparative 
studies malignant cells were more sensitive to interferon than 
non-tumour cells (Gresser and Tovey 1978), (Brouty-Boye' 1980). 
Interferons are not cytotoxic, and their action is reversible, but 
if interferons were maintained in the culture medium for more than 
48 hours cell death was often observed, (Gresser and Tovey 1978). 
Interferon interacts with the target's cell membrane, (Auget 1980), 
inducing the synthesis of RNA and polypeptides related to antiviral 
proliferation,(Friedman and Vogel 1983). Interferon binds to the 
cell surface, and a direct correlation has been found between the 
intracellular cAMP content and the degree of inhibition of cell 
multiplication induced by interferon, (Fuse and Kuwata 1978). The 
inhibitory effects of interferon on cell proliferation, may be 
similar to cAMP, as both induce the formation of protein kinase 
which contributes to the control of cell proliferation (Greengard
1978).
Collyn d'Hooghe et al., (1977) have demonstrated a marked
increase in the generation time of mouse mammary tumour cultures 
incubated with interferons. Balkwill and Taylor-Papadiraitriou
(1978) have demonstrated that interferons reduced the rate of entry 
of Balb/c 3T3 cells into S phase, together with an increase in the 
duration of Gi and G2 + S phases. Creasey et al., (1980) have 
demonstrated that human leukocyte interferon decreased the 
transition rate of Gq-G-j quiescent human melanoma cutures, into S 
phase, and also prolonged the duration of S phase, as compared to 
the cultures cultured without interferon.
Some of the events associated with the stimulation of 
quiescent cells into DNA synthesis was an increase in the levels 
polyamine biosynthesis enzymes. The induction of the activities of
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the polyamine associated enzymes, such as S-adenosyl-L-methionine 
decarboxylase and ornithine decarboxylase, were inhibited by 
interferon, (Lee and Sreevalsan 1981, as described by Friedman and 
Vogel 1983) and (Sreevalsan et al.; 1979, 1980). DNA synthesis is 
also influenced by interferon, as Lundblad and Lundgren (1982) have 
demonstrated that the treatment of human glioma cultures with 
interferon-beta, has decreased the activity of DNA polymerase of |
these exponentially growing cells, and has also decreased their f
growth rate. The inhibition of cell proliferation by interferon 
was accompanied by a reduction in DNA, RNA, and protein synthesis, 4
(Brouty-Boye 1980).
Trying et al., (1982) have shown that interferon gamma was 
cytotoxic for some cell types. The inhibitory effects of 
interferons preparations may be due to contamination with 
lymphotoxins (Stone-Wolff et al., 1984, as described by Trinchieri f
and Perussia 1985). Most of the growth-inhibiting effects of 3
interferon preparations were not observed when either lymphotoxin 
free, natural interferon gamma preparation or homogeneous 
recombinant interferon gamma were used. Interferon gamma had a 
strong synergistic effect with lymphotoxin, and cells were lysed or 
their growth was prevented by a combination of interferon gamma and 
lymphotoxin at concentrations that were inefficient separately,
(Trinchieri and Perussia 1985).
The term lymphotoxin was introduced by Granger and Kolb (1968) *
to describe the qytotoxic effects in cell cultures of soluble 
products produced by mitogen or antigen stimulated lymphocytes. %
Lymphotoxin has a variety of effects, such as inhibiting tumour 
growth in vivo, the induction of increased susceptibility of tumour 
cells to cytolytic destruction by NK cells, and to prevent the
4
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were demonstrated by Evans and co-workers (Evans 1982).
The anticarcinogenic effects of lymphotoxin are due to its 
influence on the cell membrane, thus it induces a specific increase 
in glucosamine incorporation in nontransformed hamster cells, while 
it decreases the incorporation of glucosamine in transformed 
hamster cells (Evans 1982).
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carcinogen-induced morphological transformation during 
carcinogensis. Lymphotoxins are glycoproteins, which bind to the |
receptors on target cells, and may affect the proliferative 
properties of the target cell, through alterations in the chemical 
structure of the target cell's membrane (Walker et al., 1976,
Kobayashi et al., 1979). The cytotoxic activities of lymphotoxin 
were demonstrated in terms of the enumeration of surviving cells, 
isotope release by damaged cells, and colony inhibition assays 
(Evans 1982).
Lymphotoxin can induce or stimulate interferon secretion 
(Evans 1983), and thus can augment the inhibitory activities of 
interferon by its mutual synergistic effect with interferon in 
inhibiting the clonal growth of HeLa cells as has been shown by 
Trinchieri and Perussia (1985), and as described earlier, the 
enhancing effects of interferon on NK cytotoxic activities and 
recruitment of pre-NK cells into the cytolytic forms. Thus 
lymphotoxin was controling tumour proliferation in this example in %
an indirect way. ?
-i
Moreover, lymphotoxin can increase the sensitivity of tumour 4icells to NK cell destruction ( Ransom and Evans 1982). The t
anti-carcinogenic effects of lymphotoxin on the transformation of Ihamster cells by chemical carcinogen or ultraviolet irradiation v4
I
Lymphotoxin, can therefore, contribute in a variety of ways to 
the control of tumour cell proliferation; and if its activity is 
down-regulated, it may be one of the means that a developing tumour 
cell can escape from the inherent homeostatic mechanisms that 
control tumour cell growth (Evans 1983).
1*3.5 j^e macEpphagg :
The control of cell proliferation, as has been reviewed I
earlier, was discussed in terms of humoral factors which were 
involved in cellular proliferation. However, there are other 
mechanians in which cellular proliferation may be controlled 
through cellular co-operation, besides the contribution of humoral 
mediators. Cell to cell contact is a mechanian of cellular 
co-operation in which cell proliferation is controlled, (Burger and 
Noonan 1970, Bunge et al., 1979). Cell to cell contact and 
co-operation is a feature associated with the cells of the immune 
system, and one such cell, which contributes an essential role in 
these activities is the macrophage. The macrophage, practically, 
handles most of the mechanians involved in the control of cell 
proliferation, as they secrete humoral mediators involved in the 
regulation of cell proliferation, they contribute to the regulation 
of the immune response as accessory or effector cells, and modulate 3
tumour growth. Cells of the mononuclear phagocytes series 
originate in the bone marrow. Their differentiation pathway is 
from stem cells to monoblasts, prcxnonocytes and monocytes; the 
monocytes are transported by the blood to function in the various 
tissues as tissue macrophages, and thus the mononuclear phagocytes
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are hetergeneous in nature, (Carr and Daems 1980). The supply of 
macrophages to the peripheral tissue (under steady state 
physiological conditions) is from the bone marrow (Spector 1977), 
and (Keller 1979) has demonstrated that the selective radiation 
damage to the bone marrow by radioactive strontium, has abolished 
the spontaneous cytotoxity expressed by mononuclear phagocytes from 
the peritoneum and the spleen. Under conditions of demand, in 
inflammatory sites, the macrophages increase their numbers by 
mitotic division (Spector 1977). The differentiation, and survival 
of mononuclear phagocytes depends on a line-specific growth factor 
which is selectively destroyed by the differentiated cells 
(Tushinski et al., 1982).
The various roles of the macrophage such as the control of 
cell proliferation, mechanisms of natural cytotoxity and release of 
humoral mediators, and enhancement or suppression of tumour growth 
will be discussed below. The interaction between macrophages and 
other cells may result in enhancement or suppression of the various 
functions of the target cells, in in vitro culures, depending on 
the functional activity of the effectors and the ratio of target to 
effector cells. The effector cell may affect the proliferation of 
the target cell, its viability, differentiation and its functional 
ability . The growth of cells in in vitro cultures is promoted and 
regulated by the presence of macrophages or adherent cells (Zipori 
1980). Blood monocytes and tissue macrophages produce (CSA) colony 
stimulating activity substances (Johnson and Burgess 1978), (Cline 
et al., 1974) which can contribute to the growth and
differentiation of stem cells into macrophages and granulocyte 
colonies in invitro cultures (Polverini et al., 1977),
(Gospodarowicz and Moran 1975), (Metcalf 1977-1979). The 
macrophages contribute a dual role in the regulation of
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monocytopoiesis and thus regulating their own numbers, by promoting 
their growth and survival with colony stimulating factor (CSF) 
(Tushinski 1982), and limiting their growth by prostaglandins 
(PGE2), (Kurland et al., 1978, 1979). Macrophage products are also 
involved in the regulation of erythropoiesis (Kurland et al., 
1980), in the premotion of B cell differentiation into antibody 
secreting cells, in the promotion the immature thymocytes to mature 
T cells, (Unanue 197 8) and in the control of fibroblast 
proliferation (Leibovich 1978). Mhcrophages may modulate their 
target through the production of lymphokines, such as interleukin I 
(111) which is a polypeptide with a molecular weight of 12000-16000 
dal tons (Oppenheim and Gery 1982).
IL1 augments thymocyte proliferation (Oppenheim et al., 1982) 
and induces helper activity in thymocytes (Farrar and Koopraan
1979). Interleukin I augments immunoglobulin production and 
influences the lymphocyte membrane by increasing its ability to 
bind antigen , and by inducing the formation of differentiation 
markers, such as the stable sheep erythocyte rosette in human 
lymphocytes (Oppenheim and Gery 1982). Interleukin 1 is also 
required in premoting the production of interleukin 2 (T cell 
growth factor) which promotes the proliferation of T cells (Smith 
and Ruscetti 1981). The macrophages participate as accessory cells 
in antigen processing and presentation (cell to cell contact) to B 
and T cells. T-helper cells must interact with macrophages in the 
process of surveillance for foreign antigens, and then must 
interact with B cells and cytotoxic (TC) precursor cells to 
stimulate their differentiation into plaana cells and Tc effector 
cells respectively, (Hood et al., 1978). The macrophage can
participate in a variety of ways to control tumour growth, the 
simplest form which does not require co-operation with T cells or
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their regulatory lymphokines, is by direct natural cytotoxicity, 
without even the requirement of previous exposure to target cells, 
as tfentovani et al., (1980) have demonstrated the effective
growth-inhibitory activities of human mononuclear phagocytes 
obtained frcxa various anatomical sites against target TU5 tumour 
cells in invitro cultures. In another form of target cell 
interaction, the normal macrophages exposed to tumour cells or 
antigens either acquired cytotoxicity, or induced cytotoxic 
lymphocytes. Robinson and Wheelock (1981) have demonstrated that 
tumour dormancy of a syngenic L5178Y lymphoma ascites tumour in 
DBA/2 mice was accompanied by cytotoxic T cells in the early phase, 
but at 50 to 70 days post tumour inoculation, the cytotoxic cells 
had disappeared but cytotoxic macrophages appeared and were 
considered to be the mediators of the tumour dormant state. 
Taniyaraa and Holden (1979) have demonstrated that the co-operation 
between spleen cells and gyngeneic macrophages was required for the 
induction of cytotoxicity against their target syngeneic tumour 
cells. Earlier results by Evans and Alexander (1970) have 
demonstrated the specificity of the macrophage cytotoxic response. 
Macrophages obtained from mice challenged with L51787 lymph cm a 
cells, were specifically cytotoxic against the L51787 cells and not 
other related lymphoma target cells in invitro cultures. Evans and 
Alexander (1972) have also demonstrated that T cells sensitized 
with C57BL/6 lymphoma cells, confer the specificity of target 
recognition to macrophages through a T-cell product, however, after 
the specific target killing by macrophages, the macrophages become 
activated and can ' destroy other targets no nr-specifically. 
Macrophages are also involved with specific antibody in 
antibody-dependent cell cytotoxicity (ADCC) in the destruction of 
tumour target cells (Bast et al., 1980). b^crophages obtained from
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regressing tumours were shown by Russell and McIntosh (1977) to be 
more cytotoxic than those derived from progressing tumours. 
Macrophages infiltrate tumours growing in vivo, and reach a fixed 
percentage in relation to total cellular content, which appears to 
be specific for each tumour. The level of macrophages in the
tumour may decline over raaay passages in vivo, (Evans 1972). The
relation between macrophage contents in tumours and tumour
immunoge ni city was suggested by Evans (1972), and was investigated 
by Eccles and Alexander (1974) who showed a putative relationship 
between tumour immunogenicity, tumour macrophage content, and 
tumour metastatic potential.
In a further study by Evans and Lawler (1980) on mice 
sarcomas, the relation^ip between tumour immunoge ni city and its 
macrophage content was tested, and the data indicated a lack of 
correlation between immunogenicity and macrophage content. 
Macrophages resident within a tumour are not homogeneous with 
respect to tumour cell interaction, as Evans and Haskill (1983)
have reported the heterogeneous nature of macrophages fron
different rodent tumours, or within the same tumour, in terms of 
their sedimentation velocity distributions and their respective 
effector functions in colony inhibition and ADCC assays. The 
growth of the tumour despite the presence of the macrophages does 
not necessarily mean that the macrophages were not active within 
the tumour, as Key and Haskill (1981) have demonstrated that 
macrophages from regressing tumours were highly phagocytic and 
mediated the ADCC against their target tumour cells. The control 
of tumour cell proliferation, in terms of macrophage tumour cell 
interaction may be mediated through other mechanisms which may
contribute to both tumour growth stimulation and inhibition.
Macrophages release a variety of humour al mediators such as
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thymidine (Optiz 1975a, b) which interferes with the incorporation 
of isotope uptake by cell cultures, and which was found to inhibit 
the growth of EL-4 leukemic cells (Stadecker et al., 1977). The 
results described by Vercammen-Grandjean and Lejeune (1977) on the 
inhibitory effects of macrophage supernatants on the uptake of 
isotope by target cells suggested that the inhibitory effects of 
the macrophage supernatants can be attributed to factors other than 
thymidine. Activated macrophages secrete polyamine oxidase 
(Allison 1978), which reacts with spermine or spermidine to 
generate inhibitory products on cellular proliferation. Actively 
dividing cells contain spermine and spermidine, and thus, the 
availability of poly amine oxidase in the environment of such cells 
may inhibit or regulate their proliferation. The effects of 
poly amines and poly amine oxidase on cellular proliferation will be 
discussed later in this thesis.
Chen et al., (1977) have shown that a factor prepared from 
thioglycolate induced peritoneal macrophages of DBA/2 mice 
inhibited the proliferation of L1210 lymphoma cells, and in a 
subsequent study by Chen and Broom (1980) the inhibitory substance 
was identified as arginase; the effects of arginase were reversed 
upon the addition of arginine to the cell cultures. Macrophages 
produce tumour necrosis factor (TNF), (Pennies et al., 1984) which 
retards tumour growth, and also produce Cachectin (Beutler et al., 
1985) which pousses potent TNF activity in vitro.
Mhcrophages secrete interferon and prostaglandins, and tumour 
cells also produce prostaglandins, the prostaglandins provide a 
mechanian against the macrophage's role in inhibiting tumour growth 
(Schultz 1980). Cultures of murine peritonal macrophages activated 
with mitogen, secreted prostaglandins and were not cytotoxic
- 81 -
1
against their mastocytana targets. Addition of indomethacin fÎ
promoted the cytolytic activity of the macrophages, while the 
addition of prostaglandin prevented it, and thus these mechanisms 
of macrophage tumour cell interaction were taken by Taffet and 
Russell (1981) to explain the lack of cytotoxicity of intratumour al 
macrophages. Suppressor macrophages also contribute to the
promotion of tumour growth. Kolb et al., ( 1977) have demonstrated s:
that the depressed ability of spleen cells from mice bearing 
plasmacytcxna to mount an antibody response was attributable to 
suppressor macrophages. Kennard and Zolla-Pazner (1980) have 
demonstrated that normal peritoneal macrophages may become 
suppressor macrophages for antibody production, when exposed in 
vitro to factors released by plasmaqytcmia cells. The inhibitory 
activity would be eventually exerted through the production of a 
second factor (the plasmacytoma induced macrophage substance) by 
suppessor macrophages. Ehrlich et al., (1980) have demonstrated 
that splenic NK activity was depressed in Balb/c mice bearing a 
(DMBA) dimethylbenzanthracene induced mammary carcinoma, but that 
depressed NK activity was re-potentiated when splenic macrophages 4
were removed. Similarly, Gerson et al., (1981) have demonstrated 4
that macrophages infiltrating MSV-induced tumours can actively /
suppress the cytolytic effector phase of NK cells. |
Ting and Rodrigues (1980a,b) have suggested that macrophages 
may become suppressive in response to some signal from tumour cells 
and have demonstrated the existance of an immunoregulatory circuit Iamong macrophage subsets for T-cell mediated cytotoxicity. Under ^
the influence of tumour cells, the T-cell function was positively 
or negatively regulated, through the immunoregulatory circuit of 
spleen and peritoneal macrophages. Suppressor macrophages may also 
influence some functions of T lymphocyte which may contribute to !|
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tumour growth control. The termination of tne tumour dormant state 
of lymphoma ascites in DBA/2 mice was mediated by peritoneal 
suppressor macrophages which inhibited tne generation of cytolytic 
T cells (Robinson et al., 19b3). Garrigues et al., (19îJl) have 
demonstrated that splenic macrophages from mice bearing Mua-induced 
transplantable sarcomas did not afreet tne cytotoxic ability of 
differentiated T lymphocytes, but they were inhibitory for tne 
generation of cytotoxic T lymphocytes in an MLC reaction. 
Suppressor macrophages are also present in normal individuals, and 
their suppressive effects on several immune responses in invitro 
assays have been reviewed by Varesio (1983). The suppressive 
effects of macrophages, included the inhibition of mitogen-induced 
proliferation of syngeneic spleen cells, the inhibition of tne 
generation of cytotoxic T cells in MLR cultures, the inhibition of 
development of primary antibody response to red blood cells, and 
the inhibition of maintenance of NK cell activity. These 
macrophage associated suppressive effects, may suggest a 
physiological mechanism, through which the macrophage can 
contribute to the homeostatic control of the immune system (Varesio 
1983). Apart from the promotion of tumour growth by suppressor 
macrophages, the effectiveness of the cytolytic activity of 
cytotoxic macrophages against their tumour cell targets is 
restricted to those tumour cells at Gi -8 transition. Thus the 
cytolytic macrophage which has a limited period of activity against 
a proliferating cell target would therefore exert little antitumour 
effect (Evans and Haskill 1983). The macrophage can also produce 
factors which stimulate the proliferation of tumour cells. Evans
(1979) has demonstrated that macrophages from rodent sarcomas were 
able to "condition" culture medium, the active material with a 
molecular weight less than 10,0üü stimulated the proliferation of
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normal, and neoplastic cells.
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CHAPTER TWO
MATERIALS AND METHODS
1. Tissue Culture;
Sterile techniques were used throughout tissue culture 
experiments. All sterile tissue culture procedures were performed 
in a laminar flow bench which was swabbed with 70% ethyl alcohol 
before use.
The medium used for tissue culture was RPMI 1640 (Flow Labs, 
U.K.) The medium was prepared in 100 ml aliquots that were buffered 
with 20m,moles Hepes (Sigma, U.K.) pH 7.5 and supplemented with 
200m,moles L-glutamine (Flow Labs, U.K.) together with benzyl 
penicillin 50 units/ml and streptomycin sulphate 50ug/ml (Flow 
Labs, U.K.). Foetal calf serum (FCS) (Flow Labs, U.K.) was heat 
inactivated at 56 & for 30 minutes in a Grant water bath, (Grant 
Instruments, U.K.),
All instruments and containers used for tissue culture 
experiments were sterile and were flamed when necessary.
All short term cultures were incubated in a Leec incubator at 
37 °C which was supplied with 5% CO2. The animals used (mice-rats) 
were of 7-10 weeks of age. The animals were swabbed with 70% ethyl 
alcohol before dissection and were placed under a clean perspex 
hood which was previously swabbed with 70% alcohol.
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2. Preparation of cell suspensions;
Preparation of plasmacytoma cell suspension for tumour passaging;
IThe subcutaneous tumour present in a Balb/c mouse was excised 
from the mouse and placed in a sterile petri dish and transferred 
to a laminar flow bench, where it was divided into approximately i
3-5 mm pieces. The necrotic tissue was left aside while the (pink 
coloured) viable portions were transferred to sterile 6 ml bijous 
(Sterilin 54001-129A. Sterilin. U.K.), that contained 4 ml of 37 
*b prewarmed RPMI medium.
A tumour cell suspension was prepared by the careful 4
disruption of the tumour fragments through the repeated withdrawal 
and release of the fragments by a 1 ml sterile syringe (Beckton j
Dickson. Ireland), The bijous were left over ice for one or two
minutes for the debris to settle. The supernate was then
transferred to 10 ml sterile conical base tubes (Sterilin
61044-144A5, Sterilin, U.K.), and were centrifuged in a
refrigerated 4 t (MSE.FISON-Chilspin, MSE, U.K.) bench centrifuge Ï
3for 10 minutes at 1-1,4x10 RPM , The supernate was discarded, 
while the cell pellet was resuspended in RPMI to the required 
concentration; usually 5 x icf cell/ml. The viability of the cells 
was assessed by Trypan blue exclusion, (Trypan blue; Sigma T0887.
Sigma, U.K.), A stock preparation of 0,2% was used at a final 
concentration of 1;4 with cell suspension, in an improved Neubauer 
haemocytometer (Hawkesiey ltd, U.K.),
The proportion of viable tumour cells in a tumour cell 
suspension ranged from 45%-75% , mainly due to the incorporation of 
necrotic material while dissecting the tissue.
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Preparation of plasmaoytoma cell suspension for tissue culture:
A plasmacytoma tumour was excised and a cell suspension was 
prepared as previously described. The cell suspension was filtered 
through a sterile stainless steel sieve mesh.
The clear suspension was transferred to 10 ml sterile conical 
base tubes (Sterilin. U.K.) and was centrifuged in a refrigerated 
(MSE, Chilspin) centrifuge for 10 minutes at 1,4x10^ RPM,
The supernate was discarded and the cell pellet was 
resuspended in cold 0,83% NH4CI (BDH Chemicals.U,K,)(2 vol. NH4GI: 
1 vol. cell pellet) supplemented with Hepes pH 7,4 solution at a 
final concentration of 20m.moles. The cells were left in an ice 
bath for 5 to 8 minutes, after which the NH4CI cell suspension was 
diluted with generous amounts of cold RPMI, (Boyle 1968), The cell 
suspension was centrifuged for 10 minutes at 1,4x1(f RPM, The 
supernate was discarded and the cell pellet resuspended in cold 
RPMI to the required cell concentration after assessing the cell 
viability with Trypan blue.
Preparation of normal thymocytes suspension for tissue culture:
Mice or rats (7-10 weeks of age) were killed as decribed 
previously; the thymus was carefully removed with a pair of 
forceps, and transferred to a sterile bijou containing prewarmed 37 
t RPMI 1640,
The thymus was divided into small pieces approximately 2-4mm 
in size and a cell suspension was prepared as described earlier for 
plasmacytoma cells.
Preparation of CBA mammary adenocarcinoma cell suspension:
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3CBA Mice were killed as described previously and their mammary *
Short terra culture: Microtitre tissue culture plates:
Sterilin microtitre trays (U-well type-57102-M24ARTL) were 
used for tissue culture experiments. Viable cells of certain
numbers were dispensed into the culture wells by a micropipette 
(Finnpipette), together with the substance to be tested, and a 
radioisotope; the cell dose was replicated in 5 wells.
3. Isotope labels to monitor DNA synthesis :
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tumours were excised as described for the plasmacytoma procedure. 
The tumour was divided into approximately 3-5mm pieces. The tumour 
pieces were incubated with collagenase (Sigma, U.K.) , 0,25% in
2+ 2f *3Earle’s Basal salt solution Ca ,Mg free containing EDTA 10 molar, 
in sterile bijous at 37 C, The bijous were rolled on a tube roller 
for 10-15 minutes, Tryspin (Sigma, U.K.) was added later to the 
collagenase tumour suspension, at a final concentration of 0,25% 
and incubated for a further 10-15 minutes on the tube roller. 
After the tryspin digestion, calf or horse serum was added at a 
final concentration of 10% per bijou content of tumour enzyme 
mixture. The final step was to add Deoxyribonuclease (DNASE,Sigma, 
U.K.) to the enzyme tumour mixture at a final concentration of not 
less than lOug/ml of tumour digest, and in some instances the 
amount of DNASE was double that amount. The cell suspension 
obtained from the bijous was diluted with prewarmed 37 °C medium and 
the contents were transferred into 10 ml sterile tubes and 
centrifuged for 10 minutes at 1,4 x 10^RPM in a refrigerated bench 
centrifuge. The supernate was discarded and the cell pellet 
resuspended in fresh RPMI.
‘tJ
5-Cl25I]Iodo~2-deoxyuridine, (sp. activity 5ci/rag. Amersham ?
International, Pic, U,K,) was the main isotope used in tissue 
culture experiments while [methyl-3H]Thymidine (sp, activity 5 
ci/m,mole, 1 ci/ ml, Amersham.U.K,) was used in some experiments.
A sterile stock solution of lOuci/ral of 125IÜDR was prepared 
and 0,2uci (20ul/well) were dispensed by means of a micropipette 
into each culture well. The same procedure was applied to 
3H-Thymidine, Tissue culture wells containing the cell suspension, 
the assay substance, and the isotope, were placed in a 5% CO2 
incubator at 37 t for different periods of time. After the
The filters were left to dry for 15 minutes in a drying oven. 
The portions of the filter that contained the cell deposit of each 
well; were punched into small plastic tubes; and the DNA uptake of 
125 lUDR was assessed in a gamma spectrometer (LKB 
Instruments,U.K.),
In the case of 3H-Thymidine the filter discs were dispensed 
into appropriate scintillating vials. The vials contained 5 mis of 
liquid scintillation in Toluene (BDH Chemicals, U.K.) The 
scintillation liquid contained (2-5-Diphenyl-oxazole:PP0) 6g/litre 
and 1,4-Di-2-(5-Phenyl- oxazolyl) benzene POPOP, 0,2g/litre (BDH 
Chemicals U.K.). The vials and their contents were counted in an 
SL 30 scintillation counter (Intertechnique, U.K.), using the 
thymidine setting for a minimum threshold of 25.5 cpm (counts per
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relevant incubation period, the cells were harvested from the wells 4
on to fibre glass filter paper by means of a cell harvester. The 
Titertrek cell harvester (Flow Labs), operates by delivering PBS 
buffer (BDH Chemicals,U.K.) to the wells, and withdrawing the 
contents of the microtitre wells simultaneously, to deposit them on 
a fibre glass filter.paper, (Flow Labs,),
i
I
 -
I
minute) with a maximum counting time of 10 minutes per sample. The Icounts were assessed for quenching due to pellet, and various cell
doses were prepared to assess self absorption,
4, Preparation of various sera ;
Human serum ;
15-20 ml of blood were withdrawn from human volunteers by 
venipuncture using a sterile 20 ml disposable syringe (Beckton 
Dickson, Ireland) with a sterile needle (gauge 25G5/8)
The blood was transferred into sterile 10 ml tubes (Sterilin 
144AS). The tubes were capped and left to stand for at least 90 
minutes at room temperature for the blood to clot. Subsequently 
the tubes were kept at 4 °C for 15 minutes to allow the clot to 
retract. The serum was aspirated and the tubes were centrifuged in 
a refrigerated bench centrifuge for 10 minutes at 1,4 x 10 RPM, 
The remaining serum supernate was aspirated. The serum was pooled 
and aliquoted in sterile bijous and stored at -20 *b.
CBA and CD1 mice sera:
CBA and CD1 mice were anaesthetized as described earlier, and 
blood from the respective group of mice was obtained by 
cardiac-puncture using a sterile 2 ml syringe (Beckton Dickson. 
Ireland) fitted with a sterile needle (Gauge 23G1, Beckton 
Dickson, Ireland), The blood of each group was dispensed into 
separate sterile tubes (Sterilin 144AS) and the procedure for serum 
collection was the same as described earlier for human serum.
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Rat serum :
Serum from rats was obtained according to the procedure
described for mice.
Preparation of bovine serum albumin and human serum albumin :
A 4,3% BSA solution, was prepared by dissolving 430rag of
bovine serum albumin (Sigma A7030, Sigma, U,K,) in 10 ml of RPMI, 
The solution was sterilised by passing through a sterile 0,22um 
millipore filter (Millipore, U,K,), A 4.6% solution of human 
serum albumin (Sigma A8763) was prepared by dissolving 467.5 mg
human serum albumin (Sigma, U.K.) in 10 ml of RPMI, The solution 
was sterilised by passing through a sterile 0,22um millipore
filter. Both BSA and HSA were stored at 4 °C, The concentrations 
of BSA and HSA were according to the values given by Altman and 
Dittmer (1971).
5. Preparation of hydroxyurea, thymidine and polyamine solutions :
A stock solution of 0,1 moles hydroxyurea (Sigma, U.K.) was 
prepared by dissolving 76,1mg in 10ml of RPMI 1640 and was 
sterilised through a sterile 0,22um millipore filter. The stock 
solution was serially diluted to 10^ , 10^ , 1Ô*, 10^and 10^moles, 
for experimental assays.
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Preparation of thymidine solution:
A stock solution of 0.002 moles thymidine (Sigma. U.K.) was 
prepared and sterilised through 0.22um millipore filter. The stock 
solution was stored at -20 b in sterile bijous for further use.
Preparation of spermidine and spermine stock concentrations :
Spermidine (N-[3-Aminopropyl]-1,4 butanediamine)
Trihydrochloride , (Sigma S2501. Sigma. U.K.).
Spermine (N,N -bis[3Aminopropyl]-1,4 butanediamine)
tetrahydrochloride, (Sigma 2876. Sigma. U.K.).
Spermidine was prepared at an initial stock concentration of
80mg/litre = 0.314m.moles , and was sterilised through a sterile
0.22um millipore filter, and stored in sterile glass bijous at -20 
°C .
Spermine was prepared at an initial stock concentration of
80mg/litre = 0.229m.moles; prepared and stored as for spermidine.
The stock concentrations of spermine and spemidine were 
diluted respectively to the following ug/culture well 
concentrations:
8,4,2,0,8,0,4,0,08 and 0,04,
The percentage inhibition of polymaines was calculated as 
follows:
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A=Isotope uptake by cultures without polyamine (control mean 
counts per minute)
Bslsotope uptake by cultures with polyamine ( mean counts per 
minutes)
C= % inhibition of isotope uptake = [A-B/A] x 100.
The estimate of ID50 (dose of polyamine per culture that produces a 
50% inhibition of isotope uptake by cultures) was estimated 
graphically from the linear portion of respective curves that 
described the inhibitory effects of polyamines.
6. Preparation of acid insoluble DNA precipitate from plasmacytoma 
cells :
A suspension of plasmacytoma cells was prepared as described 
earlier, and was divided into five groups according to the content 
of FC8-HI per culture group. Group 1; 5% FCS, Group 2: 10% FCS,
Group 3: 15% FCS, Group 4: 25% FCS, The plasmacytoma suspension,
was dispensed by means of a micropipette into sterile tubes (Nunc, 
U.K.) at a concentration of 0,5 x 10^cells per tube (200ul per 
tube). To each culture 0,2uci of 125IUDR were added. The tubes 
were capped and incubated for 4 hours at 37 C in a Leec incubator. 
Each group contained 5 tubes. Following the incubation, the tubes
3were spun in a bench centrifuge at 1,4 x 10 RPM for 10 minutes. 
The supernate was discarded and the cell pellet of each tube was 
resuspended in 2 ml of 1 normal NaOH solution (BDH Chemicals; 
U,k,), The tubes were incubated at 37 C for 1 hour, and on several 
occasions, during the incubation period the tubes were vibrated by 
means of a vibrating machine to facilitate the DNA extraction 
procedure. To each part of NaOH tissue homogenate, 2,5 parts of a
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freshly prepared 10% trichloroacetic acid were added (TCA.BDH 
Chemicals; U.K.). TCA and the NaOH tissue homogenate were mixed in 
sterilin tubes (Sterilin 61304 RT30); and centrifuged at 2x10^ RPM 
in a bench centrifuge for 10 minutes. The supernate was carefully |
removed with a pasteur pipette drawn to a capillary tip (lOOum in 
size). The remaining residue was washed with 5% TCA; centrifuged 
and the supernate removed as described above. The tubes and their 
contents of the remaining DNA extract were transferred to a gamma 
spectrometer to assess isotope uptake by DNA. The DNA extraction 
procedure was according to the method of Bonting and Jones (1957). I
7. Preparation of uptake inhibitory factor (UIF) : .t
UIF was prepared according to the method of Bonmassar et al.,
(1978). UIF was prepared from rat thymuses and spleens, also from 
mice thymuses, spleens, lymph nodes, and bone marrow. All RPMI 
1640 media for UIF preparation contained benzyl penicillin 50Iu/ml, I
streptomycin sulphate 50 ug/ml and 50 ug/ml of Kanamycin (Glaxo,
U.K.) to prevent microbial and mycoplasma contamination. The rats 
and mice were between 7-10 weeks of age.
Thymus UIF ;
UIF was prepared from rats and mice, each being independent of 
the other, UIF preparations from mice were never mixed with UIF 
preparation from rats. Suspensions of thymocytes were prepared as 
decribed previously.
The final cell suspension was made at a concentration of 1 x 
1(f cells/ml RPMI without FCS, Cell viability as assessed by Trypan 
blue exclusion was >98%, 5ml of 1 x irf cells/ml suspension were |
dispensed into tissue culture grade, 50mm. diameter, petri dishes 
(Sterilin 57002-302). The tissue culture petri dishes were 
transferred into clean, 70% ethyl alcohol swabbed incubation boxes. 
The box had 2 holes in its lid to allow gas exchange. The box and 
its contents of petri dishes were incubated for 16 hours at 37 °C, 
5% COg in a Leec incubator. Following the incubation, the 
supernatant from the petri dishes was transferred to 10 ml sterile 
(Sterilin 144AS) tubes and centrifuged in a refrigerated bench 
centrifuge for 10 minutes at 2100 RPM,(4l4xg), The supernate from 
the tubes was collected, pooled and sterilised through a sterile
0.22um millipore filter; collected in sterile universels and stored 
at -20 t.
Spleen UIF :
Mouse and rat spleen UIF was prepared in a similar procedure 
to that of thymus UIF,
Two fractions of spleen UIF were prepared;
A) Whole spleen UIF (RWC= red and white cells, whole spleen 
fraction UIF).
B) WCF.UIF; spleen cells UIF, except the erythocytes were
lysed, and the remaining fraction was the white cell fraction
(WCF).(The white cell fraction UIF is also called STD,UIF or 
standard UIF),
The 5M UIF (^ five million cells), was prepared as for WCF UIF
but at half culture density, i.e. 5 x 10^  cells/ml.
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Preparation of mouse bone marrow UIF i
Balb/c mice were killed as described earlier, swabbed with 70% 
ethyl alcohol; their femurs collected and transferred into sterile 
bijous containing prewarmed 37 RPMI 1640. The femurs were taken 
out from the bijous with a sterile forceps; and a sterile needle 
(Yale microlance 01101-11, gauge 25/5) which was attached to a 1 ml 
sterile syringe (Plastipak Syringes. Becton Dickson. Ireland) 
containing RPMI was inserted through one end of the femur. Medium 
was flushed into the cavity, and the contents of the washing were 
collected from the opposite side of the femur into sterile bijous. 
The process was repeated until no more particulate matter came from 
the femur. The crude bone marrow suspension, so collected, was 
dispersed into a finer suspension by the same needle and syringe, 
by gently withdrawing the contents of the crude marrow suspension 
into the syringe and releasing them back into the bijou. This 
process was repeated several times. The suspension was centrifuged 
in a refrigerated (MSE, FISON) bench centrifuge for 10 minutes at 
1,4 X 10^  RPM; the supernatant discarded and the cell pellet 
resuspended in cold RPMI 1640 to a concentration of 1 x 1(f cell/ml. 
The cell viability as assessed by Trypan blue was >98%.
Lymph node UIF ;
Balb/c mice were killed as described earlier and their lymph 
nodes from the inguinal, axillary and mesentric regions were 
collected into sterile bijous containing prewarmed 37 RPMI, The 
nodes were gently teased by carefully withdrawing and releasing the 
nodes through a 1 ml sterile syringe. The preparation of the final 
cell concentration for UIF production was described earlier for the 
previous UIF preparations.
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Preparation of freeze-thawed extracts of spleen cells (white cells 
fraction, Freeeze-Thaw UIF) :
A suspension of rat spleen cells ( white cells fraction) was 
prepared as decribed previously and adjusted to a concentration of 
2 x  10 cells/ml according to the method of Bonmassar et al., 
(1978), 20mls of 2 x 10 cells/ml were dispensed into sterile 
universels and kept at -20 °C until the suspension was completely 
frozen. The frozen suspension was thawed completely at 37 °C in a 
water bath. The thawed suspension was left at -20 °C until 
frozen, and re-thawed again. The procedure of 
freeze-thawing was repeated 3 times and the resultant supernatant 
was assessed for cell count and viability; which manifested 
neither. The supernatant was transferred into 10 ml sterile tubes 
and centrifuged in a refrigerated bench centrifuge for 15 minutes 
at 4l4xg, The supernate was collected and sterilised through a 
sterile 0,22um millipore filter. The supernate was pooled and 
stored in sterile bijous at -20 t.
Preparation of adherent and nonadherent cells UIF ;
Rat spleen suspension (white cells fraction at a concentration 
of 1 X 10^  cells /ml) was prepared as described previously. The 
supsension was diluted 1 fold to 5 x 10® cells/ml, 5ml of 5 x 10® 
cells/ml suspension were dispensed into sterile 50mm petri dishes. 
The petri dishes were transferred into an incubation box and 
incubated at 37 °C, 5% C02for two hours in a Leec incubator. The 
preparation of adherent and nonadherent cell fractions was 
generally similar to the procedure described by Hosier (1967). 
Following the 2 hour incubation the supernate containing the 
nonadherent cells was collected into sterile universels (Sterilin
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U.K.), The petri dishes were washed gently several times to remove 
further weakly adherent cells. The washing procedure consisted of 
adding 2ml of pre-warmed 37 RPMI to each petri dish, and 
following the addition of warm RPMI medium, the dishes were rotated 
gently by hand. The pooled supernate was centrifuged at 1,4 x 10® 
RPM for 10 minutes in a refrigerated bench centrifuge. The cell 
pellet of the nonadherent cells was resuspended to a concentration 
that was adjusted as to the original concentration of 1 x 10^  
cells/ml, and 5ml of which, were dispensed into 50mm sterile petri 
dishes.
Preparation of adherent cells :
2ml of prewarmed 37 t Earle’s Basal salt solution (C^*, Mg 
free) containing 0,25% Trypsin, (Sigma T 8003), and EDTA, 
(Sigma-EDS) at a concentration of 10 moles , were dispensed into 
each petri dish. The dishes were rotated gently on an axial shaker 
at 37 C for approximately 10 minutes. Immediately after 
trypsinization 500 ul of calf serum were added to each petri dish 
to stop the action of trypsin. The contents of the petri dishes 
were pooled and diluted with additional amounts of medium. The 
contents were transferred into sterile universels and centrifuged 
for 10 minutes at 1.4 x 10® RPM in a refrigerated bench centrifuge. 
The supernate was discarded and the cell pellet was resuspended in 
RPMI, The cell suspension was adjusted to a concentration of 1 x 
10^  cells/ml and 5ml containing the adherent cell fraction were 
dispensed into sterile petri dishes , Several dishes were prepared 
for the adherent and nonadherent groups. The culture dishes were 
transferred into incubation boxes for 16 hours at 37 °C, 5% COgin a 
Leec incubator, A UIF preparation was made of each fraction as 
described previously. For both fractions a cell loss of 15.8% was
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accounted for after centrifugation, before preparing the UIF 
suspension. The adherent cells were removed by mild trypsinization 
which was a final resort to remove them from the petri dishes. 
Although it would have been better to remove them by scrapping the 
dishes with a spatula tip that was covered with fine rubber tubing 
coat. The fraction of nonadherent and adherent cells of the total 
spleen cell (without red blood cells) was 60.91% and 23.26% 
repectively.
Preparation of macrophage-free spleen cell suspension (Macrophage 
Free UIF);
The procedure for preparing a macrophage free cell suspension, 
was according to the method desbribed by Lee, (1980). The carbonyl 
iron powder was washed and aliquoted into bottles and sterilised on 
the same day of the experiment for separating cells according to 
their adhering ability,
lOgm of 99+% pure carbonyl iron powder <60um (Gaf.U.K.) were 
washed with 100ml of 0,85% saline 4 times to remove any toxic 
material, A U-shaped iron magnet was used to hold the iron 
particles down in the beaker while pouring off the saline wash. 
The iron powder was resuspended in 50ml physiological saline (0,2gm 
iron/ml saline) and was kept in suspension by constant mixing,
3ml of the iron suspension were pipetted into 100 ml sterile 
screw-cap bottles. The bottles and their iron contents were 
sterilised by autoclaving at 18lb/irf for 20 minutes. Following the 
autoclaving, the bottles were immediately tapped and shaken to 
disperse the iron; discourging it to form clumps. If clumps were 
to be formed, then, an alternative procedure, to avoid iron
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clurapping through autoclaving, was to sterilise the iron powder by 
extensive washing with sterile saline containing penicillin and 
streptomycin, before dispensing the 3ml aliquots,
A rat spleen suspension (white cells fraction) was prepared as 
described previously at a concentration of 10?cells/ml. The saline 
contents of the bottles were aspirated by means of a sterile 
pasteur pipette while the iron powder was held down by a magnet. 
Each bottle received 8ml of the spleen suspension (8 x 10^  
cells/bottle). The bottles were capped tightly and incubated in a 
water bath for 45 minutes at 37 °C, During the incubation period, 
the bottles were shaken with just enough force to suspend the iron 
powder completely, every 5 minutes. At the end of the incubation 
period, the nonadherent cell suspension was pooled from all bottles 
in a single sterile beaker by placing a magnet under each bottle to 
retain the iron particles and the adhering cells with it, A magnet 
was placed for a few minutes under the container, containing the 
pooled nonadhering cell suspension to allow residual iron powder to 
settle. Following the settling of the residual iron powder, the 
cell suspension was transferred into sterile universels and 
centrifuged in a refrigerated bench centrifuge at 1,4 x ICf RPM for 
10 minutes. The cell pellet was resuspended in RPMI 1640 medium 
without FCS to prepare a macrophage free UIF. The macrophage free 
suspension was adjusted to the original concentration of 10^  
cells/ml taking into account a 34.5% loss due to the centrifugation 
steps. 5 ml of the final preparation of the nonadherent cell 
suspension was dispensed into sterile 50 mm tissue culture petri 
dishes to produce a macrophage free UIF, The procedure for UIF 
preparation was described earlier.
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Preparation of different molecular fractions of STD.UIF ;
Rat STD.UIF was prepared as described previously. The UIF was 
dispensed into an Amicon apparatus which fractionates solutions 
according to the molecular separating properties of the Amicon 
filter. Four types of Amicon Diaflo ultrfiltration membranes
(Amicon. U.K.) were used as follows;
1. A membrane that retains substances of 5 x id molecular 
weight and sizes above 5 x icf . Code; Amicon (XM)
2. A membrane that retains substances of 1 x itf molecular
weight and sizes above 1 x lO'^ Code; Amicon (PM)
3, A membrane that retains substances of 1 x 10^  molecular
weight and sizes above 1 x 10^  Code;Amicon (UM2)
4. A membrane that retains substances of 5 x 10^  molecular 
weight and sizes above 5x10^ Code; Amicon (UM05)
10 ml aliquots of STD.UIF (20 ml. total volume) were 
dispensed into an Amicon Diaflo ultrafiltration apparatus which had 
a membrane of the 5 x 10"^ molecular weight type. The STD.UIF was 
forced through the membrane under pressure [ 20/iif. 3. The
STD.UIF that passed through the filter was collected in a clean 
beaker and was refractioned on a 1 x 10*molecular weight exclusion 
filter. The fractioned UIF, was fractioned on a 1 x 10® molecular 
weight Amicon exclusion filter. The resulting UIF was again 
refractioned on a 5 x 10^  molecular weight exclusion filter, and the 
UIF which passed through the filter was retained and coded as B500 
or below 5 x 10^molecular weight substances.
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All the respective filters (1), (2), (3) and (4) were washed 
in distilled water. The distilled water washings of the Amicon 
filters were vacuum dried in a drying machine CEdwards-Ü.K.] and 
each was resuspended in 20ml RPMI 1640. All the fractions of the 
UIF were sterilized through a 0.22um millipore filter. The 
fractionation of the UIF was carried out at 4 ®C.
The STD.UIF fractions are coded as follows;
5 X ICf. for molecules of 5 x lO^molecular weight and above.
10^  for molecules below 5 x 10* to ICf molecular weight,
10® for molecules below 10 to 10® molecular weight.
A500 for molecules below 10® to 500 molecular weight.
B500 for molecules that passed through the 500 molecular weight 
exclusion filter.
All the UIF preparations were stored in sterile universels 
at -20 °C for further use.
STD.UIF was heated for half an hour at 56 ®C; A sterile
universal containing 20ml of STD.UIF was kept for half an hour in a 
water bath at 56 °C.
Preparation of dialysed Rat WCF.UIF ;
A visking dialysis tubing (size 24/32, Dept., of 
Biochemistry, Univ. of St. Andrews.) which retains substances of 
id* molecular weight and above was soaked in distilled water for 1 
hour in a clean beaker. The dialysis tubing was transferred into a 
larger beaker containing double distilled water (DDW) and was 
heated until boiling. The dialysis tubing was boiled for 3
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minutes. The dialysis tubing was later washed in DDW several 
times. Two knots were tied at one end of the dialysis tubing, and 
using a sterile 20ml syringe (Beckton Dickson. Ireland), 20ml of 
Rat WCF.UIF, (STD.UIF) were dispensed into the tubing. Two knots 
were tied at the top side of the tubing. The UIF was dialysed 
against 200ml of RPMI 1640 containing Hepes buffer for 3 days at 4 
®C. The buffer was changed twice daily (for fresh buffer) and was 
continuously stirred with a magnetic stirrer. The UIF was later 
taken out of the dialysis bag and its volume recorded. The 
dialysed UIF (which was of 1 x 10** molecular weight and above) wasF
sterilised through 0.22um sterile millipore filter and was stored 
in sterile universels at -20 ®C for further use.
Each cell culture in microtitre culture wells, which was 
incubated with any type of UIF, received 0.2 uci 125IUDR, and was 
replicated 5 times. The assessment of isotope uptake by cultures 
was described previously.
Preparation of BC3H-1 muscle cell UIF :
BC3H-1 muscle cells were grown in tissue culture grade flasks 
(Sterilin 311) as monolayers in Dulbecco’s medium (Flow Labs. 
U.K.) pH 7.4; containing 10% FCS, benzyl penicillin 50IU/ml and 
streptomycin sulphate 50ug/ml. Each flask contained 15ml of 
medium, that received an inoculum of 3 x 1C? BC3H-1 cells (3 x 10* 
cells/15ml/flask).The cells grew as monolayers; reaching confluence 
level between 4-5 days. The exhausted medium was aspirated from 
the flasks. 10ml of prewarmed 37 Earle’s Basal solution Ca"*",Mg* 
Free, containing EDTA at a final concentration of 10® molar, and 
300ul of the enzyme viocase (Gibco-U.K.) were delivered into the 
flasks. The flasks were firmly capped and were shaken mildly at 37
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*b for at least 20 minutes, on a flask shaker. A sample of the 
flasks were examined under an inverted microscope (Olympus-Japan) 
to asses the effect of viocase on separating the monolayer, into a 
single cell suspension. When that was nearly achieved, each flask 
received 1ml of calf serum to stop the action of viocase. The cell 
suspension in the flasks was pipetted up and down vigorously to 
breakdown cell clumps.
The cell suspension from the flasks was pooled and centrifuged 
in a refrigerated bench centrifuge for 10 minutes at 1.4 x 10® RPM. 
The supernate was discarded and the cell pellet was resuspended in 
RPMI 1640 at a concentration of 1 x 1(f cells/ml for the preparation 
of the (BC3H-1) UIF. The UIF preparation procedure was described 
earlier. The cell line was a kind gift from Dr J. Aison 
(Derpartment of Physiology. University of St Andrews) which was 
given by Dr J. Patrick (Salk Institute. San Dieg, California, 
U.S.A.).
8. Preparation of cytospin smears ;
Aliquots of cell suspension (100-300ul) were dispensed into 
cytospin buckets (Shandon Cytospin-U.K.). Glass slides were 
attached to the cytospin buckets. The slide side facing the bucket 
was covered with a filter paper that had a hole, which allowed the 
suspension to pass from the bucket to the slide upon spinning. The 
cytospin was used at 6 x icf RPM at room temperature. Cell 
suspensions that contained no serum had serum added to them (10% 
final concentration) before cytospinning.
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9. Procedure for assessing the optimum concentration of 
vincristine, required for metaphase arrest for plasmacytoma 
cultures in vitro :
Img of vincristine sulphate was diluted to 0.2mg/ml as 
described in the procedure for metaphase arrest experiments in
vivo. The stock concentration of 200ug/ml was diluted to the
required dilutions as follows:
1. 35ul of stock vincristine per 7ml of RPMI 1640 medium =
lug per ml.
2. 91ul of stock vincristine per 7 ml of RPMI 1640 medium =
2.6ug per ml.
3. 280 ul of stock vincristine per 7ml of RPMI 1640 medium = 
8ug per ml
4. Plasmacytoma suspension containing 20% FCS-HI.
0.5ml of each of the above concentrations of vincristine were 
added to 0.5ml of the plasmacytoma suspension, to give a final 
dilution of 0.5ug, 1.3ug and 4ug/ml respectively in 10% FCS.
10. Procedure for the assessment of the effects of UIF and 
vincristine sulphate on the metaphase accumulation of plasmacytoma 
cultures in vitro :
A plasmacytoma suspension (in RPMI 1640. 10% FCS HI.) was
prepared as described previously and was aliquoted equally as 
follows:
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1. Replicate samples of 1ml plasmacytoma suspension (0.5ml 
suspension + 0.5ml RPMI 1640 diluent at 20% FCS HI), incubated for 
4 hours at 37 5% CO2, in a Leec incubator.
2. Replicate samples of 1ml plasmacytoma suspension,
containing a fresh preparation of 0.5ug of vincristine sulphate 
(0.5ug/ml), incubated at 37 ®C, 5% CO2 for its optimum period to 
collect a maximum number of metaphases (2 hours), as described 
previously. [500ul cell suspension + 350ul medium + lOOul FCS
+50ul oncovin (0.5ug oncovin/50ul in 10% FCS RPMI].
3.Replicate samples of plasmacytoma suspension (950ul) 
containing UIF at a final dilution of 20%, were incubated for 4 
hours. Following the 4 hour incubation period, 50ul of diluted
vincristine sulphate (0.5ug/50ul 10% FCS-RPMI 1640) were added to
each tube, and were incubated for 2 hours. [0.5ml cell suspension 
+ 200ul medium + lOOul FCS + 200 ul UIF], which included the 50 ul
of diluted vincristine.
4.Replicate samples of 1ml plasmacytoma suspension containing 
UIF at a final dilution of 20%, were incubated at 37 t 5% C02for 4 
hours.
Following the incubation period, replicate samples from each 
group were transferred into a cytospin centrifuge to produce 
cytospin preparations. The cytospin preparations were stained
according to the Jenner-Giemsa Procedure. The cytospin slides were 
later examined under a microscope, (10 x 40 = 400 x magnification) 
to determine the number of metaphases. At least 2000 cells per 
slide were screened for metaphases.
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11. Procedure for determining the labelling index in cell 
cultures;
The isotope used was [methyl-3H] Thymidine, [sp. activity 
5ci/m. mole., Imci/ml]; and was diluted in RPMI 1640 to yield a 
concentration of 1uci/50ul, A plasmacytoma suspension was prepared 
as described previously and divided into 3 groups; A, B, and C.
A; Plasmacytoma suspension in RPMI 1640 without FCS
B; Plasmacytoma suspension in RPMI 1640 10% FCS-HI
C; Plasmacytoma suspension in RPMI 1640 10% FCS-HI and 20%
UIF.
Each suspension group was replicated in 5 sterile tubes 
(Sterilin-142AS)
Group A; The tubes received 500ul of plasmacytoma suspension 
+ 450 RPMI
Group B; The tubes received 500ul of plasmacytoma suspension 
+ 355ul (RPMI 1640) medium + 95ul FCS
Group C; The tubes received 500ul of a plasmacytoma 
suspension + [I65ul (RPMI 1640) + 95ul FCS] + 190ul UIF
All tubes in groups A, B and C were incubated in a Leec
incubator at 37 ^  5% C02at the same time, each tube received luci
of 3H-TDR in 5Oui of RPMI. Following the 4 hour isotope pulsing,
aliquots from each tube were spun for 5 minutes in a Shandon
(Shandon-U.K.) electronic cytospin, at 6 x 10® RPM to produce 
cytospin smears as described earlier. The cytospin slides were 
left to dry in air for 5 minutes, followed by methanol fixation for 
10 minutes, to prepare the smears for autoradiography according to
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the procedure of Kopriwa and Leblond (1962). Following the 
methanol fixation, the slides were coated with (G5) Ilford emulsion 
and kept in a lightproof dry box, at 4 ®C for an exposure period of 
24 hours. Following the exposure, the slides were developed with 
(T19) high-contrast developer for 2 minutes, and followed by 
fixation in (Hypo) sodium thiosulphate. The slides were washed 
after the fixation procedure and stained in Jenner-Giemsa, 
Following the staining procedure, the slides were dehydrated in 
several concentrations of alcohol and mounted in euparal.
1. The slides of each group were later viewed at (10 x 40) 
400 X magnification and the number of labelled cells determined ( a 
minimum of 3000 cells per slide were counted) and the proportion of 
labelled cells among unlabelled cells, [the Labelling Index (LI)] 
was determined and corrected to labelled cell per 1000 cells.
2, The cytospin preparations of each group were examined at a 
magnification of (10 x 100 oil immersion) 1000 x magnification, and 
the number of grains (3H-Tdr-grains) per cell was determined, the 
microscope eye piece had an E9A graticule (Graticules Ltd., 
Tonbridge, Kent) fixed to it. The area of the E9A at 1000 x 
magnification was 1.111 x 10 urn® . The E9A graticule contains 10 
small squares of equal size, the optimum number of grains that 
could be counted within 1 small square was 50. Thus if a small 
square was full of grains, and the number of grains was difficult 
to determine, the small square was assumed to contain more than 50 
grains. The E9A graticule was aligned on a labelled cell and the 
number of grains counted. 100 cells per cytospin slide were 
observed, and the number of grains/cell was determined. The mean 
background grain count was estimated by observing 15 random E9A 
fields , on areas that contained no cells and on cytoplasmic areas.
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Nuclei with 4 grains and less were assumed as background count and 
were not included in the grain count. The grain count was 
distributed into 3 groups and the number of cells belonging to each 
group was determined for cytospin preparations of groups A, B and 
C. The grain count was divided into 3 groups, the first group up 
to 50 grains^ each cell may contain 50 grains or less, (the lightly 
labelled group). The second group contained cells in which each 
cell's grain count was up to 100 grains (the medium labelled 
group), while the third group contained more thans 100 grains per 
cell. The lightly labelled groups were pooled from two smaller 
class intervals [0->25 and 25->50 grains per cell], the medium 
labelled group was pooled from 2 smaller class intervals of [50->75 
and 75->100 grains per cell], while the densely labelled group 
contained more than 100 grains per cell.
12. Tumour colony forming units-spleen, (Tumour.CFU-S) ;
The procedure for the determination of the dose response curve 
for Tumour.CFU-S is as follows:
Mice were irradiated with 7.2 Gy in a Siemens-Stabiliplan 
X-ray machine (Siemens - Munich, West Germany)(25OKv, I4ma and
0.5mm copper filtration) in conjunction with an applicator which 
gave 20 cm of radiation field.
The irradiated mice were divided into groups of 20 mice each, 
and were kept in a warm place at 37 °C . The mice in a specified 
group, received a certain dose of cells per 0.25ml RPMI 1640 
medium, from a freshly prepared plasmacytoma suspension. The mice 
were injected in the tail vein with a 1ml sterile syringe (Beckton 
Dickson. Ireland) and needle (25G.5/8. Beckton Dickson. 
Ireland). The needle was changed often (around 8-10 mice per
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needle), and the benches on which the mice were injected were all 
cleaned with 755^  ethyl alcohol.
Each mouse was transferred into a clean mouse injection box. 
The box is made of perspex transparent material with many holes on 
its sides to allow the mouse to breathe. Thus the mouse was 
trapped in this small box and its tail was searched for a vein, and
0.25ml of plasmacytoma suspension (without FCS) was injected 
carefully into the lateral cordai vein. 80 mice were used for this 
experiment which was performed twice. A total of 160 mice were 
used.
The cell dose/mouse for the different groups was as follows;
Group 1: 5 x ICf cells/0.25ml; Group 2: 7.5 x 1(f
cells/0.25ml; Group 3: 1 x icf cell/0.25ml; Group 4: 1.5 x 1
cells/0.25ml
The mice were kept in separate cages, 10 mice per cage, to 
minimize cross-infection and were given food and water. The water 
contained an antibiotic, (500mg tablets-Neomycin Sulphate BP. 35 x 
lO'* units/tablet) (Boots Pic., Nottingham, England). 2 tablets were 
dissolved in 2 litres of water as a final concentration for mice 
consumption.
Eight days after the injection of plasmacytoma cells, the mice 
were sacrificed under ether anaesthesia and the spleens were 
removed and fixed in Bouin's fixative for 24 hours. The Bouins was 
discarded and the spleens were kept in 75% ethyl alcohol. The 
spleens were examined under a stereomicroscope, and the number of 
colony forming unit per spleen was determined.
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13. The procedure for preparing plasmacytoma cultures with UIF or 
Ara/C. (Effects of UIF and Ara/C on Tumour.CFU-S) :
A plasmacytoma cell suspension was prepared and divided into 4 
groups 1,2,3 and 4. Group 1; contained UIF; group 2: contained
UIF-Ara/C; group 3; contained Ara/C and group 4; was without UIF 
or Ara/C (controls).
1. Sterile bijous received 0.8ml of a plasmacytoma suspension 
in [RPMI 1640 without FCS] + 0.2ml UIF-STD (3ml, per bijou)
2. The same procedure as above for the UIF cultures in group
1. Groups 1 and 2 were incubated for 4 hours at 37 °C, 5% CO2, in a
Leec incubator. Following the 4 hour incubation, the cultures in 
group 1 and 2 were centrifuged for 7 minutes at 1.4 x 10^  RPM in a 
(MSE. FISON) bench centrifuge. The supernate was discarded, and 
the cultures in group 1 were resuspended gently in 3ml of prewarmed 
37 C, RPMI 1640, while cultures of group 2 were resuspended in 
2.7ml of RPMI 1640 + 60ug of Ara/C in 300ul of RPMI 1640. Both
sets of tubes were incubated for 1 hour at 37 t in a Leec
incubator. The Ara/C [Cytarabine.Cytostar. Upjohn
Pharmaceuticals. Sussex, U.K.], was used at 20ug/ml of 
plasmacytoma suspension.
3. Sterile bijous as described above received 3ml of 
plasmacytoma suspension in RPMI 1640 without FCS.
4. The same procedure as above in group 3
Groups 3 and 4 were incubated for four hours at 37 ,5/5 COgin
a Leec incubator. Following the 4 hour incubation, the cultures
were centrifuged as described above for groups 1 and 2, and
resuspended gently in RPMI 1640. Group 3 received 2.7ml of RPMI
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1640 + 60ug of Ara/C in 300ul of RPMI 1640; while group 4 received 
3ml of RPMI 1640 without Ara/C. Both sets of tubes of groups 3 and 
4 were incubated for 1 hour at 37 °C, 5% C02in a Leec incubator.
Following the 1 hour incubation, all sets of tubes in groups 
1,2,3 and 4 were centrifuged in an (MSE.FISON) refrigerated bench 
centrifuge for 7 minutes at 1.4 x 1(f RPM. The supernate was 
discarded and the cell pellet in each tube was resuspended gently 
in cool fresh RPMI 1640 medium. The cell suspension of each group 
was adjusted to a final concentration of 4 x 10^cell/ml. The final f
cell suspension of each group was used in 0.25ml aliquots; 
administered intravenously in the tails of the irradiated mice as 
described previously. Each plasmacytoma suspension group was 
tested in 20 mice, a total of 80 mice were used for this 
experiment, which was performed twice, (160 mice).
14. The procedures for the metaphase arrest experiment in vivo:
i
Vincristine Sulphate or Oncovin Sulphate was supplied in a
sterile vial containing Img of "ONCOVIN SULPHATE", ( Lilly
Pharmaceuticals, Basingstoke, U.K.), supplied with a sterile vial
containing 10ml of sterile NaCl solution (0.955) and 0.9% Benzyl
Alcohol as preservative.
The Oncovin vial was shaken to dissolve the Oncovin Sulphate 
in 5ml of NaCl solution and was stored in the fridge at 4 t, for a
maximum period of 14 days. All preparations of Oncovin Sulphate 
were used within the 2 weeks period. Using a 1ml sterile syringe 
(Beckton Dickson - IRELAND), Balb/c mice were injected 
intraperitoneally with Oncovin Sulphate, each mouse receiving
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0,25ml of the metaphase arrest agent (0.002rag/gm. body weight), 
(Smith et al., 1974). An optimum dose of vincristine sulphate was 
used, which was the concentration which arrested all metaphases for 
a defined period of time for that specific tissue; the dose must 
also prevent complete anaphase escape, (Wright and Appleton 1980). 
The mice were kept for the required time period for oncovin to 
arrest the metaphases.
Following the administration of vincristine, the tumours were 
removed as described previously, at the time intervals mentioned 
above. Each time interval was duplicated. Thus, for example, for 
tumour size 5, 18 tumours were used; 2 mice per each time interval. 
The tumours were fixed in Bouins fixative overnight and were cut 
along their longitudinal axis, so that the plane of the section 
will be providing the maximum cross sectional area and is 
perpendicular to the axis, (Smith et al., 1974). Routine 
histological procedures were followed after the Bouins fixation, 
which were dehydrating through various strengths of alcohol, 
followed by chloroform and mounting in paraplast wax. Following 
the wax mounting, sections were cut from the tumour using a 
Leitz-Wetzlar (Leitz. U.K.), microtome set at 6urn thickness. The 
first few sections were discarded, to ensure uniformity of 
thickness, (Clarke 1968). The sections were mounted on glass 
slides and were stained with Mayers heamalum and eosin, and 
eventually covered with glass cover slips with balsam.
Histological quantitation;
(A) The method devised by Chalkley (Ohalkley H.W. 1943) as 
modified by Smith et al., (1974), was used to determine the tumour 
section components: tumour arrested metaphases, tumour cells,
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space and necrosis in a stained tumour section. The Chalkley 
graticule (G52, 25 point Chalkley graticule. GRATICULES
LTD.,Tonbridge, Kent, U.K.) which was fitted to the microscope 
eyepiece, contained 25 randomly distributed points enclosed within 
a circle divided into quadrants; was used to analyse a tumour 
section under the microscope, at (10 x eyepiece)x(40 x objective) = 
400 X magnification. The area of the Chalkley at 400 x 
magnification was 75.507 x 10 um^  . The number of points on the 
Chalkley grid that coincided over tumour cells , over space and 
over necrosis were recorded . Thus, for example, if 16 points 
coincided over tumour cells, 3 points over space, and 6 points over 
necrotic cells or fragments, the percentage for that field viewed 
under (400 x magnification) will be 64% for tumour cells, 12% for 
space, and 24% for necrotic cells or fragments. Three sections 
from a tumour were examined; a section was divided into 3 zones; 
outer, middle, and inner as viewed under the microscope.
With the aid of the Chalkley grid at 400 x magnification, the 
outer zone was analysed by viewing 9 random fields. In each field 
viewed, the proportions of tumour cells, space and necrotic cells 
were recorded. The number of metaphases for that field was also 
recorded. The procedure was repeated for the middle and inner 
zones. Each zone in each tumour section, gave a mean number of 
metaphases and a mean number for the proportion of tumour cells, 
necrotic cells and space. Each zone reading was scanned for a 
minimum of 3000 cells and was replicated in 3 sections. The tumour 
sections did not contain anaphases or telophases,
(B) The diameters of several hundred randomly distributed 
interphase nuclei in a section, irrespective of the zone, were 
recorded using a microscope scaler at a magnification of, (10 x
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eyepiece) x 100 objective - oil immersion ) 1000 x magnification, 
and the mean diameter was determined. The diameters of several 
hundred randomly distributed metaphases in a section irrespective 
of the zone were recorded also, and the mean diameter was 
determined.
(C) Each zone was scanned for an "all tumour area", free as 
much as possible from necrosis and space. Using an E9A graticule 
fixed to the microscope eyepiece the all tumour areas were observed 
under a magnification of 1000 x, (= [(10 x eyepiece)x(100 x
objective-oil immersion)].
The area of the E9A Graticule under the 1000 magnification was 
1.111 X 10 um^  . For example: an outer zone was scanned for 10
such fields (all tumour fields) and the number of cells at 1000 x 
magnification within the E9A graticule grid was determined for the 
first, second, and third sections. The three means so obtained 
were averaged into one mean that represented the outer zone from 
three sections. The same procedure was repeated for the middle and 
inner zones.
(D) the mean number of cells obtained for a zone, represented 
the mean number of cells within the surface area of the tumour 
section. This can be converted into a mean number of cells per 
unit volume, using Abercrombie's equation (Abercrombie 1946) which 
is;
P = A (M/L+M)
P = Average nuclear points per section; A = Crude count of the 
nuclei seen in the section; M = thickness (um) of the section; L = 
Average diameter (um) of the nuclei.
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In this case to correct the number of tumour cells:
(1) C» = C[t/L+t]
where C  = Average number of cells per section
C = Observed count of nuclei in the section 
t = Thickness of section = 6um 
L = Average length of the diameter
The average diameters obtained for the cell nuclei and 
metaphases are usually 79% of their true values (Abercrombie 1946). 
Riches et al., (1981) have introduced a further correction to 
Abercrombie’s equation (Abercrombie 1946), whereby the average 
nuclear diameters of interphase nuclei (De) and metaphase figures 
(Dm) can be converted into true average diameters, using the 
following equations:
(1) Dt = -(T-De/1.58)+1/1.58[T +1.l6TDe+De Dt= true average 
interphase nuclear diameter, De= average measured interphase 
nuclear diameter, T =section thickness
(2) Dp = -(T-bm/1.58)+1/1.58 [T +1.16T Dm+Dm Dp= true average 
metaphase diameter, Dm= average measured metaphase diameter, T = 
section thickness.
The average measured interphase nuclear diameter was 
(6.6lum+0.075); and the average measured metaphase diameter was 
(4.847um+0.055). Using the correction introduced by Riches et al., 
(1981), as shown earlier: the true average value for the nuclear
diameter = 7*475um and the true average value for the metaphase 
diameter = 5.3 8um.
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Applying Abercrombie's correction (Abercrombie 1946), the 
number of cells per unit volume and the number of metaphases per 
unit volume of section could be calculated, and therefore an 
estimate of the number of metaphases per 1000 cells.
(E) Having obtained a mean value for the number of tumour 
cells in an "all tumour area" for the outer zone, as has been 
described previously; an example, can be described for the 
calculation; a mean of 13.6 cells was scored under a magnification 
of 1000 X (oil immersion) within the E9A graticule. When using a 
Chalkley under a magnification of 400 x, the area that will be 
scanned by the Chalkley (G52; 25 point graticule) equals 75.5071 x 
10 um^, thus more cells will be scanned at the 400 x magnification 
when compared to that at a magnification of 1000 x. Thus the mean 
Expected number (Ex G52) of cells within the Chalkley G52 graticule 
at 400 X magnification equals the number of cells within the 
Chalkley G52 graticule at 1000 x magnification multiplied by a 
change of magnification (MF).
(1) Mean Expected number of cells per G52 or (Ex-G52) = Mean 
observed number of cells per E9A, 13.6 x MF-67.957 = 924.21
(2) 3 outer zones per section were scored (0Z1, 0Z2, 0Z3) with 
9 random fields per zone scanned using a Chalkley GG52 graticule. 
The zone has a mean value: for the metaphases; for the proportion 
of tumour cells, and the remaining proportion of necrosis and 
space.
The mean actual number of cells per G52 Ac-G52 = (Ex-G52)x(mean % 
tumour cells in 0Z1.
The mean % value of tumour cells in 0Z1 was 77.3%, 
and the mean value of metaphases in 0Z1 = 11.66.
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ÂO-G52 = (EX-G52 )x(% tumour cells in 0Z1) = 924.21 x 0.773 =
714.41 cells.
Using Abercrombie's correction (Abercrombie 1946) and Riches' 
correction (Riches et al.^  1981), the number of cells per unit 
volume can be calculated for 0Z1,
P = A [M/L+M], or
C  = C [t/L+t] = AC-G52 = G52 [t/Dt+t] = 714.41[6/7.475+6]
= (714.41)x (0.445; = 318.1 tumour cells.
The number of metaphases per unit volume can be calculated also:
M' = M [t/L+t] = M [t/Dp+t] = 11.66[6/5.38+6] =
(11.56)x(0.527) = 6.11 metaphases.
Thus a value in terms of unit volume or tumour of 6.11 metaphases 
per 318.1 tumour cells has been determined for 0Z1. The corrected 
number of metaphases per 1000 tumour cells = 6.11 x (1000/3lb.1) =
19.2. The same procedure was applied for other zones. Having 
obtained the corrected number of metaphases per 1000 tumour ceils 
for 0Z1, 0Z2 and 0Z3, a pooled mean for these 3 sets of values can 
be determined.
In a similar way the corrected number of metaphases per 1000 
ceils can be determined: using the mean actual value of cells
scored in a zone, the mean number or metaphases determined for a 
zone can be corrected to the number of arrested metaphases per 1000 
tumour cells.
The ratio of the corrected metaphase counts to the corrected 
number of tumour cells per zone is expressed as follows:
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MVC* = M[t/Dp+t]/G[t/Dt+t]
= M/C[t/Dp+t X Dt+t/t]
= M/C[13.475/11.38]
= M/C[1.18]
[ M V C  ]( 1000) = [mean number of metaphases in a
zone/AC-G52](1000)(1.18)
= [11.66/714.41](1000 X 1.18) z 19.25 metaphases per 1000 
tumour oells. Each pooled corrected metaphase per 1000 cells is 
corrected to (1+Imet) and to log^^l+lmet). Metaphase accumulation 
in the tumour was plotted as the "Collections Function" at half 
hour intervals, including zero time, to a maximum time of 4 hours. 
The y-axis on the graph represents log,o (1+Imet), the x-axis 
represents the time period. The formula for the "Collection 
Function" was developed by Puck and Steffen, (1963).
log,o(1+N(m)] z 0.301/T (tm+t)
Similarly, log,o (1+Imet) z 0.301/Tca (tm+t), when the growth
fraction is unknown.
KB z 0.301/Tca and Tea z 0.301/KB
The delay perioa observea in the action of a stathmokinetic agent 
to arrest metaphases in some tissues, (Puck and Steffen 1963, Smith 
et al., 1974, Nome 1975, Wright and Appleton 1980), must be taken 
into account when measuring the birth rate from the slope of the
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line. The data of the metaphase "Collection Function" were plotted 
against time after vincristine injection and were analysed using a 
computer, (VAX Computer, University of St. Andrews) using a 
weighted and unweighted least squares technique, (Wright and 
Appleton 1980;, The birth rate (KB) is the regression coefficient 
produced by the least squares method, from which the apparent cell 
cycle time (Tea) was estimated according to the "Collection 
Function" of Puck and Steffen (1963).
The mean birth rate is expressed as: cells per cell per hour.
The cell production rate per 1000 cells (Smith et al., 1974) can be 
estimated by multiplying the birth rate (KB) by 1000, and will be 
expressed as: cells per 1000 cells per hour. The metaphase
duration can also estimated from the "Collection Function" of Puck 
and Steffen, (1963):
t met = intercept of regression line on metaphase collection axis / 
KB
The cej.1 loss factor ((|);, (Steel 1968) was estimated from the Tea 
and (Td), tumour doubling time:
as  ^= 1-Tca/Td.
15. Measurement of tumour growth rates:
The animals used were Balb/c mice of both sexes and some were
"nude" mice with a Balb/c background. The mice used for the 
experiments were between 7 - 10 weeks of age. The mice were housed 
in plastic cages with saw dust, and were given water and mice food
diet. The "nude" mice were housed in a separate room, and their
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drinking water contained (Neomycin sulphate B.P. Boots PLC U.K.); 
2 tablets (500 mg each) which were dissolved in 2 litres of water. 
When handling the "nude" mice, a face mask was worn together with a 
clean laboratory coat for use in the "nude" mice room only. The 
mice were in a air-conditioned environment.
A cell suspension of plasmacytoma free of red blood cell was 
prepared in RPMI and was adjusted to a concentration of 5 x 10® 
cells/ml. Using 1ml sterile syringe (Beckton Dickson) fitted to a 
sterile needle ( 23-1 1/4, Beckton Dickson. Ireland) each mouse
was injected subcutaneously in the inguinal region (which was 
swabbed in 70% ethyl alcohol), with 0.1ml of the cell suspension (5 
X 10® cells) per mouse. Different cell doses were also injected in 
Balb/c mice, when required for some experiments. The mice were 
left in cages with food and water for a period of two weeks when 
the tumours in most instances reached a maximum size, after which 
the mice were killed. The mice were observed daily for tumour 
growth (nodule formation) in the inguinal region. When a tumour 
reached size group 3 (100 mm®; or tumour group size 3: equal to
ball bearing size 3.5-3.8) which were fairly palpable, tumour size 
was recorded (and taken as V=0 at T=0, intial volumesVO), and 
thereafter tumour growth was followed regularly and recorded every 
48 hours (VI, 2, 3 at T1, 2, 3...etc....) until reaching (Vmax) a 
maximum volume desired for the experiment, or otherwise until 
reaching a maximum volume tolerated by the mice and this was tumour 
size 9 after which the mice were Killed. The tumour volume was 
assessed in terms of steel ball bearings of rixed diameters. The 
tumour and the ball bearing were felt by the same hand (thumb and 
forefingers) and tumour volume was recorded accordingly. The ball 
bearings were obtained from (Hoffman Manufac. Pic. Essex, U.K.) 
and were covered with chamois leather to simulate mouse skin.
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The steel ball bearings were of the following diameters: 3/16 up
to 12/12 inch. The ball bearing size was graded as follows: 3, 4,
5, 6, 7, 8, 9, 10, 11, 12, with the corresponding ball bearing 
volume (.mm^) of: 56.55, 134.11, 260.55, 452.28, 717.75, 1071.71,
1527.27, 2095.57, 2789.07, 3619.9. The tumour volume was
calculated as follows:
* ' ^ / 3  = ^ / 6
(1/I6)in = 1.5875mm
Tumour size 3, therefore, will have the following volume: 
[3U.5875)f x^6 = 56.55 mnf .
The tumours were measured as accurately as possible and were graded 
as follows:
tumour size = 3, 3+, 3.5, 3.5+, 4, 4+, 4.5, 4.5+, 5, 5+, 5.5, 5.5+,
6, 6+, 6.5, 6.5+, 7, 7+, 7.5, 7.5+, 8, 8+, 8.5.
The corresponding tumour volume (.mm? ) was as follows: 56.55,
68.66, 89.83, 114.87, 134.11, 155.25, 190.08, 231.7, 260.55,
293.32, 347.4, 408.85, 452.28, 498.16, 575.18, 658.75, 717.75,
781.66, 883.26, 994.36, 1071.71, 1155.2, 1286.38.
The growth rate of tumours was estimated by using exponential 
regression analysis preprogrammed in a Casio-fx3600P electronic 
calculator.
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The formula for exponential regression was:
Vt = Vo exp mt 
InVt = mt + InVo
The volume doubles in a period = Td, therefore the volume at t = Td 
is, Vt = 2V0; therefore: 2 = exp mTd i.e. 2V0 = 0 exp mTd
ln2 =mTd
Td =m/ln2
m = slope of the curve, which is the growth rate (KG)
VO = initial tumour volume 
Vt = volume at time t 
Td = tumour doubling time 
InVO = intercept 
t = time of measurement.
16. Statistical Procedures:
The statistical calculations were based on the methods 
described by von Fraunhofer and Murray (1976), Kirk (1969), Parker 
(1979), Snedecor and Cochran (I967)and Sokal and Rohlf (1981).
The t test comparison of two sample means :
t = difference of means/standard error of difference between 
means.
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d* = tDa/2;k,v (2(MS error)/n)^
where tDa/2;k,v is the two-tailed value obtained from Dunnett's 
table.
a = the error rate experiment wise
2 = two tailed test
k = number of treatments, including control
V = degrees of freedom associated with MS error.
Multiple range test, using Shortest Significant Ranges 
(S.S.R.) (Parker 1979): The means are arranged in order of
magnitude and a series of S.S.R's is calculated for testing 
differences between pairs of means according to their relationship 
in the size order.
1. Analysis of variance = treatments/error
2. S.E. of treatment mean = Verror/d% freedom
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Analysis of variance (F.ratio) = treatments/error; (treatments 
= mean square between groups), (error = mean square within groups).
Dunnett's test for comparisons involving a control mean (Kirk 
1969); Comparing a number of treatment levels with a control 
condition. The difference (d') that a comparison must exceed in |
order to be declared significant is given by:
3. Q is found in the Studentized Range table
4. The values of Q were determined for the number or degrees
of freedom for error and for k, (K-1)... etc. treatments.
5. The S.S.R’s for k, (k-1)... groups were computed as Q [ 
error/d. freedom ]
6. Having arranged the treatment means in order of magnitude,
the difference between the largest and the smallest means was
tested against the S.S.R. for k treatments. If the difference was 
not significant the testing must be stopped, but if it was
significant, the testing of the difference between the largest and
the next to the smallest must be determined as described by Parker 
(1979).
Regression Analysis:
Y = a + bX 
a = intercept
b = regression coefficient
The slope or regression coefficient for tumour growth: ra or
KG ='£t(ln Vt)/%t:
Residual variance: SR = 1/N-2C (InVt)^  - (^(tlnVt)^ /Jt ]
SR =VSF, S.E. of m = w j ÿ
The t test for growth rate comparisons:
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ml -m2/V(S.E.m1)2+ (S.E.m2)"
The S.E. of Td = (S.E. of ra/m2)ln2 
The t test comparison for Td:
Td1-Td2/V(8.E.Tdlf + (S.E.Td2)^
The S.E, of Tea = S.E. of KB(0.301)/KB 
The t test comparison for Tea:
Teal-Tca2/V^S.E.Tca1)2 + (S.E.Tca2>"
The standard error of L.P.(latency perioa) = S.E. of m =
(lny-lnc)/m^. c = intercept
The latency period was estimated from the regression curve as L.P. 
= InVt-lnc/m
The S.E. of tm =V( c^x var.Tca+(Tca^x var.c ) 
c = intercept 
The t test for tm comparisons:
tml-tm2/V(S. E.tml)^ + (S. E.tm2)^
The S.E. of cell loss factor = S.E.Tca/Td
= (Tca)V(Td/[var.Td] + 1/(Tdftvar.Tca]
The T test comparisons of (f cell loss factor = ^1-^2/
V(S.E.([)1)^ +(S.E.{j>2)2
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CHAPTER ÎHREE
RESULTS
3.1. IN VITRO CULTURES: ASSESSMENT OF THE EFFECTS OF FCS AND
OTHER SERA ON CELL PROLIFERATION.
3.1.1. The relationship between the cell number per microtitre 
well and the uptake of 125IUDR by cells in short term cultures of 1 
and 4 hours.
A cell suspension of plasmacytcma cells was prepared as 
described previously in materials and methods. MLcrotitre wells 
received the following cell concentrations per well: 1 x 10* 5 x
10^ , 1 X 10® and 5 x 10®; each microtitre well, received 0.2 uci of
125IUDR. The final volume per well was 200 ul; eadi cell dose was 
replicated 5 times. Culture preparations were incubated at 37 ®C, 
5% CO2 for 1 hour, and 4 hours . Some cultures were not 
supplemented with FCS, while other cultures were supplemented with 
10% of either heat inactivated FCS (FCS-HI), or normal FCS (Active 
FCS). Similarly, a cell suspension of mouse thymocytes was 
prepared , and was dispensed into microtitre wells at the following 
cell concentrations per well: 1 x lO'*, 2.5 x 1(f, 5 x lO'^, 1 x 10®,
1.5 X  10®, and 2.5 x icf. The cell cultures were supplemented with 
10% FCS-HI; each culture received 0.2 uci 125IUDR. Cultures were 
incubated at 37 ^ C, 5% CO2, for 4 hours as described previously. 
Following the incubation, the uptake of isotope by cell cultures
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was assessed as described previously. The percent inhibition of 
isotope uptake by cell cultures was calculated as follows: [A - B]
/ [A]
A = mean cpm of control cultures .
B = mean cpm of test cultures .
The uptake of 125IUDR by cell cultures, expressed as mean 
counts per minute (mean cpm), has increased as the cell |
dose/culture increased, (Figures/Tables 1.1.1, 1.1.2, 1.1.3).
Curve [A], (Figures 1.1.1 and 1.1.2) represents cultures, cultured 
without FCS; curve [B] represents cultures, cultured with FCS-HI; 
while curve [C] represents cultures, cultured with active FCS. The 
uptake of 125IÜDR by cell cultures has also increased as the period 4
of incubation has increased to 4 hours, (Figure 1.1.2 compared to Q
iFigure 1.1.1), at all cell doses. The results (Figure/Table 1.1.2) j
have shown that the highest uptake of 125IUDR was in the 1 x 10®
cell dose group, cultured without FCS; which was significantly 
different from its counterparts which were cultured with FCS-HI, ( 
0.02>P>0.01), or with Active FCS, ( P<0.01). The difference in
isotope uptake with and without FCS-HI was approxiraatly 32% and the 
difference in uptake with and without Active FCS was 37%.
Similarly, in the 5 x 1(f cell dose group, the highest uptake of 
125IUDR was by cells cultured without FCS; which was significantly 
different from the isotope uptake by cells cultured with FCS-HI,(
P<0.01); and from the uptake by cells cultured with Active FCS, (
P<0.01). The difference in isotope uptake with and without FCS-HI 
was approximatly 46^ and the difference in isotope uptake with and 
without Active FCS was 51%.
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FIGURE 1.1.1: The relationship between the cell dose per culture 
well and the uptake of 1251UDR by cell cultures, cultured for a 1 
hour incubation period.
Plasmacytoma cultures, cultured with; A: without FCS, B: with FCS 
-H I,  C: with active FCS .
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FIGURE 1.1.2; The relationship between the cell dose per culture 
well and the uptake of 125IUOR by cell cultures, cultured for a 4 
hours incubation period.
Plasmacytoma cultures, cultured with; A: without FCS, B: with FCS 
-H I, C: with active FCS .
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FIGURE 1.1.3: The relationship between the cell dose per culture well 
and the uptake of 1251UDR by mouse thymocyte cultures, cultured 
with FCS-HI for 4 h o u rs .

In the 5 X 10^  cell the uptake of isotope by cultures, cultured 
without FCS or with FCS-HI, or Active FCS, was not significantly 
different ( P>0.05., respectively). The highest uptake of isotope 
(Table 1.1.2) was by cell dose group 1 x 10®, followed by cell dose 
group 5 X 10®both of which were cultured without FCS. However, 
there was not ar^ significant difference ( P>0.01), between both 
culture groups.
As the mean cpra of the 1x10® cell dose was on the linear 
portion of the curve, it was the dose chosen for in vitro short 
term cultures. The highest mean cpra for the thymocytes, (Figure 
1.1.3) was at a concentration of 2 x 10^  cells/well, but since the 
standard dose for the plasraacytana was chosen at the 1 x ICp 
cells/well; the dose for the thymocytes for i^ort terra cultures was 
also set at 1 x 10® cells/well to standardise the cell culture 
procedures.
The uptake of isotope by the respective cell cultures at 
different cell doses per culture, cultured with or without FCS was 
assessed. The uptake of isotope was verified in terms of the 
optimum cell dose per culture. For plasmacytoma the uptake of 
125IÜDR was assessed at two incubation periods (1 and 4 hours), in 
three different culture environments, (without FCS, Active FCS and 
FCS-HI 56 t). The uptake of 125I0DR by plasmacytoma cultures, 
varied with the culture environment, the incubation period and cell 
dose per culture. The highest uptake of isotope, therefore, was at 
the 1 X 10®cell dose, cultured for 4 hours without FCS.
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3.1.2: The relationship between the concentration of FCS per 
culture and the uptake of 125IÜDR by cell cultures.
ExpêCimeatml acaoedyreg:
Cell suspensions of plasmacytcaia, mammary adenocarcinoma and 
mouse thymocytes were prepared, and dispensed into microtitre wells 
at a concentration of 1 x 10^cells/well as described previously. 
Cells were cultured without FCS, and were also cultured with the 
following concentrations of FCS-HI : 555, ^0%, 15% and 2555 ; each
culture received 0.2 uci of 125IUDR and was replicated 5 times. 
The final volume per well was 200 ul. Plasraacytona cultures were 
incubated as described previously; for the following periods of 
time : 0.5, 1,2, 4, 6, and 8 hours; mammary adenocarcinoma for 2,
4, 6 and 8 hours, while mouse thymocyte cultures were incubated for 
1, 2, 4 and 6 hours. In another experiment, plasmacytoma cultures 
were cultured for a 4 hour period with a similar set of FCS 
concentrations. The FCS was of two types, heat inactivated at two
temperatures: 56 °C, 0.5 hour and 66 °C, 12 minutes.
The uptake of isotope by cultures was assessed as described 
previously.
Raawlta:
Each mean cpm in the 56 °C group was compared to its
counterpart in the 66 °C group. A t- test comparison, between the
mean cpm of cultures,cultured with FCS-56 °C and their counterparts 
cultured with FCS-66 °C, was not significant; although the mean cpm 
of cultures, cultured in 555 and 10% FCS-66 °C were relatively higher 
than the FCS-56 °C group, (Table 1.2.1).
130 -
.5 3  ^i
!l^3
%
S  o> 
3 ? -
I s
s 3 3
1 3
3 S 3w
s 3 ®uia S
§  1
i S B
1
18 S  3a s
The uptake of 125IÜDR by plasmacytana cultures was reduced as 
the FCS concentration per culture has increased stepwise from 5% to 
25%. This was true for all time periods of incubation, (Table
1.2.2.1 A and Figure 1.2.2.1). The percent inhibition of 125IÜDR 
uptake with increasing serum concentration has also been described, 
(Table 1.2.2.IB). The inhibition of 125IUDR uptake by cell 
cultures, was a function of the FCS concentration, and has
increased as the FCS concentration increased; for all incubation 
periods. For each serum concentration there was a relative
decrease in inhibition with increasing period of incubation, from 2 
hours to 8 hours, except for some fluctuations in the values 
between 0.5 and 1 hour. An analysis of variance (Anovar.), and 
Dunnett's test for comparisons of means involving a control mean, 
were performed to assess the significance of isotope uptake
inhibition, by each serum concentration on its respective culture, 
for each incubation period (Table 1.2.2.1 A), were as follows :
àmlisis Qt ïâriâüçêi
Anovar; F.ratio and Dunnett's test (2 tail,P= .01) between the 
mean cpm of the following culture groups : controls (0% FCS), 5%, 
10%, 15% and 25% FCS. The mean cpm of cells which were cultured 
without FCS, was significantly different fran the mean cpm of 
cultures, cultured with 5%, 10%, 15% and 25% FCS.
0.5 hour: F.ratio = 26.13, (P<.01); 1 hour: F.ratio = 46.09, 
(P<.01); 2 hour: F.ratio = 76.70, (P<.01) 4 hour: F.ratio =
240.36, (P<.01); 6 hour: F.ratio = 34.94, (P<.01); 8 hour:
F.ratio = 25.11, (P<.01).
- 131 -
22
20
18
a hrS 16ce
0)a 140)
<a
I
6 hrQCQ3
10
CO o
X2
CLO 4hrz<LU2
2 hr
I h r
1/2 hr
2510 150 5
percent  serum conc.
FIGURE1,2.2,1-.The uptake of 125IUDR by plasmacytoma cultures 
cultured with different concentrations of FCS-HI, for different 
periods of incubation time .
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The cell viability counts (3 replicates each) were assessed 
for cells cultured without FCS (056 FCS = culture controls), and 
with FCS at 556, 10%, 1556 and 2556 per culture for 2, 4 and 8 hours 
incubation periods. The cell viabilities were not significantly 4
different from each other; (t-test, P > .01).
The inhibition of 125IUDR uptake by mamammary adenocarcinoma 
cultures has increased as the FCS concentration per culuture 
increased, for each incubation period, (Figure/Table 1.2.2.2). The 
inhibition of isotope uptake has increased for each serum 
concentration, as the period of culture incubation increased.
However, at 2 hours of incubation, 5% and 10% FCS stimulated 
isotope uptake by respective cultures, the uptake of isotope by 4
cultures, cultured with 5% FCS was significantly different from the 
uptake of isotope by control cultures (0% FCS), (P < .01); while
the uptake of isotope by cultures, cultured with 10% FCS, was not
significantly different (P > .05), from the uptake of isotope by
control cultures. The change in isotope uptake by cultures, 4
cultured with 15% and 25% FCS, was not different (P > .05), from
the uptake of isotope by control cultures. At 4 hours of 
incubation, the effects of 5% to 15% serum stimulated the uptake of t
isotope by respective cultures , while the effects of 25% FCS on 
isotope uptake by respective cultures, were inhibitory. The uptake 
of isotope by cultures, cultured with 5% serum was different from 
the uptake of isotope by control cultures ( 0.05 >P> 0.01); while
the difference in isotope uptake by cultures, cultured in the other 
three serum concentrations was not different from the uptake of
isotope by control cultures (P > .05). At 6 hours of incubation 
the uptake of isotope by cultures, cultured with 5% serum was 
stimulated (0.05 > P > .01), while the uptake of isotope by
%
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F IG U R E  1 .2 .2 .2 :  The uptake of 125IUDR by mammary adenocarcinoma 
cultures, cultured with different concentrations of FCS-HI for 
different periods of incubation time.
A: 8 hours, B; 6 hours, C: 4 hours, D: 2 h o u rs .
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cultures, cultured with 10%, 1556, and 2556 FCS, was inhibited; the 
uptake of isotope by cultures, cultured with 1 056 serum was not 
significantly different from the uptake of isotope by control 
cultures, ( P > .05); while the uptake of isotope by cultures,
cultured with 15 and 25 percent FCS was different (F < .01), from
the uptake by control cultures.
At 8 hours of incubation, the effects of the respective serum 
concentrations on the uptake of isotope by cultures, were 
inhibitory. The uptake of isotope by cultures, cultured with 556 
FCS was not significantly different from the uptake by control 
cultures (P > .05). The uptake of isotope by cultures, cultured 
with 1056 FCS was different (0.05 > P > .01), so was the uptake by 
cultures, cultured with 1 556 and 2556 FCS (P < .01). The cell
viability at 8 hour in 2556 serum was not significantly different (P 
>.05) from cell viability of cultures, cultured without FCS.
The inhibition of isotope uptake by mouse thymocyte cultures has 
increased as the serum concentration per culture increased, in each 
incubation period, (Figure/Table 1.2.2.3). The uptake of isotope 
by cultures, cultured with 556 and IO56 FCS has increased with 
increasing incubation periods (1-4 hours) with a slight decrease at 
6 hours. % e  change in isotope uptake by cultures, cultured with 
556 and 1056 FCS, for all incubation periods was significantly 
different from the uptake by control ( 056 FCS ) cultures (P<.01); 
except the uptake by cell cultures, cultured with 10^ FCS, for a 1 
hour incubation period, which was also significantly different from 
the uptake of isotope uptake by control cultures, (0.05 >P> 0.01).
The uptake of isotope by cell cultures, cultured with 1 556 FCS, was 
inhibited in cultures incubated for 1, 2 and 6 hours; and was
significantly different frcm the uptake of isotope by control
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FIGURE 1 . 2 . 2 . 3  : The uptake of 1251UDR by thymocyte cultures, cultured
with different concentrations of FCS-HI for different periods of incubation 
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cultures, for the 1 and 2 hour cultures, (0.05 >P> 0.01) and (
P<.01 ) respectively; while in the 6 hour cultures, the inhibition
was significantly different ( 0.05 > P >.01 ) from the uptake of 
isotope by control cultures. At four hours of incubation, there 
was a minimal change in isotope uptake by cultures (P > .05 ) which 
was not significantly different from the uptake by control 
cultures. At 25Î& FCS for all incubation periods, the change in 
isotope uptake by cultures was significantly different from the 
uptake by control cultures {0% FCS), (P < .01); except at 4 hours 
incubation, the uptake of isotope by cultures was significantly 
different , at (0.05 > P > .01). The cell viability was assessed 
as described earlier. Two incubation periods were diosen, the 4 
and 6 hours, and in both these periods, the cell viabilities of 
cultures, cultured with 25% FCS, were not significantly different 
(P >.05), from their counterpart cultures, cultured with 0% or 5% 
FCS.
As described above, (section 3.1.2.1), the inhibition of 
isotope uptake by FCS was assessed at two FCS (56 and 66 °C) heat 
treatments. The increase in the heat treatment (66%) did not 
eliminate the inhibitory effects of FCS on isotope uptake (as 
compared to 56%) by cell cultures. The uptake of 125IÜDR by the 
respective cell cultures described above, ( section 3.1.2.2) was 
assessed in terms of the increase of the concentration of FCS in 
the culture environments; to know whether higher FCS concentrations 
exert more inhibition on the uptake of isotope by the respective 
cultures. The results have demonstrated that the inhibition of 
isotope uptake varied directly with the concentration of FCS. The 
use of three different cell lines for culture, was undertaken to 
assess whether the interaction of FCS with each culture type 
(kinetics of isotope uptake inhibition) was variable. The results
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-have demonstrated that FCS interacted differently with eadti 
culture, in terms of serum concentration and incubation time.
All cultures shared a common feature, which was the increase 
in isotope uptake inhibition as the concentration of FCS per 
culture was increased. However, the kinetics of isotope uptake 
inhibition varied with each culture type in terms of the incubation
period and the concentration of FCS per culture. For plasmacytoma,
the inhibitory effects of FCS were reduced with increasing 
incubation time, for all concentrations of FCS. Mammary
adenocarcinoma reacted differently to FCS, the general pattern of 
isotope uptake was stimulted rather than inhibited, at short 
incubation incubation periods, but was the uptake of isotope was 
inhibited at longer incubation periods. For thymocytes there was a 
constant pattern of stimulation of uptake at 5 and 10% FCS 
concentrations, and at 15% FCS there was a general constant pattern |
of uptake inhibition (versus incubation period), while at 25% FCS 
the inhibition of isotope uptake was reduced with increasing 
incubation time, (i.e. similar to the uptake of isotope by
plasmacytoma cultures at 25% FCS).
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3.1.3: The uptake of tritiated thymidine by plasmacytoma
cultures, cultured at different cell concentrations per culture 
well, in several concentrations of FCS.
Experimejg^al ££ficgdures:
Plasmacytoma cells were cultured in microtitre culture wells
-'I-i'
I
at a concentration of 5 x icf , 1 x 10^  ,and 5 x 10^  cell s per well as f
described earlier, and were incubated for 1 hour as described 1|
previously. Cultures were cultured with the following FCS-HI 
concentrations: 0%, 5%, 10%, 15% and 25%; each well received 0.2
uci of 3H-Tdr per a 200 ul cell suspension per well. Each culture 
was replicated 5 times. The uptake of isotope by cultures was 
assessed as described earlier.
Raayl&g:
The uptake of 3H-Tdr by cell cultures has decreased as the FCS
concentration per culture increased, (Figure/Table 1.3). The
highest mean cpm was for cells cultured without FCS, while the 
lowest mean cpm was for cells cultured with 25% FCS. The
percentage of 3H-Tdr uptake inhibition has increased, as the FCS 
concentration increased in each cell dose group. The difference 
between the mean cpm of cultures , cultured without FCS, and 
cultures, cultured with the other four concentrations of FCS, in 
the 1 X 10^cell culture group,were significant. The assessment of 
the significance of the these results was based on an analysis of 
variance, and Dunnett's procedure;(Anovar; F.ratios127.14; 
significant, P<.01), Dunnett's test (2 tail, P s 0.1). Similarly, 
for the 5 x 10^  cells/well group, all the differences between the 
respective mean cpm of cultures, cultured with the respective FCS
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FIGURE 1 .3 :  The uptake of 3H-Tdr by plasmacytoma cultures, cultured 
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concentrations, were significant; (Anovar; F.ratio = 150.16;
significant, P < .01) Dunnett's test (2 tail, P = 0.1).
The cell viabilities of cell cultures, cultured for 1 hour 
with 10/6 and 25^ FCS for the 1 x 10^  and the 5 x 10^  cell s/well 
groups, were not significantly different from their respective 
control cultures which were cultured without FCS, (t-test, P>.01) .
As described above, (section 3.1.3) the inhibition of isotope 
uptake by FCS on plasmacytoma cultures, using another isotope 
(3H-Tdr) was assessed. The results described above, have shown 
that the inhibition of isotope uptake was not due to the use of 
another isotope such as 125IÜDR (which may not be as efficiently 
utilized by the DNA enzymes or stem as 3H-Tdr) as the uptake of 
3H-Tdr was subjected to a similar pattern of inhibition by FCS.
3.1.4: The effects of different batches of FCS on the uptake
of 125IÜDR by plasmacytoma cultures.
A plasmacytoma cell suspension was prepared and dispensed into 
microtitre wells at a cell dose of 1 x 1(f cells per well. The 
cells were cultured for 4 hours with three different batches of 
FCS-HI, at 37 °C, 5% CO2. Cell cultures were cultured with 10^ and 
2556 serum. Each culture received 0.2 uci of 125I0DR, and was 
replicated 5 times. The uptake of isotope by cell cultures was 
assessed as described previously.
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Two batches of FCS-HI (B and C) were more inhibitory than 
batch "A" on the uptake of isotope by cultures, (P < .01), the 
difference in inhibition was approximately twofold at 10J6 FCS 
(Table 1.4). The isotope uptake by cultures was similar at 25%
serum concentration, without significant differences (P > .05).
The effects of FCS-HI batches ”B and C" on the uptake of isotope by 
cultures, cultured with 10J6 serun, were similar, ( P >.05 ).
As described above, (section 3.1.4) different batches of FCS 
were examined in terms of their effects on the uptake of isotope by 
cell cultures. The results have shown that different FCS batches 
exhibit either different or similar inhibitory patterns depending 
on their concentration in the culture environment.
3.1.5: The specificity of the uptake of 125IUDR by DNA of
plasmacytoma cultures.
Expgülmgatâl Dzaaedurea:
3.1.5.1.1: A plasmaoytana suspension was prepared as
described previously, and was dispensed into sterile culture tubes; 
at a dose of 0.5 x 10^  cells/200 ul per culture tube. Cell cultures 
were cultured in the following FCS concentrations 0^, 5^, 10#, 15# 
and 25# . Each culture received 0.2 uci of 125IUDR, and was 
replicated 5 times. Cultures were incubated at 37 5# COgfor 4
hours as described earlier. Acid insoluble DNA was thereafter 
extracted in NaOH and TCA as described earlier. The amount of 
125IUDR activity (mean cpm) in the DNA extracts was assessed as
- 138 -
described previously.
Bëaylla:
The amount of radioactivity recovered in the acid insoluble 
fraction of DNA, has decreased as the serum concentration increased 
stepwise from 0% to 5#, 10#, 15# and 25# FCS per culture, 
(Figure/Table 1.5.1.1). The highest mean cpm (1649) was present in 
DNA extracts of cultures, cultured without FCS; while the lowest 
mean cpm (151) was present in DNA extracts of cultures, cultured 
with 25# FCS. The amount of radioactivity recovered in the soluble 
fraction was highest in extracts of cells cultured without serum 
and lowest in extracts of cultures, cultured with 25# FCS. All the 
values (mean cpm) of cells cultured in their respective serum 
concentrations were significantly (P < .01) different from the mean 
cpra of control cultures (without FCS). An analysis of variance on 
the mean cpm of extracts of the insoluble fraction, i.e., , using
extracts of cells cultured with 0#, 5#, 10#, 15# and 25# FCS, was 
significant; (Anovar F.ratio = 10.45, P<.01). The comparisons
between the respective means using Dunnett's test procedure (2 
tail, P = .01); have diown that DNA insoluble extracts obtained 
from cells cultured with 25# FCS have a significantly different 
mean cpm from the mean cpra of extracts of cultures, cultured with 
5# FCS and 0# FCS, but not different frcaa the mean cpm of extracts 
of cells cultured with 10# or 15# FCS.
EgDÊZimgDtW, DZagedyrgg:
3.1.5.1.2: A cell suspension of plasmaqytoma cells was
prepared and dispensed into microtitre wells at 1 x 10^  per culture 
well. Each cell dose was cultured with and without 10# FCS-HI in
- 139 -
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FIGURE 1.5,1.1:The uptake of 125 lUDR by plasmacytoma cultures, 
cultured with different concentrations of FCS-HI for 4 hours. 
The effect of serum concentration per culture on the amount
of radioactivity of I25IUOR recovered in the acid Insoluble
fraction of DNA .
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the following molar concentrations of hydroxyurea : 0, 10, 10, 10,
10^  10% 10. The final volume per well was 200 ul, each cell dose 
received 0.2 uci 125KJDR, and was replicated 5 times. Cultures 
were incubated for 4 hours, as described previously. The uptake of 
isotope by cultures was described earlier.
The uptake of 125IÜDR has decreased as the concentration of
hydroxyurea increased, for both cell concentrations, cultured with 5
or without 10^ FCS, (Figure/Table 1.5.1.2). The lowest inhibition
~6of 125IUDR uptake by cell cultures was at concentration of 10 moles
hydroxyurea, with almost complete inhibition being achieved at 10^
moles hydroxyurea, with a slight increase in inhibition at 10 moles
hydroxyurea. The mean cpm of cultures, cultured with FCS, and 10
moles hydroxyurea, was significantly different from the mean cpm of
control culture (0.05 > P > .01), similarly the mean cpm of %
-6cultures cultured with concentrations of hydroxyurea above 10 
moles, were also significantly different , (P < .01). For a
cultures, cultured without FCS, the mean cpm of cultures, cultured
* * 4  —1in concentrations of hydroxyurea of 10 moles to 10 moles, were also 
significantly different frcxn the mean cpm (P<.01) of control 
cultures.
3.1.5.2; A plasmacytoma cell suspension was prepared and
5dispensed into microtitre wells at 1 x 10 cells per well. Cells 
were cultured with 105S FCS, 5/6 FCS and without FCS , in the 
presence of the following molar concentrations of thymidine: 1 x
10^, 5 X l”o , 1 X 10 , 5 X 10 , 1 X 10^  and 1 x 10 . Cell cultures
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FIGURE 1 .5 .1 .2 : The uptake of 125IU0R by plasmacytoma cultures, cultured 
for 4 hours with different concentrations of hydroxyurea.
A: without PCS, B: with 10% PCS .
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were incubated for 4 hours as described previously. Each culture 
with its respective thymidine concentration was replicated in 5 
wells, with FCS, 5% FCS and without FCS, Each culture received
0.2 uci of 125IUDR. The final volume per well was 200 ul. The 
uptake of 125I0DR by cultures was assessed as described earlier. 
The amount of thymidine in FCS was assessed in two ways :
1. The difference in isotope uptake (mean cpm), between 
control cultures without FCS {0% FCS), and control cultures with 
FCS {5% and FCS), was determined as a percent inhibition of 
isotope uptake ;
[ A - B ] / [ A ] = $  inhibition
A = mean cpm of 0% FCS cultures
B = mean cpm of 555 or ^0% FCS cultures
In Figure 1.5.2 , Curve A = cultures without FCS; Curve B =
cultures with 5% FCS and Curve C = cultures with ^0% FCS.
The estimated percent inhibition of isotope uptake by 555 and 
1055 FCS, were related to Curve A, to estimate the equivalent amount 
of thymidine per culture that may produce the respective 
inhibitions of isotope uptake by 5 or 10 percent FCS.
2. The shifts in Curve B, and Curve C, relative to Curve A, 
in terms of the molar concentration of thymidine per culture, at 
the 5055 inhibition value of isotope uptake of Curve A, at the 
linear segments of the curves.
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Hgsülîs:
The uptake of 125IUDR was represented by 3 curves, 
(Figure/Table 1.5.2) curves A, B, and C, represented the uptake of 
isotope by cultures, cultured without FCS, and with 5% and 10$ FCS 
respectively. As the molar concentration of thymidine per culture, 
has increased, the uptake of isotope by respective cultures, 
decreased. The highest inhibition of isotope uptake in the *
■irespective cultures, (90 to 99 percent), was achieved by a ^
- * 6  * * 4concentration of thymidine between 5 x 10 moles to 1 x 10 moles per 
culture. The lowest inhibition of isotope uptake by the respective J;
cultures, was achieved by a thymidine concentration of 1 x 10^  moles 
per culture.
The amount of isotope uptake by cell cultures, cultured with 
5$ and 10$ FCS (control cell cultures: without thymidine),
compared to cultures, that were cultured without FCS (control cell 
cultures: without thymidine), expressed as percent inhibition of
isotope uptake was equal to: 9.42$ and 29.75$ respectively. The
amount of thymidine per culture, that produced 9.42$ and 29.75$ 
inhibition of isotope uptake by cultures, as determined in terms of
* ■ 7  " 7Curve A, was equal to: 1.42 x 10 moles and 3 x 10 moles %
%respectively.
The molar concentrations of thymidine per culture, which f?
produced 50$ inhibition of isotope uptake by the respective
^  .  - 7cultures, as represented in Curves A, B, and C, were 6.6 x 10 , 5.1 
X 10^  , and 3.2 x 10^  moles respectively. Thus the amount of
thymidine in 5$ FCS was equal to: C ( 6.6 x 10^) - ( 5.1 x 10^  ) ],
1.5 X 10^  moles. Similarly, the amount of thymidine in 10$ FCS was 
equal to: [ ( 6.6 x lV ) - ( 3.2 x lF ) ], 3.2 x 10^  moles. The
50$ inhibition of isotope uptake by cell cultures, for all 3 curves
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.-7 '■6was between 1 x 10 and 1 x 10 moles. Thus the amount of thymidine 
estimated from Curves A, B and C by the 2 methods as described in 
experimental procedures were similar. In the first method 5% FCS
- 7  - 7contained 1.42 x 10 moles, and 10$ FCS contained 3 x 10 moles. In
"'7the second method 5$ FCS contained 1.5 x 10 moles and 10$ FCS
- 7contained 3.4 x 10 moles.
As described above, (section 3.1.5) the inhibitory effects of 
FCS were assessed in terms of the specificity of the uptake of 
isotope by DNA of cell cultures. The results above, have dbcwn 
that the inhibitory effects of FCS on isotope uptake were specific,
in the ænse, that the amount of 125I0DR available in the DNA
extracts has decreased as the concentration of FCS was increased in 
the culture environment. The pattern of isotope uptake by DNA was 
corroborated by the use of hydroxyurea, a phase specific (S phase) 
inhibitory substance, to demonstrate the pattern of isotope uptake 
inhibition by such a substance. The uptake of isotope was also 
assessed in terms of the inhibitory effects of thymidine, (as FCS 
may contain a vareity of nucleotides) to diow the pattern of the 
inhibitory effects of thymidine on the uptake of isotope by cell
cultures, as thymidine may compete with the labelled nucleotide, or 
block the uptake, depending on its concentration in the culture 
environment.
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3.1.6: The effects of serum type, serum subfraction, cell culture
density and incubation period on the uptake of 125 HJDR by cell 
cultures.
EgperimgDtal srasedMCsa:
3.1.6.1: Cell suspensions of plasmacytoma and mouse
thymocytes were prepared, and two concentrations of each cell type 
were dispensed into miorotitre wells: 5 x 10 cells/well and 1 x 10
cells/well. Cell cultures of plasmacytoma were cultured in 
different concentrations 0$, 5$, 10$, 15$, and 25$ of FCS-HI and 
BSA-HI respectively; while mouse thymocytes were cultured in 
FCS-HI. The final volume per culture well was 200 ul; cultures 
received 0,2 uci 125HJDR, and were replicated 5 times. Cell 
cultures were incubated at 37 C, 5$ COg, as described previously. 
The uptake of isotope by cultures was assessed as described 
previously.
The mean cpm of plasmacytoma cultures has decreased as the 
concentration of FCS per culture increased, (Figure/Table 1.6.1.1). 
In the 5 X  id* cell culture group, 5$ FCS has stimulated the uptake 
of isotope by respective cultures; while 10$ FCS has relatively 
inhibited the uptake of isotope by respective cultures, but was not 
significantly different (P >.05), from the uptake of isotope by 
control cultures. FCS at 15$ and 25$ per culture has inhibited the 
uptake of isotope by respective cultures, and the respective 
isotope uptake was significantly different (15$ FCS: .05 >P> .01 ;
25$ FCS: P< 0.01) from the uptake of isotope by control cultures.
In the 1 X 10^  cell culture group, all concentrations of FCS
- 144
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FIGURE l.61 .1 ;T h e  uptake of 125 lUDR by plasmacytoma cultures,
cultured with FCS-HI for 4 hours.
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inhibited the uptake of isotope by respective cultures. However, î
the uptake of isotope by cultures cultured with 5% FCS, was not 
significantly different (P >.05), from the uptake of isotope by 
control cultures. The uptake of isotope by cultures, cultured with J
10, 15, or 25 percent FCS, was significantly different (10% FCS:
.05 >P> .01; 15% and 25% FCS: P< 0.01).
The percentage of isotope uptake inhibition has increased in 
the 1 X 1(f cell culture group relative to the 5 x 1(f cell group, 
thus at 10, 15 and 25 percent FCS , there was an increase of 55,
92, and 84 percent inhibition respectively, in the 1 x 10^  cell
culture group relative to the 5 x 10^  cell culture group. At 10%
FCS the change was not significant (P > .05) while at 15-25% FCS 
the change was significant (0.05 > P > .01).
The mean cpm of plasmacytoma cultures has decreased as the 
concentration of BSA per culture increased, (Figure/Table 1.6.1.2).
The inhibition of isotope uptake in the 5 x  1^ and the 1 x 10^  cell 
culture groups was generally similar at 5%, 10%, 15% and 25% BSA 
per culture. The mean cpm of cultures was significantly different 
( P <.01 ), frcan the mean cpm of their respective control cultures. |
The percent change in isotope uptake inhibition in the 1 x 10^  cell
culture group at the respective BSA concentrations relative to the 2
5 X  10 cell culture group was about 7.5% for 10% BSA, none at 15%
BSA) and about 3% at 25% BSA, all of which were not significant (P y
> .05).
The mean cpm of thymocyte cultures has decreased, as the 
concentration of FCS per culture increased, (Figure/Table 1.6.1.3).
For both cell culture groups, cultured with 5% FCS, the percent 
change in isotope uptake was not significantly different ( P >.05), 
from the uptake of isotope by control cultures; while the uptake of
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FIGURE 1 .61 .2T h e  uptake of 1251UDR by plasmacytoma cultures,
cultured with BSA for 4 hours. ^
A: I  X 10 cells/culture, 8 : 5 x 1 0  cells/culture .
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FIGURE 1.6.1.3The uptake of 1251UDR by mouse thymocyte cultures,
cultured with FCS-HI for 4 hours .
A: 1 X lÿcells /culture . B: 5 x ICTcelIs/culture .
(O
isotope by cultures, cultured with 10%, 15% and 25% FCS was
significantly different ( P <.01). The percentage of isotope 
uptake inhibition in the 1 x 10^  cell group has increased relative 
to the 5 X 10"^ cell culture group, thus at 10, 15 and 25 percent FCS 
per culture, there was an increase in the inhibition of isotope 
uptake of 35, 12 and 14 percent respectively, which was not a 
significant change (P > .05), except for the 25% FCS group which 
was significant (0.05 > P > .01) and this was due to the small 
standard error of these values.
3.1.6.2: A plasmacytoma cell suspension was prepared and 
dispensed into microtitre wells at two cell concentrations per "#
well, 5 X 10"^ and 5 x 10^  as described previously. The cells were 
cultured for 16 hours at 37 C^, 5% CO2, in 3 groups;
1. without FCS
2. with 10% FCS-HI
3. with 10% Active FCS
Each culture received 0.2 uci of 125IÜDR, and was replicated 5 
times. The uptake of isotope by cultures was assessed as described 
previously.
Rgsul&g:
The effect of increasing the cell culture density and culture 
incubation time, had a marked effect on isotope uptake by the 
respective cell cultures, (Table 1.6.2). The highest inhibition of 
isotope uptake by cell cultures, 70.54%, was present in the 5 x icf 
cell culture group, cultured with Active FCS; while a relatively
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lower inhibition of isotope uptake, 53.85%, was present in cultures 
cultured with FCS-HI. The uptake of isotope in both cultures, 
(FCS: Active and HI), was significantly different ( P <.01 ), frcan
the uptake of isotope by control cultures. In the 5 x 10^  cell 
culture group the uptake of isotope was slightly stimulated but was 
not significantly different ( P >.05 ), from the uptake of isotope 
by control cultures (0% FCS). The uptake of isotope by control 
cultures, cultured at both culture densities, was similar ( P > .05 
). The cell viability of the high density ( 5 x 10^  ) culture 
group, cultured with Active FCS, was not significantly different ( 
P > .05 ), frcm the cell viability of cultures cultured without
FCS.
As described above, (section 3.1.6) the interaction of FCS and 
BSA with cultures of plasmacytoma and thymocytes at two different 
cell culture concentrations was assessed. The inhibition of 
isotope uptake by FCS on plaanacytoma was lower than that produced 
by BSA, but it was evident that while the inhibitory effects of FCS 
(at most FCS concentrations) were a function of the cell culture 
concentration (approximately twice the inhibition at the 1 x 10^  
cell dose relative to the 5 x 10^  cell dose) the inhibitory effects 
of BSA were not. Similarly the interaction of the thymocytes with 
FCS at both cell culture doses, were generally alike. Plasmacytoma 
may be secreting factors that may interact with FCS to produce such 
an interaction. The cell culture density (3.1.6.2) was increased 
10 fold from 5 x l^to 5 x 10^  cells per culture and the cultures 
were incubated for an extended period with and without FCS. The 
experiment has shown that the inhibition of isotope uptake was 
partly due to the increased incubation time and partly to the high 
cell density in the presence of FCS relative to the low cell 
density cultures. Thus a putative factor or factors due to
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plasmacytoma may be (responsible) interacting with FCS to produce 
this inhibitory effect. This inhibitory effect may also be due to 
some factors present in serum.
3.1.7 The relationship between the uptake of 125IÜDR by 
plasmacytoma cultures and the timing of 125IUDR application to cell 
cultures for different periods of incubation.
A plasmacytoma cell suspension was prepared as described 
previously; microtitre wells received 1 x 10^  plasmacytoma cells in 
10% FCS and 0.2 uci 125IÜDR per well. The cultures were incubated 
as described earlier. The cultures received 125IUDR at the 
following timing periods:
(a) 0/4 = cultures received 125IUDR at zero time (at the time of
addition of cell suspension to microtitre wells), and were 
incubated for 4 hours.
(b) 2/4 = cell cultures were initially incubated for 2 hours
without 125I0DR; after the 2 hours incubation, 125IUDR was
dispensed to cell cultures, and the cell cultures were incubated
for a 4 hour period.
(c) 4/4 = cell cultures were incubated for 4 hours without 125IÜDR. 
Following the incubation, 125IÜDR was dispensed to cell cultures 
and the cultures were incubated for a further 4 hour period. The 
uptake of isotope by cultures was assessed as described earlier.
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Regylig:
The relative uptake of 125IÜDR by cells cultured with or 2
without 10% FCS, has increased, as the timing of 125IÜDR 
application to cultures was changed from 0 hour to 2 and 4 hours, 
(Figure/Table 1.7). The increase in mean cpm for cells cultured 
without FCS between the 0/4 and 4/4 groups was 2271 counts per 
minute. The increase in mean cpm for cells cultured with 10% FCS 
between 0/4 and 4/4 groups was 3382 counts per minute. The 
relative mean percent inhibition of 125IÜDR uptake decreased by 
around 14%, as the timing of 125IÜDR application was changed frcm 0 
hour to 2 and 4 hours, from 47.78% at 0/4 to 33*99% at 4/4
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1■1incubation sequence. The respective mean cpm of cells cultured 
with FCS, was significantly different from the mean cpm of their 1
counterpart cultures, cultured without FCS (P<0.01). % e  
inhibition of isotope uptake by FCS was maintained,irrespective of 
the timing of isotope-culture incubation sequence.
The experiment described above was performed to assess the 
interactive process between FCS and plasmacytoma at three 
incubation sequences (0/4, 2/4 and 4/4). The purpose of the
experiment was to increase the incubation period before the A-
application of 125IUDR, to note whether this relatively extended %
incubation period relative to controls (0/4), would produce more 
inhibition on isotope uptake; as other experiments described later 
in other sections, have shown that the preincubation of cultures 
with some batches of FCS, have produced more inhibition on the 
uptake of isotope.
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FIGURE 1 .7  : The relationship between the uptake of 125IUDR by 
plasmacytoma cultures, cultured with FCS-HI and the timing of 
1251UDR application to cell cultures, at different periods of 
incubation tim e ,
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3.1.8: The effects of various types of sera on the uptake of ^
125IUDR by plasmaoytoma cultures.
EgpgrlmëDtâl prageduEgg:
3.1.8.1: A plasmaqytoma suspension was prepared and dispensed
into microtitre wells, at a dose of 1 x 1(f cells/well. Cells were 
cultured with either (FCS, Human, or Horse) serum, at 10% 
concentration. Each culture received 0.2 uci of 125IÜDR, and was 
replicated 5 times. The cultures were incubated for 4, 6 and 8
hours, at 37 5% CO2. All sera were heat inactivated at 56 °C, 30
minutes , before their use as culture supplements. The uptake of 
isotope by cultures was assessed as described earlier.
HpSPlts:
The mean cpm of cultures, cultured with FCS for 4 hours, was 
not significantly different ( P >.01 ), from the mean cpm of
control cultures, (Table 1.8.1). However, the isotope uptake by 
cultures, which were cultured with FCS for 6 hours, was inhibited 
by 38.09%, and was significantly different ( P <.01 ), from the
uptake of isotope by control cultures. At 8 hours of incubation, 
the inhibitory effects of FCS on the uptake of isotope by cultures, 
were reduced to 13.51%, thus the mean cpm of the respective culture 
was not significantly different ( P > .05 ), from the mean cpm of 
control cultures. Horse serum was not inhibitory on the uptake of 
isotope by cultures, cultured with the respective serum for 4 
hours. The mean cpm of the respective cultures at 4 hours 
incubation, was not significantly different ( P >.05 ), from the
mean cpm of control cultures; but at 6 hours of incubation, horse
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serum produced a marked inhibition of isotope uptake, which was a 
reduction of 90.75% in the uptake of isotope by the respective 
cultures, relative to the uptake of isotope by control cultures, 
which was a significant difference ( P <.01). The effective
inhibition by horse serum on the uptake of isotope by cultures was
maintained at 8 hours of incubation; the mean cpm of the respective 
cultures, was significantly different ( P <.01), fran the mean cpm 
of control cultures. Human serum, at 4 hours, produced 38.8% 
inhibition of isotope uptake by cultures, which was significantly 
different (P < .01), from the uptake of isotope by control
cultures. There was a relative change in the inhibitory effects of 
human serum on isotope uptake by cell cultures, at 6 and 8 hours of 
incubation; the mean cpm of the respective cultures was 
significantly different ( P <.01 ), from the mean cpm of control 
cultures. The cell viabilities of cultures, cultured with horse or 
human serum (8 hour culture) were not significantly different from 
the viabilities of cells cultured without serum (P > .05). The
inhibitory effects of sera, as described above, are a function of
incubation time;, as with this batch of FCS used in this
experiment, the inhibitory effects of FCS on isotope uptake by cell 
cultures were evident at 6 hours instead of 4 hours, but with the 
usual pattern of a decrease in inhibition with further incubation.
Horse serum, as FCS, was not inhibitory at 4 hours, but was so at 6
hours, with an inhibition which was approximately twice that
produced by the other two sera, which were nearly similar in their 
inhibitory effects. At 8 hours of incubation, the inhibitory 
effects of horse serum were about three fold more than human serun, 
and about six fold more than FCS.
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EgEeEimSBtal Bcgsëdycëa:
3.1.8.2: A oeil suspension of plasmacytoma was prepared and
dispensed into microtitre wells at 1 x 10^  cells per culture. Cells 
were cultured in the follcwing [heat-inactivated 56 °C, 30 minutes, 
and Active] sera: FCS, GDI and GBA mice sera, rat serum, BSA
(bovine serum albumin) and HSA (human serum albumin) at a 
concentration of 10/6 and 20/6 per culture; together with control 
cultures, cultured without serm . All cell cultures received 0.2 
uci 125IUDR per culture, and were replicated 5 times. Cultures 
were incubated for a period of 4 hours as described previously. 
The final volume per culture was 200 ul. The uptake of isotope was 
assessed as described earlier.
The uptake of 125IÜDR by plasmacytoma cultures in the presence 
of various types of sera has been described, (Tables 1.8.2.A and 
1.8.2.B). In the 1056 [heat-inactivated sera] group the mean ppm 
range for the FCS, rat and mice sera was between 11087 to 14165, 
the respective percent inhibition of 125IÜDR uptake ranged fran 
40.1 156 to 53.12%; all were significantly different ( P <.01 ), from 
the mean cpm of cells cultured without serum.
The inhibitory effects of rat and GDI sera were not 
significantly different fran FCS, while the inhibitory effect of 
GBA serum was different( F <.01). The mean cpm of cultures in the 
20% heat inactivated sera ranged between 7328 and 9535; the 
respective percent inhibition of 125I0DR uptake ranged between 
59.68% and 69.01%. The mean cpm of cultures, cultured with rat, 
GBA or GDI sera were not significantly different ( P >.01 ) , from 
from the mean cpm of cultures, cultured with FGS.
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In the 10% [Active sera] group, the mean cpm of cultures, 
cultured with FCS, rat, mice, BSA and HSA ranged from 8497 to 
15450; the respective percent inhibition of 125IÜDR uptake ranged 
from 34.67% to 64.4%, all were significantly different ( P <.01 ), 
fran the mean cpm of cells cultured without serum.
The mean cpm of cultures, cultured with rat or BSA sera were
significantly different ( P <.01 ), from the mean cpm of cultures, 
cultured with the FCS, while the respective mean cpm of cultures, 
cultured with GBA, GDI and HSA was not different ( P >.01 ), from 
the mean cpm of cultures, cultured with FGS.
The mean cpm in the 20% [Active sera] group, ranged between 
4708 and 10515, the respective percent inhibition of 125IUDR uptake 
ranged from 55.54% to 80.09%. The respective mean cpm of cultures 
in all types of sera was not significantly different ( P > .01 ), 
from the mean cpm of cultures, cultured with FGS.
The cell viabilities of cultures, cultured in the respective
20% [Active serum] type, were not significantly different ( P >.05
) from their control counterparts cultured without serum.
The experiments described above, (sections 3.1.8.1 and 
3.1.8.2) were assessing the effects of sera other than FGS, on the 
uptake of isotope by cell cultures, and compare and contrast these 
effects with FGS. Akinetic study, (section 3.1.8.1, effects of 
serum and period of incubation) was performed to assess the pattern 
of isotope uptake in the presence of FGS, human and horse sera. 
Human serum was generally similar to FGS in the pattern of isotope 
uptake inhibition, as in both sera the inhibitory effects were 
decreasing as the period of incubation was increasing. Horse serum 
was different fron FGS, as the inhibition of isotope uptake was
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relatively constant at extended periods of incubation.
The effects of rat serun, mice sera, BSA and HSA on isotope 
uptake were also assessed in relation to the effects of FCS, 
(section 3.1.8.2). Both sets of experiments have shown that other 
sera were also inhibitory, thus the inhibition of isotope uptake is 
not a characteristic effect of FCS.
3.1.9: The relationship between the uptake of 125IUDR by
plasmacytoma cultures, and the isotope activity remaining in 
microtitre wells used for the plasmacytoma cultures.
EgperimëDtâl D^ëfie^ü^es:
A suspension of plasmacytoma cells was prepared and dispensed 
into microtitre wells at a cell culture dose of 1 x 10 cells/well. 
Cells were cultured with 0%, 5%, 10%, 15% and 25% FCS-HI [batch A], 
as described in section 1.10.B. Each culture received 0.2 uci
125IUDR, and was replicated 5 times. Cultures were incubated for 4 
hours, at 37 °C, 5% CO2, as described previously. The cultures were 
harvested as described in materials and methods. The culture
plates were dried, and individual wells were sawn off and were 
examined for their radioactivity content in a gamma spectrometer.
The results of the isotope uptake curves, ( Figure/Table 1.9) 
are as follows: Curve A , ( column A, Table 1.9) represents the
actual inhibition produced by FCS on the uptake of isotope by cell 
cultures. Curve B, represents the difference (expressed in mean
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FIGURE 1 .9  : The uptake of 1251UDR by plasmacytoma cultures, 
cultured with FCS-HI for 4 hours.
A: actual amount of isotope uptake by cultures
B: expected amount of isotope uptake inhibition due to serum
C: actual amount of radioactivity remaining in mlcrotitre wells
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cpm) between the uptake of isotope by the respective cultures and 
cultures cultured without FCS. Curve C, represents the amount of 
radioctivity ranaining in culture wells, after cell harvest. The 
values in column D, are the percentages of values in column C, in 
terms of values in column B . As the FCS concentration per culture 
has increased, the uptake of isotope by plasmacytoma cultures 
decreased, as in Curve 1. The highest mean cpm was for cultures,
cultured without FCS; the lowest mean cpm was for cultures, 
cultured with 25SS FCS. The inhibition by FCS, on isotope uptake by 
plasmacytoma cultures, ranged from 19.99% at 5% FCS per culture, to 
84.16% at 25% FCS per culture. An analysis of variance and 
Dunnett's test ( 2 tail, P = .01 ), between the mean cpm of
cultures, cultured with 0%, 5%, 10%, 15% and 25% FCS, was
significant, (Anovar. F ratio = 101.17, P <.01 ). The mean cpm of 
cultures, cultured without FCS were significantly different from 
mean cpm of cells cultured with 25%, 15%, 10^ 6 and 5% FCS . The 
mean cpm of cells cultured with 5% FCS was significantly different 
from the mean cpm of cultures, cultured with 25%, 15% and 10% FCS. 
The mean cpm of cells cultured with 10% FCS was significantly 
different from the mean cpm of cultures cultured with 25% and 15% 
FCS. The mean cpm of cells cultured with 25% was also different 
from the mean cpm of cells cultured with 15% FCS. The quantity of 
isotope uptake inhibition, expressed in mean cpm in Curve 2, has
increased as the FCS concentration per culture increased, from 1632 
mean cpm at 5% FCS to 7454 mean cpm at 25% FCS . The mean cpm
available in culture wells which were used for plasmacytoma 
cultures has decreased as the concentration of FCS per culture 
increased. Thus the mean cpm for the 0% and 5% FCS culture wells 
were 688 and 711 respectively, which has decreased to 202 at 25% 
FCS; although an Anovar. between the mean cpm of culture wells was
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not significant, (F.ratio = 2.57, P > .05). When the mean cpm of 
culture wells was expressed as a percentage of the total mean cpm 
inhibition (Curve 3 vs Curve 2) one notes, that the reduction in 
isotope uptake by cultures, accounted for, in part, by isotope 
activity remaining in the wells, was highest at 5% FCS (43.57% 
inhibition) and lowest at 25% FCS (2.71% inhibition).
The experiment described above (section 3.1.9), was performed 
to assess the effects of serum concentration on the amount of 
isotope activity remaining in the microtitre culture dishes. The 
results have demonstrated that when the concentration of serum 
increases in the culture environment, the amount of isotope 
activity remaining in culture dishes decreases. Therefore the 
decrease in isotope activity recovered in harvested cultures (i.e. 
the amount of isotope uptake inhibition), was not due to a decrease 
(in part) in isotope availability to cell cultures, because of 
isotope remaining attached to culture dishes.
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3,2: THE EFFECTS OF (iCF OH CELLUtAR PROLCFERATCOH CH CHVCTRD CELL CLTLTtTRES
3.2.1.1.1 The effects of RAT UEF on OffA. synthesis ao assessed by the 
inhi±>ition of 125 ECJDR.uptake by cell cultures.
Experimental procedures:
Rat Thymus UTF, Rat Spleen QEF were prepared from cells of Rat 
thymus and spleen, (50 x 10® thymocytes or spleen cells were incubated 
in 5 ml of RPHE without FCS in 50 mm diameters tissue culture sterilin 
petri dishes for IS hours at 37®C); several batches of thymus urp and 
spleen UEF were prepared, A cell suspension of plasmacytoma was 
prepared and dispensed into microtitre wells at 1 x 10® cells per well 
in 10"3 FCS-HI. Wells received 5, 10, 20, and 40 ul per well of Thymus 
■ UIF (TC-UIF), other sets of wells received RCW.UTF spleen UIP (RWC = 
whole spleen. Red cells and white cells UIF), and WCF.UIP spleen UIF 
(WCf - white cell fraction without red cells). Each well received 0.2 
uci of 125 lUDR; each UIF concentration was replicated in 5 wells and 
cell cultures were incubated for a 4 hour period.
The final volume per well was 200 ul. The effect of each type 
of UIF on cell proliferation, was tested individually to assess the 
inhibition, as measured by the uptake of 125 lUDR. All cultures with 
UIF have control cultures, in which cells were cultured without UIF. 
The UIFS described in Section 2.1.1-, arid in Figure 2.1.A are coded as 
UIF batch 1.
Results i
The general trend of 125 EUDR uptake inhibition was linear, 
which increased as the amount of UIF per culture well increased, as 
described in Figure/Table 2.1.A . The Thymus UIF showed small 
inhibitions at 5 and 10 ul per well, of 0.3% and 6.94% respectively. 
The inhibition increased to 15.65% and 25.08% at 20 and 40 ul pec
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well. At 5 and 10 ul QCF pec well the lnhi±)ltloa o£ 0.30% and 6.9-V% 
were not olgnlElcantly dlEEecent Ecoiu conhcol values oE cells cultucad 
without irc?, (P>.05, t "0.0609 .and .0010 cespeet Ivaly ). At the 20 ul 
UIP pec well the inhibition oE 125 EUDR uptake w.as slqniElcant, 
(0.05>P>.0l t-3.24o,). At V^O ul pec well, the inhibition oE isotope 
uphal<.e w<as signlEicant (P>.01, t=5 . 437 ).
The spleen (UIF.R/iX3) Ecactlon showed swa.ll inhibitions 
throughtout the whole cange oE UIP concentrations per well. The 
inhibitions raunged Erorn Q.8‘% at 5 ul to 9.02% at 40 ul, and at all UIF 
concentration the Inhibition was not signlEicant, (P>.05, t=0.154,
0,226, 0.664 and 1.087 respectively Erom 5 ul UIF to 40 ul UIP).
The spleen (UIF.WCE) showed inhibitions which were relatively 
higher than the other 2 UIPS an in table 2.1A. The inhibitions increased 
with increasing UIF concentration per well Erom. 5 ul to 40 ul.
The inhibitions at 40 ul and 20 ul UIF were signlEicant (t-2tail 
P-<.01, 3dE, 4.28 and 7.01 respectively), at 10 ul UIF the inhibition 
was signlEicant (0.05>P>.01, t=2.98), while at 5 ul UIF the
inhibition was not signlEicant (p>.05, t=0.659). The eEEects o£ UIF 
on cell viability are described in table 2.2C.
The percent inhibition has been determined as described in 
section 3,1
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3.2.1-2 1 The eEEectsoE RAT UEF on DMA synthesis and the inhibition of 
125 EUDR uptake by cell cultures.
Experimental procedures ;
Rat UTF was prepared Erom cells oE the thymus or spleen (5 x 10^ 
cells in 5 ml RPÎ1I without FCS dispensed into sterile 50 mm tissue 
culture sterlin petri dishes, and were incubated for 15 hours at 37®C) 
as has been described eatrlier. Several batches of TC-UIF, WRc-UIF and 
WCf-UIF were prepared and tested for their inhibitory effects. Three 
batches of each type of UIF have been used for the experiment 
described in this section 2.1.2. The batches are coded as: 18.2, 19.2 
and 29.2. Cell suspensions of plasnvacytoma and of mouse thymocytes 
were dispensed into their respective microtitre w^ ells, each at a 
concentration of 1 x 10* cells per well. Cell ..cultures were divided 
into two parts, those cultured without FCS, and those cultured with 
10% FCS-HI. Three batches of each type of UEF were assessed. Wells 
received 20, or 40 ul of each batch of UEF and 0.2 uci of 125 lUDR; 
each UEF concentration wajs replicated 5 times. Cell cultures were 
incubated for 4 hours. The final volume per well was 200 ul. All 
cultures have control cultures, in which cells were cultured without 
UIF.
Results :
The difference in isotope uptake, expressed as cpm (mean counts 
per minute) between plasmacytoma cultures cultured without FCS (medium 
controls, 6225 cpm), and cells cultured with FCS 10% (FCS controls, 
3755. cpm) was significant, t=4.76, 2tail, P<.01 with 10% FCS causing a 
39.51% inhibition of 125 lUDR uptake as described in Table 2.1.B1 . 
The batch total mean cpm per UEF group for cells cultured without FCS 
were similar at 5869 to 5889 cpm, for UEP.TC at 20 and 40 ul
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FIGURE 2 , 1 . Bl: The uptake of 125IUDR by plasmacytoma cultures,
cultured without and with F C S -H I,  for 4 hours, with rat UIF.
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respectively, with corresponding inhibitions of around 5% for both; 
which were not significantly different from medium controls (t=0.872 
and 1.028 respectively, P>.05).
For RVi=c.aiF at 20 ul, the respective batch total mean percent 
inhibition of isotope uptake waa 15.7%, which increased twofold to 
31.8% when the urp concentration was increased to 40 ul. Both 
inhibitions were significantly .different from medium controls, 
(t=3.027 and 6.57 respectively, P<.01).
For the WCf.CJI? there was a 40.7% batch total mean percent 
inhibition at 20 ul, which increased moderately to about 58% when the 
CJIP concentration was doubled to 40 ul per well. Both values were 
significantly different from medium controls (t~8.94 and 12.81 
respectively, P<.01). The highest inhibitions ware by the ïfCf.UlF 
group, followed by RWC. UIF and the leaust inhibitory was the 
TC.aiF .
For cells cultured in 10% FCS, (JIF.TC produced around 17% 
inhibition of isotope uptake at 20 ul per well, which increased to 
eibout 28% when the UIF concentration per well was doubled. Both 
inhibitions were signficantly different from 10% FCS culture controls, 
(t-3.56 and 5.22 respectively, P<.01).
For UIF.RWC at 20 ul per well, the inhibition was 25% which 
increased to 33.7% when the UEF concentration per. well was increased 
to 40 ul.
Both were significantly different from 10% FCS controls (t"*4.37 
8.67 respectively P<.01).
For UEP.WCf the amount of inhibition produced at 20 or 40 ul 
per well were similar to RWC.UIF and were in the region of 25 to 
38.9% repectively.
Both were signficantly different from 10% FCS controls (t^4.92
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and 9.95 respectively P<.01). At 20 ul per well, an analysis of 
variance (tVnovar) between the respective mean percent inhibitions for 
the 3 UEFS in 10% FCS showed significant differences (P-=L2.19,
P<.01).
The WCf.UIF was significantly different from TC.UIF, but not 
different from RWC.UIP while the RWC.UEF was significantly
different from TC.UEF . The significance of the difference bet//een 
the UEF types was assessed by using the multiple range test - short 
significance ranges (MRT-SSR).
For the 40 ul per well, the values of percent inhibitions for 
the 3 UIFS showed no signficant differences in an Anovar at (P^x.Ol, 
P=6,26 but were significant at P=<,05). The MRT~SSR showed no 
differences between the means.
For cells cultured without FCS, the differences between the 3 
UIFS (TC, RWC, 9fCf ) on 125 EUDR uptake inhibitions at 20 ul per well 
were significantly different among their values in an Anovar at 
(P"=»<,01, F=»29.11). WCf.UIF was significantly different from RWC and 
TC.UIFS, while R'i'jC was not different frcm TC.UEF using the
MRT-SSR .
At the 40 ul per well the 3 UIFS were significantly different 
from each other, using an Anovar, (P<.01, F-=»59.15) and the KRT—SSR.
A comparison between the percent inhibitions caused by the three 
UIFS administered to cells cultured with or without FCS using a 2tail 
t-test comparison with 4 df, was as follows:
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The TC .UIF at 20 and 40 ul cultured without FCS or in 10% FCS 
were not significantly different at P<.01, alL.ough the ‘K) ul was more 
inhibitor'/ in 10% FCS than its counterpart without FCS, but was 
significant at (0.05>P>.Ql)
The percent inhibition produced by RWC.UCF at 20 or 40 ul, 
without or with 10% FCS were not significantly different from each 
other (P<.01), although RWC 20 ul in FCS was significantly greater 
than its counterpart without FCS, (0.05>P>0.01).
The percent inhibition produced by the WCf.UIF at 20 ul and 40 
ul, without FCS, or with 10% FCS; the inhibitions were significantly 
greater in cells cultured without FCS, compared to cells with 10% FCS 
(P<.0lV
The inhibitions of isotope uptake by UIF for cells cultured 
without FCS show that WCf.UIF produced the highest inhibition 
compared to RWC and TC.UIFS, however this was not an absolute case for 
cells cultured with 10% FCS. The calculation of percent uptake 
inhibition has been determined as described in Section 3«1. The 
percent inhibitions for cell cultures without FCS were determined in 
terms of control cultures without FCS, while for those cultured with 
10% FCS, the percent inhibitions were determined in terms of control 
cultures (10% FCS).
The difference in isotope uptake expressed as cpm between mouse 
thymocyte cultures, cultured without FCS (medium controls, 210) and
cultured with FCS (10% FCS controls 240) as described In Table 
2.L.B2 was 14.28% which was not significant (t-1.76, P>.05).
For cells cultured without FCS UIF.TC produced similar 
inhibitions of isotope upta:<e of approximately 15% at 20 and 40 ul UIF 
per well. For RWC.UEF there was around 17% inhibition at 20 ul UEF 
which increased to 21% at 40 ul UIF per well. The highest inhibitions
-  162 -
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were produced by ','fC^ MtF at 20 and 40 ul per well which were 40 to 
55% repectively. The mean cpm of TC .UTF at 20 and 40 ul was not
different from their culture controls mean cpm (t-1.84 and 2.05
respectively P>.05), while the mean cpm of RWC.UEF ah 20 ul was 
significant at (0.05>P>.0I, t=2.44) and at 40 ul significant at
(Pt.Ol, t=3.75). The mean cpm of WCf.UIF at 20 cund 40 ul was 
different from the mean cpm of their medium controls (t=8.38 and 9.147 
respectively Pc.Ol).
For cells cultured with 10% FCS, TC.UIP produced 14% 
inhibition at 20 ul per well, which increased to 23% at 40 ul per
well. At 20 ul UIF the inhibition was not significant, (t-1.99 
P>.05), while for TC 40 ul. The inhibition was significant at (P<.oi, 
t=4.97).
The mean cpm of RWC.UEF at 20 and 40 ul and WCf.UIF 20 and 40 ul 
were all different from the mean cpm of 10% FCS cultures controls, 
(t=4.30, 5.81 and 8.50, 9.12 respectively Pt.Ol).
The highest inhibitions were by the WCf.UIF group followed by 
(RWC.UIF), and the least inhibitory was the TC.UIF .
For cells cultured without FCS, the total mean percent 
inhibition at 20 ul per UIF, were not different from each other in an 
Anovar, (P>0.05 F=1.22). Similarly, the total mean percent
inhibitions produced by 40 ul of UIFS, TC, RWC and WCf were not
different from each other in an Anovar (P<.05, F^O.697).
For cells cultured in 10% FCS, che total mean percent innibit ion 
produced by 20 ul of UIFS, TC, RWC and WCf were significantly 
different in Anovar,* (P<.01, F-13.85) where WCf.UIF was different
from TC.UEF but not from RliC.UIF while RWC.UCF was not different 
from TC.UEF using the Multiple Elange Test - Shortest Significant 
Ranges MRT-SSR.
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The total mean percent Inhibitions of tfCFS TC, RWC and WCf at 40 
ul were significantly different in an anovar, (P<.OL, where
both WCf and RWC UCF3 were different fcocu TC.U :F, while WCf.UC? .and 
RWC.at? were not different, using the MRT-SSE; .
A comparison between the mean percent Inhibitions caused by the 
three UIP3 administered to ceils cultured with or without FCS using a 
2tail t-test has been described, (Table 2,1.2).
There was no significant difference in the mean percent 
inhibitions of isotope upta2<e between cells cultured with or without 
10% FCS at 20 ul and 'K) ul of TC.UEF .
For the RWC.UCF at 20 and 40 ul, the percent inhibitions in 
cells cultured in 10% FCS were significantly greater than* their 
counterparts cultured without FCS at Pt.OS. For the WCf.UCF at 20 
ul and 40 ul, the percent inhibitions for cells cultured with FCS were 
greater than for cells cultured without FCS at (P<.05) for 20 ul and 
(P<.01) for 40 ul UEF.
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As described above, (section 3*2.1.2) the inhibitory effects 
of ÜIF on cell cultures have been asessed. The results have 
demonstrated that WCF.UIF produced the highest inhibition of 
radioisotope uptake at both UIF concentrations (20 and 40 ul) in 
both culture environments (with and without FCS). The results have 
demonstrated that the interbatch variation (in radioisotope uptake 
inhibition) was small within each group of batches, except for the 
TC.UIF group in which the interbatch variation was relatively 
large, (i.e. some TC.UIF batches were more inhibitory than
others), as assessed on plasmacytoma cultures, cultured without 
FCS. However, this interbatch, variation within the TC.UIF group 
was minimized when the inhibition of radioisotope uptake was
assessed in cultures containing FCS. Thus FCS was potentiating the 
weak TC.UIF batches 18.2 and 19.2, rendering them as inhibitory as 
TC.UIF batch 19.2. Similarly, the uptake inhibition by RWC.UIF in 
the presence of FCS was relatively more than the uptake inhibition 
available in cultures cultured without FCS. However, the effect of 
FCS on the WCF.UIF group was different, as the inhibition of 
radioisotope uptake was relatively reduced in cultures containing 
FCS, relative to cultures cultured without FCS. Thus the 
interaction of each type of UIF with FCS may produce different 
patterns of radioisotope uptake.
Similarly, with the thymocyte cultures, WCF.UIF produced more
inhibition of radioisotope uptake than the other two UIFS. The
inhibitory effects of the UIFS TC and RWC (within each batch) were 
relatively more variable than on the plasmacytoma cultures. TC.UIF 
(batch 19.2 cultured without FCS) was mere inhibitory on the 
thymocytes than on plasmacytoma cultures, while batch 19.2 of 
RWC.UIF was more inhibitory (cultured without FCS) on plasmacytoma 
than on thymocytes.
- T65 -
The addition of FCS to TC.UIF (thymocyte cultures) produced a 
different pattern of radioisotope uptake at 20 and 40 ul; at 20 ul 
the uptake in the presence of FCS with batch 18.2 was similar to 
that without FCS, while the uptake in the presence of batch 19.2 
and FCS was approximately reduced to half the value of the uptake 
for cells cultured without FCS, while the inhibition of 
radioisotope uptake by batch 29.2/FCS was greatly increased 
relative to the uptake by cultures cultured without FCS. At 40ul, 
the inhibition of radioisotope uptake was increased in the presence 
of FCS (different from the 20ul group) than for cultures cultured 
without FCS. The change in radioisotope upt&ke for batches 19.2 
and 29.2 was similar to that of the 20ul group. For RWC.UIF, the 
general pattern of radioisotope uptake inhibition was higher in the 
presence of FCS than without FCS.
The inhibition of radioisotope uptake for WCF.UIF was nearly 
the same at both concentrations, slightly more inhibtion in the 
20ul group cultured with FCS than without FCS. It can be noted 
that the thymocytes were more sensitive to the inhibitory effects 
of WCF.UIF (in the presence of FCS) than the plasmacytoma cultures. 
Thus the inhibition of radioisotope uptake by UIF on cell cultures 
depends on several factors, such as the presence of FCS, the type 
of UIF, the batch quality of UIF, the concentration of the UIF in 
the culture and the type of cell culture used for the assessment of 
UIF,
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3 . 2 . L . 3 :  'Cite e t ' t ' e c b s  o f  mo u se  U C f  o a  DMA s y n t h e s i s  a n d  t h e  u p t a k e  o f
I2'i CC/DR by cell cultures.
Experimental procedures :
Several types of If CPS were prep.-arecl, from thymocytes, bone 
nuirrow cells, spleen cells (whole spleen DEP, RWC and white cell 
fraction WCE.UCP), and lymph node cells (Inguinal, axillary <xnd 
mesentrlc,). Each C/CP was prepared Independently In tissue culture 
grade petri dishes (50 ram diameter sterilin) at a concentration of 
ixio? cells/ml RPXE without FCS, with a total of 5xlo? cells per petri 
dish. 'Che cultures were incubated for 16 hours at 37®C In a Leec
incubator. The thymocyte (TC.tJCP), spleen (WCf and RWC.C/EPS), bone
mar row (BH.C/IP) and lymph node ( E2f. CEP ) batches are coded as A, B and 
C.
Suspensions of plasmacytoma cells and mouse thymocytes ’i^re
prepared and each was dispensed into separate mlcrotitre wells, at a 
concentration of ixlo^ cells per well. Cell cultures were divided 
into two parts, those cultured with lOt FCS-HE and those cultured
without PCS.
Each well received 20 ul or 40 ul of the respective LfCP,
together with 0.2 uci 125 EUDR. 'Ehe final volume per wqll was 200 ul. 
Each UEP concentration was replicated in 5 wells. All cultures have 
control cultures, in which cells were cultured without C/EF.
Results !
The difference in cpm between plasmacytoma cultures cultured
without PCS (medium controls, 10343) and cultured with 10% PCS (PCS
controls 7758 ) as described in Table 2.1.Cl was 24.99% due to PCS, 
and was significant (t-=4.l92 P<.01).
For cells cultured without PCS, the mean cpm for the respective
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T-tests corrp,u'i3cas foc Tible 2.1.CL.
colar.n 1 - UIF batch voroos co,Ttrols (without 10’ PCS) 
col-wT-ji 2 = ut? hatch versus controls (w ith ICL FCS)
UIF Ty,
TC
20 ul
•10 ul
FWC 
20 ul
•10 u l
Wcf 
20 u l
40 u l
40 ul
EH
20 u l
P*/*=.05>P).01P:'* = (.01 p-'"' = >.05
ace batches oE JCF.‘rc wece all slqnLEicantly dlEEecent Erooi the mean 
cfm oE culture control (pc.QL) as described In the t-test comparison 
table. ‘Che mean percent innlbltIon oE Isotope • pt.ike at 20 ul ULF was 
2B‘l which inreased to about 4Vt with 40 ul tfCF per well, for 
C/Cf.RWC the cpm o£ the respective batches were all signlElcantly 
dlEEerent Erotn control cultures, (P<.01) except Eoc batch h (40 ul 
(JCF) at (O.OS>P> .01). The mean per cent inhiJsition produced by 20 ul 
CJCP was 25% with a minor increase to 31% at 40 ul ai? per well. for 
UCf.WCE , the Cpm oE the respective batches were all significantly 
different from culture controls, (p<.01) as detailed in the test 
table. At 20 ul (JIF per well, there was about 38% inhibition of 
Isotope uptake, which increased moderately to 58% at 40 ul UCf per 
well. The cpm for the respective batches of UlP.LN at 20 and 40 ul 
were all significantly different from culture control cpm, (P<.01). 
‘Che mean percent inhibition at 20 ul CJCF per well was around 35% with 
a fair increase to 51% at 40 ul UIF per well.
for crif.BM similarly, the cpm. of the respective batch.es were 
all significantly different from the cpm of control cultures, (Pc.oi), 
except for batch 8 (20 ul UTP) at (0.05>P>.01). The mean percent
inhibition at 20 ul UCf per well was 18% which Increased by a factor 
of 2 to 37% with 40 ul UIF per well.
An Analysis of Variance (Anovac.) for the 20 ul CiEF per well 
between the mean percent inhibitions of all the batches of CJEFS: TC, 
RWC, w c f ,  L N  and B M ,  showed that they were not significantly different 
from each other, (P>.05, P. ratio-=2.88 ). similarly for the 40 ul per 
well gcoup, the Anovar., showed no significant differences (P>.05 
F-3.33).
For cells cultured with 10% FCS, the cpm of the respective 
batches o£ UEF.TC were significantly dlEEerent from the cpm of
- 1 6 8
control cultures (P<.OL) except Eoc batch C (70 ul UCF) at 
(0.05>P> .01). At 20 ul rJCF the mean percent Inhibition oE Isotope 
upt.Uce was around 20% with a small increase to 36% at -K) ul tjc? per 
well. For ÜCF.RWC at 20 ul UIF per well the cpm oE respective 
batches were not significantly different from cpm of culture controls, 
(P>.05). At 40 ul per well the cpm of batch A was not significantly 
different from culture controls, (P>.05), whereas batches B and C were 
different, (o .05>P>.01 ) .
However, the total mean cpm for the three batches of UIP.RWC 
at 40 ul per well was not significantly different from culture 
controls, (P>.05, t=2.26Q).
At 20 ul per well, RWC.UIF produced a mean percent inhibition 
.of 5.5% with a minor increase to 10% at 40 ul per well. For 
îVCf.UIF , the mean percent inhibition at 20 ul UIF per well was 
around 31% which increased to 40% with 40 ul UIF per well.
The cpm of the respective batches of WCf.UIf at 20 ul or 40 ul per 
well were significantly different from the cpm of control cultures 
Pc.01 as described in the t-test table.
The mean cpm of the respective batches of UIF.LN at 20 and 40 
ul per well were all significantly different from the mean cpm of
control cultures, Pc.01. At 20 ul UIF per well, the mean percent
inhibition was approximately 28% which increased moderately to 41% at 
40 ul UIF per well.
The mean cpm for the respective batches of UIF.8M at 20 ul or 40 ul 
per well were all significantly different from the Cpm of control 
cultures (Pc.01), except for batches B and c, 20 ul UIF, ( o .05>p> .0 L ). 
The mean percent inhibition produced by 20 ul UIF per well was 38%
which increased to about 43% at 40 ul UIF per well. An Anovar-
between the mean percent inhibitions of all the batches of UCF; 'IC,
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RWC, '■.iCf, Cl( and ÜH were algnflcanh at 20 ul, (0.05>P>.01, F--‘V.53),
and at 40 ul per well, (Pc.OL, F-6.10 ).
At 20 ul CJCP, wcf, 'LC and CK-UCPS were different from 'bTC.UCP 
while BM.CJtP was not different. UtPS; VrCf, 'tC, LN and BM were not 
different among each other. At ‘VO ul per well, CJEFS: li(, VCc .and TC
were different from RS-KT.UEF, while 8H.UCF was not. CJTF3: CiC, '.ice and 
BM were not different among each other. The differences among the 
UEFS were ,assessed by using the multiple r<ange test using short
significant ranges (MRT—SSR).
For cells cultured without FCS and 20 ul UIF, the highest
inhibition was produced by »\Cf 37.88%, followed by LN 34.71, TC 28.33, 
r:*iC 25.46 and BM 18.43. At 40 ul the h-ighest Inhibition was by WCf 
58.33% followed by LN 51.26, TC 46.83, 8H 37.07, and KfC 31.02%, as 
described in Table 2.1.Cl .
For cells cultured in 10% FCS with 20 ul UCF the highest
inhibition was by NCf.UlF 30.76%, followed by TC and LN UIFS which 
were similar at 27.8%, BM 17.71% and RWC 6.66%. At 40 ul UIF the
highest inhibition was by LN.UIF 41.36%, followed by WCf 40.16%, TC 
35.83%, BM 23.96% and RSVC 10.38%.
A comparison between the mean percent inhibitions cauded by the 
three UIFS administered to cells, cultured with or without 10% FCS, 
using a 2tail t-test has been described, (Ta.ble 2.1 .3)
The mean percent inhibitions for TC.UIF , 20 ul and 40 ul were
not different between cultures containing FCS or without PCS. For the 
RWC.UIF at 20 and 40 uls, the mean percent inhibitions were higher 
for cells cultured without FCS than with FCS. The Wcf.UIF , at 20 or 
40 ul with or without PCS showed no difference in mean percent 
Inhibitions, so was the case with LN.UIF .
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The BM.UCF at 40 ul, was more inhibitory for cells cultured 
without FCS than with FCS, although at 20 ul there was no diffeieace. 
The percent inhibition described in Table 2.1.Cl were determined as 
has b-een described in Table 2.1.31.
Resultsi
The difference in cpm between mouse thymocytes cultured without 
FCS (medium controls, 192 cpm) and cells cultured with 10% FCS (FCS 
controls, 186 cpm) as described in Table 2.1.C2 was 3.1% which was 
not significant t-0.197 P>.05 2tail.
For cell cultures, cultured without FCS, the batch total mean 
cpm for UCF.TC at 20 and 40 ul per well were significantly from the 
mean Cpm of the control culture^ (P<.01, t-7.38 and 8.54). The
corresponding mean percent inhibition at 20 ul per well was 63% which
increased to 71.8% at 40 ul per well. For UCF.RWC the batch total
mean cpm at 20 and 40 ul per well were signifcantly different from 
culture control, (0.05>p>.01 t-2.73), (P<.01, t=5.00) respectively.
At 20 ul the batch total mean percent inhibition was 31.5%, which 
increased to 45% at 40 ul UIF per well. The batch total mean cpm of 
UEF.WCf at 20 and 40 ul per well were also significantly different 
from the mean Cpm of culture control (P<.01, t-3.44 and 4.916)
respectively. The batch total meajn percent inhibition at 20 ul per 
wall was 42% which icnreased to 51% at 40 ul UIF per well.
An Anovar., comparison between the mean percent Inhibitions for 
UIFS: TC, RWC and WCf at 20 ul (without FCS) showed that some
differences existed (0.05>P>.01, F=8.78). TC.UIF was different from 
RWC.UIF but not from WCf.UIP , and RWC.UIF was not different from
w c f . UCF . At 40 ul par well there were no significant differences
among the mean percent inhibitions of the respective UIFS, (P>.05, 
F-2.497), and an MST-SSR analysis.
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For cells cultured with iu% FCS, the batch total mean percent 
Inhibitions at 20 and 40 ul per well were small, at 1 to 10%, and the 
batch total mean cpm for both UIF concentrations were not 
significantly different from the cpm of culture control (P>.05, 
t-0.161 and 1.53 respectively). Similarly, for RWC.UIF the batch 
total mean cpm at both concentrations of UIF per well, were not 
significantly different from culture control (P>.05, t=0.827 and
1.016) respectively. The respective inhibitions at 20 and 40 ul UIF 
per well were similar at around 17%. For WCf.UIP , the batch total 
mean cpm for 20 and 40 ul were significantly different from controls, 
(0.05>P>,01, t-=2.429, and P<.01, t^3.89), respectively. The batch
total mean percent inhibition at 20 ul was 19% which inreased fairly 
to 32% ah 40 ul per well. An Anovar between the batch total mean 
percent inhibitions at 20 or 40 ul of UIFS TC, WRC and WCf, showed no 
significant differences (P>.05, F-1.96 and 1.63), respectively.
The highest inhibition of 125 EUDR uptake for cells cultured 
without FCS, was by TC.UIF at 20 ul: 63.3%, followed by WCf.UIF :
42.16% and RWC.UIF: 31.53% and at 40' ul TC.UIF produced 71.83%
inhibition, followed by WCf 51.16% and RWC 45.1% inhibition.
For cells cultured with 10% FCS the highest inhibition was by 
WCf.UIF 20 ul axid 40 ul: 19.13% and 32.03% respectively, followed by 
RVYC.UIF : of 17.5% and 17.22% respectively and for TC.UIF.: 1.4%
and 10.7% at 20 ul and 40 ul respectively.
A comparison between the mean percent inhibitions caused by the 
3 UIFS administered to cells, cultured with or without 10% FCS using 
2tail t-test has been described, (Table 2,1 .3).
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1 .2 : T-te si comparisons.
ul.
ÜIF.FCS VS UIF WITHOUT FCS
TC:20, P*
40, P’‘
RWC:20, P'/f40,
WCF:20, pf/f
40,
P'/* = .05>p :F’** = .01
P> = .05
Table 2.1.3: T-test comparisons. 
20 & 40 ul.
UIF.FCS vs UIF WITHOUT FCS
Pc Te
TC:20, F'- pry-
40, P-i
RWC:20, Pf/* P V "40, pf/f p^
WCF:20, P*
40, P^ P''
LN;20, P-^
40,
BM:20, Pr
40, Pf/f
Pc = pin snia cyt oa.a 
Te = Ihymocytes
The mean percent inhibition for TC.UIF In cultures without 10% 
FCS were signifcantly greater than their cou*iterparts cultured with 
10% FCS; at 20 ul and 40 ul.
For the RWC.UIF the mean percent inhibition was greater in 
cells cultured without FCS tban with FCS Pc.OS at 20 ul; while at 40 
ul no differences existed.
For the WCf.UIF the mean percent inhibitions for cells 
cultured without FCS were not significantly different from their 
counterparts qultured with FCS.
The percent inhibitions doseri bed in Table 2.1.C2 were 
determined as has been described in Table 2.1.81.
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As described above, (section 3.2.1.3) the effects of several 
mouse UIFS on the uptake of radioisotope by plasmacytoma and mouse 
thymocytes were assessed.
For plasmacytoma cultures, the difference (within the
respective batches) on the inhibition of radioisotope uptake were 
relatively less than that present among the rat UIF batches, 
(section 3.2.1.2).
Similarly, the inhibitory effects differed among the
respective UIFS, and at 20ul UIF (without FCS) the highest 
inhibition was by WCF and LN UIFS followed by TC, RWC and the least 
inhibitory was BM UIF. At 40ul UIF (jith FCS), the highest 
inhibition was by WCF, LN and TC UIFS (which were within a similar 
inhibitory range), while the least inhibitory was BM UIF. The 
relative inhibition of radioisotope uptake was modulated by FCS and 
the inhibitory effects of UIFS (without FCS) were all decreased by 
the presence of FCS, (except TC and BM 20ul) especially RWC UIF. 
It was also demonstrated that mouse TC UIF was more inhibitory than 
rat TC UIF described earlier, (section 3.2.1.2).
For the thymocytes, the variation in the inhibition of 
radioisotope uptake within each respective UIF group was small. 
The highest inhibition of uptake was by the TC group (20ul without 
FCS) followed by WCF and RWC UIFS. Similarly at 4o ul, the highest 
inhibition was by the TC group followed by WCF and RWC UIFS which 
were in the same inhibition range. This was not the case with FCS 
culture group, as the highest inhibition of radioisotope uptake was 
by WCF UIF followed by RWC and the least inhibitory was TC UIF.
FCS has interacted with UIF in the presence of the thymocytes to
produce this reverse in inhibition, which was not evident in the 
plasmacytoma cultures, (sections 3.2.1.2 and 1.3), but it was
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rather similar to the effects demonstrated with rat TC UIF on mouse 
thymocytes, (section 3.2.1.2). As with rat UIF, FCS was 
demonstrated to interact selectively with each UIF group.
Mouse UIFS, were generally more inhibitory than rat UIF. The 
UIFS produced from cells from different haemopoietic environments 
(bone marrow, lymph nodes, spleen and thymus) were assessed in 
terms of their inhibitory effects on radioisotope uptake by 2 cell 
culture types, and were shown to be inhibitory to various degrees.
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3 . 2 . 2 :  The  e f f e c t s  o f  v a r i o u s  t y p e s  o f  r a t  UCF on t l ie  u p t a k e  o f  125CUDR
by cell cultures.
BxperImeatal 9 roceduces :
The following UCBS (L-7 ) were prepared from Rat spleens:
L. UCF prepared from cells of the spleen Wcf (white cells only and
this Is coded as STD, the standard UCF, to which other UCFS will 
be compared with, (STD.UCF).
2. UCF prepared from adherent cells of the spleen's (Wcf) white cell
fraction, (AD.UCF).
3. UCF prepared from non-adherent cells of the spleen's (Wcf) white
cell fraction, (NAD.UIF).
4. UIF prepared from macrophage free cells, of the spleen's (Wcf)
white cell fraction, ( <i>free .UIF ).
5. UCF prepared from cells of the spleen’s white cell fraction (Wcf), 
but at 5x10® cells per ml (5M.UCP).
6. UIF prepared from the spleen's white cell fraction (Wcf) which was 
later dialysed, (02.UCF).
7. UIF prepared from the spleen's white cell fraction (Wcf) which had 
been frozen and thawed, (F.TH.UIF).
8* UIF prepared from the 8C^H~1 muscle cells; (8.UIF).
The procedure for the preparation of Wcf the standard UIF (STD) 
was by Incubating 50x10° cells in 5 mis of RPMC in 50 mm diameter 
petri dishes, for 16 hours at 37°C. The detailed procedures foe the 
preparations of all the UCFS listed above have been described In 
materials and methods.
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c g LT. suspensions of plasuvacytonia. cells and of mouse thymocytes 
were prepared and dispensed Into their respective mlcrotitre wells, 
each at a concentration of ixlO^ cells per well. Cell cultures were 
divided into two parts, those cultured without FCS, and those cultured 
with 10% FCS. Mlcrotitre wells received 20 and 40 uls of each type of
UIF, and 0.2 uci of 125 EUDR In a final volume of 200 ul per well.
Each UIF concentration was replicated 5 times. The incubation periods 
were as follows: 0/4, 2/4 and 4/4 sequences.
In the 0/4 group, the UIF and 125 EUDR were added to cell
cultures at zero time. The cell cultures were incubated for 4 hours
at 37°C.
In the 2/4 group, the UIF was added to cell cultures at zero
time, and incubated for 2 hours at 37 °c. Following the 2 hour
Incubation, 125 EUDR was added to the cell cultures and re-incubated 
for 4 hours at 37°C.
In the 4/4 group, the UIF was added to cell cultures at zero
time and incubated for 4 hours at 37*c. Following the 4 hours
incubation, 125 EUDR w.as added to cell cultures and re-incubated for 4 
hours.
All cultures have their controls, in which cells were cultured 
without UIF.
Results :
The mean cpm of plasmacytoma cultures cultured without 10% FCS 
was (medium controls) 13596 cpm , and with 10% FCS was (FCS controls) 
6588 cpm , as described in Table 2.2.A1, (incubation sequence 0/4). 
The difference between the respective control cultures was significant 
(Pc.01, t=19.523) which represented a 51.9% inhibition due to serum.
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For cells cultured without FCS, the mean percent Inhibitions oc 
125 CUDR uptake by 20 ul oE UCF, were similar Cor NAD and AD.DCFS at 
approximately 30%, which were the highest in the spleen group followed 
by STD.urP at approximately 15%, and all their respective com were 
significantly dlCEerent from their control cultures mean cpm, (Pc.01, 
t-=15.93, 13.63 and 9.716 respectively).
The least Inhibitory were: f{>£ree.UTF (0.09%), DZ.UtF (0.5%),
5M.U1F (0.67%) and F.TH.UIF (6.1%) of which, the mean cpm of the first 
three C/IFS were not significantly different from the mean cpm of their 
control cultures, (P>.05, t-=0.092, 0.294, 0.181) respectively, while
the mean cpm of cultures, cultured with F.TH.C/CF was slgnflcant 
(0.05>P> .01). The 8.U1F produced the highest Ihhibltlon of 65.8%, with 
its mean cpm was significantly different from the mean cpm of control
cultures^ ( P<.01, t=44.3).
Adding 40 ul of UTF (for cells cultured without PCS) the me tin 
percent inhibitions Increased relative to the 20 ul described above. 
NAD and AD C/EFS were of similar strength at 50 to 46% Inhibition,
followed by STD.CTEF at 31.6% Inhibition. The respective mean cpm of
these 3 CJEFS was significantly different from the mean cpm of their 
control cultures (P<.01, t=37.12, 27.25 and 19.14) respectively. The
least Inhibitory were OZ.UTF (1.4%), Ofree.UIF (4.67%), 5H.UEF (11.8%) 
and F.TH.UIF (12.5%). The mean cpm of cultures, cultured with DZ.UIF 
was not, significantly different from the mean cpm of culture controls 
(P>.05, t-=0.975); the mean cpm of cultures with ^free.UEF was
significantly different from the mean cpm of culture controls 
(0.05>P>.01, t-=2.86) while the mean cpm of 5M.UEF and F.TH.UIF were
also significantly different from the mean cpn of controls (p<.0l, 
t-7.77 and 7.65 respectively). The B.UEF produced the highest
Inhibition of 83.4%,(p<.01, t=82.4).
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Thus for 20 ul aiF cultured without PCS the relative Inhibitory 
activities of all UEFS In terras of STD.UIF were as follows 
The highest Inhibition In the spleen group was produced by NAD and 
AD.UEP3 which were In the region of 18 - 171 and were significantly 
different frora STD.UEF, (P<.OL, t=7.34 and 5.23) respectively. The
other tJEFS; (#free, 5N, DZ) were similar In their stimulation of
Isotope uptake, and were all In the region of +17%, while F.'iTH 
stimulated the uptake by 10.12%. All stimulations of uptake were 
significantly different frora STD.UIF; P<.OL, except F.TH.UIF, 
0.05>P>.01. The t-test values were 5.14, 3.65, 7.29 and 3.32
respectively. 8.UTF produced the highest Inhibition of 61.1% relative 
to STD.UIF, which was slgnflcantly different, (P<.01, t=28.75). With
40 ul of UIF (cells cultured without serum) the relative mean percent
inhibitions relative to STD.UIF were higher than in 20 ul UIF. NAD.UIF 
produced 27.21% Inhibition of isotope uptake, and AD produced 21.12%. 
The stimulatory activities of F.TH and 5M UIFS were similar, and 
were around 23%, while $free and DZ UIFS were more stimulatory and
both ware In the region of 40%. The stimulatory activity of 40 ul UIF
was higher than that of 20 ul UIF. The hrghest Inhibition at 40 ul of 
UIF was produced by B.UIF, which was 75.77% and Its respective mean 
cpm was significantly different from the mean cpm of culture controls 
i.e. STD.UIF cultures (P<.01, t=37.88). The F.TH, 5K, (ijfree and DZ
UIFS Stimulatory activities were all significantly different from 
control, (P<.01, t=10.16, 11.10, 14.40 and 17.49 respectively').
UIF used In conjunction with plasmacytoma cultured In 10% FCS 
has also depressed 125 EUDR uptake.
At 20 ul UIF per wall, NAD.UIF produced the highest Inhibition
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In the spleen group which was 41.6%, followed by AD.CJtP at 32.4%, and 
the least inhibitory were STD.UIF at 5.17% and F.TH.UIF at 0.7%. The 
mean cpm of call cultures cultured with NAD and AD UIFS were
significantly different from their control cultures mean cpm (P<.01, 
t-5.937 and 5.822 rc^apncrtivcly)^  whi.le the mean cpm of cultures with 
STD and F.TH UIFS were not, (P>.05, t-0.B53 and 0.135).
The effects of ^free, 5H and DZ UIFS were all stimulatory with 
Increased 125 lUDR uptaZce of +5.62%, +11.75% and +12% respectively,
although their respective mean cpm values were not significantly 
different from the mean cpm of 10% FCS control cultures, (P>.05, 
t=0.962, 1.882 and 2.21 respectively’). At 40 ul UIF per well, there
was more Inhibition of 125 lUDR uptake, with AD.UIF producing 43.44% 
Inhibition, NAD.UIF 37.52%, STD.UIF 19.89%, F.TH 12.9% while Ofree.UIF 
was the -leant Inhibitory at 4.75%. The mean cpm of cultures, 
cultured with AD, NAD, STD and F.TH UIFS were significantly different
from the mean cpm of cell culture controls (P<.01, t-8.420, 5,302 .and
, 3.809), respectively; (F.TH 0.05>P>.0l, t-2.465), while *free w.as not,
(P>.05, t-=0.622). 5M and DZ UIFS were similar in their stimulation of 
Isotope uptalce at around 4% and were less stimulatory than at 20 ul 
UIF. The mean cpm of cell cultures cultured with UIFS; 5M and OZ were
not significantly different from the mean cpm of culture controls
(P>-05, t~0.B07 and 0.879) respectively. B.UIF 'produced the highest
Inhibition of 75.6%, and Its mean cpm was significantly different from 
the mean cpm of culture controls (P<.01, t^L4.5as). The relative
Inhibitions or stimulations of 20 ul and 40 ul UIFS cultured with 10% 
FCS In terms of STD.UIF are described In a t-test table,
comparison, (Table 2.2,A).
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Thus the effects of all the respective UIFS on isotope uptake by cell 
cultures were significantly different from STD.UIF, as AD, NAD and B 
UIFS were inhibitory while #free, 5M, DZ and F.TH were stimulatory. 
Comparing the mean percent inhibitions produced by the respective UIFo 
(20 ul and 40 ul) between cells cultured without and with 10% FCS have 
shown that at 20 ul UIF, STD.UIF was less inhibitory with FCS than in
cultures without FCS. AD and NAD UIFS were more inhibitory with FCS 
than without FCS, F.TH was less inhibitory with FCS than without 
FCS, and ({>free, 5H, DZ UIFS were all stimulatory, where as without FCS 
they were slightly Inhibitory. At 40 ul of UIF, STD.UIF was less 
Inhibitory with FCS than without FCS; AD.UIF produced approximate 
Inhibitions with or without FCS, NAD was less Inhibitory In PCS, the 
Inhibition produced by 4>free UIF was similar In both with and without 
FCS; 5M and DZ were stimulatory with FCS compared to some inhibition, 
without FCS. F.TH was similar In Inhibitions with and without FCS. 
B.UIF produced similar Inhibitions at 20 ul, while at 40 ul, the 
Inhibitions with FCS were slightly less than without FCS. A t-test 
table, (Table 2.2.B) shows the significance of the difference
between Inhibitions or stimulations, with and without 10% FCS, at 20 
ul and 40 ul of UIF. (T-test: mean percent Inhibition (without FCS) VS 
mean percent Inhibition with 10% FCS*)»
Thus at 20 ul UIF all comparisons were not significant except for 
STD and DZ UIFS which were significant. AT 40 ul all comparisons were 
significant except for AD, ^free and F.TH UIFS which were not.
The effects of the respective UIFS on cell viability ace 
described in Table 2.2.CO,
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Résulta ;
The mean cpm of of plasmacytoma cultures cultured without FCS 
was (medium controls) 15305 cpm , and with 10% FCS controls was (FCS 
controls) 9011 cpm as described in Table 2.2.A2, (incubation 
sequence 2/4) which was a difference of 41.12% Inhibition of 125 lUDR 
due to FCS, and which was significant (P<.01, t=17.29).
The mean percent inhibitions of Isotope uptake by cell cultures 
produced by 20 ul and 40 ul UIF (without FCS) ware as follows; At 20 
ul of UCF, AD and NAD produced similar Inhibitions of 30 to 29% which 
were the highest inhibitions In the spleen group, followed by STD.UIF 
at 15%. The least Inhibitory were F.TH (5.28%), 5M.UIF (1.29%) and 
4s free.UIF (0.27%). DZ.UIF was +2.52% stimulatory. The highest
Inhibition was produced by H.UIF (71.07%). At 40 ul UIF the mean 
percent Inhibitions were higher than at 20 ul UIF. Similarly NAD 
and AD UIFS were the highest inhibitors in the spleen group at 51 to 
49%, while STD.UIF Inhibited the isotope uptake by 32%. Smaller 
Inhibitions were produced by F.TH.UIF (17.72%), 5M (9.05%) and bfree 
(6.23%), while DZ.UIF wajs +1.39% stimulatory. The highest
inhibition was produced by B.UIF (35.44%). The significance of the 
mean percent Inhibitions of 20 ul and 40 ul of the respective UIFs in 
terms of their cpm, relative to the mean cpm of culture controls is
described, (Table2.2.C ).
Ihus all comparisons were significant except for 4>free and 5M 
UIFS ah 20 ul, while for DZ.UIF at both concentrations.
The relative inhibitions of the respective UIFS in terms of 
STD.UIF and their significance are described in a t-test comparison.
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FIGURE 2.2.A2: The uptake of 1251UDR by plasmacytoma cultures, cultured without and with FCS-HI, for 4 hours with rat UIF.
2/4 Incubation sequence. The UIF types are described In Fig. '2.2.A1
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At 20 ul CitP, AD and MAO were relatively cr.ore Inhibitory than 
STD.fJCir, while k^ tcee, 5H, OZ iind F.TEI were stimulatory rather than 
inhib Ltory. 8. a CP was more inhibitory th^ an STD.
At ‘10 ul if CP, iVD and ff^VD DC PS were more inhibitory that STD. D CP, 
while . E^rea, 5M, DZ and P.Th were all stimulatory. The highest 
inhibition was produced by B.acP.
The significance or the inhibitory or stimulatory activities or 
the rec-ectiva DTPS in terms of their respective mean cpm, relative to 
the mean cpm of STD.DCP are as follows in the t-test comparison of the 
respective CJCFS VS STD.DCE^( Table 2*2.D) Thus all comparisons were 
significant.
The mean percent inhibition for 20 and 40 ul DIP (with lO'i FCS) 
were as follows: At 20 ul DTP, NAD and AD UIFS produced similar 
inhibitions of isotope uptake by cell cultures of 36 to 35%, while STD 
and F.TH UIFS were half as strong, inhibiting uptake by 18 to 16% 
respectively.
UIFS, ififree, 5H and OZ produced stimulation of 125 EUDR uptaZre 
of +0.53%, +1.56% and +5.76% respectively. The highest inhibition of 
125 EUDR uptake of 66-04% was produced by B.UEF. At 40 ul of UEP 
there w<as more inhibition of isotope uptake by NAD and AD UIFS at 43 
to 45% respectively, followed by STD and F.TH UIF at 21 to 19%, while 
the leaist inhibitory w<as 5M.UEP at around 3 to 4%. 4>free and DZ UIFS 
produced stimulations of 125 EUDR uptake of +3.05 and 1.76 
respectively. The highest inhibition was by B.UEF of 78.89%.
The significance of the inhibitory or stimulatory activities of 
20 and 40 ul of UEP (with 10% FCS) in terms of their cpm relative to 
the mean cpm of their culture controls ( 10% FCS) is described in a 
t-test comparison, (Table 2.2.E),
- 1 8 3  ~
Thus all comparisons were significant except cj>free, 5M and n% UIFS 
which were not at both UIF concentrations.
The relative inhibitions or stimulations of the respective UIFS 
in terms of STD.UIF are described in a t-test comparison below. At 20 
ul UIF, AD and NAD UIFS were more inhibitory than STD.UIF. ijifree, 5M, 
DZ and F.TH UIFS were all stimulatory compared to STD.UIF. The 
highest inhibition relative to STD.UIF was produced by B.UIF at 20 and 
40 uls.
The significance of the inhibitions or stimulations of the 
respective UIFS (20 and 40 uls) in terms of their cultures mean cpm, 
relative to the mean cpm of STD.UIF cultures are described in a t-test 
comparison, (Table 2.2.P)
Thus all comparisons were significant except for F.TH.UIF at both
concentrations which was not.
Comparing the mean percent inhibitions or stimulations produced 
by the respective UIFS (20 ul and 40 ul) between cells cultured with 
and without 10% FCS have shown that at 20 ul of UIF, the mean cpm of 
cultures cultured with STD, AD, NAD and F .TH UIFS were more inhibitory 
with. 10% FCS than without FCS. B.UIF was less inhibitory with 10% FCS
than without FCS. *free, 5H, DZ were more stimulatory with 10% FCS
than without FCS. At 40 ul of UIF, the mean cpm of cultures cultured
with STD, AD, NAD, 5M and B UIFS were relatively less inhibitory with
10% FCS than their corresponding counterparts cultured without FCS. 
F.TH.UIF was more inhibitory with 10% FCS than without FCS. (|)free and 
DZ UIFS were more stimulatory with FCS than without FCS. A t—test 
comparison^ (Table 2,2.Ct) shows the significance of the difference 
between the mean inhibitions oc stimulations with 10% FCS, or without 
FCS.
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Tablo 1.1. X'. Table 2.2.B:
UIF typo Vo oTD UIF UIF.FCS VS UIF w L thou t
10 ul 20 ul 40 ul20 ul P V +STD; pA +AD: P^* p <• f AD; ?■* O'»M.AD; P-*- p* + MAD: O'- P^/*
$Fr:1 ?+/* pV- ({) Fr : P^ P*5M;; P*-*- 5M: P<- p+*DZ ! P^* p«-+ DZ: pA + p«- +
FTH : P=<- P + + FTH: P* P-tÜ : P^ ‘ P+ + B: P + p*A
Table 2.2.C;
UIF cpm VS Coabrol cpm (without FCS) 
20 ul 40 ul
STD:
AD:
XAD:F^r: P* 
5H: P* DZ; P* 
FTH; P** 
B: P**
P**
p**p**p>
P +  +p*+
Table 2,2.0 Table 2.2.E
UIF type VS SCO UIF (without FCS) UIF cpm V3 Control cpm ( 10>, FCS)
20 ul 40 ul 20 ul 40 ul
AD: p*.(- pfi- STD; P*'* P**
MAD: p* * p* + AD: ?** P + ‘
l()Fr; p*^ p:ff MAD; P** P* +
5M:; P** p** (J)Fr: P ’^ P+
DZ;; P*-+ pit-4. 5M: P* P+
FTH;; p** P** DZ: P + p.+
B:; P** p*d- FTH: Ft/* p**
B: P+*
2 . F Table 2.2.0
UIF.FCS VS UCF without FCSUIF type VS STD UIF (tO>1 FCS)
20 ul 40 u 1
20 ul 40 ul STD: ?*■
AD; p^^ .AD: P V " P»
MAD; P+* ptit' MAD: P-* P--»
iJiPr ; p4* pif-it ^Fr: P+ P'//.
5M; P** 5M: P + P-/ +
DZ: p-+.f- p-f+ DZ: P»/ + P*
FTH: P* P-*- FTH; P+ P*
B: p* + p/- + B: P + P-^ *
P+/+ = .05 > P ?  .01 P*'^ =<.01
P* =>.05
Thun ab 20 ul UIP, STD, .tjcree, 5H, F.TH and B UCF3 were nob
3ignlfi-canbi'/ dit'cerenb croiu bhelr counhecparba, while AD, MAD and DZ 
were difcerenb.
Ab 40 ul all UIFS were aignicicanb Ly dlEcecenb except for AD, 
DZ, and F.TH UIFS which were nob.
Résulta :
The mean cpm cor 125 CÜOR uptake by olascmac^ /tormi cultures, 
cultured without FCS was (medium controls) 14724 cpm , and with 10% 
FCS W.03 ( FCS controls) 11229 cpm , aa described in (Table 2.2 .A3,
incubation sequence 4/4). There was a difference of 23.74% inhibition 
of 125 lUDR upbal<e due bo FCS, which was significant, (Rt.Ol, 
b-10.743).
The mean percent inhibitions or stimulations of isotope uptaire
by cell cultures, produced by 20 ul and 40 ul UIF (without FCS) were 
as follows; At 20 ul UIF, AD and NAD produced the highest inhibition 
of isotope uptaJre in the spleen group ah 33 to 31% respectively, while 
STD.UIF was less inhibitory, at 11% inhibition. *free, 5M, DZ and F.TH
produced a stimulation of isotope uptake of +4.23%, +5.05%, +3.53%,
and 11.34% respectively. The highest inhibition of 75.18% was
produced by B.UIF. At 40 ul UIF, AD, NAD, STD, F.TH, 5M, #free and B
UIF were relatively more inhibitory than ah 20 ul, while OZ
stimulations were similar, as described in Table 2.2.A3 .
The significance of the inhibitions or stimulations produced by 
the respective UIFS at 20 and 40 ul in terms of their cpm relative to
the mean cpm of control cultures are described in a t-test
comparison, (Table 2,2,H). Thus at 20 and >10 ul, the mean
cpm of ail UIF cultures were significantly different from their
culture controls mean cpm except for #free, 5M and DZ UIFS which were 
not.
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FIGURE 2.2.A3: The uptake of 125IUDR by plasmacytoma cultures,
cultured without and with FCS-HI, for 4 hours with rat UIF.
4/4 incubation sequence. The UiF types are described in Fig. 2.2.A1.
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produced by 20 ul and 10 ul UC? with 10'^  FCS were as follows ; At 20 ul
of UIF, all UIFS were inhibitory. STO.UIF produced the highest 
inhibition in the spleen group of 23%, followed by AD, MAD and F.lFi 
UIFS which were similar at 23% inhibition. DZ.UIF was 13% inhibitor^/ 
while 5H and cï>frea were the least inhibitory at 4 and 0.77% 
respectively. B.UIF produced the highest inhibition at 63%. At 40 
ul, all UIFS were cr.ora inhibitory than ac 20 ul, the highest
inhibitions in the spleen group ware produced by AD and MAD UIFS at 46 
to 43% respectively, followed by STD and F.TH UIFS ab 37 to 31% 
respectively, while DZ produced 21% inhibition. The least inhibitory 
were 5M and <î>frae UIF at 14 to 7.95% respectively. The significance 
of the inhibitions produced by the respective UIFS at 20 or 40 ul in 
terms of their cultures mean cpm, relative to the mean cpm of control 
cultures are described in a t-test comparison, (Table 2.2,1%
Thus at 20 and 40 ul all UIFS were significantly different from their 
controls except for 0free at both concentrations, and for 5M at 20
ul.
The relative mean percent inhibitions of the respective UIFS in 
terms of STD.UIF (20 and 40 uls) without FCS as described In Table 
2.2.A3 were as follows: At 20 and 40 ul, AD and MAD UIFS were more
inhibitory than STO.UIF, while ({jfree, 5M, DZ and F.TH UIFS were more 
stimulatory and not inhibitory as compared to STD.UIF. B.UIF
produced the highest inhibition .as compared to STD.UIF. The 
significance of these inhibitions or stimulations produced by the 
respective UIFS in terms of their cultures mean cpm, relative to the
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mean cpm of STD.UIF cultures are described in a T-tesb comparison, 
‘■Table 2.2.J) .
Thus the effects of the respective UIFS were all significantly 
different from STD.UIF-
The relative mean percent inhibition of the respective UIFS in 
terms of STD.UIF (20 and 40 uls) with 10% FCS were as follows: At 20
ul UTF, all UIFS were stimulatory (i.e. produced relatively less 
inhibition) with respect to STD.UIF, except B.UIF which was 
inhibitory. At 40 ul UIF, AD, MAD and 8 UIFS were more inhibitory 
than STD.UIF, while 4>frea, 5M, DZ and F.TH UIFS were stimulatory.
The significance of these inhibitions or stimulations by the 
respective UIFS in terms of their cultures mean cpm, relative to the 
mean cpm STO.UIF cultures are described below in a t.test comparison, 
(Table 2.2.K)
Thus ah 20 ul, AD, MAD, DZ and F.TH UIFS ware not significantly 
different from STD.UIF while ^free, 5M and B UIFS were different. At 
40 ul all UIFS were significantly different from STD.UIF.
Comparing the mean percent inhibitions or stimulations produced 
by the respective UIFS (20 and 40 uls) between calls cultured with and 
without 10% FCS have shown that at 20 ul UIF: STD, <>free, 5M, DZ and 
F.TH UIFS were more inhibitory with 10% FCS than without FCS. AD, îlAD 
and a UIFS were relatively less inhibitory with 10% FCS than without 
FCS. At 40 ul UIF: STD, «pfree, 5M, DZ and F.TH UIFS were more
inhibitory with 10% FCS than without FCS, while AD, MAD and B UIFS 
were relatively less inhibitory with 10% FCS than without FCS.
— 1 8 7  —
The significance of the difference between the percent 
inhibitions or stimulations between cells cultured with or without 10% 
FCS in the presence of 20 ul and 40 ul of UIF, are described below in 
a t-test comparison, (Table 2.2.L)
Thus at 20 ul, all UIFS were significantly different, except for 4>frea 
and 5H UIFS. At 40 ul, all UIFS were significantly different, except 
for STD and ^frea which were not different.
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T b^le 2.2.A4: A reference table for tables 2.2.A1, A2 and A3, for
mean percent Inhibitions produced by the respective 
UIFS on cells cultured with and without 10% PCS at 
0/4, 2/4 and 4/4 incubation periods.
Cultured without 10% FCS Cultured 'with 10% FCS
UIF
Type 0/4 2/4 4/4 0/4 2/4 4/4
20 ul
STD 14.8 15.03 11.34 5.17 18 82 28.29AD 29.8 30.03 33.77 32.4 35 89 23.33NAD 30.8 28.72 31.30 41.6 36 31 23.59«S Free 0.09 0.27 +4.23 +5.62 +0 53 9.775M 0.67 1.29 +6.06 +11.76 +1 56 4.14DZ 0.5 +2.52 +3.53 +12 +6 76 18.20FTH 6.1 5.28 +11.34 0.7 16 45 23.82B 66.8 71,07 76.18 63.8 66 04 68.4
40 Ul
STD 31.6 32.18 33.75 19.89 21 32 37.79AD 46.1 49.65 59.48 43.44 48 86 46.33NAD 50.2 51.22 57.51 37.62 45 09 43.36«5 Free 4.67 6.28 1.16 4.75 +3 06 7.955M . 11.8 9.06 5.07 +4.4 3 66 14.58DZ 1.4 +1.39 +2.68 +4.5 +1 76 21.60FTH 12.5 17.72 16.16 12.9 19 95 31.77B 83.4 85.44 89.14 75.6 78 89 82.23
+ = stimulation of uptake.
STD OIF = Standard UIF (spleen white cell fraction without red cells);
AD UIF = Adherent cells (of the white cell fraction spleen);
NAD UIF = Non-adherent cells (of white cell fraction spleen); 
é Free UIF = Miite cell fraction of the spleen without macrophages;
5M UIF = STD UIF, but cultured at half original density of 5 x 10^celIs per 
petr dish.
DZ UIF = dialysed STD UIF: FTH UIF = Freeze thav«d (white cell fraction 
spleen); BUIF = BC^H-l muscle cell line UIF.
Reuulks:
'L'he mean ccni Eoc nouoe bhyinocyte cultures cultured without FCS 
was 357 cpm -(medium controls) and Eor cultures cultured with lü^ FCS 
was 287 com - (lO% FCS Controls) as described In Table 2.2.81, 
Incubation sequence 0/4 . There was an Inhibition o6 55.83% due to 
FCS, which was significant, (t=5.5G, P<.01).
For cells cultured without FCS, the highest mean percent 
Inhibition oE Isotope uptake by cell cultures In the UIFS o£ the 
spleen group, was by STD.UEP at 59%, although AD amd MAD UIPS were In 
the same region of Isotope inhibition uptake at around 56 to 52%. 
B.UIF produced less inhibition and was around 42%, followed by DZ at 
32% while the least inhibitory was free. UEP at 13%. SM.UIF was 
fairly stimulatory with 20% more uptake, but F.TH.UIF was most 
stimulatory, achieving +80% uptake of 125 lUDR by thymocyte cultures, 
which was not the case with plasmcytoma cultures. At 40 ul UIF there 
was some increase in the inhibition of isotope uptake by cell 
cultures, although not a substantial one for all the UIFS. Again, 
STD, AD and NAD UIPS produced the highest inl'.lbltlon In the spleen 
group and were in the region oE 61 to 68% inhibition, followed by 
B.UIF at around 57% inhibition. DZ produced 41% inhibition while 
Ofree was slightly weaker at around 28% inhibition.
The significance of the stimulations or inhibitions produced by 
the respective UIPS (20 and 40 ul per well) in terms of their cultures 
mean cpm, relative to the mean cpm of control cultures, are described 
in a T-test comparison^ ( Table 2,2oM),
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FIGURE 2 .2 .Bl; The uptake of 1251UDR by mouse thymocyte cultures, 
cultured without and with FCS-HI, for 4 hours with rat UIF.
0/4 Incubation sequence. C; control cultures without UIF.
S; standard UIF. A: adherent cells UIF. N; non-adherent cells UIF. 
0: macrophage free UIF. 5: standard UIF, produced at half its culture 
density. D: dialysed UIF. F; freeze thaw UIF. B; muscle cell UIF.
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Thus di: 20 dad 40 uL di L como.drLsona we ce aigait'ioanh except cor ;>t'ree 
and 5M which were not.
Foe ceLia cultured with 10% PC3, with 20 u! of UTF, the highest 
Inhibition of isotope upta:<a in the spleen groi j was by M^D UIF at 
17.9% followed by a nearly similar inhibition by ^Eree UIF at around 
15%. STD and AD U1F3 ware inhibitory, around a similar amount of 
7-8%, while the least inhibitory was B.UEF at 4.8%. 5M and OZ UEF3 
were stimulatory at about the same amount of 5-7% while F.TH UCF was 
approximately 6 times more stamulatory than ■ 5M UIF producing an 
increase of 45% 125 EUDR uptake. At 40 ul UIF, there was a fair
increiisa in the affects on isotope uptalce by cell cultures, whether 
inhibitory or stimulatory except for 5M UCF which had a similar value 
to that at 20 ul per wall.
•Che significance of the stimulations or inhibitions oE the
respective UIFS in terms of their cultures mean cpm, relative to the 
mean cpm of the control cultures has been described in a T-test 
comparison, (Table 2,2,^).
Thus ah 20 ul UIF, the mean cpm of cultures in all UIFS were not 
different from the mean cpm of culture control /aiues except for F.TH. 
At 40 ul, AD, MAD, 5M and B UIFS were not significantly different from 
controls, while STD, 4jfree, DZ and F.TH were different.
The relative inhibitory or stimulatory effects of the respective 
UEFS in terms of STD.UIF for cells cultured without FCS are as
follows : At 20 ul UIF all UIFS were stimulatory, i.e. (less
inhibitory than STD.UIF), and at 40 ul all UIFS were stimulatory
except for AD and MAD UEFS which were slightly more inhibitory. The 
significance for the respective stimulations or inhibitions of the
1 9 0 -
respective UtPS in terms of their cultures mean com, relative to the 
mean ccm of STD.UIF cultures are described below in a T-tast 
cum pa L’L SÜ ti, (Tabic 2.2.0)
Thus at 20 ul UIF, the mean ccm of cell cultures, cultured in all UIFS 
ware different from the mean. ccm. of STD.UIF cultures except for AD and 
MAD UIFS which ware not. At 40 ul UIF, the mean ccm of cultures, 
cultured in all UIFS were- different from the mean cpm STD.UIF culture 
except for AD, MAD and 3 UIPS.
The relative inhibitory or stimulatory effects of the respective 
UIFS in terms of STD.UIF for calls cultured with 10% FCS are as 
follows: At 20 ul UIF, all UIFS were relatively stimulatory (i.e.
less inhibitory than STD.UIF) in terms of STD.UIF, except AD, MAD .and 
cî)Eree UIFS which were inhibitory. At 40 ul, all UIFS were stimulatory 
( less inhibitory) in terms of STD.UIF. The significance of the 
relative stimulations or inhibitions by the respective UIFS in terms 
of their culturels m<>an cpm, relative to the mean cpm of STD.UIF 
cultures are described In at T— test coniparisou, (Table 2.2.P),
Thus at 20 ul UIF per well, the mean cpm of cultures, cultured in all 
UIFS were nob significantly different from the mean cpm of STD.UIF 
cultures except for F.TH.UIF. At 40 ul UIF, the mean ccm of cultures 
in all UIFS were not different from the mean cpm of STD.UIF cultures 
except for 5M, DZ and F.TH UIFS which were significantly different.
Comparing the percent inhibitions or stimulations between ceils 
cultured with and without 10% FCS at 20 ui UIF, have shown that all 
the UIFS whether stimulatory or inhibitory, except (ï>free.UIF, produced 
lass inhibition or stimulation when cultured with 10% FCS, than 
without PCS. ^cree.UIF produced a slight increase in Inhibition with
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10% FCS, compared to non FCS cultures. At 40 ul, all UIFS produced 
.1233 inhibitions or stimulations with 10% FCS, as comp.ared to PCS 
lacking cultures. The signlcicance oc the difference between the 
percent inhibitions or stimulations between cells cultured with or 
without 10% FCS in the presence of 20 ul or 40 ul of UIF, is described 
in a T-hest comparison, (Table 2.2,Q)
Thus at 20 or 40 ul UIF per well all differences were significant 
except for f*>frae, 5M and F.TH UIFS which were not different.
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Cilvlo 2. 2, H
20 uL
SID: P V *AD; p * <•
NAD : P + +
<)Fr: P +
5M; P*DZ; P +
FTH: p V -B: p+ <•
L ' o l  C p m  ( w i t h o u t  FCS)
Table 2.2.1 
UIF G pm VS
40 ul 20 ul
P^' STD: P+ +
P - * AD: p y y
P** NAD : P + +P-" (iiFr : P +
py. 5M: P +P + DZ: P  + +
P + + FTH: P* +? + * B: P* +
40 uL
p . .
P'-
P'-P^ "
Table 2.2.J
UIF type V3 STD UIF (without FCS)
20 ul 40 ul
Table 2.2.K
UIF type VS STD UIF (: Ox  FCS)
AD: P-+ XAD: P-+(JPr; p*,*
5M:
DZ; P** 
FTH:
B: P+ +
P+ +
p*+p*K-P + * P+* p^ *
20 ul 40 ul
,\D:1 P» P+ +
NAD:, V* p+*
(|Fr:; B** p* +
5M;: P+* ■2**DZ;; ?» p»y-
FTH;1 ?» ¥*/*B;; P+» py-y.
:.L Table 2.2.M
UIF.FCS VS UIF (without FCS) UIF cpm VS Control cpm
20 ul 4o ul 20 ul 40 1
STD: P»+ P* • STD: P+» pyy.AD; ?»» py* AD: P** pyy-
NAD: P/+ p**- NAD: ?»* p+#
(^Fr; P» 2* ÔFr: P+ P*
5M: P» 2** 5M: P* P*DZ: P»+ pyy DZ: p V * P+ +
FTH: ?»» p*+ FTH; P^+ pyyB: W » P** B: P+*
Table 2.2.N Table 2.2.0
UIF cpm VS Control cpm ( 10ÿ'FCS) UIF typo VS UIF STD (without
20 ul 40 ul 20 ul 40 ul
STD: P» p** AD; py 2*AD; P» P* NAD: py- 2*NAD; p* 2* éFr : pyy pyy(|)Fr : P* 2*/* 5M: pyy py*5M: P* B* DZ: pyy 2**DZ: P* 2*/* FTH: py* pyyFTH: B*/* py-y- B: 2*/* P»B: 2* P*
Table 2.2.P
UIF type VS UIF STD (10>5 FCS) 
20 ul 40 ul
AD: P+ 
NAD: P* 
$Fr : P ’*' 
5M: P + DZ: P+ 
FTH: p V *  B; P+
P*P+P*p*/^p**
py-*
P*
Table 2.2.Q***
UIF FCS VS UIF (without FCS)
20 ul 40 ul
STD: pyy pyy-
AD: p*y pyy
NAD: p V * pyy<|iFr : P+ py
5M: P» P*DZ; py# p**
FTH: P* P*B: pyy p**
Re 3 u I t 3 :
'Che mean ccm for mouse thymocyte cultures, cultured without t’C3 
was 145 cpra (mod I urn controls) and for cells cultured with 10% RCS 
was 226 cpm (lO% FCS controls) as described In T.ible 2.2.82, 
incubation sequence 2/4 . There was a stimulation of 55.17% due to 
FCS, which w<3s not significant, ( t=2 .162, 9 >.05).
Tne mean percent of isotope uptake by cell cultures (without 
FCS), with 20 and 40 ul UCF were either stimulatory or Inhibitory. 
However the mean cpra of call cultures in the respective UCFS were all 
near culture control mean cpm value, except for the mean cpm of 
cultures, cultured with F.TH and 5h UCFS which were relatively 
higher.
The jugnificance of these inhibitions or stimulations produced 
by the respective UIFS in terms of their cultures mean cpra, relative 
to the mean cpra of culture controls, are described below in a t-test
comparison, ( Table 2.2.R).
Thus at 20 uI UCF per well, the mean cpm of cell cultures In all UlFS 
were not different from the mean cpm of culture controls except for
the m e m  cpm of cultures, cultured with F.TH UCF which significantly 
different. Similarly at 40 ul, the mean cpra of cultures in all UCFS 
were not different except for the mean cpm of cultures in 5M and F.TH 
UIFS which were significantly different, from the mean cpm of culture 
controls.
The moan percent of isotope uptake by cells cultured with 10% 
FCS, and 20 or 40 ul UIF, were either inhibitory or stimulatory in 
their effects on the uptake of 125 lUDR by thymocytes. ■ However, as
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FIGURE 2.2.B 2: The uptake of 125IUDR by mouse thymocyte cultures,
cultured without and with FCS-HI, for 4 hours with rat UIF.
2/4 incubation sequence. The UIF types are described in Fig. 2 .2 .Bl.
a  a
Sll
§ a
m o\ V) 03 3 CO oî s oî in r-
g +1 4-1 4-1 +1
H
4 s 3 s s S 3 3 R s s
1
in R CO 3 3 S R lÔ % 3 R m i R
•S"
•H -H 4*1 -H 4*1 «I*! -H 4*» +1 44 +1 4*1(NUO'ûr^ WOr^ Œ p"r'r“'Oco<7»u3vû f4 r*4 iH CN r4 fH C4 r4 m\or~cor~Mmr'(Nr4f4r4f4r4(Nfnr4(X
V f4 rs* <N '<j* m m ^
r4 m  rH in *H P** 4*
is
4-1 4*1 4*1 41 4*1 -H 44 4*1ovocor^ oi'croaos f*imoOCNCNVû<7v^ f-4 r4 #-4 (N M M r4
<N U3 o o cnf4 CM #"4 rH r4
+1 4*1 4-1 +1 4*1 4*1 +1 *W +1
f N v n N * r ^ C M C T » ( N o o i n  rsmMmcNvooQOv iHfHrH n»HVOi-4f*4
3
is;j  ,5*586i J
was the cose with the FCS lacking cultures, the mean cgm oZ cultures 
In the respective UIFS were all near the mean ccm value oc control 
culture, except cor the mean cpm oc cultures, cultured in 10 ul F.TH 
QIF which was relatively higher. However the mean ccm oc call 
cultures, cultured in all the respective UtPs were not signiEicantly 
dlEEerent Erom the mean com oc control cultures as described in the 
t-test comparison below. The signiclcanca the respective
inhibitions or stimulations produced by the respective UEF3 in terms 
of their cultures mean cpm, relative to the mean cpm oE control 
cultures, are described ' in a t-test comparison, (^able 2,2,8)'
Comparing the mean peccent inhibitions or stimulations produced 
by the respective dCFS (20 and 40 uls) between cells cultured with and 
without LOI FCS have shown that STD, AD, (HAD, 40 ul), 5M, DZ, F.TH 
and 3 UCFS were all more inhibitory with LO i FCS than their 
counterparts without FC3, while HAD.{20 ul^ and ^crea DCFS were less 
inhibitor/ with 10'^  FCs than without FCS. The signiEicance oE the 
diccerence between the percent inhibitions or stimulations between 
cells cultured without or with 101 FCS in the presence o£ 20 and 40 
uls oE DCF is described in a t-test comparison^ (Table 2.2.T).
Thus at 20 ul DTP all comparisons were not signlEicant except for 5H, 
DZ and F.TH DIFS. At 4D ul UIF all comparisons were not signlEicant 
e:<cept for 5M, F.TH and B DIFS which were significantly different. 
Results ;
The mean cpm Eor mouse thymocr/te cultures cultured without FCS 
was 145 cpm (^ medirun control), and Eor cells cultured with 101 FCS
w.as 126 cpm (^ 101 FCS control), as described in Table 2.2.33,
incubation sequence 4/4 . There was an inhibition oE 13,101 due to FCS
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FIGURE 2.2.B3: The uptake of 125IUDR by mouse thymocyte cultures, 
cultured without and with FCS-HI, for 4 hours with rat UIF.
4/4 incubation sequence. The UIF types are described in Fig.2 .2 .B l.
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vhich was not signiElcant, (t^O.703, P> .05 iis). Poe colls cultured 
without PCS, with 20 ul ÜCP or 40 ul UCP the inhibition oc st unulat ion 
oE isotoc-e uptake w-xs not predictable as with previous cultures with 
UCP. "Chua STO at 20 ul was stimulatory and at 40 ul was inhibitor'/. 
AD, MAD, (fEree and 3 UIP3 produced substantial inhibitions at 20 ul, 
whereas at 40 ul, they were less inhibitory. Similarly, 5H.CJIP wais 
inhibitory at 20 ul, while at 40 ul, it was stimulatory. DZ.triF w.is 
nearly similar in its inhibition oE isotope uptake at both CJCF 
concentrations, while the predictable P.TK.CfCP maintained its 
stimulation oc uptaZce, more so at 40 ul than at 20 ul (Jl? per well. 
The signiEicance oE the mean com oE cultures in the respective 01? in 
terms oc the mean ccm o£ control culture is described in a t-test 
comparison^ ( Table 2,2,11) •
Thus at 20 ul OCP, the mean cpm o E cultures in all OCP3 were
signiEicantly dlEEerent Erom the mean cpm oE control cultures except?
cor 3T0, 5M and DZ OCP3. At 40 ul, the me .an cpm oE .all cultures in
UCF were signiEicantly dlEEerent Erom control cultures except Eor h.AD,
5h, OZ .arid B OCPS, which were not dlEEerent.
For cells cultured with LOI FCS, 20 ul UIF produced inhibitions
o£ isotope uptake by STD, AD, dAD .and ^Eree UCFS. These inhibitions
increased with ‘■W ul UCF except Eor f^AD which decreased. 5M, DZ, F.TH 
and a UCFS were stimulatory at 20 ul and at 40 ul the stimulations 
decreased except Eor F.TH which increased. however, the mean ccm oE 
most cultures in the respective UCFS at 20 or 40 ul were not 
signiEicantly dlEEerent from the mean cpm o£ control culture as 
described in the t-test comparison^ ( Tab le 2.2.V),
Thus at 20 ul UCF, the mean cpm o£ cultures in all UCFs were not 
signiEicantly dlEEerent Erom the rae.an cpm value oE culture control.
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except for DZ.UCF which w5ls different from controls. At 40 ul, the 
mean cpm of cultures in all UIFS were not significantly different from
the mean cpm of culture control, except for cultures in AD and F.TH 
which were.
Comparing the mean percent inhibitions or stimulatins produced 
by the respective UEFS (20 and 40 uls) between cells cultured with and 
without 10% FCS have shown that at 20 ul UCF, i\D, <^ free, 5H, DZ, F.TH 
and S were all less inhibitory with 10% FCS than without 10% FCS, 
while STD and NAD.UCFS was more inhibitory with FCS than without PCS.
At 40 ul UCF, STD, bfree, DZ, and 8 UCFS were all less inhibitory with 
10% FCS than without FCS, while AD, 5M and F.TH UCFS were more 
inhibitory with 10% FCS than without FCS. The significance of the
difference between the percent inhibitions or stimulations between 
cells cultured with or without 10% FCS in the presence of 20 ul or 40 
ul of UCF, is described below in a t-test comparison, (Table 2.2. W)
Thus at 20 ul UIF all comparisons were different except for NAD UIF 
which was not. At 40 ul all comparisons were not significantly 
different except for STD, DZ and F.TH UIF3 which were different.
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TabL.î-2.2.R
UIF cpm VS Control cpm (without PCS)
Table 2 . 2 .S
UIF cpm VS Control cpm ( 10>; F C S )
STD:
20 ul 
F-^
40 ul
px STD:
20 ul 
P*
40 ul 
P-
AD: P* .AD: P* P'
NAD : p<- NAD : P ’‘ P'
ÔFr : 
'5M:
P'^ P^ ■fFr: P* P*
P* p** 5M: P* P * ‘
DZ: P'^ p>. DZ: p.
FTH : p** FTH: P* P' +
B: P* B; P-^ P-
Table 2.2.T
UIF FCS VS UIF without FCS
Table 2.2.U
UIF cpm VS Control cpm (without FCS)
20 ul 40 ul 20 ul 40 ul
STD; P* P^ STD; P*- ?*/*
AD; P» P* AD: P^*- P V *NAD; P'' P* K.AD; ?*/* p*
f()Fr: P^ P* ()Fr: r* p ^ h5M: f-'* p** 5M; P^ p*
DZ: P^/* P* DZ; p*
FTH: P ’^* FTH: P’'-^ p**
B; P* P*/* B; P*/* p*
,2 .V Table 2.2.7
UIF c pm VS Control cpm- (lOf(’ FCS) UIF PCS VS" UIF (withoL
20 Ui 40 ul 40 ul 40 ul
STD: P* P-^ STD; p V"^ P* +AD: P ’'- pé/* AD: P Y * P^N.ID; P> P* NAD: P^ p+
QFr: P^ ÔFr: P+/* P*5M: P^ P* 5M; P-V* P*DZ; P-"» P* DZ: P** p * hFTH: P* p * t(- FTH; P*'^ p^*. B: P-^ P* B: P*/* p.*
P*/+ = ,05 P** =<.01
I-^  =>.05
As described above, (section 3.2.2, Figure/Tables 2.2.A1, A2 
and A3) the effects of various sources of spleen UIF on the uptake 
of radioisotope by cell cultures was assessed in cultures, cultured 
with and without FCS, at three incubation sequences 0/4, 2/4 and 
4/4.
It was demonstrated (20ul UIF/without FCS) that when spleen 
UIF was prepared from cultures depleted of macrophages, the 
inhibition of radioisotope uptake was eliminated. Similarly it was 
demonstrated that an inhibitory factor present in STD UIF was 
dialyzable, as the inhibition of radioisotope uptake was also 
eliminated. It was also shown that the inhibitory strength of STD 
UIF depended on the culture density of cell cultures producing the 
UIF, as STD UIF produced from cells cultured at half the culture 
density that produced STD UIF, was not inhibitory.The inhibition of 
radioisotope uptake at 40ul was generally higher than counterparts 
at 20ul. Adherent and non-adherent UIF was (surprisingly) more 
inhibitory than STD UIF at both UIF concentrations.
The effects of FCS on the inhibitory potential of UIF were 
varied. For STD UIF, there was a marked decrease in inhibition 
relative to counterpart cultures (without FCS), however, the 
inhibition of uptake increased (with FCS) with respect to the 
incubation sequence which was not evident in counterpart cultures. 
The inhibition of radioisotope uptake by adherent and non adherent 
UIFS was slightly lower at the 4/4 sequence than counterpart 
cultures, (without FCS). For dialyzed and freeze thaw (FTH) UIFS, 
there was a marked inhibition of radioisotope uptake at 4/4 and 
2/4, 4/4 sequences respectively relative to counterparts (without
FCS).
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5M and macrophage free UIFS were rather similar in both 
environments (with and without FCS), however, at 40ul of UIF, 5M 
and macrophage free were more inhibitory at the 4/4 sequence than 
counterpart cultures (without FCS). At 40ul, the inhibition 
produced by STD and AD UIFS were similar in both environments, 
while that of NAD was reduced with FCS relative to conterparts 
without FCS. The inhibition of radioisotope uptake by dialyzed and 
FTH UIFS in both environments were similar to that of that of the 
20ul group. Thus the inhibitory effect of spleen UIF depended on 
several factors such as , the culture density of UIF producing 
cultures, and the presence or absence of macrophages in culture 
preparations of UIF producing cultures.
The effect of the respective spleen UIFS on the uptake of 
radioisotope by mouse thymocytes, (Figures/Tables 2.2.B1, B2 and 
B3) were also variable with respect to the incubation sequence and 
the presence or absence of FCS.
At the 0/4 incubation sequence (20ul without FCS), the effects 
on radioisotope uptake by thymocytes were relatively greater than 
counterpart plasmacytoma cultures. The most noteworthy feature was 
the stimulating effect of FTH UIF on the uptake of radioisotope 
which persisted with the thymocyte cultures in all culture 
environments and incubation sequences. At 20ul (UIF-FCS) all the 
inhibitory effects of UIF were eliminated as compared to 
counterpart cultures without FCS. However, at 40ul, the effects of 
the respective UIFS and FCS were different. The inhibitiory effect 
of STD UIF was reduced substantially, that of macrophage free was 
maintained at the same level of inhibition while that of AD and NAD 
UIFS were reduced to a level of insignificance relative to 
counterparts cultured without FCS.
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The change in uptake at 2/4 and 4/4 sequences was not as 
definitive as that of the plasmacytoma cultures, (where there was 
some increase associated with an increase in incubation sequence) 
as the change of radioisotope uptake by the respective UIFS was not 
consistent with an increase in the incubation sequence. The uptake 
of FCS by control cultures was relatively quite low, so was the 
uptake of most of the respective UIF cultures, that the relevance 
in the change of radioisotope uptake may be doubtful. However, the 
change of radioisotope uptake by cell cultures incubated with FTH 
UIF was consistent, in the sense that the stimulation of uptake 
persisted in the respective incubation sequences, although the 
uptake was relatively less with, than without FCS, but remained 
significantly different from the uptake of control cultures.
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Expe c Itaenbal pcocoduce-:j ;
ColL ouppenulono o E p LianiacytoicLi oc nioape Ehytrocytos wpco 
pcop.icûd la RPMC medium (wLbh oc wltbouh 10% FCS) and were dispensed 
(each typo oc cell suspension) into sterile tubes Eoc lymphocyte 
culture (NCRfC-Uk) At 1.5 x 10*^  cells/ml. Each cell suspension was 
cultured In the presence oE 20% CTEF except Eor control cell cultures 
which were not. The tubes were capped and were Incubated Eoc 4, 9 or 
12 hours in a Leec Incubator at 37'^ C. Each type o E culture was 
replicated three times. Following the incubation, aliquots Erom each 
tube, were assessed Eor call viability and cell number usi.ng the trypan 
blue exclusion test in an improved neubauer haemocytometer (Hawksley 
Ltd UK). Group A vvas cultured with 10% FCS, Group 8 was cultured 
without FCS.
Results ;
The values described in Table 2.2.CO were calculated as the 
diEEerence in cell numbers between control culture mean cell number 
and the mean cell number in the respective UEP culture, which was 
related to control's mean cell number.
The mean viable cell numbers oE plasmacytoma or thymocytes were 
either slightly above ( + ) or below (-) the 100% control values oE 
culture controls, and all were not signiEicantly dlEEerent Erom the 
mean number oE control cultures (P>.05).
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3.2-3; üCl" RevecaLbLLlty; hhû GCt'GCta ot e;<po3lnq call culhucaa to aci’ 
CGC a ohoct a paclcd, on tho uptake oE 125 CCJDR by cell cultures 
without the presence oc If IF in the a.ame cultures.
Experimental oroceUures;
A. suspension or pl.asmacytoma cells was prepared and divided into 
2 groups, the tlrst contained 10% EC.s in HPHl, fhe other was without 
ECS. Five replicate n ter lie tubes Eor lymphocyte cu 1 ture ( . UK )
received 1 ml oE plasmacytoma cells (1.25 x io° cells/ml) without FCS, 
each. Another live replicate tubes received 1 ml each of cell 
suspension containing 10% FCS. similajrly another set of tubes 
received 1 ml each of plasmacytoma cells that contained 20% UIF STO;
(5 tubes with 10% FCS and 5 without FCS ).
All the tubes were incubated for -t hours at 37*C, after which 
they were all centrifuged at 1.4 x 10^ rpm for 5 minutes and the 
supernate discarded. The tubes that contained 10% FCS were 
resuspended in 1 mi of prewarmed KPHI-10% FCS, the other 10 tubes were 
resuspended in RPMI without FCS. Each tube received 100 ui of 125 
lUDR (1 uci per culture) and were incubated for 4 hours. The 
procedures for preparing rah STD-UIF and the assessment of lUDR uptake 
by cell culture were described earlier.
Results :
The uptake of 125 lUDR was nearly similar by UIF cell cultures 
and control cultures as described in Table 2.3 , as there was a 
slight decrease In the mean Cpm of both UIF test cultures, compared to 
the mean Cpm of their respective control cultures. The difference in 
the mean Cpm between UIF cultures and controls (without FCS) was not 
significant, (t-0.974, P>.05), so was the difference between the mean
Cpm o-t UIF cultures and controls (with 10% FCS) which was not^
( P > os)
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3 . 2 , 4 :  The  e f f e c t  o f  STD .UCF on t h e  o . i scaqe  o f  c e l l s  f r om o phase to
mitosis, and the nuinb-ec of arrested metaphases.
Expe rImental procédures :
A: The optimum dosage of vincristine sulphate (Oncovin) required 
for arresting the mascicnum number of metaphases at several incubation 
periods. A cell suspension of plasmacytotna cells in 20% FCS was 
prepared, and aliquots of 0.5 mis were dispensed into 45 sterile tribes 
( hUNC .UK) for lymphocyte culture. '[Tie tubes were groupsd into 3 
groups of 15 tubes each. The tubes in the first group received an
equal volume (0.5 ml) of 1 ug/ml onconvin each, the second received 
2.& ug/ml oncovin , and the third group received 8 ug/ml. Thus the 
final concentration of oncovin in 10% FCS in the first group was 0.5 
ug/ml, in the second group: 1.3 ug/ml and in the third group: 4 ug/ml. 
Three tubes of each oncovin group were incubated for the following 
periods in hours at 37°C: 0.5, 1, 2, 3 and 4 hours i.e. 9 tubes per
incubation period. After each incubation Period, Cytopsin-smears of 
e.ach tube were prepared and stained in donner-Ciemna. The Cytopsln 
slides wore later scored for motaphase counts at 10 x 40 
magnification . At least 2000 cells per slide were screened for 
metaphases.
8: STD.UIF was Incubated with plasmacytoma cells for 4 hours,
after which, the optimum dosage of oncovin v/ais applied to the cell 
culture for a specified time period. A plasmacytoma cell suspension 
was prepared aa described previously and dispensed as 950 ul aliquots 
into sterile tubes for lymphocyte culture. T,;o sets of 5 tubes each 
were incubated for 4 hours at 37*C. The first set of tubes contained 
a suspension of plasmcytoma cells in 10% FCS and 20% of STD.UIF. Tne 
second set had a plasmocytoma cell suspension in 10% FCS without 
STD.UIF. Following the 4 hour incubation period, 50 ul of RPMC.lot
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FCS that contained 0.5 uvj of oncovin were dispensed Into each tube oc
the t'/o sets, ..and were Incubated for a further 2 hour period at 3/‘^c.
Another 2 sets of 5 tubes each received I ml per tube of pi as 1000/to ma 
suspension In 10% FCS. The first set of plasmacytoma suspension was 
cultured In the presence of STD.UCF at a concentration of 20%. 'I'he
other set was without STD.UCF, and served as a control culture for the 
experiment- The 2 sets of tubes were incubated for 4 hours at 37=’C,
Cytopsln slides were prepared .and metaphases counted .as described
above and 4 slides of each set were assessed for their metaphase
count.
Results !
The effect of oncovin on arresting metaphases was linear in the 
case of the 0.5 .and 1 ug groups, between 0.5 and 2 hours, and 
decreased thereafter between 2 to 4 hours as described in 
Figure/Table 2.4.a . In the 4 ug group, the number of arrested
metaphases were nearly constant, between 0.5 to 3 hours, which
decreased thereafter at 4 hours. The highest metaphase count of 107 
was for the 0.5 ug group at 2 hours of Incubation. In the 0.5 ug 
group, the difference in metaphase numbers between the 0.5 hour .and 1 
hour incubation periods wan not significant, (t-i.943, P>.05), while
the difference between the 0.5 hour and 2 hours incubation periods was 
significant, (t=3.215, 0.05>P>.0I). At the 2 hour incubation period,
tho difference between the 0.5 ug and 1.3 ug groups was not
significant, (t-1.749, P>.05), while the difference between the 0.5 ug 
.and 4 ugs groups was significant, (t=2.941, 0.05>P>,01).
The m.ean metaphase count for pl.asmacytoma cultures cultured with 
vincristine .and UCF as described in Table 2.4.B were as follows*, in 
the F1-V2 group, ^plasmacytoma cultures with vincristine) the mean j
met.iph.ase count was the highest at 141 metaphases, while the STD.FI-V2 Ii- 203 - I
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FIGURE 2.4A; The accumulation of metaphase figures in plasmacytoma 
cultures, cultured with different concentrations of vincristine sulphate, 
for different periods of incubation time.
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nu'h.luh.iLio couat o£ L03 . 'Ch a h LE Garance between the .ind
(]coup, ^pLaemacr/toma cultures with STD.cJCt") had a mean metaphase count 
n \1ghtly hLgher hha n 
( LL3 . 12 . V3 .107 ) which was not signiEicant, (t-=Q.37 3, P>.05). The UCF,
g rou
there rore, decreased the mitotic index slightly <is in the 3TD. PtV2
group but was not diEcarent Ecom the FtV2 group.
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3.2.5: The at'fee ta of STD.LfCF on hha Labe I Ling Index and gcaln count of 
p Lasmacytoma ce I la.
S'.cpec La\ec\tal procedures :
A. suspension of plaamacytoma calls was prepared as described
previously, and war, divided into 1 groups. The first group was a 
suspension in RPME without. Hi—t’CS and H’l'U.UCF, The second suspension 
was with 10% fC3, while the third group contained 10 i FCS and 20 i
STD.OLP. Aliquots of each suspension were dispensed into sterile
lymphocyte culture tubes ( trUlfC-UI< ) ; I ml per tube and 5 tubes per
group.
Each tube received 50 ul of RPMI containing 1 uci of H^-'Tdr (5 
cl/mrrol sp.ach). The cultures were incubated for 4 hours at 37'^ C. 
Following the incubation, ' samples from each group were transferred 
into a cytopsin centrifuge, and cytopsin-smearn were prepared. The 
cytopsin-smaars were processed for autoradiography according to the 
procedure of Kopriwa and Leblond (1962) and were stained in 
haeraaho:<ylin-eo3in stain.
The slides were assessed for the Labelling Index ah 10 x 40 
mag, , and for grain counts at 10 x 100 mag . For the determination 
of the (GC) Labelling Index, 4 cytopsin smear slides of each group 
were examined, and 4000 cells per slide were scored to determine the 
proportion of labelled to unlabelled cells per slide. For the 
determination of the grain count, 4 cytopsin slides of each group were 
examined, and 100 labelled cells per slide were scored for their grain 
count as described in materials and methods.
Results :
The highest Labelling rndnx for piasmucytoma cultures, as 
described in Table 2.5  ^was for cells cultured without FC3, followed
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Table 2.5; The labelling index and mean grain count o£ plasmacytoma 
cells, cultured without PCS, with 10% rcs and with 10% 
PCS and 20% ÜIF. The t standard error is included.
Nunber of cells containing the respective mean 
grain count ± S.E.
Grain count
Group M F UP
A 3 ±1 4.5 ± 1.5 13.25 t 1.3
B 4.5 t 1.5 8.5 t 1.3 10.75 t 0.47
C 92.5 ± 2 87.0 t 2 76.00 t 1
Mean nurrber of labelled cells ± S.E.
M F UP
241 ± 49 181 t 28 175 ± 19
Percent Labelling index i S.E.
24.1 t 5.91 18.1 ± 2.86 17.5 ± 1.89
Group Grain count and class interval
A 0 ---> 50 lightly labelled .
B 50---> 100. medium labelled
C above 100 densely labelled.
M = cells cultured without PCS 
F = cells cultured with 10% PCS 
OF = cells with 20% UIF - 10% PCS
by coLLa culfcuc^d with LU% FCS .ind cut lu cultured with .Lût t’Cb -- 
20% CJCF . Thu die fa ranee In the labelling Induces between cells 
cultured with 10% FC5 .and cello cultured without t'CS w.vs nut 
significant, (t=l.L74, P>.05), and neither w.xo the difference between
cello cultured with 10% PCS and cells cultured with 20% UIF-10% PCS, 
significant, (t-0.203, P>,05).
Cn class inter/al [o - 50 grains per cell] .lightly labelled
group, the mean nuiTiber of cells, cultured with UtF ( UF ) was 13 cells, 
which was the highest in this class interval, followed by cells 
cultured with FC3 without UtF (F) and cells cultured without PCS and 
UIF (H), which were the lowest in coll number, at 4.5 to 3 cells 
respectively. The difference botwoon the col 1s cultured with 20% 
UIP-10% PCS , and cells with 10% PCS was significant(t=4.811, P<.01 
while the difference between cells cultured with 10% PCS and without 
PCS was not significant, t=0.355, P>.05 NS. The mean number of cells 
in class interval [50 - 100] was the highest for those cultured in 
UP at about 11 cells, followed by cells cultured in F , while the 
without PCS group had the lowest mean cell count of approximately 5 . 
The difference between the P and UP groups was not significant, 
(t-1,603, P>.05), and neither was the difference significant between
the P and M groups, (t=1.9G, P>.05).
In the densely l.abelled group [above 100 grains per cell] the 
mean number of cells that were cultured without 10% PCS had the 
highest count, at about 93 cells followed by cells that were 
cultured with 10% PCS, and the number of colls which were cultured 
with 20% UIP-10% PCS was the lowest, at 76 cells.
The difference between the 10% PCS-20% UtF and the 10% PCS 
groups w.as signific.ant, (t-=4.4L7, P<,01), while the difference between 
the 10% PCS and without PCS groups was not significant, (t-1,022.
- 2 0 6
P>.0‘3), Thus foc celLs cultured with CJCP-PCS the re was a reduction 
of 12.6% compared to cells cultured in PCS without UCP In the
densely Labe Lied Group C .
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3.2.5; 'L’ho .'dt'foct of S'L’O.aCP oa p La£îin.icy toma co Lon y focxnak ion In kho 
oploeno of mice.
Expo c i.nienkal p cocodaroa ;
A.; Eighty 8aLb/C mice wore irradiated with (7.2 Gy) In an :c-cay 
machine and were divided in 4 groups (20 mice/group), A plasmacytoma 
suspension was prepared <as described previously in RPMC without ECS 
and was diluted to the following concentrations; 6x10^ ceils/mi, ixio^ 
cells/ml, 3x10^ cells/ml and 2x10^ cells/ml. Each mouse in the first 
group received l.Sxio^ cells per 0.25 ml through a sterile needle (23 
Gauge li Oeckton Dickson - Ireland) into the tall vein from a L ml 
sterile syringe (Beckton Dickson - Ireland); the second group received 
1x10^ cells/0.25 ml per mouse; the third group received /.5xlo* cells/ 
0.25 ml per mouse and the fourth group received 5x10  ^ cells/0.25 ml 
per mouse. Nine days following the injections, the a\ice were 
sacrificed under ether anaesthesia, and spleens were assessed for
their plasmacytoma colony content as described In materials and 
methods.
B: Eighty Balb/C mice were irradiated as described above^ (A) 
and each group of 20 mice received 0.25 ml (10^ cells/mouse)
plasmacytoma suspension in RPMI without FCS per mouse, as follows: 
Group ly mice received a plasmacytoma suspension which was incubated 
with 201 UIF.STD (4 hour incubation t 1 extra hour without UIF) at
37*C; Group 2 mice received a plasmacytoma suspension which was 
ificuba.led with 201 UIF, (4 hour incubation, followed by 1 hour 
incubation with Ara/C (20 ug/ml)); Group 3 mice received a
plasmacytoma suspension which was incubated for [4 hours in RPMI 
medium t 1 hour incubation with Ara/C, 20 ug/ml] at 37‘^C; Group 4 
mice received a plasmacytoma suspension in RPMI, which was incubated 
for 4 hours, followed by 1 hour incubation without Ara/C. The
-  2 0 8  -
pcoceduce foc the préparation of the 4 types of phismacr/tonLi cuLtuces 
has been doser,Ibod in detail in nu.teri.als .and methods.
tfino d.iys f o l l o w i n g  the; i nject i ons, the mice were saccicice-l 
under ether anaesthesia, and the spleens were assessed for their ceil 
colony contents under .a stereo microscope.
Results :
rt Is evident that there w.as a linear relation between th.] 
number of cells injected into mice, and the number of tumour colonies 
formed in their spleens as described in Table 2.6.A . The highest 
(Tumour .CFU-3 ) count of 45 colonies was for the 1.5x10^ cei.is/mousn 
dose, while the lowest ( Tumour .CPU-S ) count of 8.2 colonies was for 
the 5x10^ cells/mouse dose. The 7.5x10* and 1x10^ cell doses had 
intermediate colony contents of 15 and 20 respectively.
In another series of experiments, several duplicate trials were 
made for the doses 1x10* and 1.5x10* cells injected into mice, to
assess the respective (Tumour.CFU-S) content for the two doses. The 
results were variable, the 1x10* cell dose gave the following range 
for mean (Tumour.CFU-3 ) content - 14.7 - 27.3 - 54.72 with a new
result of 48 colonies as shewn in Table 2.6.B. For the 1.5xio* cell 
dose, the mean (Tumour.CFU—S ) content ranged from 36.75 - >60 colonies 
per spleen, ( too many to be counted), and in Table 2.8.A the ma an 
(Tumour.CFU-3) content for 1.5xlo^ cell dose was 45.
Therefore, it was decided for experiment 2.6.B to choose a cell 
dose, that does not give a high colony count such as the 1.5xio* cell 
dose/mouse which renders the colony counting difficult.
The dose used for a_Ll experimental treatments described in 
Table 2.6.3 w,as Ixio* cells/mouse . Mict; which received the
p l.asnracytoma suspension which w.as without t/L'F or Ara/C (Control
animals) had the highest (Tumour.CFU-3) content of 48 colonies per
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L!pl.iOc\. Klco wh LCh cuci-ilvoii thï-î p Laumacyhoiiia uujpatxa Ion v/hlch wau
t: coated with Aca/C, hid a mean colony content ot 38. Thuj the
percentage oG cello that were In cycle and susceptible to the eEcects 
oc i\ca/C. equals 20.8 31.
c’or plasmacytoma cultures, treate<3 with C/tP and Aca/C the mean 
number oE colonies p-er spleen droced to 11, while cells treated with 
UIF without Ara/C gave a mean colony content oG 9.1 which represented
an 80.111 reduction in mean colony content as compared to normal
controls values.
The difference in mean colony content between the Ara/C and
UIF-Ara/C groups was significant, (P<.QI, t-5.87), while the
difference between the UIF and UIF-Ara/C wan not significant, (t-=0.13, 
P>.05). The difference between the UIF and control (without UCF) 
groups was significant, (t—18.16, P<.OI), and the difference between
the Ara/C and control (without UIF) groups w.as also significant, 
(t-=2.39, P=0.030 or 0.05>P>0.02'1.
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As described earlier, (section 3.2.3) the inhibitory effects 
of UIF .on cell cultures were reversible, and STD UIF was not 
cytotoxic or having a lasting inhibitory effect on DNA synthesis.
Similarly, (section 3.2.4) the inhibitory effects of UIF were 
not evident on the passage of cells through S phase, and the 
metaphase count was similar to that of control cultures.
Similarly, (section 3.2.5) the labelling index of plasmacytoma 
cultures was similar to control cultures. The grain count 
distribution may suggest that UIF was competing with radioisotope 
for DNA as was evident in the densely labelled group. However, 
this was not evident in the other two groups. As judged by the 
above mentioned results (together with the cell viability tests), 
UIF therefore, had no significant effect on the proliferation of 
plasmacytoma cultures, (see below).
The results described above, (section 3*2.6) have demonstrated 
that the percentage of cells in S phase was approximately 21%. The 
results have also demonstrated that with this method of cell 
proliferation assessment (colony formation-spleen) UIF proved to be 
inhibitory for cell proliferation as the colony content of spleens 
from UIF treated cultures, was the lowest among other counterpart 
cultures especially that of Ara/C, which is an S phase specific 
cytotoxic drug.
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3 . 2 . 7 :  T h e  o G c c c k S  o f  UCF u L t c a c  L L l : r a t '2 d c a c b l o n u  o n  hho u p t . i k a  o t  12 ‘5
CUDR by plaomacytorr-i cells.
S:<pecImoncal ococecluces :
Rat STD.UCF was prepared as described previously and was divided 
Into 3 groups. The Elrst group was normal STD.UCF, the second group
was heated Eor hour at 56=C in a water bath, and the thrld group was
f r.ict i (mod In an Am Icon ( Am icon - U:C) DlaElo ultrafiltration
apparatus. The Diaclo ultrafiltration procedures, fractioned the UCF 
into 5 moleculcLr weight groups*. Above 5x10 ^ -= fraction 5x10^, Above 
IxlO'*' and below 5x10 ' - fraction 10^, Above 1x10^ and below 1x10^ = 
fraction 10^, Above 5x10^ and below 1x10^ ^ fraction A3Q0, and below 
5x10^ - fraction B500, as described in materials and methods.
A plasmacytoma suspension was prepared with and without lOT FCS, 
and was d1npons(Hi at ixlO^ cells per microtitre well of each 
suspension. 40 ul of each type of UIF were dispensed into 5 microtitre 
wells, together with 0.2 uci 125 lUDR per well. The final volume per 
well was 200 ul. The pulsing procedure was as follows: 0/4, 2/4 and 
4/4. In the 0/4 incubation sequence, the UIF and the 125 lUDR were 
dispensed at zero time, together, to the cell suspension and incubated 
for 4 hours at 37*^ 0. In the 2/4 incubation sequence, the UCF was added 
to the cultures and incubated for 2 hours at 37°C, followed by the 
addition of 125 CUDR and a further incubation of 4 hours at 37®C. In 
the 4/4 incubation sequence, the UIF was added to the cultures and 
incubated for 4 hours at 37*C, followed by the addition of 125 lUDR 
.and a further incubation of 4 hours at 3 7 * c .
Results :
In the 0/4 incuh.ahion group, the highest Inhibition of isotope 
upt.ike by cells cultured without FCS were by whole UCF.STD, UCF.5ô'=’C
-  2 1 2  -
and amLeon fraction 8500 as described In TMbLe/Figure 2.7 which were 
around the s.une region of 27 to 301 Inhibition and were significantly 
different from their culture controls (P<.01), while amIcon fractions 
A500, 10^, lO'', and 5x10 ' ware weakly Inhibitory, if any, and were not
significantly different (P>0.5) from control cultures without UEF. For 
colls cultured with LOI FCS, the Inhibitions of isotope uptaire 
produced by the respective am icon fractions were similar at around the 
201 region except for A500 which was around 151. STD.UIF produced 
211 inhibition while STD S8*C UIF produced a relatively higher 
inhibition of ■ 301. The respective mean Cpms of cell cultures, 
cultured in all UIF groups were significantly different from control 
cultures mean Com (P<.0L and 0.05>P>0.1) aa described in the t-test 
comparison for Table 2.7. All UIF fractions produced more inhibitions 
in LOI FCS and were significantly different from their counterpart 
cultures without FCS (p<.01) except for 8500 which was not 
significantly different. Similarly the inhibitions produced by STD.UIF 
56*C were similar in both cultures, P>.05, while for STD.UIF there was 
a drop in inhibition of about 61 in LOI FCS cultures which was 
significant 0.05>P>.0I.
In the 2/4 group (without FCS) the highest inhibition of Isotope 
uptaZre by cell cultures, was produced by amicon fraction 6500 at 281 
followed by a nearly similar inhibition by both UIFS.STD and 55®C at 
around the 201 region, which were all signf leant ly different from 
control cultures (P<.0L) as described in the t—test comparison of 
table 2.7. Similarly, as in the 0/4 group the least inhibitory were 
csmicon fractions A500, 10^, 10*, and 5xio* which were within the 4—51
inhibition. However, due to their small standard errors in terms of 
the relatively large Cpm value for each fraction including control 
cultures, they were signiCrcantly different from control cultures
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(P<.01 and 0,05>P>0.1) as described in the t-test comparison of 
Table 2.7.
The inhibitions of radioisotope uptake produced in 10% FCS 
cultures by the respective ÜIFS or amicon fractions, was highest 
for STD.UIF at 27%, followed by a similar inhibition of 23% by
UIF.56 °C, while B500 was relatively smaller at 16%; all of which 
were significantly different from the uptake of radioisotope by 
control cultures (P <.01). The least inhibitory, were UIF amicon 
fractions: A500, 10% 1 (f and 5 x 1 oY with an inhibition range of 4
to 5%, all of which, were not significantly different from the 
uptake of radioisotope by control cultures (P >.05), except for 
fraction 10^  which was different (0.05>P>0.01) due to its relatively 
low cpm and standard error in terms of the value of control
cultures. The respective mean percent inhibitions in 10% FCS
cultures were not significantly different from their counterpart 
cultures, cultured without FCS (P>.05), except for B500 which was 
more inhibitory in cultures without FCS , than in cultures
containing 10% FCS.
In the 4/4 incubation sequence culture group (without FCS), 
the highest inhibition of radioisotope uptake by cell cultures was 
produced by amicon fraction B500, at around 34%, followed by
STD.UIF, at around half as less to 17%, while its variant, UIF.56 
t, at a slightly higher inhibition of 22%; all of which were
significantly different from the uptake of radioisotope by control 
cultures (P<.01). Again amicon fractions A500, 1 cf, 1 0* and 5 x 1 (f 
were least inhibitory, with a range of 3 to 9% inhibition, of 
which, the mean cpm of fractions A500 and lu^were not significantly 
different from the mean cpm of control cultures, where as the mean 
cpm of fractions 10^and 5 x 10* were different (0.05>P>.01 and
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FIGURE 2 .7 : The Uptake of 125IUDR by plasmacytoma cu ltu res , cu ltu red  
w ithout and w ith F C S -H I, for 4 hours w ith d ifferent fractions of rat 
standard (STD) U IF . The incubation sequence for th e  respective incubations  
was: 0 /4 , 2/4 and 4/4 . U IF  c o n c e n tra tio n  = 20%
1: control cu ltures w ithout U IF . 2: STD U IF. 3: STD UIF heated 5 6 c ,30 m in . 
4: 8500. 5 :A 5 00 . 6 :1 0 l 7 : 1 0 \ &  5 X 1 0 \
* ' ‘*:see table 2 .7  for details.
Table 2.7: The effect of amicon ultra filtrate fractions of UIF on
the uptake of 125IUDR by plasmacytoma cultures. The values 
are expressed as .mean counts per minute (cpm) and as 
percent inhibition. The t standard errot is included.
The cultures were incubated for 0/4, 2/4 and 4/4 hours 
incubation periods.
0/4 hours incubation sequence.
Without 10% rcs With 10% FCS
UIF mean cpm Percent mean cpm Percent
Fraction t S.E. Inhibition ± S.E. Inhibition
± S.E. 4 S.E.
5 X 10“* 12542 t 331 2.07 ± 2.5 10046 > 589 21.78 4 4.5
io“ 12772 t 235 0.2 ± 1.8 9917 ± 344 22.79 4 2.6
10^ 12388 ± 227 3.2 ± 1.7 9773 i 130 23.90 4 1
A 500 12655 ± 188 1.1. ± 1.4 10945 t 307 14.78 4 2.3
B 500 9204 ± 206 28.13 ± 1.6 9808 ± 213 23.63 4 1.6
56“C 8907 ± 177 30.45 ± 1.3 8964 t 198 30.20 4 1.5
STD 9249 ± 97 27.78 ± 0 10024 t 253 21.90 4 1.9
Controls 12807 t 148 0.00 12844 4 656 0.00
2/4 hours incubation sequence
5 X lO'* 13514 ± 121 6.77 + 0 13418 4 149 4.2 4 1
10“* 13865 t 127 4.30 t 0 13361 4 385 4.6 4 2.7
10^ 13575 ± 199 6.30 t 1.3 13184 4 176 5.9 4 1.2
A 500 13964 ± 135 3.60 ± 1.4 13435 4 234 4.1 4 4.5
B 500 10402 ± 163 .28.20 ± 1.1 11743 4 258 16.2 4 1.8
56 “C 11456 ± 310 20.97 ± 2.1 10766 4 254 23.194 1.8
STD 11445 ± 263 21.05 ± 1.8 10178 4 437 27.394 3.1
Controls 14496 t 100 0.00 14018 4 305 0.00
Table 2.7. (Continued)
4/4 hours inculpation sequence
Without 10% PCS With 10% ECS
UIF mean cpm Percent mean cpm Percent
Fraction ± S.E. Inhibition ± S.E, Inhibition
t S.E. t S.E.
5 X lo'* 13759 ± 128 8.8 i 0 12554 ± 592 8.3 ± 4.3
lO'* 14638 ± 160 3.04 ± 1 12984 ± 848 5.2 ± 6.1
10^ 14184 ± 204 6.04 ± 1.3 12147 + 259 11.3 ± 1.8
A 500 14402 ± 219 4.6 t 1.4 13214 i 630 3.5 ± 4.6
B 500 10013 ± 229 33.6 ± 1.5 11644 i 404 14.9 t 2.9
56 “C 11852 i 414 21.5 t 2.7 10138 t 724 25.9 ± 5.2
STD 12465 ± 212 17.42 ± 1.4 11975 ± 761 12.5 t 5.5
Controls 15097 t 222 0.00 13697 t 627 0.00
STD => Standard UIF; 56C = STD.UIF heated for 30 min at 56°C. 
Amicon molecular weight fractions; 5 X 10*^  = > 5 X 10^ ,
10^ = 5 X 10^ > molec.wt.). 10^ ,
A 500 = 10^ > molec.wt. > 5 x 10^ ,
10 =10 > molec.wt. > 10
B 500 < 500.
T -cü£C Tahiti nor Table 2 .7 .
( I j -  wichcut ECS, (2)= w ith  lü i  ECS
0/4  Group
UIF.VS. Controls (U UIF.VS. C ontrols (21 UIF.VS.S'IO.UIP. (1) UIF.VS.STO.UIF. (2)
5 X 10"' = P p*<-/->2 p*lv*K" p-X
It ) ' -= P':v p-X- -X- p-X-
10^ = p-K- pVT-X- pvHv p-X
A 500 = p-X" p-X-/*X- p-A"X* p-X-/ -X-
B SCO = pvt-X- piv-X- p-X- p-:x-
50c = p-iv-X* p-A'-X- p-X-
3T0 = p-X-X-
2/4 Group
5 X 10'' = p X4f p'% P*-X- pvE5v
10 ' = p%'" p * P'X- A* Pv'viv
10^ = p-iV-X^ F * / * pX -^
A 500 = p-X-/5-> p-X- p-X"}f
B 500 = pv>-X* FX--X- p-x-iv
56c = p w v r p-X- p-X-
STO = p - u * P'X-'X-
T-ce^o Table toe Table 2 .7.  (concinuid) 
(1) = wichout PCS, (2) = w ith  lO t FCS
4/4 Croup
UIF.VS. Controls I D UIF.VS. C ontrols (21 UIF.VS.STO.UIF (L) UIF.VS.SID.UIF. (2)
5 X  lO'* = p # - # p-X- p-X-Vs: p-;-r
10^' = p-X- P * p i f * P-X-
iO^ = p-x- pK*-X- p-X-
A 500 = P * pX<- iHfX- px-
B 500 = p-X-4f p-X- -X- P*-%- p x
56C = P-X-tC- P-A--X* P-K- p x
s ro  = P-X--X- p4P
T-taac Table fo r  Table 2 .7  (UIF-FCS) .VS. (UIP -  W ithout FCS)
0/4  Group 2/4  Group 4/4 Group
5 X 10^ = p P * pX-
la^ = prfjt p-*- p*
lu"^ = • p * * P * p*
A 500 = p)E* p * p*
B 500 = p-X-» P*-H- pTT^r
56C = p * P-X P^
s-ro = p-X-/» p * P"
.05 7 P >.01
,*
= < 0 1  
=  >.05
P<.01) respectively. For cells cultured with 10% FCS, the highest 
inhibition of radioisotope uptake was produced by UIF.56 °C, at 
approximately 26%, followed by STD.UIF at half as less inhibition 
of around 13%, with a slight increase of 2% inhibition by B500, to 
15%.
Amicon fraction 10^  produced 11% inhibition, the 5 x 1 (f 
fraction produced 8% inhibition, while the A500 and 1 (f fractions
were between 3 to 5% inhibitory. The mean cpm of cell cultures ,
cultured in all the respective UIFS (and fractions), were not 
significantly different from the mean cpm of control cultures 
(P>.05), except for B5Û0 and UIF.56 °C, which were different 
(0.05>P>,01 and P<.01) respectively.The differences in the mean 
percent inhibitions of radioisotope uptake between cultures 
cultured with the respective UIFS, in the presence or absence of 
FCS, were not significant for all UIFS (P>.05), except for B500, 
which produced higher inhibitions when cultured without FCS, than 
its counterpart culture which was co~culturod with FCS (P<.01).
Comparing the mean percent inhibitions of radioisotope uptake 
of the respective UIFS (and fractions) in terms of the inhibition 
of radioisotope uptake produced by STD.UIF, the following results 
were obtained:
In the 0/4 incubation culture group (without FCS), UIF
fractions 5 x lO'*, 1 o"*, 10^  and 500 were all significantly different 
from STD.UIF, while UIF fraction B500 and UIF.56°C were not. In 
cultures cultured with 10% FCS, all UIF fractions were not
significantly different from STD,UIF, except for fraction A500, and 
UIF.56 °C, which were different as described in the t-test
comparison of Table 2.7.
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In the 2/4 culture group (without FCS) and with (10% FCS), all 
fractions were significantly different from STD.UIF, except UIF.56 
°C, which was not different.
In the 4/4 culture group (without FCS), all fractions were 
significantly different from STD.UIF, except UIF.56°C, which was 
not. In cultures cultured with 10% FCS, all fractions including 
UIF.56 ®C, were not significantly different from STD.UIF as
described in t-test comparison of Table 2.7.
In the 0/4 culture incubation gi'oup, the mean cpm of control 
cultures (with and without FCS) were similar (P>.05).
In the 2/4 incubation group, the mean cpm of control cultures 
cultured with 10% FCS were slightly lower than the mean cpm of 
control cultures, cultured without FCS by 3«3%, which was not a 
significant difference (P>.05).
In the 4/4 culture group, the mean cpm of control cultures 
cultured with 10% FCS was less by 9.26% than the mean cpm of contol 
cultures, cultured without FCS, which was not a significant 
difference (P>.05), but may signal that the inhibition of 
radioisotope uptake by cell cultures may be increasing as the 
culture incubation sequence is changed to longer incubation 
sequences.
As described above,(section 3.2.7) the effects of various 
fractions of UIF on the uptake of radioisotope by cell cultures 
with respect to the incubation squence and the presence of FCS in 
cultures have been assessed.
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The results have demonstrated that FCS and the incubation 
sequence may influence the uptake. Thus for fractions 5 x 1 (f,
10^and A500, the inhibition of radioisotope uptake (0/4 without 
FCS) was barely evident, while for the same fractions (cultured 
with FCS) the inhibition of radioisotope uptake was quite 
effective. However, at 2/4 and 4/4 incubation sequences the 
effects of the above mentioned fractions (with and without FCS) 
were minimal and the respective radioisotope uptake was not
significantly different from that of control cultures.
The most inhibitory fraction among the UIF fractions was the
B500 fraction, which suggests that the active inhibitory substance
was of small molecular weight. Similarly, the effects of FCS on 
B500 were not potentiating, as the inhibition of radioisotope 
uptake (with FCS) in the 2/4 and 4/4 sequences were reduced 
relative to the inhibition in serum free cultures. The heat 
inactivated UIF was also inhibitory (more inhibitory than non heat 
treated STD UIF) which suggested that some constituents of UIF 
which produced the inhibition were heat resistant. It was also 
noticed that the inhibitory effect of UIF 56^ remained stable in 
both FCS environments.
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3.3. IN VITRO CULTURES: ASSESSMENT OF THE EFFECTS OF
POLYAMINES ON CELL PROLIFERATION.
3.3.1.1: The effects of spermine and spermidine which were
preincubated with FCS or human serum for 16 hours at room 
temperature on the uptake of 125IUDR by cell cultures.
Experimental procedures:
Several concentrations of spermine and spermidine were 
prepared and mixed with FCS in the proportion of lOOul spermine or 
spermidine to 20 ul FCS (100ul polyamine: 20 ul FCS) for 16 hours
at room temperature. The following cell suspensions were prepared 
in RPMI 1640: plasmacytoma (PC), mammary adenocarcinoma (M.Aden),
normal rat thymocytes (RTC), and normal mouse thymocytes (MTC). 
Each cell suspension was dispensed into tissue culture microtitre 
wells at 1 X 10 cells/well. The final concentrations of spermine 
and spermidine per 200 ul final volume per well were as follows: 
8ug, 4ug, 2ug, 0.8ug, 0.4ug, 0.08ug and 0.04ug.
The following additions of the polyamine incubates were added to 
microtitre wells
120ul incubate [lOOul polyamine+2Oui FCS]+60ul cell suspension + 
20U11251UDR
120ul incubatedOOul polyamine + 2Oui RPMI)+6Oui cell
suspension+20ul125lUDR
Control cultures for the above cultures contained no polyamines. 
Each cell suspension was cultured independently in separate 
microtitre culture plates with 0.2 uci of 1251UDR and pulsed for 4 
hours at 37 °C, 5% CO2. Five replicate cultures for each polyamine
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concentration were prepared. The uptake of isotope by cultures was 
assessed as described previously.
In a similar experiment, human serum was used instead of FCS and 
the procedure of the experiment was similar to the one described 
above for the FCS group, but with the following concentrations of 
polyamine per well,: 8ug, 4ug, and 0.8ug. The cell cultures were
also similar, apart from the mouse thymocytes which were not 
included. The culture incubation sequence was 0/4 hours , i.e. 
the polyamine incubate was added at the same time as 125IUDR to the 
cell cultures. The incubation sequence of the above mentioned 
cultures was as follows: 16 PC. 0/4, 16 M.Aden. 0/4, 16 RTC.
0/4, 16 MTC. 0/4 .
Results:
The spermidine-FCS and the spermine-FCS reactions produced a linear 
dose response effect on the inhibition of uptake of 125IUDR by 
plasmacytoma cultures, (Figure/Table 3.1.1 A. PC.0/4 incubation 
sequence) at 0.8 to 8ug/well concentrations. The inhibitions were 
similar, and were in the regions of 40 and 90% respectively. The 
inhibition of isotope uptake in both cultures was linear and dose 
dependent. The mean cpm of the respective cultures was 
significantly different from the mean cpm of control cultures, 
(P<.01). The ID50 (polyamine-FCS) for spermidine and spermine was 
approximately similar, and was 16.96 and 20.10uM respectively, 
(Table 3).
For cultures, cultured without FCS, the uptake of isotope at 
the respective polyamine concentrations was neither linear nor dose 
dependent. No significant inhibition of isotope was observed, 
(P>.05) and the general trend of isotope uptake was higher in
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FIGURE 3 .1 .lA: The uptake of 125IUDR by plasmacytoma cultures,
cultured for 4 hours with different concentrations, of polyamines per
culture. 0/4 Incubation sequence.
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cultures cultured without FCS. The mean cpm of the respective 
cultures was not significantly different from controls, (P>.05). 
The inhibitory effects of polyamines in the presence of FCS 
contrasts with the effects of polyamines when incubated without 
FCS.
The uptake of 125IÜDR by mammary adenocarcinoma was inhibited 
by spermidine-FCS and spermine-FCS with a linear dose-response 
effect, (Figure/Table 3.1.1B)(M.Aden. 0/4 incubation sequence). 
For both spermidine and spermine the inhibition of isotope uptake 
at the 0.8 to 8ug/well concentrations was similar, and was in the 
region of 50-60 to 80^ respectively. The mean cpm of the 
respective cultures was significantly different from the mean cpm 
of control cultures, (P<.01). At higher dilutions of the 
respective polyamines, (0.8ug) the mammary adenocarcinoma was more 
sensitive to the inhibitory effects of the polyamine FCS reaction, 
than the plasmacytoma.
The ID50 (polyamine-FCS) for mammary adenocarcinoma cultured 
with spermidine and spermine, was 16,81 and 7.58uM respectively, 
(Table 3).
The uptake of isotope by mammary adenocarcinoma cultured with 
the respective polyamines (without FCS), was neither linear nor 
dose dependent, and was not significantly different from the uptake 
of isotope by control cultures, (P>.05). The pattern of uptake in 
these cultures, (polyamine without FCS) is in contrast to the 
pattern observed in cultures cultured with polyaraines and FCS, in 
which there was a marked inhibition of isotope uptake.
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FIGURE 3 .1 .IB: The uptake of 1251UDR by mammary adenocarcinoma 
cultures, cultured for 4 hours with different concentrations of 
polyamines per culture. 0/4 incubation sequence.
without FCS; spermidine o o , spermine □ — Q
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The polyamine-FCS reaction produced a linear dose-response 
inhibition on the uptake of 125IUDR by rat and mouse thymocytes, 
[(Figures/Tables 3.1.1C and ID)(RTC. and MTC. 0/4 incubation 
sequence)3.
The inhibition of isotope uptake by spermidine and spermine 
(0.8 to 8ug per well concentrations), on rat and mouse thymocytes 
cultured with FCS, was similar. The inhibitions were in the 
regions of 80 and 90$ respctively, (Figures/Tables 3.1.1C and ID). 
The mean cpm of the respective cultures was significantly different 
from the mean cpm of control cultures, (P<.01). The rat and mouse 
thymocytes were more sensitive (approximately twice as sensitive) 
to the inhibitory effects of polyamine-FCS than either the 
plasmacytoma or mammary adenocarcinoma, at higher dilutions (0.4ug) 
of the respective polyamines.
The XD50 for rat and mouse thymocytes (spermidine-FCS), was 
similar, and was 5.02 and 6.28 uM respectively. The ID50
(spermine-FCS) was also similar for both sets of cultures, and was 
3.67 and 2.8? uM respectively, (Table 3). The ID50 of both sets of 
cultures was less than that of plasmacytoma and mammary
adenocarcinoma.
For both sets of cultures, cultured with the respective
polyamines (without FCS), the uptake of isotope was neither linear
nor dose dependent, and this contrasts with the inhibitory effects 
produced by the respective polyamines on cultures cultured with 
FCS.
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FIGURE 3.1.1C: The uptake of 125IUDR by rat thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines 
per culture, 0/4 Incubation sequence .
without FCS: spermidine o— o , spermine □ ------ □
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FIGURE 3.1.1D: The uptake of 125IUDR by mouse thymocyte cultures, 
cultured with different concentrations of polyamines per culture, for 
a 4 hours Incubation period. 0/4 incubation sequence.
without PCS: spermidine o----- o, spermine □ — □
with FCS-HI; spermidine #----- #, spermine m 1

The plasmacytoma, mammary adenocarcinoma and rat thymocyte 
cultures, were incubated with a polyamine-human serum 16 hours - 
room temperature incubate, together with 125IÜDR for 4 hours (0/4 
incubation). For plasmacytoma cultures there was a slight 
inhibition of 125IUDR uptake at 4ug and 8ug of spermidine at around 
3-4% and for spermine at around 1-5%, (Figure/Table 3,1.IE). Their 
respective mean cpm was not significantly different from the mean 
cpm of control cultures (P>.05). For mammary adenocarcinoma and 
rat thymocytes there was stimulation rather than inhibition of 
125IUDR uptake; both with and without human serum. Thus human 
serum was not as effective as FCS in its interaction with the 
polyamines, in producing the inhibition of isotope uptake by cell 
cultures.
As described above, (section 3.3.1.1: Figures/Tables 3.1.1 A, 
IB, 1C ,ID and IE) the effects of interaction between the 
respective polyamines with serum (FCS and human serum) on the 
uptake of isotope by the respective cultures were assessed. The 
results described above have demonstrated that while FCS interacted 
with the respective polyamines to produce a significant inhibitory 
effect on the uptake of 125IUDR by the respective cell cultures , 
human serum was not effective in producing such an inhibition. The 
results have also demonstrated that spermine (FCS) was more 
inhibitory than spermidine (FCS) on the uptake of isotope by cell 
cultures. It was also demonstrated that there was a differential 
sensitivity among cultures in relation to the inhibitory effects of 
the respective polyamine-FCS. Mammary adenocarcinoma was more 
sensitive to the effects of spermine-FCS than plasmacytoma. The 
thymocytes, (normal cell types) were more sensitive to the 
inhibitory effects of both polyamines-FCS, than either plasmacytoma 
or mammary adenocarcinoma.
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FIGURE: 3.1.1G: The uptake of 1251U0R by (1) plasmacytoma,
(2) mammary adenocarcinoma and (3) rat thymocyte cultures, 
cultured with different concentrations of polyamines per culture 
for a 4 hours Incubation period. 0/4 Incubation sequence. 
Human serunt spermidine o o, spermine□ — o  '
TABLE 3.1.1 G: The effects of spermine and spermidine in the presence
of 10% human serum on the uptake of 123IUDR in a 0/4 incubation 
sequence by the following cell cultures: plasmacytoma, mammary adeno­
carcinoma and rat thymocytes. The values are expressed as mean counts 
per minute (cpm) and as a percent inhibition. The ± standard error is included.
polyamine 
conc. pg/well
plasmacytoma 
mean cpm ± SE 
SO SM
% inhibition ± SE 
SD 5M
8
4
0.8
control
conc. pg/well 
8 
4 
0.8 
control
3578 ± 216 3886 ± 162
3555 ± 2 1 9  3650 t 234
3704 ± 146 4282 ± 109
3696 ± 245
3.19 ± 5.84 
3,81 ± 5.96 
+0.21 ± 3.96
mammary adenocarcinoma
427 ± 36 
459 ± 16 
390 ± 11 
367 ± 22
368 ± 8 
378 ± 14 
382 ± 29
+16.34 ± 10.10 
+25.06 ± 4.43 
+6.26 ± 3.20
5.14 ± 4.40 
1.24 ± 6.37 
+15.85 ± 2.95
+0.27 ± 2.31 
+4.08 ± 8.08 
+4.08 ± 8.08
conc. pg/well 
8 
4 
0.8 
control
rat thymocytes
147 ± 12 134 ± 18 +21.19 ± 10.58 +10.49 ± 15.24
158 ± 15 134 ± 20 +30.29 ± 13.21 +10.61 ± 16.81
141 ± 15 145 ± 11 +16.13 ± 12.72 +19.38 ± 9.05
121 ± 19
SD = spermidine
SM = spermine
+ = stimulation of uptake
3.3.1.2: The effects of polyamine incubated for 2 or 4 hours with
cell cultures and FCS at 37 on the uptake of 125IUDR by cell 
cultures.
Experimental procedures: The culture procedures were similar to
that described in section 3.3.1.1 with the following variation:
Polyamine and FCS were added directly to cell cultures 
(without preincubation of polyamine and FCS), as described earlier 
in section 3.3.1.1. The respective polyamine-FCS mixture (and 
polyamine without FCS) together with the respective cell culture 
were incubated for 2 or 4 hours at 37°C, 5^ CO2 . Following the 
respective incubations, each culture received 20ul (0.2uci) of 
I25IÜDR . All cultures were reincubated for a further 4 hour 
period at 37°C. i.e., 2/4 and 4/4 types of incubation and pulsing
sequence The cell cultures used, were plasmacytoma and normal mouse 
thymocytes. PC 2/4 and 4/4, TC 2/4 and 4/4.
Results:
Both spermidine and spermine in the presence of FCS produced a 
linear dose response inhibition on the uptake of isotope by 
plasmacytoma cultures, (Figures/Tables 3.1.2A and 2B, PC. 2/4 and 
4/4 incubation sequences). Both polyamines (0.4ug per well) 
produced similar inhibitions of uptake of approximately 17%, 
(P.<01) which was significantly different from the uptake by 
control cultures, (Figure/Table 3.1.2A). However, the uptake 
inhibition curve of spermine had a relatively steeper gradient than 
that of spermidine, and at the 8ug/well concentration spermine 
produced an inhibition of 64%, while spermidine was slightly short 
of the 50% inhibition value. The mean cpm of both isotope uptake 
values was significantly (P<.01) different from control cultures.
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FIGURE 3.1J2A; The uptake of 125IUDR by plasmacytoma cultures, 
cultured for 4 hours with different concentrations of polyamlries 
per culture. 2/4 Incubation sequence .
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FIGURE 3.1.2B: The uptake of 1251UDR by. plasmacytoma cultures; 
cultured for 4 hours with different concentrations of polyamines 
per culture. 4/4 incubation sequence .
without PCS: spermidine o------ o, spermine □ — □
withFCS-HI; spermidine #----- #, spermine a — a
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Thus in the 2 hour preinoubation period spermine-FCS generated more 
isotope uptake inhibition than spermidine-FCS, and consequently 
while the ID50 for spermine-FCS was 21.53uM, the ID50 for 
spermidine-FCS could not be determined from the isotope uptake 
inhibition curves, as the maximum inhibition produced by spermidine 
was 46.99%.
When the period of polyamine-FCS interaction was increased 
from 2 to 4 hours, the inhibitory effects of the respective 
polyamines-FCS, (Figure/Table 3.1.2B) were higher as was evident 
from the steeper curve gradients of both polyamines between the 0.8 
and Bug/well concentrations, than the respective polyamine-FCS 
uptake inhibition curves, (Figure/Table 3.1.2A). At concentrations 
of 0.4 to 8ug/well, (Figure/Table 3.1.2B. PC.4/4 incubation 
sequence) the respective mean cpm of cultures was significantly 
different from the cpm of control cultures, (P<.01). The 
inhibitory effects of both polyamines were similar at the 0.8 to 
Bug/well concentrations, and were in the 90% region. At 
0.4ug/well, spermine was approximately 3 times more effective than 
spermidine. The ID50 for spermidine (10,99uM) was two folds 
greater than the ID50 for spermine which was 5.97uM, (Table 3).
For both sets of cultures, (Figures/Tables 3.1.2A and 2B) 
cultured with polyamines without FCS, the inhibitory effects of the 
respective polyamines were marginal, and in some cases the uptake 
was stimulated. The uptake of isotope was neither linear nor dose 
dependent, and this contrasts with the inhibitory effects of 
polyamines which were incubated with FCS.
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The inhibitions of isotope uptake by the respective 
polyamine-FCS incubates on mouse thymocytes cultured at 2/4 and 4/4 
incubation sequences, (Figures/Tables 3.1.2C and 2D) were similar 
between the 0.4 and 0.8ug/well concentrations, and all were in the 
region of the 90% inhibition value.
The mean cpm of the respective cultures were all significantly 
(P<.01) different from the mean cpm of control cultures. However, 
with an increase in the incubation period from 2/4 to 4/4, the 
inhibition of isotope uptake in the 4/4 group was higher at higher 
dilutions of polyamines (0.04 and 0.08ug/well concentrations), than 
their counterparts in the 2/4 group. The thymocytes at both 
incubation periods were more sensitive to the inhibitions of the 
respective polyamines-FCS, than their plasmacytoma counterparts, 
(Figures/Tables 3.1.2A and 2B),
The ID50 for the thymocytes at both incubation sequences were 
similar, (2/4 spermidine-FCS, Spermine-FCS :3.77 and 1.83uM 
respectively. 4/4 spermidine-FCS, spermine-FCS ; 2.98 and 2.35uM
respectivley.)
The inhibition of isotope was either marginally inhibited or 
stimulated, but in either case the change in isotope uptake was 
neither linear nor dose dependent, when the thymocytes were 
cultured with the respective polyamines (without FCS). The lack of 
inhibition of isotope uptake in these cultures, contrasts with the 
inhibition observed in cultures, containing FCS that reacted with 
the polyamines to produce the factors that inhibited the uptake of 
isotope by the respective cultures.
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FIGURES; 3.1.2D(above), and 3 .1 .2 C(below) :
The uptake of 125IUDR by mouse thymocyte cultures, cultured 
for 4 hours with different concentrations of polyamines per 
culture. 2/4 and 4/4 incubation sequence respectively.
without FCS: spermidine o----- o, spermine □ — □
with FCS-HI: spermidine #-----# spermine a  1
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As described above, (Figures/Tables 3*1*2A, 2B, 2C and 2D) the 
effects of the preincubation period of polyamine and FCS (in the 
presence of cell cultures), on the uptake of isotope by cell 
cultures was assessed. The results have demonstrated that as the 
period of incubation was increased, the inhibitory effects produced 
by the interaction of polyamine with FCS have increased as was 
evident from the uptake of isotope by plasmacytoma cultures.
The mean cpm of the culture controls (10# FCS) at the 2/4 and 
4/4 incubation sequences was 11782 and 8162 respectively, which 
represented a 30.72# inhibition of isotope uptake by cell cultures 
for a 2 hour inubation time difference which was significant 
(P<.01). The mean cpm of culture controls without FCS at 2/4 and 
4/4 was 10471 and 10713 respectively. This represented a slight 
stimulation of 125IUDR uptake at 4/4 of 2.25# which was not 
significant (F>.05).
3.3.2: The effects of polyamine-FCS preincubated for 2 or 4 hours
at 37 °C, on the uptake of 125IUDR by cell cultures.
Experimental procedures:
lOOul of spermine and spermidine were dispensed into 
microtitre wells (each polyamine in a separate tissue culture 
plate) together with 20ul of FCS or without FCS. Several tissue 
culture plates were prepared, and were incubated at 37°C, 5# COg, 
as described earlier. Some plates were incubated for 2 hours and 
the others for 4 hours.
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1:
(lOOul of spermine or spermidine + 20ul FCS + 6Oui cell 
suspension + 20ul 125HJDR)
(lOOul of spermine or spermidine + 20ulRFMI + 60ul cell 
suspension + 20ul 125IUDR)
Following the incubation of polyamines for 2 or 4 hours at 37 
°C; separate tissue culture plates received plasmacytoma cells (FC), 
mouse thymocytes (MTC) or rat thymocytes (RTC), at a concentration 
of 1 X 10^  cells/well; each well received 20ul (0.2uci) 125IÜDR and 
the tissue culture plates were pulsed for 4 hours at 37 i.e.
2-FC.0/4, 4-FC.0/4, 2-MTC.0/4, 4-MTC.0/4, 2-RTC.0/4, and 4-RTC.0/4
incubation sequences. Each culture was replicated 5 times. The 
uptake of isotope by cultures was assessed as described previously,
2: In a variation to the above procedure, tissue culture
plates received lOOul polyamine + 20ul of FCS or without FCS and 
were incubated at 37 °C as above (in number 1) section 3.2. 
Following the incubation, each plate received 1 x id' cells/well of 
one type of cell suspension, of plasmacytoma, normal rat thymocytes 
or normal mouse thymocytes. The cell cultures were incubated with 
the polyamines for 4 hours at 37 t:, followed by the addition of 
20ul (0.2uci) of 125IUDR to each well and incubated for a further 4 
hours at 37 t i.e. 4-FC.4/4, 4-MTC.4/4, 4-RTC.4/4 incubation
sequences.
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Results;
There was a linear dose response relation between the 
inhibition of isotope uptake by plasmacytoma cultures, cultured 
with FCS and the concentration of spermidine and spermine, 
[(Figures/Tables 3,2.1 A and IB)(2 and 4-PC.0/4 incubation 
sequences)] In both sets of cultures, the inhibition of isotope 
uptake between the 2-8ug/well concentrations was significantly 
different (P<.01) from the uptake of isotope by control cultures. 
In the 4-PC.0/4 incubation sequence, the extra incubation time 
produced more inhibition on the uptake of isotope as judged from 
the isotope inhibition curves, (Figure/Table 3.2.IB) which was 
relatively steeper than their counterpart curves,(Figure/Tables 
3.2.1 A). The isotope uptake inhibition was relatively greater at 
the 2 and 8ug/well concentrations, (around 68# for both polyamines 
at 2ug, and around 80# for both polyamines at 8ug) (Figure/Table 
3.2.1.B) than counterpart cultures, (Figure/Table 3.2.1 A) in which 
the inhibition of isotope uptake was relatively lower, (38.9 and 
56.8# at 2ug spermidine and spermine respectively, and at 8ug 72.7 
and 59.8# respectively).
Further, when the pulsing period was increased from 0/4 to 
4/4, (Figure/Table 3.2,1C) there was a marked increase in the 
inhibition of isotope uptake by both polyamines which was 
approximately 100#, (P.<01 relative to control cultures) at the 2
to 8ug/well concentrations.
Thus the respective ID50 for each polyamine has decreased as 
the preincubation time or sequence has increased, (Table 3).
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FIGURE 3 .2 .lA ; The uptake of 125IUDR by plasmacytoma cultures, 
cultured for 4 hours with different concentrations of polyamines 
per culture. 2-0/4 incubation sequence.
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FIGURE 3.2.1B; The uptake of 125IUDR by plasmacytoma cultures, 
cultured for 4 hours with different concentrations of polyamines 
per culture. 4-0/4 incubation sequence.
without PCS: spermidine o------ o, spermlneo— □
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FIGURE 3.2.1C: The uptake of 125lUDR by plasmacytoma cultures, 
cultured for 4 hours with different concentrations of polyamines 
per culture. 4-4/4 incubation sequence.
without FCS: spermidine 0------- o, spermine o — o
with FCS-Hl; spermidine #------- # spermine a— a

Spermidine; 2-PC.0/4, 4-PC.0/4 and 4-PC.4/4 = 61.9, 29.06 and 
22.78uM respectively.
Spermine: 2-PC.0/4, 4-PC.0/4 and 4-PC.4/4 = 34.46, 18.03 and
12.63uM respectively. In both sets spermine was more inhibitory.
Another feature of this experiment was that the uptake of 
isotope by cell cultures cultured with the respective polyamines 
(without PCS) was either slightly inhibited or stimulated, (P>.05, 
relative to control cultures) and the inhibition of isotope uptake 
was neither linear or dose dependent, (Figures/Tables 3.2,1 A and 
IB, incubation sequences 2 and 4-PC.0/4 respectively). However, 
when the incubation sequence was changed to 4/4, (Figure/Tables 
3.2.1C) there was a marked inhibition of isotope uptake at all 
doses of the respective polyamines. The ID50 (polyamine-FCS) for 
spermidine was 22.78uM and for spermine was 12,63uM which was 
slightly lower than the respective counterparts described earlier, 
(Tables 3 and 3.2.IB).
The uptake of 125IUDR by plasmacytoma cultures, cultured with 
polyamine without FCS, was inhibited at all concentrations for both 
spermidine and spermine but not in a dose dependent manner. As can 
be seen in the results (Table 3.2.1C), the inhibition caused by 
spermidine at all concentrations had a mean of 34.97%, a standard 
error of 0.378 and a range of inhibition between 24.97% and 
44.02.%. Similarly for spermine, the mean inhibition for all cell 
concentrations had a mean of 41.57%, a standard error of 2.39, and 
a range of isotope uptake inhibition between 32.74% and 51.37%. 
The mean cpm of cell cultures in all concentrations of spermidine 
and spermine, were all significantly different from the mean cpm of 
culture control (P<.01). The inhibitory effects were remarkably 
different from those described earlier, (Table 3.2.IB).
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In effect, upon manipulating culture conditions, by 
withholding the administration of 125IUDR, and allowing the 
respective polyamines to interact for a 4-hour period with the 
respective cultures, followed by the addition of isotope, has 
resulted in the inhibition of uptake of the isotope by cell 
cultures. This inhibition of isotope uptake was not evident in the 
results shown earlier (Table 3.2.IB), where the isotope was added 
together with the respective polyamine. Similarly, the inhibition 
of isotope uptake, (Table 3.2.1C) without FCS was more marked than 
its counterpart (Table 3.1.3B) without FCS.
The inhibition of isotope uptake as assessed on mouse 
thymocytes, had a similar pattern to that of plasmacytoma cultures, 
cultured with polyamine-FCS. The inhibition of isotope uptake by 
polyamines-FCS in the 2-MTC incubation sequence, (Figure/Table
3.2.2A) (spermidine) was in the 60% region and 70% for the other 
polyamine (spermine), the mean cpm of both polyamines was
significantly different (P<.01) from the mean cpm of control 
cultures. These respective inhibitions of isotope uptake have 
increased to 70 and 90% respectively (P<.01, relative to control 
cultures), when the preincubation period was increased to 4 hours,
(Figure/Table 3.2.2B). The inhibition of isotope uptake has
further increased, when the period of the incubation was increased 
to the 4/4 sequence, (Figure/Table 3.2.2C) to produce an inhibition 
of approximately 100% at the 2-8ug/well concentrations, (P<.01, 
relative to control cultures).
The ID50 for the respective polyamines were as follows;
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FIGURE 3.2.2A: The uptake of 125IUDR by mouse thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines per 
culture. 2-0/4 incubation sequence.
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FIGURE 3 .2 .2B: The uptake of 125IUDR by mouse thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines per 
culture. 4-0/4 Incubation sequence.
without PCS: spermidine o------ o, spermine □— -o
with FCS-HI: spermidine • ----- 1, spermine
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FIGURE 3.2.2C: The uptake of 125IUDR by mouse thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines per
culture, 4-4/4 incubation sequence.
without FCS: spermidine o------- o, spermine □ ---- □
with  FCS-HI: spermidine e------- # te rm in e  s ---- *
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Spermidine; 2-MTC.0/4, 4-MTC.0/4 and 4-MTG.4/4 = 30.636,
15.71 and 12.56uM rrespectively.
Spermine: 2-MTC.0/4, 4-MTC.0/4 and 4-MTC.4/4 = 9.19, 7.81 and
5.97uM respectively. Spermine was more inhibitory than spermidine, 
and the thymocytes were more sensitive to the effects of 
polyamine-FCS than the plasmacytoma cultures, (Figures/Tables
3.2.1 A, IB and 1C.),
The inhibition of isotope uptake by the respective polyamines 
and FCS on rat thymocytes was also linear and dose dependent, 
(Figures/Tables 3.2.3 A, B and C) and the inhibition of isotope 
uptake (mean cpm of the respective cultures) was significantly 
different (P<.01) from the uptake (mean cpm) of control cultures. 
However, the extension of the preincubation period from 2 to 4 
hours, and the change of the culture incubation sequence from 0/4 
to 4/4 did not change the amount of uptake inhibition considerably, 
(Figures/Tables 3.2.3A, B and C). The respective ID50 for 
spermidine and spermine, (Table 3).
Spermidine: 2-RTC.0/4, 4-RTC.0/4 and 4-RTC.4/4 = 7.85, 7.85
and 7.12uM respectively.
Spermine: 2-RTC.0/4, 4-RTC.0/4 and 4-RTC.4/4 = 5.74,
1.72 and 1.l4uM respectively. Spermine was more inhibitory 
than spermidine.
The variation in the uptake of isotope by the respective mouse 
(Figures/Tables 3.2.2A, B and C) and rat (Figures/Tables 3.2.3A, B 
and C) cultures, cultured with the respective polyamines (without 
FCS) was neither linear nor dose dependent. As compared to the 
results of plasmacytoma which were described earlier, (Figure/Table
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FIGURES 3.2.38 (above) and 3.2.3A (below):
The uptake of 125IU0R by rat thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines 
per cu ltu re .2-0/4 and 4-0/4 incubation sequence respectively.
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FIGURE 3.2.3C: The uptake of 125IUDR by rat thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines 
per culture. 4-4/4 Incubation sequence.
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3.2.1C) the results describing the inhibition of isotope uptake by 
rat thymocytes (Figures/Tables 3.2.3A, B and C) were not as 
definitive as as that of plasmacytoma, as the mean cpm of the 
thymocytes control cultures was quite low, (near background levels) 
to be useful in isotope uptake comparisons with the respective 
isotope uptake at the respective polyamine dilutions. Similarly, 
the inhibition of isotope uptake by mouse
thymocytes,(Figures/Tables 3.2.2A, B and C) was neither linear nor 
dose dependent nor was the change in isotope uptake as meaningful 
as that of the plasmacytoma, as there was not a clear pattern of 
inhibition at all the respective dilutions of either polyamine.
As described above, (section 3.3.2) the effects of polyamines 
preincubated with and without FCS on the uptake of isotope by cell 
cultures were assessed. Two incubation sequences (0/4 and 4/4) 
were used to assess the contribution of the incubation sequence to 
the effects of polyamines (with and without FCS) on the uptake of 
isotope by cell cultures. The results have demonstrated that the 
increase in incubation sequence from 0/4 to 4/4 increased the 
inhibition of uptake slightly. The results have also demonstrated 
(plasmacytoma cultures), that polyamines can be inhibitory without 
the requirement of FCS, on the uptake of isotope by cell cultures, 
when the incubation period was changed from 0/4 to 4/4,
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3.3.3: The effect of polyaraine-FCS added simultaneously with
125IUDR to cell cultures without a preincubation period, on the 
uptake of isotope by cell cultures.
Experimental procedures:
A plasmacytoma suspension was prepared and dispensed into 
microtitre wells as described previously. The polyamine and FCS 
were not incubated as in previous experiments, but were dispensed 
into tissue culture plates together with the respective cell 
suspension and 125IUDR and incubated for 4 hours i.e. (0.0/4 
incubation sequence), 100 ul of spermine or spermidine together 
with 20ul FCS were dispensed (each polyamine) into separate 
microtitre plates, followed by the addition of 1 x 10^  cells and 
(0.2uci) 125IUDR to each well and incubated for 4 hours at 37 ^ C, 5% 
COg.
[lOOul polyamine +20ul FCS]+60ul suspension+20ul 125IUDR 
[lOOul polyamine +20ul RPMI]+60ul cell suspension+20ul 125IÜDR
The cell cultures used for this experiment were plasmacytoma and 
rat thymocytes. The incubation sequence was as follows; 0-PC,
0/4, 0-RTC 0/4. Each culture was replicated 5 times. The uptake
of isotope by cultures was assessed as described previously.
Results:
The inhibition of isotope uptake by the respective
polyamine-FCS mixtures on plasmacytoma cultures [(Figure/Table
3.3.1 A)(0-PC.0/4 incubation sequence)], was linear and dose
dependent. The uptake of isotope at 0.8 to 8ug/well concentrations 
was significantly different from the uptake of isotope by control
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FIGURE 3.3.1A; The uptake of 125 iUDR by plasmacytoma cultures, 
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FIGURE 3.3.1B: The uptake of 125 lUDR by rat thymocyte cultures, 
cultured for 4 hours with different concentrations of polyamines 
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cultures (P<.01), The uptake of isotope ranged from 20 to 60/5 for i
each of the respective polyamines.
Similarly, the inhibition of isotope uptake by the respective 
polyamine-FCS mixtures on rat thymocytes [(Figure/Table ^
3.3.IB)(O-RTC.0/4 incubation sequence)], was linear and dose 
dependent. The uptake of isotope at the 2 to 8ug/well 
concentrations was significantly different from the uptake (P<.01) 
of control cultures. The uptake ranged from 30 to 50^ for 
spermidine and was around 50$ for the three respective dilutions of 
spermine.
It can be seen (Table 3), that the ID50 for plasmacytoma was
lower than the ID50 of rat thymocytes. The relative change in the
respective sensitivities of the respective cultures was related to 
the change in the variables of culture incubation, (i.e. period of 
incubation of polyamines with FCS, the timing of the addition of 
polyamines to cultures with or without isotope and the length of 
the incubation period), as the timing of the addition of polyamines 
(which were not preincubated), FCS and isotope were all set at time 
zero,(same experimental time).
It was evident in previous results (Figures/Tables 3.1.1 A and 
1C) (Table 3) (Figure/Table 3.2.IB and 3B), that the ID50 for the 
thymocytes was lower than plasmacytoma. Thus the amount of isotope 
uptake by polyamine-FCS mixtures on the respective cell types was
related to the timing of application of the inhibitory substance
and isotope to the cell cultures.
The ID50 for the respective cultures, (Table 3) were as 
follows;
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Plasmacytoma; 34.56 and 24.12uM respectively for spermidine 
and spermine.
Rat thymocytes; 78.55 and 57.43uM respectively for spermidine 
and spermine.
As described above (section 3.3.3) the relative sensitivities 
of cell cultures (normal and transformed) to the inhibitory effects 
Of polyamine-FCS mixtures, were assessed. It was demonstrated in 
previous results (sections 3.3.1 and 3.3.2) that the thymocytes 
were more sensitive than the plasmacytoma to the inhibitory effects 
of polyamine-FCS. The results described above have demonstrated 
that the sensitivity of cell cultures to the inhibitory effects of 
polyamine-FCS was related to the culture incubation conditions.
3,3.4: Polyamine reversibility; The effects of exposing cell
cultures to polyamine-FCS for a short period, on the uptake of 
125IÜDR by the same cell cultures without the presence of 
polyamine-FCS,
Experimental procedures;
A suspension of plasmacytoma cells was prepared as described 
previously and was divided into 3 sets. The first set contained 
39.27 uM of spermidine in 10$ FCS, the second contained 28.71 uM 
spermine in 10$ FCS, while the third group contained 10$ FCS 
without polyamines. Five replicate sterile tubes for lymphocyte 
culture (NUNC., U.K.) were prepared for each set, each tube 
containing (2x10® cells/ml) with the respective polyamines for sets 
1 and 2. The polyamine-FCS cell culture and isotope pulsing was 
similar to the procedure for the experiment which was described in
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Table 3.2.1C and as described in materials and methods, (i.e. 
4-PC.4/4 incubation sequence). All cultures were incubated for 4 
hours at 37 ®C, as described earlier. Following the incubation, the 
tubes were centrifuged for 5 minutes (1.5 x 1C? RPM), after which 
the supernate was discarded. The cell pellet in each tube was 
resuspended in 900ul of warm 10$ FCS-RPMI. Each culture received 
lOOul of 125IÜDR (luci) and all cultures were incubated for 4 
hours. Following the incubation, the uptake of isotope was 
assessed as described previously.
Results;
The respective mean cpm of cell cultures, cultured with spermidine 
or spermine, was lower than the mean cpm of 10$ FCS control 
cultures by 18.51$ and 2.75$ respectively, (Table 3.4). The 
differences between the respective means were significant in an 
Anovar; ( F.ratio = 4.574, P<.05). However the differences among 
the means were not significant as assessed by Dunnett's comparison 
of means procedure.
The results have demonstrated that the inhibitory effects of 
polyamine-FCS on cell cultures were not cytotoxic but were 
reversible and without a lasting effect either on the cell membrane 
or on the process of DNA synthesis.
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3.4. THE GROWTH KINETICS OF PLASMACYTOMA IN BALB/C MICE.
3.4.1; The growth rate of plasmacytoma in vivo in Balb/c mice: t■s
Experimental procedures:
Thirty normal Balb/c mice (around 8 weeks of age) were divided 
into 3 groups of 10 mice each. A plasmacytoma cell suspension was 
prepared as described previously in RPMI 1640 without FCS and was 
diluted into 3 different concentrations of 1 x 10^  , 5 x 10^  and 1 x 
1(f cells per ml. Each mouse received 0,1 ml of a cell suspension 
as described previously. The dose for the first group of mice was 
1 X 10^  cells/mouse. The dose for the second group was 5 x 1(f 
cells/mouse, while the dose for the third group of mice was 1 x 10® 
cells/mouse. The mice were observed daily to note tumour growth, 
and when the tumours were palpable at the earliest size (tumour 
size group 3)» the tumour size of each mouse was recorded , f
thereafter every 48 hours, until reaching the final volume (tumour 
size group 7).
Results:
The results (Figure/Table 4.1) for the growth rates of the 
respective cell implants into mice, were similar and were not 
significantly different among each other (ml and m2- P>0.5), (ml
and m3- P>0.5), and (m2 and m3- P>0.5) although the tumour doubling 
time was slightly shorter at a higher cell dose at approximately 2 
hours difference for each cell dose. Vo., and Vmax., were reached *-Ï
earlier for the relatively higher cell dose at 2 days respectively.
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FIGURE 4.1; The growth curves of plasmacytoma of different initial 
cell inocula In Balb/c mice.
A: 1 X 10®cells/mouse; B: 5 x 10®cells/mouse; C: 1 x lOtells/mouse.
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Therefore the 5 x 1(f cell dose was chosen as the standard cell dose 
for further experiments.
As described above, the relation between the growth rate of 
tumours and cell dose injected into mice was assessed. The results 
have demonstrated that the growth rate and hence the doubling time 
of the tumour was independent from the cell dose, i.e. a higher 
cell dose does not produce a tumour with a faster growth rate 
(shorter doubling time) relative to the growth rate of tumours 
which grew from smaller cell implants.
3.4.2.1: The growth rates of plasmacytoma in normal Balb/c mice
and congenitally athymic "nude" mice with Balb/c background:
Experimental procedures:
A plasmacytoma suspension was prepared as described earlier 
and adjusted to a concentration of 5 x 10 cells/ml in RPMI 1640 
without FCS, Two groups of mice (10 per group), the first, was 
normal Balb/c and the second was the congenitally athymic "nude" 
mice with Balb/c background, were injected with 0.1 ml (5 x 10^  
cells) of the plasmacytoma suspension per each mouse as described 
previously . The mice were left for a period of time, until the 
tumours were palpable at size 3.5, and thereafter the tumour size 
was recorded every 48 hours as described previously.
Results:
The growth rate which is the slope (m or KG) was slightly faster 
(36# faster) in the "nude" mice compared to control Balb/c, 
(Figure/Table 4.2.1) but the difference was not (P>0.05)
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significant. The corresponding tumour doubling time (Td) was 
higher for Balb/c than for "nude" mice by 26,7%, but similarly the 
difference was not significant (P>0.05). However, the latency 
period which was the time required for the tumour to reach a 
specified volume of (100 mm) was about twice as long for "nude" 
mice, relative to normal Balb/c mice, which was a significant 
difference, (P<.01)
As described above,(section 3.4.2.1) the kinetics of tumour 
growth in two different immunological environments (nude and normal 
mice) were assessed. The results have demonstrated that the 
latency period (the period for the tumour to reach a specified 
volume after the implantation of tumour cells into mice) was quite 
different between the two environments. The tumour took more time 
to reach the pre-set tumour volume in "nude" than in normal mice. 
However, the overall growth rate in the "nude" mice was relatively 
faster than in normal mice, but the difference was not significant.
3.4.2.2.1: The mean Birth rate and related growth kinetic parameters
of plasmacytoma growing in Balb/c mice at tumour sizes (5, 6 and 
8), and in congenitally athymic mice with Balb/c background:
Experimental procedures:
A plasmacytoma suspension was prepared and was adjusted to a 
concentration of (5 x 10® per ml). Seventy Balb/c mice and 18 
athymic "nude" were injected in the inguinal region with an 
inoculum of 5 x 10^cells per mouse as described previously. When 
the tumours reached a palpable size, tumour growth was measured as 
described previously. Three tumour sizes (tumour size, 5,6 and 8)
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were chosen for the stathmokinetic experiment, and when the tumours 
reached these sizes, each mouse was injected with 0.25ml of 
vincristine sulphate solution as described previously. Following 
the administration of vincristine, the tumours were removed, at the 
following time intervals of 0, 0.5;1;1.5;2;2.5;3,3.5; and 4 hours. 
Each time interval was duplicated, thus, for example, for tumour 
size 5, 18 tumours were used; 2 mice per each time interval. The 
tumours were processed for histological studies as has been 
described previously. The procedure for the estimation of mean 
birth rate and related kinetic parameters has been described in 
materials and methods.
Results:
The mean birth rate (KB) [unweighted regression analysis] 
dropped progressively as the tumour size increased (Table 4.2.2.1), 
with a corresponding increase in (Tea) the mean apparent cell cycle 
time. The increase in tumour volume from size 5 to 6 was 
accompanied by a reduction in the mean birth rate of approximately 
125& (0.02>P>.01), and as the tumour volume increased to size 8, the 
mean birth decreased by 15% (0.01>P>.001). Thus the change in the 
mean birth rate between tumour sizes 5-6 and 5-8 was significant, 
while the difference in the mean birth rate between tumour sizes 6 
and 8 which was 3.5%i was not significant (P>.05). The Tea at 
tumour size 6 increased by approximately 5 hours, relative to 
tumour size 5 which was an increase of approximately 13%, which was 
a significant difference ( 0.02>P>0.01). The difference in the Tea 
between tumour sizes 5 and 8 was 6.58 hours which was significant 
(P.<.01), which was an increase of approximately 18% at size 8 
relative to size 5. The increase in Tea from size 6 to size 8 was
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FIGURE 4.2.21.6: The metaphase accumulation tine for Baib/c 
plasmacytoma (tumour size 6). The bars Indicate 95% confidence 
limits of the line.
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FIGURE 4 .2 .21 ,8; The ivietaphase accumulation line for Balb/c 
plasmacytoma (tumour size 8). The bars indicate 95% confidence 
limits of the line.
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FIGURÉ 4 .2 .2 1 .6n: The metaphase accumulation line for Balb/c plasmacytoma 
(tumour size 6 ’’nude mice"). The bars indicate 95% confidence limits of the 
line.
small (1.54 hours) and was insignificant (P>.05).
The cell loss factor ([), was nearly constant at the three 
tumour sizes, with (|) at 0.55 and 0.53 for tumour size 6 and 8, and 
slightly higher at size 5 with (|) at 0.60. The difference in cell 
loss between the respective tumour sizes (5, 6 and 8) was not 
significant (P>.05), i.e. (size 5 and size 6 , t = 0.182), (size 5 
and size 8, t = 0.223), (size 6 and size 8, t = 0.051).
The metaphase duration (tm) increased with increasing tumour 
size from approximately 18 minutes at size 5, to 25.5 and 29.7 
minutes at tumour sizes 6 and 8 respectively, however, this 
increase in time was not significant (P>.05) for all comparisons; 
(tm 5 and tm 6, t = 1.319), (tm 5 and tm 8, t = 1.579), (tm 6 and 
tm 8, t = 0.583).
The mean cell birth rate at tumour size 6 in "nude" mice was 
0.0094 cells/cell/hour which was slightly higher than its 
counterpart (size 6) in normal Balb/c at 0.00070 cells/cell/hour, 
which was significant , (0.02>P>0.01). The corresponding mean Tea 
in "nude" mice was lower than its counterpart in Balb/c (tumour 
size 6) by 10.5 hours, which was a significant difference (t = 
2.908, P<.01). The cell loss in "nude" and Balb/c (tumour size 6) 
was similar to 0.55 and 0.54 respectively (t = 0.037, P>.05).
The estimates of the respective kinetic parameters (Table
4.2.2.2), were based on the weighted regression analysis. The mean 
birth rate (KB) for all three tumour sizes, including the "nude" 
mice (size 6) tumour was relatively less than that described in the 
unweighted regression analysis, (Table 4.2.2.1). The mean birth 
rate at tumour size 5 was slightly higher than the mean birth rates 
in tumour sizes 6 and 8, while the mean birth rate in tumour sizes
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6 and 8 was similar. The differences between all the respective 
mean birth rates in tumour sizes 5,6 and 8 were not significant 
(P>0.05). Similarly the difference between the mean birth rate 
between tumour size 6, growing in athymic mice, and its counterpart 
tumour size 6 in normal Balb/c mice was not significant (P>0,05),
Ialthough the mean birth rate in the tumour of "nude" mice was f
slightly higher.
For the "nude" mice, the mean birth rate of their tumours was
measured on 3 intervals of time (0.5, 1 and 1.5 hours) as only 6
mice survived the experiment. Therefore, the birth rates described 
for the tumours growing in athymic "nude" mice, (Tables 4.2,2.1 and
2.2) may probably not be a true estimate, like their counterparts 
in Balb/c mice where the mean birth rate was estimated from 9 
intervals of time, (i.e. from 0,05 hours up to 4 hours in half 
hour intervals) with a total of 18 mice surviving the experiment.
The mean apparent cell cycle time (Tea) for tumour size 6,
increased by approximately 4 hours relative to tumour size 5, which 
was not a significant difference, (t = 1.887, P>0.05). The mean
Tea for tumour size 8 increased by approximately 3 hours relative 
to tumour size 5, which was not a significant differnce (t = 1.671,
P>.05).
The Tea for tumour size 8 was about 1 hour less than that for 
tumour size 6, which was not a significant difference (t = 0.594,
P>.05). The Tea for tumour size 6 in "nude" mice was lower than
its counterpart tumour size 6 in Balb/c mice by 8.21 hours,
however, this difference was not significant (t = 1.862, P>0,05)
due to the large standard error associated with the Tea of the 
"nude" mice tumour. The metaphase durations (tm) in the respective
tumour sizes 5, 6 and 8 growing in normal Balb/c mice and tumour
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size 6 growing in athymic mice, were similar at around 30 minutes. 
The respective t-test comparisons between tm in the respective 
tumuor groups, [ sizes: (5 and 6), (5 and 8), (6 and 8) and
(tumour size 6 of Balb/c normals versus 6 "nude") , (t = 0.412,
0.740, 0.230 and 0.845 respectively, P>.05)3, were not significant.
Similarly, the cell loss was nearly the same for all tumour 
groups. The respective cell loss (t-test) comparisons between 
tumour sizes 5,6 and 8 were not significant, [i.e. ( size 5 and
size 6, t z 0.132), (sizes 5 and 8, t = 0.1) and (sizes 6 and 8, t
= 0.033)]. Similarly the comparison between tumour size 6 growing 
in "nude" mice and its counterpart tumour size 6 in normal Balb/c 
mice was not significant (t = 0.184, P>0.05).
In the weighted regerssion analysis the precent variability 
accounted for by the regression line (PVA) has slightly increased 
for Balb/c tumours 5, 6 and 8 (in all tumour zones), except for the 
"nude" mice where the PVA has decreased. The birth rates and their 
standard errors in the weighted regression analysis for tumour 
sizes 5, 6 and 8 have decreased, relative to the unweighted
regression. The Tea, has increased in the weighted regression, for 
tumours sizes 5 and 6, but not so, for size 8. The standard error 
associated with the Tea in the weighted regression was similar to 
its counterpart [unweighted regression] for tumour sizes 5 and 6, 
with a relative decrease in size 8, [ weighted versus the
unweighted regression]. In the "nude" mice, the mean birth rate, 
in the weighted regression decreased, together with its standard 
error, relative to the unweighted regression. The Tea has
increased in the weighted regression as compared to the unweighted 
regression, while the standard error has increased in the weighted 
regression relative to the unweighted regression, (Tables 4.2.2,1
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and 2.2).
The results (Tables4.3.1, 2 and 3) for the mean birth rates 
and the respective Tea and their associated standard error were as 
follows:
The mean birth rates and their standard errors [weighted 
regression] in all 3 zones (outer, middle, and inner), of tumour 
size 5, have decreased as compared to the unweighted regression. 
The mean Tea has increased accordingly in the unweighted regression 
together with a small increase in their standard errors, as 
compared to the weighted regression. Similarly, the respective 
mean birth rates in all zones of tumour size 6, and their standard 
errors [weighted regression] have decreased as compared to the 
unweighted regression, (Table 4.3.2), The respective Tea has 
increased, [weighted regression] relative to the unweighted 
regression, although the standard error were similar in both 
regression models.
The mean birth rates of tumour size 8 in the outer and middle 
zones and their associated standard errors in the weighted 
regression have decreased, relative to the unweighted regression, 
(Table 4.3.3). In the inner zone there was a slight increase in 
the mean birth rate in the weighted relative the unweighted 
regression. The mean Tea of the outer zone (weighted) was similar 
to its (unweighted) counterpart, while the Tea of the middle and 
outer zones (weighted) were approximately 1 hour different than 
their (unweighted) counterparts. The standard errors of the 
respective Tea in the weighted regression were all lower than their 
counterparts in the unweighted regression.
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TABLE 4 .3 .1  : Metaphase c o l le c t io n  fu n c tio n .
1. Unweighted and 2 . w eighted regress ion  a n a ly s is  ; B ir th  ra te s  and 
r e la te d  param eters  fo r  tumour s iz e  5 (o u te r , m iddle and in n er) zones. 
B a lb /c  m ice.
1.
O uter M iddle In ner t
I n t . 0 .002668 0 .00302 0.00168
± SB 0,000851 0 .00124 0.00157 KB : o u te r  v s . m iddle
KB 0 .007284 0 .008117 0.008714 t  = 1 .3 2 5 , P > 0 .5  NS
i SE 0 .000355 0.000516 0.000654 KB : o u te r  vs in ner
CPR 7.284 8 .117 8.714 t  = 1 .9 2 1 , P > .05 NS
Tea 4 1 .3 30 37.087 34.546 KB : m iddle vs in ner
± SE 2 .0122 2.3571 2.5919 t  = 0 .7 2 1 , P > .05 NS
PVA 89.4% 83.1% 77.9%
2.
O u ter M iddle In n e r t
I n t . 0 .003123 0 .004041 0.003090
± SE 0.000591 0 .000719 0.000858 KE' t o u te r  vs m iddle
KB 0.006984 0.007248 0.008576 t  = 0 .4 6 6 , P > .05 NS
± SE 0 .000355 0 .000431 0.000515 KB Î o u te r  vs in ner
CPR 6 .984 7 .2 4 8 7.576 t  = 0 .9 4 7 , P > .05  NS
Tea 4 3 .102 4 1 .535 39.734 KB : m iddle vs in ner
± SE 2 .1 9 0 2.4711 2.6992 t  «= 0 .4 8 0 , P > .05  NS
PVA 88.5% 84.9% 81.2%
I n t .  = in te r c e p t
KB = b i r t h r a t e  ( c e l l ' /c e l l /h o u r  ) = reg ress ion  c o e f f ic ie n t  
CPR = c e l l  p ro d u c tio n  r a t e .  C e lls /1 0 0 0  c e lls /h o u r
Tea ■ = apparen t c e l l  c yc le  tim e (hours)
PVA = p e rc e n t v a r i a b i l i t y  accounted fo r  by reg ress io n  l in e
t  = t - t e s t  comparison
TABLE 4 .3 .2  ; Metaphase c o lle c t io n  fu n c tio n .
1. Unweighted and 2 . weighted reg ress ion  a n a ly s is  : B ir th  ra te s  and 
re la te d  param eters fo r  tumour s iz e  6 (o u te r , m iddle and in n e r) zones. 
B alb /c  m ice.
1.
O uter M idd le In ner t
I n t . 0 .00297 0.003074 0.00301
±  SE 0.00108 0.000997 0.00110 KB O ut. v s  KB M id .
KB 0.006363 0.007341 . 0 .007548 t  = 1 .5 8 6 , P > .05  NS
± SE 0 .000453 0.000410 0.00046 KB O u t. v s  KB In n .
CPR 6 .363 7.341 7.548 t  = 1 .8 3 5 , P > .05 NS
Tea 47.307 41.008 39.881 KB M id . VS KB In n .
±  SE 3.3664 2.3363 2.4326 t  = 0 .3 3 3 , P > ,05  NS
PVA 79.7% 86.0% 84.3%
2.
Outer M iddle In n e r t
In t . 0 .002914 0 .003536 0.003606
± SE 0.00074 0.000597 0.000653 KB O u t. vs KB M id.
KB 0,006281 0.006703 0.006915 t  = 0 .7 7 0 , P > .05  NS
± SE 0.000426 0.000344 0.000376 KB O u t. vs KB In n .
CPR 6.281 6 .703 6.915 t  = 1 .1 1 6 , P > .05  NS
Tea 47.926 44.912 43.530 KB H id . vs KB In n .
± SE 3.2497 2 .3037 2.3650 t  = 0 .4 1 6 , P > .05  NS
PVA 81.2% 88’. 3% 87.1%
I n t .  = in te rc e p t
KB = b ir t h r a t e  (c e l ls /te l l /h o u r )  = reg re s s io n  c o e f f ic ie n t
CPR ' = c e l l  p rod uction  r a t e .  C e lls /1003  c e l ls /h o u r
Tea = apparent c e l l  cyc le  tim e (hours)
PVA = p e rce n t v a r i a b i l i t y  accounted fo r  by reg re s s io n  l in e
TABLE 4 .3 .3 :  Metaphase c o lle c t io n  fu n c tio n .
1. Unweighted and 2. w eighted reg ress io n  a n a ly s is  B ir th  ra te s  and 
re la te d  param eters fo r  tumour s iz e  0 (o u te r , m iddle and in n er) zones. 
B alb /c  m ice.
1.
O uter M idd le In n e r t
In t . 0 .003447 0.003206 0.00352
± SE 0.000638 0 .000904 0 .00112 KB O u t. vs KB H id .
KB 0 .006613 0.007380  ^ 0 .006515 t  = 0 .2 8 5 , P > .05  NS
± SE 0 .000266 0 .000377 0.000468 KB O u t. vs KB In n .
CPR 6 .613 7 .3 8 0 6 .515 t  = 0 .0 3 6 , P > .05  NS
Tea 45.523 4 0 .7 88 46.206 KB M id . vs KB In n .
± SE 1.8316 2 .0832 3.3209 t  = 1 .4 3 9 , P > .0 5  NS
PVA 94.5% 91.4% 84.3%
2.
O uter M id d le In ner t
In t . 0 .003255 0.004062 0.003306
± SE 0.000254 0 .000355 0.000455 KB O ut. vs KB M id .
KB 0.006572 0.007114 0.006697 t  = 1 .8 4 4 , P > .05  NS
i  SE 0.000171 0.000239 0 .000307 KB Out. vs KB In n .
CPR 6 .5 7 2 7.114 6.697 t  = 0 .3 5 5 , P > .0 5  NS
Tea 45.803 42.313 44.948 KB M id . vs KB In n .
± SE 1.1919 1.4237 2.0614 t  = 1 .0 7 1 , P > .0 5  NS
PVA 97.6% 96.1% 92.9%
I n t .  = in te r c e p t
KB = b i r t h r a t e  (c e lls /z e ll /h o u r )  = reg re s s io n  c o e f f ic ie n t
CPR = c e l l  p ro d u c tio n  r a t e .  C e lls /1 0 0 0  c e l ls /h o u r
Tea = apparen t c e l l  c yc le  tim e (hours)
PVA = p e rce n t v a r i a b i l i t y  accounted fo r  by reg re s s io n  l in e
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FIGURE 4.3.1.1; The metaphase accumulation line for the outer zone 
of Balb/c plasmacytoma (tumour size 5). The bars Indicate 957» 
confidence limits of the line.
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FIGURE 4.3.1.1: The metaphase accumulation line for the middle zone 
of Balb/c plasmacytoma (tumour size 5). The bars indicate 95% confidence 
limits of the line.
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FIGURE 4.3.1.I: The metaphase accumulation line for the inner zone 
of Balb/c plasmacytoma (tumour size 5). The bars indicate 95% confidence 
limits of the line.
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FIGURE 4.3.2.1 : The metaphdse accumulation line for the outer zone of 
plasmacytoma (tumour size 6). The bars indicate 95% confidence 
limits of the line.
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FIGURE 4.12.1: The metaphase accumulation line forthe middle zone of 
plasmacytoma (tumour size 6). The bars Indicate 95% confidence 
limits of the line
0J025-
oÇ
CDO ao 15-
000 5-
o-
TIME AFTER V INCRISTINE INJ.(HOURS)
FIGURE4.3.2I; The metaphase accumulation line for the inner zone of 
pJasmacytomaftumcur size 6). The bars indicate 95% confidence 
limits of the line.
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FIGURE 4.3.3.1:The metaphase accumulation line for the outer zone of 
plasmacytoma {tumour size 8) . The bars indicate 95% confidence limits 
of the line.
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FIGURE 4.3.3.1: The metaphase accumulation line for the middle zone of 
plasmacytoma (tumour size 8). I he bars indicate 95% confidence limits 
of the line.
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FIGURE 4.3.3.1: The metaphase accumulation line forthe Inner zone of 
plasmacytoma (tumour size 8). The bars indicate 95% confidence limits 
of the line.
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The mean birth rates in all three zones of tumour size 6 
growing in "nude" mice and their associate standard errors, in the 
weighted regression were lower than their unweighted counterparts 
(Table 4.3.4). Accordingly, the respective mean Tea in the 
weighted were higher than their unweighted counterparts. However, 
the standard error for the respective Tea in the weighted 
regression were all relatively higher than their unweighted 
counterparts.
The mean birth rates in the inner and middle zones 
[unweighted] were slightly higher than the outer zone (Table 
4.3.1), although the difference between the three zones was not 
significant (P>.05). Similarly the mean Tea decreased from the
periphery to the centre of tumour by approximately 7 hours, 
although the respective differences in Tea for each of the two 
tumour zones was not significant (P.>05) except for one comparison,
i.e. tumour size 5 (outer and middle zones, t = 1.375), (outer and 
inner zones, t = 2.072, 0.05>P>.02), (middle and inner zones, t =
0.727). In the weighted regression, again, there was a slight 
increase in the mean birth rate from the periphery to the centre of 
the tumour which was not significant (P>.05), together with an 
associated decrease in Tea from the periphery to the centre by 
approximately 3 hours, which was also not significant (P>.05),i.e 
(outer and middle zones, t = 0.475), (outer and inner zones, t =
0.973) and middle and inner zones, t = 0.493).
The mean birth rates in the unweighted regression in the inner 
and middle zones of tumour size 6 were slightly higher than the 
outer zone, (Table 4.3.2), although the differences between the 
respective zones were not significant. Similarly, the mean Tea 
decreased from the periphery to the centre of the tumour by 7
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TABLE 4 .3 ,4  : Metaphase c o lle c t io n  fu n c tio n .
1. Unweighted and 2 . w eighted reg ress ion  a n a ly s is  ; B ir th  ra te s  and 
re la te d  param eters fo r  tumour s ize  6 (o u te r , middle and in n er) zones, nude mice w ith  B a lb /c  background.
I.
O uter M iddle In ner t
In t . 0.003158 0 .00366 0.00453 KB:Out. vs M id.
± SE 0.000866 0.00194 0.00214 t  = 0 .1 :4 ,  P > .05 NS
KB 0.008679 0.00995 0.00963 KB; Out. vs In n .
± SE 0.000802 0 .00180 0.00198 t  = 0 .4 4 5 , P > .05  NS
CPR 8.679 9 .9 5 9 .63 KB: M id . VS In n .
Tea 34.681 30.251 31.256 t  =• 0 .1 1 9 , P > .05  NS
± SE 3.204 5.472 6 .426
PVA 87.2% 63.5% 57.0%
2.
Outer M iddle In ner t
In t . 0.003763 0.00519 0.00594 KB : O ut. vs Mid.
±  SE 0.000631 0 .00139 0.00138 t  =» 0 .1 2 5 , P > .05  NS
KB 0.008002 0.00824 0.00805 KB : O ut. vs In n .
± SB 0.000783 0 .00172 0.00171 t  => 0 .0 2 5 , P > .05  NS
CPR 8 .0 0 2 8 .24 8 .0 5 KB ; M idd. VS In n .
Tea 37.620 36.550 37.392 t  = 0 .0 7 8 , P > .05 NS
± SE 3.679 7.636 7.9314
PVA 85.9% 56.3% 55.5%
I n t .  = in te rc e p t
KB = b i r th r a te  (c e l ls / :e l l /h o u r )  = reg ress ion  c o e f f ic ie n t
CPR = c e l l  p rod uction  r a t e .  C e lls /1 0 0 0  c e lls /h o u r
Tea = apparent c e l l  c yc le  time (hours)
PVA = p ercen t v a r i a b i l i t y  accounted fo r  by reg ress io n  l in e
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FIGURE 4.3.4.1 : The metaphase accumulation line for the outer zone of 
plasmacytoma (tumour size 6 "nude mice"). The bars indicate 95% 
confidence limits of the line.
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FIGURE 4.3.4.1 ; The metaphase accumulation line for the middle zone 
of plasmacytoma (tumour size 6 "nude mice"). The bars indicate 95% 
confidence limits of the line.
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F iCURE 4 .3 ,4 .1  : The metaphase accum ulation lin e  for the  in n e r  zone 
of plasmacytoma (tum our size 6 "nude m ice"). The bars indicate 95% 
confidence lim its of th e  lin e .
hours, although the differences between the respective mean Tea for 
each zone were not significant (P>,05), i.e. (outer and middle 
zones, t = 1.540), (outer and inner zones, t = 1.792) and (middle 
and inner zones, t = 0.758).
In the weighted regression the mean birth rate was nearly 
similar in the 3 zones (P>.05). The Tea is sensitive to a change 
in the regression coefficient (KB) and the slightest change in KB 
can lead to a magnified difference in Tea. Thus the difference 
between (KB : outer and inner zones) is 0.000634 units which has
accounted for about 4 hours difference in Tea between these 2 
zones. The mean Tea has decreased from the periphery to the tumour 
centre, but the respective differences between each zone were not 
significant (P>.05). (outer and middle zones, t = 0.758), (outer
and inner zones, t = 1.095), ( outer and inner zones, t = 0.419).
The mean birth rate [unweighted regression] in the zones of 
tumour size 8 fluctuated slightly, (Table 4.3.3) with the outer and 
inner zones being similar in KB and both were slightly less than 
the middle zone, although these differences were not significant 
(P>.05). Thus the mean Tea in the inner zone was approximately one 
hour more than the outer zone, and the middle zone was 
approximately 5 hours different than either adjacent zone. 
However, these differences were not significant (P>0.05), (outer 
and inner zones, t = 1.717), (outer and inner zones, t = 0.179),
(middle and inner zones, t = 1.384). Similarly, the same was true 
in the weighted regression for KB as in the unweighted regression, 
where the differences between the respective zones were not 
significant, (P>.05). Also, the difference between the respective 
mean Tea for each zone was not significant (P>.05),(outer and 
middle, t = 1.887), (outer and inner zones, t = 0.362) and (middle
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an inner zones, t = 1.04).
The mean birth rates in the middle and inner zones [unweighted 
regression] of tumour size 6 growing in ’'nude" mice were relatively 
higher than the outer zone, whereas in the weighted regression they 
were almost similar, (Table 4.3.4). The differences in the mean 
birth rates between the respective zones [unweighted and weighted 
regressions] were not significant (P>.05).
The mean Tea in the unweighted regression outer zone was 
relatively higher than either the middle or inner zones by 
approximately 4 to 3 hours respectively; however, the difference in 
Tea between the respective zones was not significant (P>.05), 
(outer and middle zones, t = 0.699), (outer and inner zones, t = 
0.478), and (middle and inner zones, t = 0.118).
The mean Tea in the weighted regression was essentially the 
same for all 3 zones, except for the middle zone which was 
approximately 1 hour shorter than either adjacent zone. The 
respective differences in Tea between the respective zones were not 
significant (P>.05), (outer and middle zones, t = 0.126), (outer
and inner zones, t = 0.029) and (middle and inner zones, t =
0.076).
As described above, (section 3.4.2.2) the kinetics of tumour 
growth were assessed in normal and "nude" mice. Tumour growth was 
assessed in terms of cell production rate, apparent cell cycle time 
and cell loss factor at various stages of tumour growth.
The results have demonstrated that the birth rate has 
decreased as the tumour grew larger (a function of tumour size or 
age). Consequent with this reduction in the birth rate, the 
apparent cell cycle time has increased. The cell loss factor was
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generally similar at the various stages of tumour growth.
The birth rate in the "nude" mice was relatively higher than 
its counterpart in normal mice, although the cell loss factor was 
similar in both groups.
The respective birth rates and apparent cell cycle times were 
examined in terms of a weighted and unweighted regression analyses, 
to assess the contribution of the weighted analysis (as compared to 
the unweighted analysis), to the reduction of the standard error 
associated with the respective apparent cell cycle time. The 
results have demonstrated that the use of the weighted analysis 
variant was useful in reducing the standard errors in some curves,
and was not a general effect.
The respective birth rates were also assessed in terms of
tumour zones, to know whether the birth rate varied between the
tumour's periphery and centre. Tumour centres are usually more 
necrotic than peripheral areas which have a relatively better 
supply of blood than central areas. The results have demonstrated 
that the birth rate did not decrease as a function of tumour zone, 
from the peripheral areas to the central areas. In the 
plasmacytoma tumour, reported in this work, the distribution of 
necrosis was similar among the respective tumour zones.
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TOBLE 4 .3 .5 Î  The percentage o f  c e l ls  in  normal B a lb /c  mice tumours 
s ize  5 , 6 and 8 in  t h e i r  re s p e c tiv e  zones (o u te r , m iddle and in n e r ) .
% c e l ls p e r zone
Tumour S ize O uter M iddle In n e r Tumour Mean
5 72.87 76.78 7 6 .20 75.32
6 77.13 7 6 .50 75.72 76.45
8 76.78 77.59 75.26 76.54
Zone Mean 7 5 .6 2 7 6 .9 6 75.72
A n a ly s is  o f  v a rian ce  o f  T ab le  4 .3 .5
S tratum DF SS MS F P
Environm ent 2 150.3 75.1 0 .246 > .0 5 , NS
Zone 2 178 .6 8 9 .3 0 .293 > .0 5 , NS
E n v ir . Zone 4 4 83 .0 120 .7 0 .396 > .0 5 , NS
R es id u a l 477 145557.7 305 .2
TOTAL 485 146369.5
NS = n o t s ig n i f ic 2u it 
S = s ig n i f ic a n t
CHAPTER FOUR
DISCUSSION
In vitro systems are often used to assess the effects of 
regulators of cellular proliferation. It is necessary to evaluate the 
culture conditions when using these types of assays as many factors 
can affect cellular proliferation. The effects of culture environment 
have been investigated using a murine plasmacytoma (MPC-11). Most 
cultured cells show an absolute dependence on serum for growth (Holley 
1974) (Lanks and Kasambalides 1980), as apart from the basal nutrient 
mixture of salts, sugars, aminoaoids and vitamins, which are required 
by the cultures, serum is essential for cell survival as it contains 
hormones, nutritional factors and stromal elements, and proteins, 
(Barnes and Sato 1980). Essentially, the serum can provide a complex 
of hormones that are growth stimulatory for a given cell type (Mather 
1984), as Hyashi and Sato (1976) have shown in the pituitary cell 
line, which was grown in serum-free medium supplemented with hormones, 
growth factors and transferrrin. A variety of sera have been used as 
supplements for in vitro cultures, the most popular of which is FCS 
(foetal calf serura). However, when FCS is used in conjunction with 
assays to assess cellular DNA synthesis , using labelled precursors 
such as 3H-Tdr or 125IUDR, FCS can influence DNA synthesis.
When plasmacytoma cultures were cultured at various cell 
concentrations per well, there was a good relationship between cell 
dose and uptake of 125IUDR, (Figures/Tables 1.1.1 and 1.1.2) and there 
was a higher uptake of isotope by cell cultures cultured without FCS 
than with active or heat decomplemented FCS (FCS-HI heat inactivated). 
The inhibition of isotope uptake by active FCS was more than that
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produced by FCS-HI (Table 1.6.2), and this may correspond to the 
inactivation of the complement proteins (Goetze and Muller-Eberhard
1976) which may bind to antigen-antibody complexes, activating the 
classical pathway, or without the requirement for antibody (except 
IgA) to activate the alternate pathway and thus perturbing or damaging 
the cell's membrane (Brown and Frank 1981), (Weiler et al., 1982). 
Kierszenbaum and Budzko (1977) have described the cytotoxic effects of 
normal sera (human, rabbit and guinea pig) on lymphoid cells which 
were antibody independent, as they were affected through the alternate 
pathway. Thus both C4-deficient guinea-pig serum and C2 deficient 
human serum displayed cytotoxicity on target cells. Sera from all 
three types were active in the absence of free Ca^which was required 
to activate complement via the classical pathway , although when the 
sera were heated for 20 minutes at 56 t) to destroy the activity of 
factor B of the alternate pathway the cytotoxic activity was lost. 
Eidinger et al., (1977) have shown that human serum induces cytolysis 
of mouse thymus and thymoma cells and cytostasis of bone marrow and 
spleen cells. Decomplementation procedures have demonstrated that the 
heterocytotoxic effects were mediated in part by the alternate pathway 
of complement. Similarly, the activation of the alternate pathway in 
FCS by mouse thymocytes were reported by Eisenberg et al., (1979). 
The activation of the alternate pathway by human lymphoblastoid B and 
T cell lines has also been demonstrated by Praz and Lesavre (1983). 
The inhibition of 125IÜDR uptake was maintained, even when the cell 
cultures were pre-incubated for various lengths of time before the 
addition of 125IUDR , (Figure/Table 1.7). Furthermore, the inhibition 
of isotope uptake by FCS was dose dependant, when the FCS 
concentration was increased, the uptake of isotope decreased, (Tables
1.2.1 and 1.2.2.1 A, Figure 1.2.2.1).
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The uptake of 125IUDR by DNA was assessed in two ways; First, was 
the estimation of isotope uptake in DNA extracted from plasmacytoma 
cultures, cultured in several FCS-HI concentrations, and the second, 
was through the specific inhibition of 125IÜDR uptake by hydroxyurea.
The amount of isotope incorporated into DNA decreased with increasing 
serura concentration, and this was corroborated when the acid insoluble 
and acid soluble fractions were extracted and assessed for isotope 
uptake as described in Figure/Table 1.5.1.1. The effects of FCS on 
the amount of isotope incorporated by cell cultures is discussed in 
the lipoprotein section.
Hydroxyurea is a phase specific cytotoxic substance, specifically 
inhibiting the uptake of isotope by cell cultures in S phase, (Young 
and Hodas 1964), (Young et al., 1967), (Krakoff et al., 1968) (Iversen 
et al., 1982), (Shu and Hoshino 1983) (Dormer and Bohmer 1984). The 
uptake of 125IÜDR was effectively blocked (>90# uptake) by hydroxyurea
„  3  " Iat doses between 10 and 10 moles as described in Figure/Table 1.5.1.2.
This was similar to the results of Riches et al., (1976) using CBA 
mammary adenocarcinoma in a 4-hour culture with hydroxyurea. Gerald 
and Neumuller (1983) using Hela S3 cells have shown that 3H-Tdr 
incorporation into DNA was inhibited ( 90#) by 2.5 x 10 moles in a 
3-hour incubation period. Larson and Yachnin (1983) have shown that 
1m.mole of hydroxyurea was required to abolish the 14C-thymidine 
uptake by chronic leukemic cells cultured with cytochalasin B.
Peiffer and Tolmach (1967) using Hela cell cultures, have shown that 
the uptake of isotope was inhibited by hydroxyurea with a
•• 4  "3  .concentration between 2 x 10 moles and 10 moles, with similar 
estimates by Young et al., (1967) of 1 x 10 moles to 10^ moles, and
Young and Hodas (1964) of lO^moles to lO^ raoles. Similarly, Sinclair ;!
(1965) has shown that the uptake of 3H-Tdr by Chinese hamster lung
- 4  “ 3cells was blocked by hydroxyurea at a concentration of 5 x 10 to 10
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moles after a 1-hour culture period.
lododeoxyuridine an analogue of thymidine (Pursoff 1959), has 
been shown to be utilised as an isotope, exclusively into DNA of 
proliferating cells (Hofer and Hofer 1971, Kelly et al., 1981), and is 
an adequate and stable tracer for studying DNA metabolism and cellular 
kinetics (Commerford 1965). The réutilisation of 125IÜDR is very low 
compared to 3H-Tdr where réutilisation is greater after release from 
dead cells (Hughes et al., 1964, Dethlefsen 1970, 1971, 1974, Hofer
and Hofer 1971). 125IUDR has been used extensively for measurements 
on cell proliferation (Bonnmassar et al., 1975), (Riches et al., 1981) 
and cell loss in vitro (Dethlefsen 1971, Dethlefsen and Riley 1973, 
Dethlefsen et al., 1977, Begg 1977, Franko and Kallman 1980, Kelly et 
al., 1981, Porschen et al., 1983); as a cellular label to monitor cell 
distribution in various organs (Hofer et al., Joel et al., 1977, 
Ottaway et al., 1983, Spach and Motta 1983, ); as a cellular label to 
assess DNA synthesis in vivo (Siegers et al., 1979, Rijke et al.,
1981) and in vitro (Riches et al., 1976, Bonmassar et al., 1978, 
Mistry et al., 1983, Buchanan 1984, Nelson et al., 1984), and for 
cytotoxicity assays (Oldham et al., 1973, le Mevel et al., 1973, Ting 
et al., 1977, Evans and Eidlen 1983). However, 125IUDR is chemically 
toxic (Cheong et al., .1960, Morris and Cramer 1966, le Mevel et al., 
1973, and radiotoxic (Mak and Till 1963, Hofer and Hughes 1971, 
Porteus 1971, le Mevel et al., 1973, Burki et al., 1973), thus it is 
important to use low doses of this isotope in experimental assays. 
Cheong et al., (I960) have shown that there was an inhibition of 
growth in in vitro cell cultures of H.E.P. cells at a concentration 
of 1-5 ug/ml of lUDR ( 30# inhibition at 5ug/ml). Morris and Cramer
(1966) showed that 1-2x10* moles lUDR inhibited cell proliferation 
after one cell division. Cold lUDR at a concentration of 1.41x10 
moles incubated with MCA-10 cells for 18 hours; inhibited the division
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of cells up to 91 hours after the incubation with cold lUDR (le Mevel 
et al., 1973).
le Mevel et al., (1973) using 0.5 uci per lOOul per culture well 
(stock solution 50 uci/ml containing 0.005 mg/ml lUDR) have shown that 
the uptake of 125IUDR was linear with time between 6 to 18 hours, and 
thereafter declines up to 72 hours, and have also shown that as the 
concentration of isotope increased (5uci per 100 ul per culture well), 
the 125IUDR toxicity for the cell cultures increased, le Mevel et 
al., (1973) have shown that the MCA5 and MCA10 cell lines (explants 
from 3- methylcholanthrene induced sarcomas) appeared to be more 
damaged by isotope (0.5uci/well) than the MCA-2 cell line and the 
normal cell lines (normal muscle C57BL/6 and C3H/F mouse cell lines), 
between 30-48 hours incubation period.
Riches et al., (1976) have used 1 uci of 125IUDR (sp.act 1-6
mci/mg) per 3ml culture medium which was equivalent to a maximum of
- 60.333ug per ml of lUDR (a,1x10 moles), for a 24 hour culture period,
and was shown to be not cytotoxic for CBA mammary adenocarcinoma
explants. In the experiments reported in this thesis, the 125IUDR
used ( 500uci per 0.5ml;sp.act. 5ci/mg.) was at a concentration of
0.2 uci per 200ul culture medium per well which was equivalent to 2 x 
- 4 “ 1010ug/ml or 5.64 x 10 moles, which was unlikely to be cytotoxic for a 4 
hour or a 16 hour incubation period. Porteus (1971), using 125IUDR of 
similar specific activity to that of Riches et al., ( 1976) has found 
no effect on the growth of BP8 cells cultured for 17 hours with 0.03 
uci/ml, but with 0.1 to 1uci/ml, there was some reduction in growth.
Plasmacytoma cultures were also incubated with 3H-Tdr, to assess 
DNA synthesis in relation to serum effects, (Figure/Table 1.3). There 
was a similar inhibition of 3H-Tdr uptake by the cell cultures with 
increasing serum concentration. There are pitfalls in 3H-Tdr, used as
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an isotope to measure cell proliferation (Laurence et al., 1979), and 
these have been reviewed by Maurer (1981). 3H-Tdr affected clonal 
growth of Hela S3 at a concentration of 0.1uci/ml 
(sp.actj1.88ci/mmole), (Drew and Painter 1959), while Weizsacker et 
al., (1981) using a similar specific activity reported an inhibition 
of 9L rat gliosarcoma cell growth at a concentration of
0.2uci— 10uci/ml 3HTdr. 3H-Tdr also affected the progression of cells 
through the cell cycle (Ehmann et al., 1975, Marz et al., 1976, 
Darzynkiewicz et al., 1984). However, 3H-Tdr is more efficiently 
utilised by Thymidine kinase, [ ATP; thymidine-5'-phosphotransferase 
E.G.2.7.1.2.1], (Cleaver 1967, Baugnet-Mahieu and Goutier 1968, Webb 
et al,, 1980), this is because more thymidine di-phosphates and 
tri-phosphates are formed with thymidine (3H-Tdr) than with 
lododeoxyuridine (125IUDR), (Baugnet-Mahieu and Goutier 1968). The 
fact that IÜDR is much less phosphorylated to the tri-phosphate stage 
than thymidine, decreases the probability of its réutilisation, and 
justifies the use of 125IUDR as a suitable marker, (Baugnet-Mahieu and 
Goutier 1968).
The inhibitory effects of FCS on isotope uptake by cell cultures 
were selective, as FCS interacted differently with each cell type, in 
terms of FCS concentration and the period of incubation. Thus for 
plasmacytoma cultures (Tables 1.2.2.1 A and IB) at all concentrations 
of FCS, there was inhibition of isotope uptake, although the relative 
amount of isotope uptake inhibition was decreasing at later periods of 
incubation.
For the mammary adenocarcinoma cultures as described in 
Figure/Table 1.2.2.2 there was a stimulation of isotope uptake rather 
than inhibition, at some serum concentrations and incubation periods, 
although the relative amount of isotope uptake inhibition was
- 254 -
increasing at later periods of intubation.
For the normal thymocytes, as described in Figure/Table 1.2.2,3, 
the effects of FCS were opposite, that is, at 5-10# FCS there was a 
stimulation of isotope uptake at any incubation period, while at 
15-25# FCS there was an inhibition of isotope uptake, which was fairly 
constant at 15#, while at 25# the inhibitory effects decreased as the 
incubation period increased. One common feature among all these 
cultures was an increasing inhibitory effect on isotope uptake as the 
FCS concentration increased in each incubation period.
However, FCS may also be inhibitory to normal thymocytes at a 
concentration of 10#, in fact, more inhibition of isotope uptake was 
produced on thymocytes than on plasmacytoma cultures with a certain 
batch of FCS as described in Tables 1.6.1.1 and 1.6.1.3. The effects 
of FCS on the uptake of isotope by cell cultures were variable, as 
different batches of FCS produced different inhibitory effects as 
described in Table 1.4. Honn et al., (1975) have shown that different 
batches of FCS were variable as to their contents of ions, |
cholesterol, hormones, proteins and albumin. In some batches, the 
variability was quite large. Bovine serum albumin and human serum 
albumin were equally inhibitory on isotope uptake by plasmacytoma | 
cultures, as described in Tables 1.8.2.A and B. Rat, mouse, horse and 
human sera were equally inhibitory on isotope uptake even when they 
were heat inactivated, as described in Tables 1.8.1 and I.8.2.B.
The inhibitory effects of FCS on isotope uptake by cell cultures 
were not due to a non-specific effect of isotope activity remaining in 
the wells as a function of serum concentration as described in Table 
1.9; i.e.; as the serum concentration in the cell cultures increased, 
the amount of isotope remaining in the cell culture wells decreased.
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The interaction of BSA with plasmacytoma cultures at two 
different cell culture densities was similar, that is, (there was not 
an increase in isotope uptake inhibition at high compared to low cell 
densities, (Table 1.6.1.2). FCS interacted differently with normal 
thymocytes (Table 1.6.1.3) producing a small increase in isotope 
uptake inhibition at a higher cell density, and in the plasmacytoma 
cultures (Table 1.6.1.1), the inhibition was higher at a higher cell 
density, although these inhibitory effects in the case of plasmacytoma 
varied with the FCS batch and incubation period, but as described in 
Table 1.6.2 there was a marked inhibition of isotope uptake at a high 
cell density in the presence of FCS, than without FCS, in an extended 
incubation period. The plasmacytoma were probably able to sustain 
their proliferation for an extended period of incubation without the 
requirement for serum, as tumour cells have been known to produce 
their own peptide growth factors, (Sporn and Roberts 1985). The 
labelling index of plasmacytoma cells cultured in FCS as described in 
Table 2.5 was slightly reduced, although not significantly as compared 
to cultures without FCS. Thus FCS had no significant inhibitory 
effect on cells in S-phase, or on the passage of cells from Gi to S. 
However, some constituents of serum such as lipoproteins, may block 
the flow of cells from Gito S-phase, but this was not evident in the 
incubation sequence described in Figure/Table 1.7, although there was 
a decrease in uptake of isotope by cell cultures in some incubation 
sequences with different batches of FCS as described in Figure/Table 
2.7 and Figures/Tables 3.1.3A and 3B. This may be due to the effects 
of lipoproteins or the interaction of polyamine oxidase with 
polyamines as will be described below.
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FCS contains polyamine oxidase, an enzyme which converts spermine 
and spermidine into their respective aldehydes, which can interfere 
with DNA synthesis, (Bachrach and Reches 1966, Higgins et al., 1969, 
Allen et al., 1979, Gaugas 1980, Tabor and Tabor 1984). The 
intracellular concentration of polyamines are generally highest in 
rapidly growing cells (Raina et al., 1980; Scalabrino and Ferioli
1982), and lowest in non-growing or quiescent cells (Heby and 
Andersson 1980). Spermidine may be released from cells when their 
growth is restricted by high density culture, or by inhibitors, or 
lack of growth factors, (Melvin and Kier 1980, Wallace and Keir I98I, 
Pegg and McCann 1982), and released from dead or dying cells, 
(Andersson and Heby 1980, Heby et al., 1980). Polyamine oxidase 
availability in mice sera, (Barford 1980) in horse and human sera 
(Barford 198O, Gaugas I98O, Allen et al., 1979) have been reported to 
be minimal and thus not eliciting the strong reaction produced by FCS 
on polyamines. However Higgins et al., ( 1969) have reported that 
horse serum contained more polyamine oxidase than FCS.
The interaction of polyamines (spermine and spermidine) with 
foetal calf serum in in vitro cultures and their effects on the 
inhibition of labelled precursor uptake in DNA synthesis have been 
shown by Byrd et al., ( 1977), Allen et al., (1997-1979), Gaugas
(1980), and on the the inhibition of cellular growth (Higgins et al., 
1969), (Katsuta et al., 1975) and (Maurer and Maschler 1979). Enzymic 
degradation of polyamines are required in order to elicit the 
suppression of normal and tumour cell proliferation, (Bachrach et al., 
1967), (Higgins et al., 1969), and (Bachrach 1970). Polyamine oxidase 
(E.C.1.4.3.4.) oxidatively deaminates both ends of spermine but only 
the aminopropyl end of spermidine to produce the aminodialdehyde and 
arainomonoaldehyde respectively, (Tabor et al., 1964), (Bachrach and 
Reches 1969), (Morgan I98O), (Gaugas 1980), (Seiler et al., 1981), and
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as shown by Allen et al., (1979) that the inhibitory effects of 
polyamines were dependent upon the presence of either polyamine 
oxidase or FCS. The results in Tables 3.1.1 A to 3.1.4B, and Tables
3.2.1 A to 3.2.3c confirm and extend the results shown by Byrd et al.,
( 1977), Allen et al., (1977-1979), Maurer and Maschler (1979) and ■!=
Smith et al., (1983) on the inhibitory effects of polyamines in in 
vitro cultures on a variety of cell types.
The interaction of spermine or spermidine with FCS did inhibit 
the uptake of 125IÜDR by cell cultures of plasmacytoma, mammary 
adenocarcinoma and normal non lectin-stimulated thymocytes from mice 
and rats. The amount of isotope uptake inhibition by cell cultures, 
has markedly increased, as the pre-incubation period of polyaraine-FCS 
has increased as described in Figure/Table 3.1.3A and 3B, which was a 
similar observation to that described by Bachrach and Reches (I966).
The inhibition produced by the reaction of spermine with FCS was 
stronger than that produced by spermidine with FCS, as the dose of 
polyamine required to produce the ID50 (50# inhibition) of isotope 
uptake by the respective cell cultures was smaller for spermine than 
spermidine as described in Table 3. The ID50 for spermidine on 
plasmacytoma and adenocarcinome (0/4 incubation sequence, table 3 
section 3.1) was similar at around l6uM, whereas for spermine, the 
adenocarcinoma was about 3 times more sensitive to its inhibitory 
effects, than plasmacytoma.
The thymocytes were more sensitive to the inhibitory effects of 
oxidised polyamine than the plasmacytoma or mammary adenocarcinoma 
described in Table 3, and this contrasts with the results of Allen et 
al., (1979) who have shown that the ID50, (spermine or spermidine) was 
higher for untreated normal rat thymocytes than for the leukemia and 
lymphoma cell lines. However, in only one experiment, described in
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Figure/Table 3-3.1 A and 1B, the thymocytes were more resistant than
plasmacytoma to the inhibitory effects of oxidised polyamine as
described in Table 3, section 3-3; thus the inhibition, depended on
the culture incubation sequence. Rijke and Ballieux (1978) have shown
that in invitro cultures of mouse thymocytes which were in spontaneous
DNA synthesis were insensitive to the inhibitory effects of oxidised
spermine or spermidine, with a similar finding by Allen et al., (1979)
on rat thymocytes. The results described in Figures/Tables 3-1-1A to 
3-3-IB show that mouse or rat thymocytes which were in spontaneous DNA
synnthesis were sensitive to the inhibitory effects of oxidised
spermine and spermidine.
However, Rijke and Ballieux (1978) and Allen et al,, (1979) have 
shown that mitogen-stimulated lymphocytes and lymphoma cells in 
synchronous cultures (Allen et al., 1979), were inhibited by oxidised 
polyamines, thus implicating the ihibitory effects of oxidised 
polyamines on late Gi phase or possibly at Gi/S interphase (Allen et 
al., 1979); which is closely related to polyamine biosynthesis, as the 
cellular levels of putrescine, spermidine and spermine progressively 
increase, as the cells traverse the cell cycle from G to mitosis, 
(Heby and Adersson 1980), (Boynton et al., 1980), (Heby 1981), (Pegg 
ad McCann 1982). Oxidised spermine has been shown by Bachrach et al,,
(1967) to inhibit protein and DNA synthesis, and to inhibit the growth 
of Ehrlich ascites after exposing the cells to oxidised spermine in 
invitro cultures. Oxidised polyamines (spermine and spermidine) can 
be converted into acrolein (Alarcon 1964-70), (Kimes and Morris 
1971a), (Seiler et al., 1981), Kimes and Morris (1971b) have 
implicated oxidised polyamine and acrolein for the inhibition of 
nucleic acid and protein synthesis in E.coli.
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However, the effects of the mono- and dialdelydes produced by the 
oxidation of spermidine and spermine were not cytotoxic as described 
in Table 3.5, and the inhibition of 125IUDR uptake was reversible, 
(Tables 3.4). Similarly, Byrd et al., (1977) and Allen et al., (1979) 
have shown that the effects of oxidised polyamines on their cell 
cultures were reversible and not cytotoxic.
Hussain et al., (1983) have shown that acrolein inhibited DNA 
synthesis and was cytotoxic for a 72-hour lectin stimulated rat 
thymocyte cultures, whilst oxidised spermine was not cytotoxic, yet 
inhibited 3H-Tdr incorporation at a much lower dose than acrolein. 
Preincubating the cultures with concentrations of acrolein in excess 
of 8uM for 3 hours prior to PHA stimulation, produced an irreversible 
inhibition of protein synthesis, due to its cytotoxicity, whilst a 
preincubation with FCS-spermine (50uM) for 24hours did not cause any 
inhibition of protein synthesis. Thus in a prolonged period of 
incubation, one would expect a sufficient amout of oxidised polyamine 
to be coverted to acrolein with ensuing cell death, yet as shown by 
Hussain et al., (1983) that during this prolonged incubation period in 
the presence of (50uM) spermine there was an insignificant change in 
cell viability.
If culture conditions and the incubation sequence were 
manipulated, the inhibitory effects of polyamines need not require FCS 
for its oxidation as described for plasmacytomas, (Figure/Table 
3.2.10) and mouse thymocytes, (Table 3.2.20) which was a similar 
observation to that described by Smith et al., (1983) on the growth of 
lymphocyte and granulocyte colony cultures. Polyamine oxidase 
activity has been shown in cell homogenates by Quash et al., (1979) 
and Morgan (1980) and is produced by cells (Morgan et al., 1980), 
(Sunkara et al., 1981), and it is probable therefore that the source
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of the enzyme is from the cells, which was oxidising the exogenous 
polyamines, as has been suggested by Smith et al., (1983).
Oxidised polyamines have been shown by Bachrach and Eilon (1967) 
and Eilon and Bachrach (1969) to cross link with DNA and form 
complexes with deoxynucleotides, deoxynucleosides, and as polyamines 
(spermine) has been ^own to be required to stabilise DNA (McCormick
1977), (Gaugaus 1980), it may be that oxidised spermine may be 
competing or interfering with the function of native spermine (Allen 
et al., 1979), (Gaugas 1980). Polyamines in the presence of human 
serum were not inhibitory on isotope uptake by the respective cell 
cultures as described in Figures/Tables 3.1.2C, which was similar to 
the results of Allen et al., (1979) who showed that polyamines in the 
presence of either human or horse sera were not inhibitory as these 
two sera do not contain polyamine oxidase activity, (Allen 1979), 
(Smith et al., 1983).
All the sera which have been used for these experiments including 
bovine and human serum albumin were as effective as FCS on the 
inhibition of isotope uptake by cell cultures. There have been 
various reports in the literature on the effects of the above 
mentioned sera or their subfractions on their inhibitory effects on 
DNA synthesis and cell proliferation and growth. The effects of human 
serum and FCS were described by Curtiss and Edgington (1976); mice and 
foetal calf sera were described by Ablett et al., (1978); calf, FCS, 
horse and other sera by Harrington and Goodman (1980); mice sera by 
Chan (1971), Nelson (1972), Nelson and Shneider (1974), Beran 
(1974-1975), Metcalf and Russell (1976), Tomasi (1977) and Smith and 
Hammerstrom (1979); rat sera by Wilson (1973), Nadal and Bofa (1975), 
Nelson and Gatti (1976), Chan and Pollard (1978) and Zucker et al.,
(1981); human sera by Cooperband (1976), Chisari (1977), Curtiss and
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Edgington (1977-1978), Green and Helson (1978), Chisari (1980), Douay 
et al., (1983); Szmitkowski (1983) and Cuthbert and Lipsky (1984). A 
variety of regulatory factors are present in serum and these have been 
reviewed by Cooperband et al., (1976), Nelson and Gatti (1976), Tomasi 
(1977), and Cathcart (1984) and some of which will be described as 
follows:
C reactive protein (CRP); a gamma migrating protein which 
attaches to cell membranes, inhibiting T cell rosette formation 
(Mortenson et al., 1975) and human mixed lymphoid reaction. The CRP 
is characterized by its ability to precipitate the C-polysaccharide of 
pneumococci in the presence of Ca^ (^ Cathcart 1984).
Alpha fetoprotein; an embryonic glycoprotein which interacts with 
cellular membranes, inhibiting rosette formation of human lymphocytes 
with SRBC (Gupta and Good 1977). Alpha fetoprotein inhibits mitogen 
induced lymphocyte transformation (T & B cells) and mixed lymphoyte 
reaction cultures (Tomasi 1977).
Alpha-2-macroglobulin is a large molecular weight component of 
serum which is able to interact with proteases to suppress lymphocyte 
proliferation (Hubbard 1978). This raacroglobulin has been 
demonstrated to be associated with lymphoid cells surfaces (McCormick 
et al., 1973) and probably may regulate immunological reactivity of 
these cells. High doses of alpha-2- macroglobulin have been shown by 
Ford et al., (1973) to suppress antigen induced lymphocyte 
proliferation, and by Streilein and Hart (1977) to suppress 
polycolonal B cell proliferation of a B cell line.
Human alphaglobulin described by Cooperband et al., (1976) was 
found to antagonize the blast transformation and its attendant 
increase in protein and DNA synthesis of human blood lymphocytes
- 262 -
induced by variety of antigens to which the donor was sensitive to, 
and by PHA stimulation or the mixed lymphocyte reaction, and
suppressing the primary and secondary antibody response to sheep red 
blood cells in vivo. Cooperband et al., (1976) have termed their 
factor as Immunor egulat ory alphaglobulin (IRA), with similar 
inhibitory effects on thymidine uptake by lectin stimulated 
lymphocytes or the mixed lymphocyte response and with 
immunosuppressive activity when assayed in vivo. The serum factor of 
Cooperband et al., (1976) was specific for lymphocytes, binds 
relatively weakly to a separate receptor and was not competing for 
lectin receptors and not cytotoxic. The globulin appeared to
antagonize some early metabolic event in lymphocyte activation both in 
vitro and vivo. Harrington and Goodman (1980) have described a 
non-toxic factor present in normal sera of calf, foetal calf, human 
and rat which migrated with alpha-2-globulins, which selectively and 
reversibly inhibited the proliferation of cells in culture. DNA 
syntheses of normal rat hepatocytes, human lymphoblast lines and 
mitogen stimulated murine spleen cells were inhibited by (>90%), and 
to a lesser extent murine myeloma and human colon carcinoma. The
active fraction which affected the transit of cells from Gi to S was a ,i
protein that contained no lipoprotein. Harrington and Goodman (1980) 
concluded that their factor was not related to the lipoprotein, 
described by Leffert and Weinstein (1976), or the low density 
lipoprotein-inhibitor (LDL-In) that prevented mitogenesis of 
lymphocytes, which was described by Curtiss and Edgington (1976).
Several investigators have described the inhibitory effects of 
sera used in their experiments, on cellular proliferation and growth, 
and have described the effects of the lipoprotein fraction of serum as 
the factor responsible for this inhibition.
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The lipoproteins are a hetrogeneous group of macromolecules which 
are classified according to their density, (VHDL, HDL, IDL, LDL and 
VLDL) (very heavy, heavy, intermediate, low and very low density 
lipoproteins) or according to their electrophoretic mobility as Pre-B, 
B and A, They are produced by the liver and the intestines, (LLoyd 
and Fostbrooke 1976),(Jackson et al., 1976).
The lipoprotein were shown to be involved in the inhibition of 
cell colony growth in in vitro cultures, as described by Chan (1971) 
and Beran (1975), both have used mice sera, which were shown to be 
inhibitory for mouse bone marrow cells colony formation, and the 
growth of granulocytic and macrophage colonies respectively. Chan
(1971) and Beran (1975) have shown that the inhibitory activity was 
removed by ether extraction. Metcalf and Russell (1976) have also 
described the inhibitory effects of mouse serum on haeraopoietic colony 
formation. Szmitkowski (1983) has described the inhibitory effects of 
human serum on granulocyte-macrophage colony formation, implicating 
the lipoproteins for this inhibition, and similarly Douay et al., 
(1983) have shown that human (LDL) inhibited the proliferation of 
normal human haempoietic progenitors in vitro.
Ablett (1978) have described the inhibitory effects of mice sera 
on the growth rate of sarcoma 180 and mastocytoma P-815 cell cultures, 
implicating the lipoproteins for this inhibition.
Ito et al., (1982) have shown that the growth rates of human FL, 
mouse FL, Swiss 3T3, and hamster embryo cells were inhibited by around 
50% within 48 hours after introducing human (LDL) to these cell 
cultures which were preincubated for 24 hours before receiving the 
lipoprotein.
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Nelson (1972) has shown that when mouse spleen cells were 
cultured in 5% mouse serum and stimulated by PHA, the uptake of 
tritiated thymidine by the spleen cells was depressed. Nelson (1972) 
has implicated the lipoprotein constituents of serum as the factors 
responsible for this inhibition.
The inhibitory effects on DNA synthesis by 5% mouse serum on 
mitogen stimulated lymphocytes and resting cells were also described 
by Nelson and Shneider (1974). These inhibitory effects were 
confirmed by Tomasi (1977) but with 10% mouse serum. Similar findings 
were reported by Smith and Hammerstrom (1979). DNA synthesis was 
depressed in mitogen stimulated rat lymphocytes when they were 
cultured with rat serum in concentrations above 5%, (Nelson and Gatti 
1976).
The effect of rat serum lipoprotein on cell proliferation was 
described by Leffert and Weinstein (1976) who showed that very low 
density lipoproteins (VLDL) inhibited the pre-replicative protein 
synthesis required for the initiation of DNA synthesis in foetal rat 
hepatocytes cultured in lipoprotein deficient FCS, thus blocking the Gi 
to S transit. Zucker et al., (1979) have shown that VLDL from normal 
rats inhibited DNA synthesis and protein synthesis in rat bone marrow 
cells, and similarly Zucker et al., (1981) have demonstrated that rat 
VLDL inhibited lymphocyte stimulation by mitogens. The effects of 
human lipoproteins were described by Curtiss et al. ( 1977) who 
showed that both human and murine low density lipoproteins (LDL) 
inhibited the two way mixed lymphocyte reaction using human and murine 
cells. The effects of human VLDL on the inhibition of the induction 
of DNA synthesis in human lymphocytes stimulated by mitogens and 
allogeneic cell stimuli were described by Chisari (1977) and Yi et 
al., (1981). Similarly Cuthbert and Lipsky (1984) have shown that
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human LDL inhibited mitogen stimulated T-lymphcytes. The lipoproteins 
discussed above, have excluded the mention of FCS, and it may be
reasonable to suggest that the lipoproteins in FCS may contribute in
some comparable way to the inhibition of 125IUDR uptake by
plasmacytoma, adenocarcinoma and murine thymocyte cultures, 
considering the following observations:
1. The lipoproteins have been shown to be species non specific in
their action
a) Curtiss et al,, (1977) have shown that human or murine LDL were 
effective in inhibiting the two way mixed lymphocyte reaction of 
human and murine cells.
b) VLDL from rats at an advanced stage of pregnancy have been 
shown by Chan and Pollard (1978) to be cytotoxic to rat prostate 
adenocarcinoma cells, hamster BHK21, human Hela cells but not
foetal rat kidney cells
c) Ito et al., (1982) have shown that human (LDL) lipoprotein
fraction was not specific in its action, as it inhibited the
proliferation of human, mouse and hamster cells, but not the
transformed cells lines of hamster.
2. Curtiss and Edgington (1977) and Curtiss et al., ( 1977) have
shown
a) That human lymphocytes have receptors for (LDL-In) 
lipoproteins, and that both T and B lymphocytes were sensitive to 
LDL-In, (Curtiss and Edgington 1979). Similarly rat lymphocytes 
were shown by Zucker et al., (1981) to possess receptor for VLDL.
b) Curtiss and Edgington (1978) have shown that FCS at a 
concentration of 10% used in human lymphocytes cultures, did
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compete with 125 Iodine-labelled human LDL-In for receptor sites 
on the lymphocyte surface; i.e.: there was a 64 % decrease in the
number (125I-LDL-In) of labelled molecules per cell in the 
presence of FCS, as compared to cells cultured in 
lipoprotein-depleted FCS,
3. Vogt et al., (1969) have shown that transferrin isolated from 
FCS and cultured with mouse spleen cells, enhanced DNA synthesis, with 
a higher incorporation of tritiated thymidine, than when cultured with 
intact FCS. In contrast to whole FCS, there was less flattening of 
isotope uptake curve, with increasing amounts of foetal bovine 
transferrin within the range tested of 1 to 16%, At 16% FCS
concentration, there was a depression of isotope uptake compared to 8% 
FCS concentration. Vogt et al., (1969) have suggested that FCS seemed 
to possess besides the stimulatory factor, another component which 
inhibited DNA synthesis. Vogt et al (1969) have tested mice sera, and 
were found to be inhibitory as well.
Cuthbert and Lipsky (1984) have shown that human LDL inhibited 
mitogen stimulated T lymphocyte DNA synthesis; and have also shown
that the addition of transferrin reversed the inhibition of LDL 
containing cultures. Cuthbert and Lipsky (1984) have stated that both 
LDL and transferrin bind to their specific cell surface receptors, and 
enter the cell by similar means of receptor-mediated endocytosis, and 
concluded that LDL interfered with transferrin metabolism. 
Transferrin was shown by Rudland et al., (1977) to be essential for 
the cells to proceed to cell division, and was shown by 
Dillner-Centerlind et al., (1979) to be able to substitute serum as
growth promoter for activation of T lymphocytes by mitogens.
4. Ito et al., (1982) have described the effects of human (LDL) 
lipoprotein fraction on the uptake of 3H-leucine, 3H-uridine and
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3H-thymidine by human FL cells. The uptake of 3H-leucine was slightly 
suppressed during the first 9 hours, and the inhibition after 24 hours 
of incubation remained moderate. However, the inhibition of uptake of 
3H-uridine and 3H-thymidine into the acid soluble and insoluble 
fractions was evident at 1 hour of incubation and progressively 
increased with time by 9 hours. After 24 hours of incubation the 
uptake of 3H-uridine recovered to moderate levels, whereas the uptake 
of 3H thymidine into acid insoluble fraction decreased drastically 
after 24 hours of incubation. Ito et al., (1982) have attributed this 
inhibition of incorporation of 3H-thymidine or uridine into acid 
insoluble fraction in the early period of treatment, mainly to the 
inhibition of uptake of the labelled compounds into the nucleotide 
pool, and in the case of 3H-thymidine there was a preferential 
inhibition of DNA synthesis at later periods of incubation. Ito et 
al., (1982) have also demonstrated that the rate of uptake of labelled 
thymidine or uridine within 1 hour of incubation was depressed as 
compared to control cultures without the lipoprotein fraction, and 
thus suggested, that the lipoprotein caused a decrease in the 
transport of these nucleosides across the cell membrane.
Ito et al., (1982) have also confirmed the early decrease of 
nucleosides transport across the plasma membrane, and showed that the 
intracellular metabolites derived from 3H-thymidine, in cells that 
were cultured with the lipoprotein fraction, were half less than that 
of cells cultured without lipoprotein. Thus as described in Table 
1.5.1.1, the amount of the acid insoluble fraction decreased with 
increasing FCS concentration; with a similar decrease in the acid 
soluble fraction. The lipoprotein fraction may influence the cell 
membrane by raising the intracellular level of cAMP, and interfering 
with nucleoside transport across the membrane as Hauschka et al.,
(1972) have shown that the rate of uptake of 3H-Tdr into the acid
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insoluble pool by Chinese hamster cells in the presence of BugcAMP or 
Bt2cAMP, [dibutyryl adensonsine 3*:5*- cyclic monophosphaste] was 
inhibited by 50% (relative to controls) in the first 40 minutes of 
incubation, and with total inhibition at ^10 hours of incubation. 
Hauschka et al., (1972) have also demonstrated in a different 
experiment to the one cited above, that the initial rate of uptake of 
3H-Tdr into the acid soluble pool of hamster cells, cultured with Bu 
cAMP was inhibited by 84% (relative to controls) and concluded that 
the nucleoside transport was the primary process controlled by Bu 
cAMP, and that the labelling of acid insoluble material was a 
consequence of inhibited 3H-Tdr transport. Similarly, aminophylline ( 
a drug which inhibits the action of phosphodiestrase, that degrades 
endogenous cyclic AMP) significantly decreased the pool size of acid 
soluble 3H-Tdr, and thus Hauschka et al., (1972) remarked that such a 
result should be expected if cyclic AMP were involved in the control 
of 3H-Tdr transport.
5. Ablett et al., (1978) have shown that the growth and 
multiplication of cell cultures of sarcoma 180 and mastocytoma P-815
was optimum when cultured with 10% FCS, however, when the
concentration of FCS was increased to 15-20%, there was some
inhibition in the growth rate. Ablett et al., (1978) have implicated 
the lipoproteins for the decreased growth rate.
6. Stimulated T lymphocytes secrete factors that contribute to the 
control of cell proliferation. Wolf and Merler (1979) have 
demonstrated the production by dividing human T cells, of an inhibitor 
of DNA synthesis and immunoglobulin synthesis. The inhibitor has been 
shown by Wolf and Merler (1979) to consist of two moieties, a
non-dialyzable protein (which was inert with regard to inhibition of 
proliferation) and a polar lipid moiety, bound to the protein
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fraction. The lipid protein, contained the inhibitory activity for 
inhibition of cell proliferation.
7. Schrier and Nordin (1977) have shown that the ability of different 
batches of FCS to support in vitro immunization of mouse spleen cells 
(PFC in vitro) was variable. Some batches were less supportive than 
others; even within the same (supportive quality) FCS batches, 10% FCS 
was more inhibitory for cell cultures relative to 5% concentration. 
Chisari (1980) has shown that human VLDL inhibited the primary 
haemagglutinin response of mice to SRBC (sheep red blood cells).
Chisari (1980) has suggested that the immunoregulatory effect of human 
(VLDL) was caused by inhibition of early inductive events in the 
colonal expansion and entry of primed lymphocytes in the memory pool, 
and proposed a physiologic role for lipoproteins as growth regulators. 
The concentration required for complete suppression of lymphocyte 
proliferation was below or in the same range as their concentration in 
plasma. This suggested a normal suppressive role for lipoproteins in 
keeping the immune system in check (Cathcart 1984).
A regulatory role for lipoprotein in the sera of pregnant rats 
has been described by Chan and Pollard (1978), whose reconstitution 
studies with this type of serum has suggested that the cytotoxic 
activity associated with VLDL described earlier was usually masked by 
some inhibitors present in normal serum. However, when the rats were 
in an advanced stage of pregnancy the VLDL synthesis was enhanced and 
exceeded the masking effect of its inhibitor. The VLDL was heat 
resistant (56 '’c) and to proteolytic enzymes.
Chan and Pollard (1978) have also suggested that the lipoproteins 
apart from being carriers for triglycerides, cholesterol and steriod 
hormones, may also contribute to surveillance against neoplasia like 
other non immunological host defences, which were reviewed by Apfel
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phase, either due to the relative prolongation of the other phases of 
the cell cycle, a decrease in the number of cycling cell or both. 
Similarly Lippman et al., (1976) and Riley et al., 1978) have shown 
that high concentration of estrogens, decreased the uptake by mammary 
carcinoma cells of 3H-Tdr into DNA, with cell death ensuing later. 
Clemens et al., (1979) have described the inhibitory effects of 
steriods on the uptake of 3H-Tdr by DNA synthesizing, mitogen
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(1976).
The lipoproteins may also be implicated in the interaction 
between macrophages, lymphocytes and tumour growth. Chapman and Hibbs
(1977) have shown that the macrophage’s cytotoxic effect could be 
inhibited by lipoproteins of the low density type, and have shown that 
the macrophage’s cytotoxic ability can also be inhibited by enriching 
its membrane with cholesterol. Low density lipoproteins have a 
relatively high content of cholesterol and cholesterol esters, and 
have been shown by Bates and Rothblat (1974) to transfer free 
cholesterol to L cells. The rate of cholesterol synthesis in tumour 
cells is high (Howard and Kritchevsky 1969), (Chen and Heiniger 1974), 
and thus the lipoproteins can transport the extra cholesterol to the 
macrophage plasma membrane, and may modify the macrophage function.
Apart from the lipoproteins, sera contain a variety of factors 
which may influence cell proliferation. Honn et al., (1975) have 
shown that different batches of FCS were quite variable with regards 
to some of their constituents especially hormones. Hormones may exert 
their effects on target tissues through receptors on the target cell’s 
membrane and cytoplasm (Malkinson 1978).
High concentration of estrogens were shown by Weichselbaum et 
al., (1978) to decrease the proportion of mammary carcinoma cells in 8 *
?
stimulated or MLC lymphocyte cultures. Progesterone (Clemens et al., 
1979) reduced the incorporation of 3H-Tdr into the alcohol soluble 
pool which contains the phosphorylated nucleotides that may be 
incorporated into DNA, and the alcohol insoluble pool containing the 
3H-Tdr that had already been incorporated into DNA. The inhibitory 
effects were reversible, and Clemens et al., (1979) have suggested 
that the reduction of 3H-Tdr incorporation into DNA might be secondary 
to a decrease in the amount of 3H-Tdr entering the cell.
Steroid hormones can influence several aspects of the function of
the immune system. Some of these effects were reviewed by Stevenson
and Fauci (1981) which included some selective effects on suppressor 
and helper T cells, the suppression of proliferation in the mixed 
leukocyte reaction, suppression of NK cell activity, and the 
stimulation of antibody production by B cells. The steroids in some 
systems, suppressed the production of lymphokines and suppressed its 
action on macrophages. The steroids also blocked the Fc receptor 
binding and function and depressed the bacteriocidal activity.
Prostaglandins are available in serum, and are secreted by 
stimulated macrophages (Bonney et al., 1978-1979). Upon stimulation 
the prostaglandins of the »E’ series are able to regulate
immunological effector systems syoh as lymphocyte mediated
cytotoxicity and the inhibition of lysosomal enzymes release from 
polymorphonuclear leukocytes, possibly by increasing cAMP levels; 
(Metcalfe and Kaliner 1981), (Wolf et al., 1977)
Foetal sera contain an inhibitor of lymphocyte proliferation 
(Wolf et al., 1977); which is non-toxic, produced by unstimulated 
foetal monocytes, this factor was not produced by adult mononuclear 
cell cultures. Wolf et al., (1977) have postulated that this foetal 
factor contributes to the depressed maternal cell-mediated immune
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response observed in pregnancy, besides the effects of thymus derived 
foetal suppressor cells which were described by Olding and Oldstone
(1976). Nucleosides are present in sera and the uptake of labelled 
precursor by cell cultures for DNA synthesis can be influenced by 
serum, due to the presence of nucleosides in serum (Bernheim and 
Mendelsohn 1977). Carlton and Hamill (1977) have found that different 
batches of FCS at 10% concentration, contain between 0.6-8 uM of 
thymidine, and as described in Table 1.5.2, 10% FCS contains 3.4 uM of 
thymidine. The assessment of the amount of thymidine in serum was 
demonstrated in terms of a simple experiment, based on the dilution of 
label, which assumed that the inhibition of isotope uptake was mainly 
due to thymidine.
Unlabelled precursor, therefore, can compete with 3H-Tdr or 
I25IUDR to reduce the uptake of labelled precursors by DNA. Apart 
from dead cells in vivo which can contribute to the presence of 
thymidine in serum, macrophages are active secretors of thymidine 
because they lack thymidine kinase (Van der raeer 1980). Macrophages 
and the lymphoid cells secrete a variety of substances which are 
present in serum, whose function is to contribute to the control of 
cell proliferation.
Thus nonspecific suppression of DNA synthesis assessed in terras 
of isotope uptake (125IUDR, 3H-Tdr) by humoral factors present in 
serum, should be viewed critically, and considered, when this in vitro 
system is used in assaying inhibitors of cellular proliferation.
A number of factors released by human (Green et al., 1970), 
(Hersh et al,, 1974); by guinea pigs (Ernstro ra and Nordlind 1977) 
rats and mice (Metcalf 1971)» (Waldraan and Gottlieb 1974), (Badger et 
al., 1974), (Bonmassar et al., 1978), (Jegasothy and Battles 1979), 
(Miyata and Kihara 1982) normal and stimulated lymphoid cells have
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been reported in the literature, which were active in inhibiting the 
uptake of isotope by normal or tumour cells in vitro.
UIF (isotope uptake inhibitory factor), was produced by non 
stimulated spleen cells, thymocytes, lymph node and bone marrow cells. 
UIF is non species specific as it was produced by rat spleen cells and 
thymocytes, and mouse spleen, thymus, bone marrow and lymph node cells 
and was found to be active in inhibiting DNA synthesis of normal cell 
targets (mouse thymocytes) and tumour cells (murine plasmacytoma), in 
the presence or absence of FCS. The UIF described by Bonmassar 
(Bonmassar et al., 1978), was also produced by non stimulated cells 
and was not species or tissue specific. The production of inhibitory 
activity in UIF depended on the number of cells, cultured per
petridish (i.e.: cell culture density), as UIF which was prepared
from 25 x 10® cells per 5ml per petridish did not produce any
significant inhibition even for a prolonged period of incubation as
7compared to UIF which was prepared from 5x10 cells per 5 ml per
petridish which produced a stronger inhibition of isotope uptake as
described in Tables 2.2A1, A2 and A3. Similarly the strength of the 
inhibitory activity of UIF, described by Bonmassar (Bonmassar et al., 
1978) depended on the culture density, with the inhibitory activity 
increasing as the culture density increased.
Hersh et al., (1974) have suggested that "cell overcrowding" in 
cultures i.e. cells cultures at high density in vitro, released 
substances which inhibited DNA synthesis. Green et al., (1974) have 
made a similar observation, to which ,Lopatin and Ranney (1977) have 
confirmed, adding that, with maximum cell to cell contact, their 
spleen cultures released a low molecular weight suppressor substance 
(LMWS) that inhibited DNA synthesis and decreased the mitotic index. 
Kasahara and Shiori-Nakano (1976) have also shown that peritonial
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exudate cells cultured at high and low cell densities produced 
supernates with corresponding strength on the inhibition of DNA 
synthesis. Similarly, Lipkin et al., (1978), and Harel et al., (1984) 
have demonstrated that when cells were seeded at low density and 
allowed to proliferate until reaching stationary phase (contact 
inhibition), the cells released substances which inhibited cellular 
growth and DNA synthesis.
The UIFS which were produced by adherent and non-adherent cells 
were equally inhibitory. However when spleen cell cultures were 
depleted of macrophages by carbonyl iron treatment, no significant 
inhibition was produced by the macrophage depleted UIF preparation. 
The inhibitory activities of the adherent and non adherent spleen 
cells UIFS, described by Kasahara and Shiori-Nakano (1976) was 
stronger in the non adherent fraction than in the adherent fraction. 
The adherent cells are the macrophage enriched fraction, while the 
non-adherent cells are the lymphocyte rich fraction as has been 
described by Hosier (1967). The results described for the inhibitory 
effects of adherent and non adherent UIFS, and those reported by 
Kasahara and Shiori-Nakano (1976) are in contrast to the results 
described by Lopatin and Ranney (1977) who have shown that non 
adherent spleen cells produce relatively weaker UIF compared to 
adherent cell UIF which was more inhibitory, although the number of 
cells used for the preparation of adherent and non adherent UIFS by 
Lopatin and Ranney (1977) was equal, i.e. it was adjusted to 7, 5 or 
3 X 10^  cells per ml in each group, taking into consideration that 
adherent cells comprised about 30%, and non adherent cells about 
60-70% of spleen cells, which were similar to the values described in 
this work.
In Kasahra’s work (Kasahara and Shiori-Nakano 1976), the non adherent
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fraction produced more inhibition of isotope uptake than the adherent 
cell fraction, as in those experiments the cultures were incubated 
according to their fractional content i.e. two thirds of the spleen 
white cell fraction were cultured as non-adherent and the remaining 
third as adherent, (Lopatin and Ranney 1977). Therefore the UIF of 
the non-adherent cell fraction of Kasahara and Shiori-Nakano (1976) 
was more inhibitory due to its higher cell culture density, but it 
should be noted that the inhbitory activity of the UIFS of the 
non-adherent spleen cell cultures reported in Tables 2.2A1, A2 and A3, 
and by Kasahara and Shiori-Nakano (1976) and by Lopatin and Ranney
(1977) may have contained phagocytic cells which were moderately 
adherent, as it can be seen that the UIF produced by spleen cells 
depleted of macrophages by carbonyl iron and cultured at the same 
density of whole spleen STD UIF (standard UIF containing adherent and 
non-adherent cells) produced no significant inhibition of isotope 
uptake by plasmacytoma cultures even when assayed for an extended
period (Table 2.2 A3).
Zipori (1980) has shown the mice spleen adherent cells retarded |
■5the growth of a Balb/c Abelson MuLv transformed cell line. Similarly, |1Zipori (1980) has also demonstrated that the growth of MPC-11 myeloma j
was inhibited when it was co-cultured with bone-marrow adherent cell j
1fraction. UIF as described in Tables 2.2A1, A2 and A3 and 2.7 may |
;|contain several substances of high and low molecular weights such as <|
the undialysable product%1^ daltons ( Tables 2.2A1, A2, A3) and the |
araicon ultra filtrate which was less than 500 daltons (Table 2.7). j
Similarly, the observation that cell culture supernates contained 
different substances was made by Fernbach et al., (1976) and Bonmassar 
et al., (1978). Bonmassar’s UIF (Bonmassar et al., 1978) was 
partially sensitive to heat and proteolytic enzyme treatments as the
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UIF inhibitory effects on 125IUDR uptake by leukemic cells was 
relatively reduced compared to the non-treated UIF. The STD.UIF, 
described in this work, was heat resistant and was relatively more 
inhibitory than its counterpart STD.UIF which was not heat treated, as 
described in Table 2.7. The difference between the respective 
inhibitory activities of the respective UIFS, may be examined further 
in terras of their effects on the amount of radioactivity available in 
the acid soluble and insoluble pools.
The UIFS produced by unstimulated spleen or thymus cells which 
were described by Miyata and Kihara (1979, 1982) were proteinaceous 
with a molecular weight of 11 x 10^to 14 x 10^  , that were released 
within the 3 hours of culturing, and which inhibited DNA synthesis of 
target cells by interacting with single-stranded DNA. The UIF (low 
molecular weight suppressor: LNWS) described by Lopatin and Ranney
(1977), was released by unstimulated spleen cells after a 60-hour 
culture period, with a molecular weight between 500-800, which 
inhibited DNA synthesis and was not reversed by deoxycytidine. The 
UIF described by Kasahara and Shiori-Nakano (1976) contained low 
molecular weight substances some of which, identified as thymidine or 
thymidine monophosphate. Opitz et al., (1975a, 1975b), Evans and 
Booth (1976) and Fernbach et al., (1976) have shown that supernatants 
produced by cultures of spleen cells, thymus cells, peritoneal exudate 
cells or macrophages, contain low molecular weight substances that 
interfere with the uptake of isotope by cell cultures, but does not 
act as a true inhibitors of DNA synthesis with a consequence on 
cellular proliferation. Fernbach et al., (1976) have suggested that 
these supernatants may contain a true inhibitor of cellular 
proliferation, together with thymidine; a similar observation to that 
of Lenfant et al., (1973). Opitz et al., (1975b) have shown that 
macrophages can enzymatically degrade DNA of dead cells into
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deoxynucleosides and deoxynucleotides.
Indeed, Staedecker et al., (1977) have confirmed and extended the 
observations made by Opitz et al., (1975b), and have shown that 
macrophages release substantial amounts of de novo synthesized 
thymidine, into their culture environment (0.4 - lug thymidine per 10^  
macrophages per 24 hours culture period), because macrophages lack the 
enzyme thymidine kinase (Stadecker et al., 1977), (Stadecker and 
Unanue 1979) and (Chan and Lakhchaura 1982). Apart from the secretion 
of thymidine, Chan and Lakhchaura (1982) have demonstrated that 
macrophage culture supernatants contain deoxycytidine, and thus the 
secreted deoxycytidine may counteract the growth inhibitory or 
cytotoxic effects of thymidine. Chan et al., (1974) have previously 
demonstrated that fibroblasts lacking thymidine salvage enzymes such 
as thymidine kinase, will release de novo synthesized thymidine. The 
UIF described by Bonmassar et al., (1978) had its activity reduced by 
50% upon treating the spleen cell cultures with (Fudr) 
fluorodeoxyuridine. Fudr is taken up by the cell and converted into 
the monophosphate, which inhibits the endogenous production of 
thymidine by inhibiting thymidylate synthetase, which converts 
deoxyuridine monophosphate (dUMP) into deoxythymidine monophosphate 
(dTMP), (Wheeler and Simpson-Herron 1973), (Adams et al., 1976). The 
inhibitory activity of spleen UIF, described by Bonmassar et al.,
(1978) was not impaired by immunosuppressive doses of x-rays, lethal 
for lymphoid cells in donor mice or in in vitro cultures. Neither was 
it impaired by an anti-macrophage agent such as silica particles, 
administered into donor mice prior to the culture of spleen cells in 
vitro. However, as described earlier in Tables 2.2A1, A2 and A3 that 
the UIF produced by spleen cell cultures depleted of macrophages had 
no significant inhibition compared to standard UIF, which was not 
depleted of macrophages, on the uptake of 125IUDR by target cells.
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stadecker et al,, (1977) have shown that the inhibitory effects of 
their macrophage supernatant on the uptake of tritiated thymidine by 
EL-4 leukemic cells could be reversed by the addition of 
deoxycytidine. Stadecker et al., (1977) have demonstrated that the 
dose of exogenous thymidine added to the EL-4 leukemic cells to 
produce 50% inhibition of cellular growth, was 1x10® moles.
The 50% inhibition of isotope uptake by plasmacytoma cultures in 
the presence of thymidine for a 4 hour incubation period, described in 
( Figure/Table 1.14) was 6.6 x 10^ moles of thymidine for cells 
cultured without FCS, and 3.2 x 10  ^ moles of thymidine for cells 
cultured with 10% FCS. The total inhibition (?90% of 125IÜDR uptake
"  4was achieved at 1 x 10 moles of thymidine for both cultures with and 
without FCS. Reynolds et al., (1979) have shown that the growth rates 
of murine tumour cell lines (MPC11.45 and lymphoma EL.41) were 
inhibited by 50%, over a 3-5 day culture period with an exogenous dose
• - 3  *" 4 * 9of added thymidine of 1 x 10 and 1 x 10 moles respectively. Albert et 
al., (1982) have shown that the growth rate of a murine leukemic 
(L1210) cell line, was inhibited by 50% in a 48 hour culture period, 
with a concentration of 3 x 10®moles of thymidine.
-2Tsuboi and Kwong (1978) have shown that a dose of 1 x 10 moles of 
exogenous thymidine, has fully blocked the growth of normal (HS) 
colonic cells and its tumour variant (HT-29), without selective 
resistance to the inhibitory effects of thymidine. However, Lee et 
al., (1977) have demonstrated that there was selective resistance to 
the effects of thymidine in the murine (MEF) cell line, where 60% of 
the tumour variant of the (MEF) cell line died after an exposure 
period of 24 hours to 4.1 x lO^moles of thymidine, while 6.6% died in 
the normal (MEF) cell line.
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A prerequisite for DNA synthesis, is the availability of all four 
deoxyribonuGleosides triphosphates. De novo synthesis of
deoxyribonucleotides occurs by the reduction of the corresponding 
ribonucleotides by ribonucleotide reductase. Alternatively, an 
exogenous supply of deoxynucleosides such as thymidine 
(1_B-D-2-deoxyribofuranosyl thymine, or deoxythymidine) can be used by 
the cell for DNA synthesis through the nucleoside kinases. Thus 
thymidine is incorporated into the cell by its thymidine kinase system 
to produce the respective Thymidine-mono, di, and triphosphates. 
Thymidine* TMP TTP DNA 
(Cleaver 1967, Reichard 1978)
The inhibitory effects of UIF on DNA synthesis, described in this 
work, may also be due to elevation of the adenyl cyclase levels in the 
plasma membrane, which produces relatively higher amounts of cAMP. As 
a consequence of higher levels of cAMP, the thymidine kinase activity 
may be reduced, as has been described by Hauschka et al., (1972). 
Reduced thymidine kinase activity will influence DNA synthesis, and 
hence cell proliferation will be affected.
Exogenous thymidine causes an increase in the intracellular 
concentration of TTP pools and to a lesser extent of TDP and TMP pools 
(Reichard et al., 1961, Gentry et al., 1965, Morse and Potter 1965, 
Reynolds et al., 1979 and Albert et al., 1982), while the 
concentration of deoxycytidine triphosphate drops (Reichard et al., 
1961, Lee et al., 1977, Reynolds et al., 1979, de saint Vine al. 
1980, Howell et al., 1980, Eriksson et al., 1984). High levels of 
exogenous thymidine produce high levels of (dTTP) deoxythymidine 
tri-phosphate which have a feed-back inhibitory effect on the 
conversion of cytidine di-phosphate (GDP) to deoxycytidine 
di-phosphate (dCDP); the (dTTP) binds to the ribonucleotide reductase,
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thereby decreasing the (dCTP) pool; (Bjursell and Reichard 1973, 
Reynolds et al., 1979, Howell et al., 1980, Albert et al., 1982, 
Eriksson et al., 1984) and thus affecting DNA synthesis. Addition of 
deoxycytidine prevents the thymidine induced lowering of the dCTP 
pools and the block in DNA synthesis, (Morris et al., 1963, Howell et 
al., 1980, Eriksson et al., 1984). Cells deficient in the enzyme 
thymidine kinase were not inhibited by excess thymidine, which 
indicated that a phosphorylated derivative of thymidine acted as an 
inhibitor, (Morris and Fischer 1963). Apart from using deoxycytidine, 
to verify the presence of thymidine, one can use an isotope of low 
specific activity (Lederman et al., 1981) which will be sensitive to 
exogenous thymidine; as exogenous thymidine will be competing with 
labelled isotope, apart from diluting the labelled precursor pool. 
Some inhibitors of cellular proliferation were found to reduce the 
grain count of cell cultures incubated with 3H-Tdr, without affecting 
the labelling index of the same cultures such as the bovine spleen 
extract described by Diatloff et al., (1978). Similarly the labelling 
index of plasmacytoma cultures, cultured with UIF were not 
significantly different from cells cultured without UIF, although the 
distribution in the number of cells containing the relevant grain 
count interval has changed, especially in the densely labelled group 
as described in Table 2.5. This may show that some substance was 
competing with isotope uptake, but if that were the case, then, one 
would expect that the frequencies in the light and medium labelled 
groups would have also changed relative to cultures without UIF, but 
that was not evident in the results. A further experiment to be 
envisaged is to pulse the cultures with isotope of a relatively low 
specific activity (in the presence of UIF) and process the slides 
autoradiographically in such a procedure which would allow a low, yet 
reasonable amount of grains to be present in the control and
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experimental cultures. Having established this procedure, then the 
inhibitory effect of UIF may be noticed easily, in terms of isotope 
uptake and hence, the effects on grain count. But one point which was 
evident about UIF, was that it did not alter the labelling index of 
cell cultures as compared to control cultures, cultured in FCS without 
UIF; i.e. there was not any effect on 8-phase cells that may have 
been effected by UIF.
Low molecular weight suppressors (i.e. LMWS= low molecular 
weight UIF) of DNA synthesis which were not cytotoxic, produced by 
macrophages have been described by Waldman and Gottlieb (1973), 
Calderon et al., ( 1974) and Ulrich (1974). Similarly, the inhibition 
of protein synthesis by LMWS, have been reported for spleen cells UIF 
(Kasahara and Shiori-Nakano 1976), (Lopatin and Ranney 1977), and 
thymocytes UIF (Ulrich 1974).
The UIF described in Table 2.2C was not cytotoxic as judged by 
trypan blue exclusion test, and its inhibitory effects on isotope 
uptake by cell cultures were reversible, (Table 2.3). The passage of 
cells through S phase, to mitosis was not blocked as the metaphase 
index was slightly reduced in the presence of UIF (Table 2.4.B), but 
the difference was not significant relative to the metaphase index of 
control cultures . However, when plasmacytoma cultures were incubated 
with UIF in vitro, and thereafter injected into mice to assess their 
growth in the recipient’s spleen in terms of Tumour colony formation 
(Tumour CFU-spleen); UIF was inhibitory as described in Table 2.6B, 
The inhibition of UIF treated cells on colony formation was quite 
marked, and was more than that produced by Ara/c treated cell 
cultures. The inhibitory effects of UIF on colony formation may have 
changed the homing patterns of the plasmacytoma cells, or UIF may 
contain some inhibitory substances which have selectively killed some
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tumour cells, or have blocked these cells from proliferation, while 
the remaining cells which proliferated to form tumour colonies in the 
spleen , were resistant to the effects of UIF. The inhibitory effect 
of UIF may probably be due to an inteference with cellular metabolism, 
which was not associated with any membrane damage, at least, as 
assessed in terms of trypan blue exclusion ability, in in vitro 
incubation periods of up to 12 hours with UIF, as described in Table 
2.2C. The inhibitory effects of UIF may be analagous to 
lymphotoxin-induced cytolysis, which required extended periods, 
frequently greater than 12 hours to produce its effects, (Evans 1982). 
Similarly the inhibitory effects in UIF may be analagous to 
lymphotoxin in terms of colony growth, as lymphotoxin was shown by 
Evans (1982) to retard colony growth of aL929 cells. Another example 
which may be relevant here, is the supernatant which was described by 
Jeffes and Granger (1975). The supernatant which was produced by 
mitogen stimulated human lymphocytes, contained a variety of factors, 
such as proliferation inhibitory factor (PIF), cloning inhibitory 
factor (GIF) and lymphotoxin (LT). The activities of these factors 
were present in the same supernatant, and the particular effect was 
shown to depend on the concentration of the medium and the type of 
target cells employed. The medium effects were: (1) cytotoxic, at
high concentrations of supernatant; (2) growth-inhibitory, at 
intermediate concentrations; and (3) transient reversible effects on 
cell division at low concentrations. The UIF described in this work 
was not produced by mitogen-stimulated cells, but the example of 
Jeffes and Granger (1975) was cited, as it may be that cell cultures 
produce some inhibitory substance without the need for cell 
proliferation or stimulation, as described by Greene et al., (1981), 
Fleisher et al., (1981) and Nair and Schwartz (1982).
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The inhibitory effect of ÜIF may also be analogous to that of 
interferon or BtzcAMP, in which growth inhibition is mediated through 
the inducation of protein kinase (Greengard 1978). Moreover, if UIF 
was increasing the intracellular levels of cAMP, then it may influence 
cell proliferation. Coffino et al., (1981) and Insel and Fenno (1978) 
have shown that Bt2 cAMP decreased the levels of ODC and 
S-adenosylmethionine decarboxylase (SAMD) activities, ODC and SAMD 
are required for the production of polyamines and hence for cell 
proliferation as has been described earlier. Apart from the need for 
the assessment of activities of the polyamine biosynthetic enzymes, in 
relation to the inhibitory effects of UIF; RNA and protein syntheses 
must also be assessed, as UIF may have several effects on 
intracellular processes. UIF sensitive cells may be affected by UIF 
at some stages in their cell cycle. The UIF described by Bonmassar et 
al., (1978) was cytotoxic or cytostatic, inhibiting the cellular 
proliferation of hamster sarcoma, Balb/c carcinoma and Hela cells in 
vitro. Similarly, the spleen UIF (Chalone) described by Attalah and 
Houck (1976) was cytotoxic for (L1210) murine leukemic cells but not 
for normal lymphocytes. It is apposite here to point out, that the 
previous molecular weight estimates of lymphocyte chalones were
between 10^  and 5 x 10^  while the new estimates are of low molecular
weights between 500 and 2 x 10^as shown by Patt and Houck (1980).
Low molecular weight suppressor of proliferation, may be
associated with larger molecules, as Allen et al., (1977) have 
demonstrated that a lymphocyte "thymic chalone" was a complex of 
spermine and a high molecular weight carrier molecule. Attalah and 
Houck (1976) have suggested that their spleen chalone was cytotoxic 
for Gi - Go resting cells, because no cytotoxic effects were observed in 
in vitro cultures incubated with the spleen extracts for around 6 
hours, while it was evident at later periods of 8 to 10 hours. It may
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probably be that some of the constituents of UIF  ^described in Table 
2.6b have affected some Gior Go cells from forming spleen colonies. It 
can be seen (Table 2.2A4) that the inhibitory effects on 125IUDR 
uptake by STD.UIF, dialysed STD.UIF and freeze- thaw (F.TH.UIF) have 
slightly increased when the incubation period was increased from 2 to 
4 hours in the presence of FCS, which may be due to an interference 
with the flow of cells from Gi to S, as Allen et al., (1979) have 
suggested that the effects of oxidised polyamine is between late Gi and 
early S phase. It is also evident, (Table 2.2A4) that the same UIFS 
referred to above when assayed without FCS maintained a relatively 
constant effect on uptake without an increase in inhibition on uptake 
when the incubation period was increased from 2 to 4 hours. It may be 
due to the interaction of FCS with any of the STD.UIF substances which 
may contain polyamines, producing relatively more inhibition than 
their counterparts cultured without FCS, although the cultures that 
were cultured without FCS, may also contain polyamine oxidase. Patt 
amd Houck (1980) have pointed out, that one of the problems in the 
identification of endogenous inhibitors, was that most tissues contain 
polyamines. The presence of spermidine in the JB-1 ascites chalone 
preparation was demonstrated by Barford (1978) and Barford and 
Schjerbeck (1982).
The polyamines in the presence of FCS can produce the inhibitory 
mono and dialdehydes, or without the requirement of FCS if the 
polyamine oxidase enzyme is available in the culture supernatant as 
has been pointed out earlier. It can be seen, (Tables 3.1-3A and SB) 
that when plasmacytoma cells were cultured with 0.Bug/culture with 
either spermine or spermidine in the presence of FCS, there was an 
increase in the inhibition of 125IUDR uptake by cell cultures by a 
factor of 6 for spermidine, and 3 for spermine when the incubation 
period was increased from 2 to 4 hours before pulsing with 125IUDR.
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Similarly, the inhibitory effects of polyamine were dose dependent and 
more marked when incubated with FCS, but were dose independent and 
nearly constant, when incubated without FCS, as described in Table 
3.2.1C.
The freeze thaw (F.TH. UIF) has produced a significant 
inhibition of isotope uptake in an extended incubation period (Tables 
2.2A1, A2, A3 ) and the inhibitory substance which was released, did 
not depend on active cellular metabolism for its production. The 
action of F.TH.UIF was selective, while it inhibited the uptake of 
125IUDR by plasmacytoma cultures, it stimulated the uptake of isotope 
by normal thymocytes (Tables 2.2B1, B2, B3) in the presence or absence 
of FCS, although being higher in cultures devoid of FCS. The 
stimulatory effects on DNA synthesis of murine thymocytes by F.TH.UIF 
may be analagous to the effects produced by lymphocyte activating 
factor (LAF), or interleukins 1, 2 and 3 as described by Maizel et 
al., (1981), Altman (1981), Larsson (1982), Oppenheim and Gery (1982), 
Garland (1982), Watson and Prestidge (1983) and Wood (1984 ).
The freeze thaw extract from macrophages (Waldman and Gottlieb 
1973)I and the spleen freeze thaw extract described by Lopatin and 
Ranney (1977) did not inhibit DNA synthesis, while the freeze-thaw 
spleen cell UIF described by Bonmassar et al., (1978) was of marginal 
inhibitory activity. Similarly, the freeze-thaw extract of Kasahara 
and Shiori-Nakano (1976) was of marginal inhibitory activity, when the 
cell concentration used to prepare the extract was 2.5 x 10^  cells/ml. 
But when the cell concentration was raised to 5 x 10^  cells/ml, the 
extract was inhibitory. The differential effects of F.TH.UIF, (Tables 
2.2A1-A3 and 2.2B1-B3) needs to be investigated further. Cell culture 
supernatants of macrophages or of cell cultures that contain 
macrophages, contain a variety of substances that may be produced by
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macrophages , some of which may be thymidine, hydrolytic enzymes, 
complement components, arginase, prostaglandins, polyamines and 
polyamine oxidases. Arginase has been shown to suppress the in vitro
generation of cytotoxic response in the mixed leucocyte culture (Kung
et al., 1977), and to suppress the growth of tumour cells in in vitro 
cultures (Currie 1978, 1980), (Van der Meer 1980) and (Schneider and 
Dy 1985). Arginase depletes arginine from the medium, as arginine is
required by in vitro cultures for optimum growth (Eagle 1959).
Arginase is also present in foetal calf sera and its concentration 
varies among different batches of FCS (De Laiter and Kihara 1968), and 
is relatively heat resistant up to 60°C, for 1 hour. Bona and Chedid
(1976) and Goodwin et al., (1978) have demonstrated that human blood 
mononuclear cells liberate prostaglandins 1 and 2 into the culture
medium, and when the cell cultures were depleted of adherent cells the
amount of released prostaglandin was reduced to an insignificant
amount.
Prostaglandins (PGE2) have been demonstrated by Gery and Davies
(1979) to act as an antiproliferative agent in lectin stimulated 
thymus or spleen cultures. The addition of indoraethacin to 
macrophage-containing cultures, prevented the production of 
prostaglandins (Gerry and Davies 1979), thus indomethacin can be used 
to verify the source of inhibitory material in cell culture 
suprenatants (Lederman I98I). Caution should be used when 
interpreting data of inhibitory effects from culture systems in which 
macrophages, spleen cells or products thereof, contribute to the 
inhibition of DNA synthesis or cellular proliferation. This caution 
must also be viewed in terms of the effects which may be contributed 
by FCS, and the culture incubation sequence. The influence of FCS on 
the effects of UIF on the control of isotope uptake by cell cultures, 
together with the effects of culture incubation sequence, have been
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described in the tables of section 2 of chapter 3- The effects of 
culture incubation sequence on isotope uptake were also evident in 
some of the results of the polyamine experiments described in section 
3 of chapter 3.
If the properties of spleen UIF described in the tables of 
section 2 are taken into account, it may be difficult to assess the 
possible similarities or differences of UIF with any of the "isotope 
uptake inhibitory factors" described in the literature. The UIF 
described by Metcalf (1971), which inhibited bone marrow colony 
formation, was dialyzable, heat resistant and species non-specific. 
It was produced by cultures of normal bone marrjcw, spleen, lymph node 
and thymus cells, as well as by leukemic cells. The production of UIF 
by splenocytes in in vitro cultures, described by Bonmassar et al.,
(1978) was not impaired when donor mice were pre-treated with (IDF) 
immunodepressive factor that impairs T-dependent allograft reactions, 
and UIF was also produced by Balb/c nude splenocytes that lack T 
cells. All the UIFs which were described in this work (except the
muscle cell line UIF), have been produced from cells of the central 
and peripheral lymphoid tissues. A variety of soluble mediators 
produced by mitogen stimulated and unstimulated human peripheral blood 
mononuclear cells have been reported by Green et al., (1981) and 
Fleisher et al., (1981) to inhibit mitogen-induced T cell
proliferation and pokeweed mitogen stimulated B cells. The soluble
suppressor factors described by Shou et al., (1980) and Nair and
Schwartz (1981, 1982) were produced from unstimulated peripheral blood 
lymphocytes, and were shown to have suppressor activity towards 
lymphocyte responses to mitogens, and alloantigens in MLR and towards 
NK and ADCC functions. Nair et al., (1981) have also demonstrated 
that a certain fraction of mouse thymocytes was able to suppress the 
cytolytic activity of NK cells against their target cells in in vitro
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cell cultures. These observations imply that lymphocytes or their 
products may contribute a role in normal immunologic homeostasis. It 
may be, therefore, that the inhibitory effects of UIF may contain a 
factor or factors which may contribute to the control of lymphocyte 
proliferation or effector functions. The inhibitory effects of UIF, 
therefore, must be examined further, in terms of their effects on 
lymphocyte proliferation and effector functions. The UIF was also 
produced by tumour cells in in vitro cultures, and was also found in 
the plasma of tumour bearing mice, (Bonmassar et al., 1978). UIF, 
therefore, may contribute at least in part, to the decline of tumour 
cell proliferation in lymphoma bearing mice close to leukemic death 
(Hofer and Hughes 1970).
As stated earlier UIF may contain a variety of substances which 
may contribute to the inhibition of isotope uptake, protein synthesis 
or cellular proliferation, in a specific or nonspecific way, as the 
UIF which was described by Miyamoto and Teryama (1971) produced by 
liver cells which inhibited the uptake of isotope by tumour cell 
cultures, contained thymidine hydrolase, an enzyme which can convert 
thymidine into thymine, and thus influencing the uptake of isotope by 
cell cultures. The BC3H-1-muscle cell line UIF inhibited the uptake 
of isotope by plasmacytoma cultures or thymocytes as described 
earlier, (Tables 2.2k and 2.2B), and therefore the BC3H-1.UIF may 
contain thymidine or some other substance which was contributing to 
this nonspecific inhibition, as the target cells and source of UIF 
were different types of tissues. That does not imply that the effects 
of spleen UIF, lymph node UIF, thymus or bone marrow UIF were 
specific, because each of the above UIFS was able to inhibit the 
isotope uptake of plasmacytoma cultures or thymocytes, as has been 
described earlier (Table groups: 2.1, 2.2, 2.3). Lopatin and Ranney
(1977) have shown that their spleen macrophage rich fraction LMWS UIF
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was species independent, effective against B and T precursor cells, 
whereas non lymphoid cells were unaffected by concentrations that 
produced a 50% inhibition of lymphoid targets.
A regulatory role has been suggested by Lopatin and Ranney (1977) 
for their LMWS, which was produced by unstimulated cells. When the 
cells were stimulated for example in an MLR culture, the production of 
LMWS decreased, but coinciding with peak proliferative activities, the 
levels of LMWS in stimulated cells began to reapproach levels of 
unstimulated cells and thus Lopatin and Ranney (1977) postulated a 
feedback regulatory control on lymphocyte division, which involved a 
sequential signal mechanism between activated lymphocytes and adherent 
cells or macrophages. Some of the contributions of macrophages to the 
regulation of cell proliferation were referred to earlier in the 
introductory chapter.
A regulatory role for adherent cells was suggested by Zipori
(1980) for the inhibition of growth of plasma cell tumours by bone 
marrow adherent cells which were effective against the mature types 
rather than immature cells (in terms of their differentation pathway), 
that is, according to Zipori the bone marrow is a site for the 
proliferation of lymphocyte precursors rather than for accumulating of 
mature lymphoid cells. Zipori (1981) has shown that cell to cell 
interaction was required between adherent bone marrcw cells and the 
MPC-11 nyeloma, rather than a substance secreted by the adherent 
cells.
Bonmassar et al., (1978) have shown that when 2 types of lymphoma 
cell lines were co-cultured in vitro with spleen cells collected from 
lethally-irradiated donors compatible or not for the Hh-H2 complex, 
the uptake of 125IÜDR by the tumour cells was inhibited, relative to 
control cultures incubated without spleen cells. The results
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-described by Bonmassar et al., (1978) using humoral factors from 
spleen cells or cell co-cultures to assess the inhibitory effects on 
tumour proliferation, were an in vitro correlate to results obtained 
earlier by Bonmassar and Cudkowicz (1976) and Campanille et al.,
(1977) which showed that normal haemopoietic or lymphoraatous cells do 
not proliferate in the spleen of lethally irradiated recipient "nude" 
or normal mice incompatible for the Hh-locus. UIF produced by spleen 
cells may therefore contribute a role in the control of cell 
proliferation and inhibition. Apart from T and B cells, the spleen 
contains macrophages and natural killer cells (Stutman et al., 1980), 
(Herberman 1983)» (Keller 1983)» and these two cell types, contribute 
to the control of tumour cell proliferation in vivo host environments 
as shall be described in the section of tumour growth kinetics in 
normal and athymic "nude" mice.
The contributions of spleen cells, and cells of other lymphoid 
organs, or their products to the regulation or inhibition of 
plasmacytoma cell proliferation in invitro cultures, may have some in 
vivo correlates. One of these, is to assess the growth properties of 
plasmacytoma in two different immunological environments. But before 
discussing the growth properties of plasmacytoma in different in vivo 
environments, a short discussion on one of the techniques "the 
metaphase arrest" which is involved in kinetic studies, is 
appropriate, due to its usefulness in the study of tumour growth 
parameters.
The stathmokinetic or the metaphase arrest method has been a 
useful and a simple technique to determine the rate of entry of cells 
into mitosis or the cell birth rate, (Frei et al., 1964), (Tannock 
1967), (Rolf Smith et al., 1974), ( Riches et al., 1981) and ( Jones
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and Camplejohn 1983). Vincristine sulphate was used for the metaphase 
arrest experiment because it is a relatively better stathmokinetic 
agent than other agents such as colcemid, (Tannock 1967) and (Rolf 
Smith et al., 1974). The mice received an optimal dose of vincristine 
sulphate for a maximum period of 4 hours (Smith et al., 1974), and the 
number of metaphases was linear for this observation period, if a dose 
of a stathmokinetic agent were not optimal, and if the observation 
period were not optimal for the estimation of arrested metphases, 
metaphase loss will occur through incomplete arrest, or by 
degeneration (Tannock 1967)» (Aherne and Camplejohn 1972), which will 
underestimate the mean birth rate (Wright and Appleton 1980) and 
therefore will overestimate the mean apparent cell cycle time (Tea).
In calculations of metaphase, or cell densities in tissue 
sections, corrections are required to allow for the overestimation of 
counts as fragments of these elements are included in the tissue 
section count.
Abercrombie, (1946) described a formula for correcting this 
overestimate, which included a relation between nuclear diameter,
thickness of the tissue cross section, and the number of nuclei 
present in the section. The experimentally derived measurements of 
nuclear diameters in the tissue section are assumed to be equal to the 
mean random chord, which is equal to 0.79 of the value of the true
diameter. However, true nuclear density estimates require a
measurement of the true nuclear diameter. The value of the true
diameters calculated assuming the experimentally measured diameters as 
equal to the mean random chord length, will in fact overestimate the 
true diameter. An over-estimate in nuclear diameter will result in an 
under-estimate in the nuclear density of the section, (Riches et al., 
1981). Thus Riches (Riches et al., 1981) has introduced a correction,
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to estimate true diameters from experimentally measured diameters, to 
derive correct nuclear density estimates. The values of the true 
average interphase and metaphase diameters which were determined with 
Riches's formula (Riches et al., 1981), were used in Abercrombie's 
correction (1946) to estimate the number of metaphases per unit volume
and the number of cells per unit volume.
Moreover, by using the modifications of Riches 's group (Rolf 
Smith et al., 1974) in which the metaphase counts were related to the
percentage of tumour cells available in each tumour zone (thus
excluding the necrosis and space), the cell production rate per unit 
volume was calculated for tumour cells only. This is an accurate 
procedure, as the proportions of necrosis and space, may vary 
according to the zone, section, and tumour age, and consequently the 
non-necrotic or space areas will vary accordingly. The mean birth 
rate has slightly decreased as the tumour aged or increased in size 
from size 5 to size 8. The growth of the tumour in normal Balb/c 
mice, (Figure 4.2.1) was slightly convex upwards (towards the time 
axis) as the tumour volume increased to size 8, a sign of growth 
retardation. Tumour growth depends on tumour cell production (apart 
from cell input due to celular infiltrates) and cell loss. The tumour 
cell production rate is determined by the growth fraction (Ip) and 
median intermitotic cell cycle time (Tc) . As cell loss was almost 
equal at the three tumour volumes (sizes; 5, 6 and 8), and as the 
cell production rate was decreasing with increasing tumour volume, a 
reduced growth fraction or an increase in Tc , may be the contributors 
to the declining birth rate.
Wright (1975) has demonstrated that in the solid transplantable 
(Balb/c- mice) sarcoma , the birth rate decreased with increasing 
tumour age, with a relative decrease in the growth fraction; while Tc
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remained nearly constant. Cell loss which increased with tumour age 
was a primary contributor to growth retardation. Similarly, Feaux De 
Lacroix and Lennartz (1981) have shown that in the solid 
transplantable (CgH-mice) mammary carciraoma, the Tea was increasing 
with tumour size or age, with a relative decrease in the growth 
fraction, an increase in cell loss, while the duration of Tc was not 
prolonged before the plateau phase of growth was reached. Frindel et 
al., (1967) and Lai a (1977) reported a small decrease in the growth 
fraction, with a nearly constant Tc in a solid fibrosarcoma and an 
ascitic tumour growing in solid form, respectively. However, .Simpson- 
Herren and Lloyd (1970, as described by Lala 1977) have shown that Tc 
has increased substantialy with tumour age, together with a reduced 
growth fraction in the transplantable sracoma 180, while in the 
transplantable plasacytoma, Tc was slightly increased together with a 
nearly constant growth fraction.
The cell production rates in the different zones (outer, middle 
and inner zones) described in this work were generally similar, apart 
from a small increase in the middle and inner zones relative to the 
outer zone. Tannock (1968) has demonstrated that the mitotic and 
labelling indices in a mammary tumour, were lower in tumour areas near 
necrotic regions and higher in regions near vascular supply, and 
accordingly the growth fraction was low in the former areas and high 
in the latter areas, while To was essentially the same for the two 
areas. Hirst and Denekamp (1979) have reported similar observation 
with their murine mammary carcinoma to that of Tannock (I968) with the 
new finding that Tc was higher in areas near necrotic regions. Wright 
(1975) has found evidence that the birth rate decreased gradually from 
the periphery to the centre of tumour, accompanied by a similar 
decrease in the growth fraction, although Tc remained constant in the 
three tumour zones. Similarly the cell birth rate and the growth
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fraction, decreased progressively as the distance between the tumour 
cells and the blood vessel which supplied them, increased, (Jones and 
Camplejohn 1983). In the Balb/c tumours, reported in this study, the 
amount of necrosis was similar in all three zones of all respective 
tumours, apart from the "nude" mice tumours, which were relatively 
less necrotic.
The results described by Lauder et al., (1979) on their murine 
lymphoma were comparable to the results described in this thesis, in 
the sense, that the growth fraction in the inner and middle zones was 
slightly higher than the peripheral outer zone.
In general, as the tumour grows larger, restriction on the supply 
of nutrients and oxygen may become more limiting on cellular 
proliferation especially in the centre of the tumour, together with 
the accumulation of waste products, causes cells to cease 
proliferation and die. Apart from these factors, specific growth 
control mechanisms, may also be operating, such as chalones, which may 
contribute to the control of tumour growth, (Bullough 1977), (Rytomaa 
et al., 1977); (Laurence 1979) (Barford 1981) and (Barford and 
Schjerbeck 1982).
The differences between the weighted and unweighted regression 
analyses were small, in terms of the variability accounted for by the 
regression line. In the weighted model, there vjas a slight increase 
in the percentage variability accounted for by the regression line, 
(PVA), relative to the unweighted model tumours, except for the 
results of the "nude" mice, where the PVA has decreased relative to 
the unweighted regression. The variability in the metaphase 
collection function was due to two components; 1- Intertumour 
variability (as two tumours from two different animals were used for 
each metaphase determination in each time interval of observation),
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2- The time variability, that is the number of metaphases increases 
with increasing time after vincristine injection.
As the variance of the metaphase count, is usually proportional 
to the mean metaphase count, it was considered to minimize this 
variation by weighting each mean metaphase count by the reciprocal of 
its variance. Wright and Appleton (1980) have suggested the weighted 
regression model was likely to reduce the variance of the turnover 
time obtained. The standard error associated with the respective Tea 
in tumour sizes 5, 6 and 8 in their respective zones in the weighted 
regression were slightly higher for tumour size 5 (and its respective 
zones), and slightly lower for tumours sizes 6 and 8 (and their 
respective zones), as compared to the unweighted regression. As for 
the tumours of the "nude" mice, the standard errors of the respective 
Tea were all higher in the weighted regression than their counterparts 
in the unweighted regression. Therefore the weighted regression was 
relatively beneficial for reducing the standard error in tumours sizes 
6 and 8, but not for tumours size 5 and size 6 of the "nude" mice, 
together with the fact, that the cell production rates of all tumours 
in the weighted regression were less than that in the unweighted 
regression.
In the "nude" mice the birth rate in the unweighted and weighted 
regression analyses was higher than its counterpart (tumour size 6) in 
Balb/c mice together with a shorter Tea for the tumours of the "nude" 
as compared to normal Balb/c mice.
The cell loss factor was similar between the tumours of the 
"nude" and normal mice in the unweighted regression although in the 
weighted regression the cell loss in the tumours of the "nude" mice 
was slightly less. The higher cell production rate in the "nude" mice 
may be due to a higher growth fraction or a shortened To or a
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contribution by both.
Rajewsky and Gruneisen (1972) have assessed cell proliferation of
a transplantable rat mammary tumour in syngeneic rats in two
immunological environments. One group of rats was treated with
antithymocyte serum to raalce them deficient in T-lymphocytes, while the
other group was untreated. Rajewsky and Gruneisen (1972) have found
that the cell production rate of the tumour was similar in both
environments, while the cell loss factor was higher in the normal rats 
than in the T-lymphocytes deficient group. The growth fraction and Tc
were higher in T-cell deficient group, than in the normal group. The
higher Tc in the T-cell deficient group was mainly due to a marked
extention of the Gi phase, relative to the normal mice.
The shortening of Tc in the untreated normal rats was interpreted 
as a selection against cells with long transit times through Gi. 
Further studies are required to assess the growth fraction and Tc with 
its phase duration and the immunological components that influence 
them, for the Balb/c plasmacytoma tumour growing in two different 
immunological environments, that of the athymic "nude" and normal 
mice.
The purpose of the study of tumour growth in "nude" mice and 
their normal counterparts Balb/c mice was to know whether differences 
existed in tumour growth parameters or not, as the transplanted 
plasmacytoma was growing into two different immunological 
environments. The thymus is absent in the "nude" mouse, with a 
consequent severe deficiency in T lymphocytes (Rygaard 1978) while 
their phenotypically normal littermates have a thymus together with 
the T lymphocytes.
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One of the theories in tumour growth, is that transformed cells 
arise frequently during the life span of the organism, and that these 
cells are eliminated before clinical detection, by the defence 
mechanism of the host, known as immunological surveillance.
The concept of immunological surveillance against nascent tumour 
cells was formulated by Thomas (1959) and Burnet (1971) to account for 
an evolutionary mechanism that protected the host from aberrant cells, 
and as an explanation for the phenomenon in transplantation immunity, 
in which cellular immune responses were directed against foreign 
histocompatibility antigens. As T cell-mediated immune responses are 
involved in this process, immunosurveillance was viewed as antigen 
specific T cell-mediated process that led to the rejection of tumour 
cells, as these tumour cells expressed new antigens on their 
membranes, which are not present on their normal counterparts. Indeed 
T-cells contribute to the process of tumour rejection , and as will be 
discussed later, natural killer cells and macrophages contribute to 
the regulation of tumour cell proliferation.
This surveillance mechanism is asserted by the observations that 
: 1. Tumour cells have tumour associated or specific antigens which
are distinct from those on the normal cells from which they arose, 2, 
The ability to induce an immune response against these antigens by 
thymus dependent lymphocytes, equivalent to allograft rejection. Thus 
the prediction of the surveillance mechanism is, 1 : Tumours that grow
despite immunosurveillance, are poorly immunogenic, and, 2: Any
condition which is associated with a depressed T-cell mediated 
immunity, i.e. immunodeficiency disease, immunosuppression, 
immunologically priviliged sites, and age, should be associated with 
an increased tumour incidence.
-  2 9 8  -
Support for the immunosurveillance mechanism has come from 
evidence on allograft recipients, undergoing immunosuppressive drug 
therapy, who have been found to have a high incidence of tumours, the 
majority of which were of epithelial origin, although lymphomas were 
prominent also (Penn and Starzl 1972), (Green et al., 1981). In 
immunodeficiency states, there was an increased incidence of malignant 
disease mainly of the lymphoreticular system, such as Wiskott-Aldrich 
syndrome (Currie 1980), which is due to a loss of T-cells (Hood et 
al., 1978). Suppression of the immune system with antilymphocyte 
serum or neonatal thymectomy increased the incidence of tumours 
induced by RNA or DNA tumour viruses, (Law 1969).
The argument against immune surveillance was that there was no 
increased incidence of the majority of tumour types in 
immunosuppressed patients, (Moller and Holier 1978). Similarly mice 
made immunodeficient by thymectomy or irradiation, do not show an 
increased incidence of spontaneous or chemically induced tumours 
(Gillete and Fox 1975). Moreover, no spontaneous tumours appeared in 
"nude" mice, as described by Rygaard and Povlsen (1976) and Rygaard
(1978), although Outzen et al., (1975) reported some increase in 
lymphoreticual tumour incidence in "nude" mice, but they have also 
shown that there was no increased incidence in "nude" mice compared to 
their heterozygate littermates, in sarcoma formation, induced by 3 
methylcholanthrene. Also, there was no increased incidence of tumours 
in immunologically priviliged sites, (Moller and Moller 1978).
Prehn (1976) has shown that an extremely small inoculum of 
immunogenic tumour cells may grow when transplanted into syngeneic 
recipients, but a slightly larger dose may be inhibited. This 
"sneaking through" phenomenon has also been taken as an argument 
against T-cell mediated surveillance of small immunogenic tumour foci.
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However, Gatenby et al., (1981) have suggested that "sneaking through" 
may result not from the failure to stimulate cytotoxic T-lymphocytes 
(TcL) but from the induction of suppressor (TsL) T-lymphocytes 
inhibiting the action of TcL lymphocytes. Also a very weak immune 
reaction (as the reaction must be, because it is directed against 
weakly immunogenic spontaneous tumour cells) may facilitate 
(immunostimulate) rather than inhibit tumour growth (Prehn 1976, Prehn 
and Outzen 1980). "Nude" mice which lack T-cells, have been shown by 
Kiessling et al (1975) to have high numbers of a cell type that showed 
cytotoxic activity against mouse leukemia cells, and was called 
"natural" killer (NK) cells. NK cells are present in mice apart from 
"nudes", humans and other animal species. These lymphoid cells, from 
normal mice which were not innoculated with tumour cells and other 
sources of antigen, had significant levels of cytotoxic reactivity 
against certain syngeneic or allogeneic tumour cells, (Herberman 
1978). "Nude" mice were found to exhibit a high degree of resistance 
towards transplantation of a variety of syngeneic tumours, and 
therefore, alternative non T cell-mediated mechanisms have been 
suggested, to contribute a role in the protection against tumour 
growth, such as NK cells (Stutman and Lattime 1983) and macrophages 
(Keller 1983). The action of NK cells in vivo is direct and very 
rapid (within 4 hours ) in the elimination of tumour cells labelled 
with 125IUDR. The elimination of isotopically labelled tumour cells 
was evident in normal mice (NK cells from high responder mice, more 
rapid than in low responder mice) and in "nude" mice, (Riccardi et 
al., 1980). The elimination of labelled tumour cells, correllated 
positively for in vitro and vivo assays, and for high responder mice 
the effectiveness for NK cells was more than that for macrophages. 
Similarly Riccarrdi et al., (1980) have shown that treating mice with 
pyran copolymer 2-3 days before the assays enhanced the NK cell
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reactivities, but a marked decrease in the levels of NK reactivities 
have been noticed at seven days time when higly activated macrophages 
were detected. Riccardi et al., (1980) have argued that a possible 
role for TcL can be ruled out since in this system there was not 
sufficient time for sensitization, and since similar results were 
obtained in "nude" mice.
Alternative approaches to describe the effectiveness of NK cells 
against tumour growth in "nude" mice were reported by Habu et al., 
(1981) who have shown that upon depleting the NK cells in "nude" mice 
with selective antibody (anti-asialo GM1), the "nude" mice showed 
increased susceptibility to transplantation of syngeneic tumours. 
Adoptive tranfer of lymphocytes enriched for NK cells and depleted of 
T and B cells, into irradiated recipient mice has been shown to 
enhance the resistance of the recipient animals to growth of NK 
sensitive tumours (Herberman 1983). Karre et al., (I98O) using beige 
mice (C57BL/6-bg/bg) which have a pronounced defect in NK cells, with 
no effect on T and B cells, have shown that the incidence of tumour 
formation by low dose inocula of chemically or virally induced 
leukemia was significantly increased, and the latent period decreased 
in bg/bg mice as compared to their normal (bg/+) normal heterozygote 
littermates.
Macrophages may also contribute to tumour surveillance, as 
Greenberg and Greene (1976) have reported a T-cell independent 
rejection of a low cell dosage of several tumour lines inoculated 
subcutaneously into syngeneic mice. The type of the cell involved in 
this T-cell independent rejection process was shown by Chow et al
(1979) to be macrophage rather than NK cell dependent.
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From the above discussion, the results that are described in 
Figure/Table 4.2.1 confirm the belief that resistance to tumour growth 
can be contributed to, by a non T-cell mediated response. The most 
obvious feature was the latency period of the "nude" mice tumours,
which was twice as long as for normal Balb/c mice, and as the
resistance weakened, the tumours eventually grew at a relatively 
faster rate in "nude" mice as compared to normal Balb/c.
The difference in the latency period may be accounted for, by the 
higher levels of NK activity in the "nude" mice than in normal Balb/c 
mice (Herberman and Holden 1978) and due to the antagonistic
relationship between the presence of a thymus and the levels of NK
cells in the animal, (Gidlund et al 1980). Gidlund et al, (1980) have 
also stated that the thymus was generating cells that suppressed the 
activity of NK cells.
Small and Trainin (1976), and Gabizon et al., (1976) have 
demonstrated that the anti-tumour effects of splenic T cells in tumour 
bearing mice were gradually dominated by a population of T cells which 
stimulated tumour growth, as the tumour progressed in growth. Umiel 
et al., (1978) have demonstrated the existence of two subpopulations
of thymocytes in mice which retarded or enhanced tumour growth. Small
et al., (1979) have postulated that thymocytes of tumour bearing
animals, might be released prematurely into the spleen, where they may 
be involved in contributing to the inhibition of an anti-tumour
response; thus enhancing tumour growth, A certain fraction of
thymocytes which inhibited NK cell activity against its target cell,
was described by Nair et al., (1981), and was shown to contain high 
amounts of (TdT) terminal deoxynucleotidyl transferase activity, a
marker enzyme for precursor T cells or immature thymocytes. The TdT 
containing thymocytes may be similar to the thymocytes described by
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Small et al., (1979).
The kinetics of target cell elimination are very rapid in the NK 
cell system, and with this virtue, it fits the description of a cell 
involved in surveillance, rather than the relatively slower T-cell 
response in target recognition and elimination. The latency period 
extention in the "nude" mice may also be related to the remarkably 
effective macrophage function against target cells. Zinkernagel and 
Blanden (1975) have demonstrated, the effective bacteriocidal activity 
of peritoneal macrophages against listeria in "nude" mice which was 
about twice as effective within the first 30 minutes after injection, 
as their normal littermates.
Meltzer (1976) has also demonstrated that macrophages from 
conventionally housed "nude" mice were highly cytotoxic against tumour 
monolayers, and were about twice as cytotoxic as macrophages from 
their normal littermates. However, Meltzer (1976) had also 
demonstrated that the cytotoxicity of macrophages from germ-free 
"nude" mice were similar to their normal littermates. Meltzer (1976) 
concluded, that macrophage activation in "nude" mice was dependent 
upon environmental stimuli, and added, that the presence of activated 
macrophages in untreated "nude" mice was consistent with the very low 
incidence of spontaneous tumours observed in these mice. The 
macrophage can achieve target cell destruction by surface to surface 
contact, and by the release of humoral mediators, such as UIF which 
has been described earlier.
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Summary and Conclusion:
Cell proliferation kinetics of plasmacytoma has been assessed in 
vitro and in vivo.
The proliferation of plasmacytoma and other cell cultures in 
vitro has been assessed in terms of the culture environment, and 
humoral mediators (UIF) produced by cells of the central and 
peripheral lymphoid tissues.
Foetal calf serum (FCS), has been demonstrated to influence DNA 
synthesis as assessed in terms of isotope uptake by cell cultures.
The amount of radioactivity in the acid soluble and insoluble 
pools, was reduced as the concentration of FCS in the culture was 
increased. The relative change in isotope availability in both pools 
was approximately similar. The reduction of isotope activity in the 
acid soluble pool may suggest that FCS was interfering with the 
transport of isotope across the cell membrane; and the reduction of 
isotope activity in the acid insoluble pool may be a consequence to 
the effects observed in the acid soluble pool.
The inhibition of isotope uptake by FCS may depend on several 
factors, such as, the batch of FCS, the type of cell culture under
investigation, its culture density, culture incubation time and
culture incubation sequence.
FCS may interact with other substances available in the culture 
environment, either by increasing or decreasing the relative amount of 
isotope uptake by the respective cultures. The uptake of isotope by 
cell cultures that secrete polyamines into their culture environment
which contains FCS, will consequently be reduced. The inhibitory
effects of some UIF preparations on the uptake of isotope by cell
-  3 0 4  -
cultures were modulated by FCS, and by the culture incubation 
sequence. The inhibitory effects of some of the fractions of UIF at 
some incubation sequences (with FCS), may be regarded as either "false 
positives" or the inhibition is a transitional one in the sense that 
it depended on the incubation sequence. Thus the interpretation in 
the change of radioisotope uptake must be viewed critically. UIF may 
contain heat sensitive substances , as the inhibitory effect of UIF 
56c remained stable in both FCS environments and this may suggest that 
some factors in UIF which were heat sensitive were reacting with FCS 
to influence the inhibitory pattern of radioisotope uptake. Similarly 
the inhibitory effects of polyamines without FCS on the uptake of 
isotope by cell cultures, were evident when the culture incubation 
sequence was changed.
Supernatants (UIF) produced by cells from the spleen, lymph
nodes, bone marrcw and thymus, were found to inhibit the uptake of 
isotope* by cell cultures. The UIFS, which were obtained from the 
spleen, have demonstrated that the macrophage was the main source for 
the production of the inhibitory supernatants. The inhibitory 
material may contain a variety of substances, apart from thymidine, 
which may contribute to the regulation of cell proliferation.
The growth kinetics of plasmacytoma in vivo, in two different
immunological environments have revealed that tumour growth may also
be controlled in T-cell deficient environments, as the latency period
of tumour growth, was longer in the "nude" mice than in the normal 
counterparts Balb/c mice. Natural killer cells and macrophages may be 
some of the contributors to the suppression of tumour cell 
proliferation in the earlier periods of tumour growth.
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The growth kinetic studies of plasmacytoma in vivo, have 
demonstrated that the tumour birth rate was decreasing with increasing 
tumour age. Cell loss was approximately similar at the different 
stages of tumour growth, thus the grewth fraction and the average 
intermitotic time may be influencing the cell production rate.
The birth rate was assessed in terms of a weighted and unweighted 
least square regressions, to compare the reductions in error 
variability associated with the metaphase "Collection Function" 
curves, and its consequent effects on the standard errors of the 
respective Tea associated with each birth rate curve. In some birth 
rate curves the variance was generally proportional to the metaphase 
index, but in others the variance was not proportional. To reduce the 
error variability associated with the birth rate curves, other types 
of transforms may be required apart from the variance weighted 
transform.
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